<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Pharmacol</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Pharmacol</journal-id>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Pharmacology</journal-title>
</journal-title-group>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30283331</article-id>
<article-id pub-id-type="pmc">6157328</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2018.00940</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Intracrine Regulation of Estrogen and Other Sex Steroid Levels in Endometrium and Non-gynecological Tissues; Pathology, Physiology, and Drug Discovery</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Konings</surname>
<given-names>Gonda</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/547001/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brentjens</surname>
<given-names>Linda</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/544755/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Delvoux</surname>
<given-names>Bert</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Linnanen</surname>
<given-names>Tero</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cornel</surname>
<given-names>Karlijn</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Koskimies</surname>
<given-names>Pasi</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/528369/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bongers</surname>
<given-names>Marlies</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kruitwagen</surname>
<given-names>Roy</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xanthoulea</surname>
<given-names>Sofia</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Romano</surname>
<given-names>Andrea</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/346858/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>GROW–School for Oncology and Developmental Biology, Maastricht University</institution>, <addr-line>Maastricht</addr-line>, <country>Netherlands</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Obstetrics and Gynaecology, Maastricht University Medical Centre</institution>, <addr-line>Maastricht</addr-line>, <country>Netherlands</country></aff>
<aff id="aff3"><sup>3</sup><institution>Forendo Pharma Ltd.</institution>, <addr-line>Turku</addr-line>, <country>Finland</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Walter Jäger, Universität Wien, Austria</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Ashwini Chand, Olivia Newton-John Cancer Research Institute, Australia; Philippa Saunders, University of Edinburgh, United Kingdom</p>
</fn>
<corresp id="c001">*Correspondence: Andrea Romano <email>a.romano@maastrichtuniversity.nl</email></corresp>
<fn fn-type="other" id="fn001">
<p>This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology</p>
</fn>
<fn fn-type="other" id="fn002">
<p>†These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>19</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>9</volume>
<elocation-id>940</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>3</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>02</day>
<month>8</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2018 Konings, Brentjens, Delvoux, Linnanen, Cornel, Koskimies, Bongers, Kruitwagen, Xanthoulea and Romano.</copyright-statement>
<copyright-year>2018</copyright-year>
<copyright-holder>Konings, Brentjens, Delvoux, Linnanen, Cornel, Koskimies, Bongers, Kruitwagen, Xanthoulea and Romano</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Our understanding of the intracrine (or local) regulation of estrogen and other steroid synthesis and degradation expanded in the last decades, also thanks to recent technological advances in chromatography mass-spectrometry. Estrogen responsive tissues and organs are not passive receivers of the pool of steroids present in the blood but they can actively modify the intra-tissue steroid concentrations. This allows fine-tuning the exposure of responsive tissues and organs to estrogens and other steroids in order to best respond to the physiological needs of each specific organ. Deviations in such intracrine control can lead to unbalanced steroid hormone exposure and disturbances. Through a systematic bibliographic search on the expression of the intracrine enzymes in various tissues, this review gives an up-to-date view of the intracrine estrogen metabolisms, and to a lesser extent that of progestogens and androgens, in the lower female genital tract, including the physiological control of endometrial functions, receptivity, menopausal status and related pathological conditions. An overview of the intracrine regulation in extra gynecological tissues such as the lungs, gastrointestinal tract, brain, colon and bone is given. Current therapeutic approaches aimed at interfering with these metabolisms and future perspectives are discussed.</p>
</abstract>
<kwd-group>
<kwd>intracrinology</kwd>
<kwd>endometrium</kwd>
<kwd>estrogens</kwd>
<kwd>lungs</kwd>
<kwd>gastrointestinal tract</kwd>
<kwd>central nervous system</kwd>
<kwd>bone</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">KWF Kankerbestrijding<named-content content-type="fundref-id">10.13039/501100004622</named-content></funding-source>
<award-id rid="cn001">UM-13-5782</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="3"></fig-count>
<table-count count="8"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="498"></ref-count>
<page-count count="51"></page-count>
<word-count count="38737"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>The term “intracrinology,” coined in 1988 by prof Labrie, refers to the ability of peripheral tissues to use blood precursors and generate steroids (Labrie, <xref ref-type="bibr" rid="B207">1991</xref>). Several studies have been published but several controversies still exist and relate to the following technical and biological aspects: (a) some intracrine enzymes in peripheral tissues have low expression (300–50,000-times lower than in endocrine glands Stoffel-Wagner, <xref ref-type="bibr" rid="B411">2001</xref>; Murakami et al., <xref ref-type="bibr" rid="B274">2006</xref>, close to the detection limit of standard methods like western blotting and immunohistochemistry -IHC); (b) the technology to robustly quantify steroids (liquid-/gas-chromatography tandem mass-spectrometry -LC-MS or GC-MS), became available during the last 5–10 years only (Rosner et al., <xref ref-type="bibr" rid="B350">2013</xref>); (c) intracrine pathways are highly complex.</p>
<p>This review summarizes our knowledge of intracrinology in peripheral tissues like the endometrium, lungs, gastrointestinal tract (GIT), bone and central nervous system (CNS), with special attention to the metabolism of estrogens. Drug development and potential therapeutic approaches are discussed. In this review, the enzymes involved in steroid deactivation/clearance (Rižner, <xref ref-type="bibr" rid="B342">2013</xref>, <xref ref-type="bibr" rid="B343">2016</xref>; with the exclusion of steroid sulphotransferases) and those involved in the transport of conjugated steroids through the plasma membrane (Rižner et al., <xref ref-type="bibr" rid="B346">2017</xref>) are not described. Studies on serum/tissue steroid levels are reported and discussed only if based on gold standard GC/LC-MS.</p>
</sec>
<sec id="s2">
<title>From ovarian estrogen synthesis to intracrinology</title>
<p>Local steroid metabolism is possible because those enzymes responsible for steroid synthesis in classical glands (ovaries, adrenals, testes) are expressed in peripheral tissues, where additional and alternative routes for metabolizing steroids are present and make intracrine networks intricate and flexible (Figures <xref ref-type="fig" rid="F1">1</xref>, <xref ref-type="fig" rid="F2">2</xref>, Tables <xref ref-type="table" rid="T1">1</xref>, <xref ref-type="table" rid="T2">2</xref>). In particular, several compounds generated through these pathways, although not being estrogens, can have estrogenic action, because able to bind and activate the estrogen receptors. The biologic activity of the various compounds is given in Table <xref ref-type="table" rid="T1">1</xref>, and in Figure <xref ref-type="fig" rid="F2">2</xref>, by the color codes.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>Steroid structure. <bold>(A)</bold> structure of the C21 steroid progesterone (P, used as an example), with carbon numbering and steroid ring numbering. In the storied graphics in Figures <xref ref-type="fig" rid="F1">1B</xref> and <xref ref-type="fig" rid="F2">2</xref>, the H groups and the relative bonds will be omitted (with the exclusion of the H in 5α-reduced steroids - androstanes and pregnanes). Methyl groups will be indicated by the bonds only without the CH<sub>3</sub> group. <bold>(B)</bold> structures of C21 pregnene (Δ<sup>4</sup> and Δ<sup>5</sup>, i.e., double bond between C4 and C5 or between C5 and C6, respectively), pregnane (5α-reduced steroid), C19 androstene (Δ<sup>4</sup>, Δ<sup>5</sup>) and androstane and C18 (A-ring)-aromatic estrogens. Chemical structures were designed with the aid of Sketcher V2.4 (Ihlenfeldt et al., <xref ref-type="bibr" rid="B163">2009</xref>), available online at PubChem (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov">www.ncbi.nlm.nih.gov</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://www.pubchem.ncbi.nlm.nih.gov">pubchem.ncbi.nlm.nih.gov</ext-link>) (Kim et al., <xref ref-type="bibr" rid="B189">2016</xref>).</p>
</caption>
<graphic xlink:href="fphar-09-00940-g0001"></graphic>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>Intracrine networks. Major intracrine networks metabolizing steroids. In this figure, each reaction reports the catalyzing enzymes whose role in that specific reaction is established based on robust evidences (<italic>in vitro, ex vivo, in vivo</italic>). Additional enzymes whose involvement in the same reactions is less robustly demonstrated or based only on <italic>in silico</italic> or cell-free assay are reported in Table <xref ref-type="table" rid="T2">2</xref>. The role of 17βHSD3 is disregarded in this figure because restricted to tissues that are not assessed in the present review (testes, prostate, Table <xref ref-type="table" rid="T2">2</xref>).</p>
<p>Color codes:</p>
<p>
<inline-graphic xlink:href="fphar-09-00940-i0001.jpg"></inline-graphic>
</p>
<p><sup>OV</sup> ovarian specific referring to 3β-HSD2 (see text); — dotted arrows indicate reactions that are not fully demonstrated to occur or for which the responsible enzyme is not identified yet; (enzyme name) enzymes indicated by brackets are supposed to catalyze the indicated reaction based on the theoretical assumptions, no experimental proof is yet available; <sup>&amp;</sup> these compounds (THP, 3αDHP and allopregnandiol) exist as various hydroxyl α/β isomers (3, 5, 17) with no activity, classic action or neuroactivity (see Table <xref ref-type="table" rid="T2">2</xref>); * the role of DHRS11 in steroid metabolism is reported only recently by one publication (Endo et al., <xref ref-type="bibr" rid="B103">2016</xref>).</p>
</caption>
<graphic xlink:href="fphar-09-00940-g0002"></graphic>
</fig>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p>Major steroidal compounds.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>1. Abbreviation (used here)</bold>
</th>
<th colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Blood concentration <xref ref-type="table-fn" rid="TN2"><sup>**</sup></xref> (nM)</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Biologic activity<xref ref-type="table-fn" rid="TN3"><sup>***</sup></xref></bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Entries<xref ref-type="table-fn" rid="TN1"><sup>*</sup></xref></bold>
</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>2. Common name</bold>
</th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>3. Chemical name</bold>
</th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">1. <italic>none</italic></td>
<td align="center" colspan="1" rowspan="32" style="border-right: thin solid #000000;border-left: thin solid #000000;" valign="middle">PREGNANES</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CAS:516-59-6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2. <italic>none</italic></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:60408</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3.5α-pregnan-20-ol-3-one<xref ref-type="table-fn" rid="TN5"><sup>1</sup></xref></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CB:0504265</td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">ChEBI:81469</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">1. <italic>none</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">3a. M <italic>S</italic>: 28–49<sup>10</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">3a. GABA<sub>A</sub>+</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2. allopregnandiol (4 isomers)</td>
<td align="left" colspan="1" rowspan="1" valign="top">3a. F: 0.2–0.7<sup>10</sup>; <italic>S</italic>: 13–20<sup>10</sup></td>
<td colspan="2" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3 a. 5α-pregnane-3α,20α-diol <xref ref-type="table-fn" rid="TN4"><sup>∧</sup></xref></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">a.CAS:566-58-5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"> b. 5α-pregnane-3β,20β-diol</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">b.CAS:516-53-0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"> c. 5α-pregnane-3β,20β-diol</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">c.CAS:516-53-0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"> d. 5α-pregnane-3β,20α-diol</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">d.CAS:516-53-0</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">1.5αDHP</td>
<td align="left" colspan="1" rowspan="1" valign="top">F: 0.2–1.1<sup>(5, 10)</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">PR+ GABA<sub>A</sub>+</td>
<td align="left" colspan="1" rowspan="1" valign="top">CAS:566-65-4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2. allopregnanedione</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:0003759</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3.5α-pregnane-3,20-dione</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">ChEBI:28952</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">1. <italic>none</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td align="left" colspan="1" rowspan="1" valign="top">CAS:570-59-2</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2. <italic>none</italic></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CB:4441841</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3.5α-pregnan-17α-ol-3,20-dione</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">1. <italic>none</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td align="left" colspan="1" rowspan="1" valign="top">CAS:6890-65-9</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2. <italic>none</italic></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CB:7269033</td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">3.5α-pregnan-3,17α-diol-20-one <sup>2<xref ref-type="table-fn" rid="TN4"><sup>∧</sup></xref></sup></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">1. THP (isomer 1/4)</td>
<td align="left" colspan="1" rowspan="1" valign="top">All: 0.2–10<sup>6</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">GABA<sub>A</sub>+</td>
<td align="left" colspan="1" rowspan="1" valign="top">CAS:516-54-1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2. allopregnanolone<sup>3</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">M: 0.1–0.2<sup>10</sup>; <italic>S</italic>: 3.6–10<sup>10</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:0001449</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3.3α-hydoxy-5α-pregnan-20-one</td>
<td align="left" colspan="1" rowspan="1" valign="top">F: 0.1–0.2<sup>10</sup>; <italic>S</italic>: 4.0–6.7<sup>10</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">PC:262961</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">1. THP (isomer 2/4)</td>
<td align="left" colspan="1" rowspan="1" valign="top">M <italic>S</italic>: 8.6–18<sup>10</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">GABA<sub>A</sub>+</td>
<td align="left" colspan="1" rowspan="1" valign="top">CAS:128-20-1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2. pregnanolone<sup>3</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">F: 0.06–0.1<sup>10</sup>; <italic>S</italic>: 5.5–10<sup>10</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:0062782</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3.3α-hydroxy-5β-pregnan-20-one</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CHEBI:1712</td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">PC:31402</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">1. THP (isomer 3/4)</td>
<td align="left" colspan="1" rowspan="1" valign="top">M <italic>S</italic>: 7.8–10<sup>10</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">GABA<sub>A</sub>−</td>
<td align="left" colspan="1" rowspan="1" valign="top">CAS:516-55-2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2. isopregnanolone<sup>3</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">F: 0.08–0.2<sup>10</sup>; <italic>S</italic>: 3.7–7.1<sup>10</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">(THP-S)</td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:0001455</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3.3β-hydoxy-5α-pregnan-20-one</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">PC:92787</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">1. THP (isomer 4/4)</td>
<td align="left" colspan="1" rowspan="1" valign="top">All: 0.3–3<sup>6</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">CAS:128-21-2</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2. epipregnanolone<sup>3</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">M <italic>S</italic>: 0.4–0.6<sup>10</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">GABA<sub>A</sub>−</td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:0001471</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3.3β-hydoxy-5β-pregnan-20-one</td>
<td align="left" colspan="1" rowspan="1" valign="top">F: 0.02–0.04<sup>10</sup>; <italic>S</italic>: 1.5–2.5<sup>10</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">(THP-S)</td>
<td align="left" colspan="1" rowspan="1" valign="top">PC:228491</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">1.3αDHP</td>
<td align="center" colspan="1" rowspan="13" style="border-right: thin solid #000000;border-left: thin solid #000000;" valign="middle">PREGNENES</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td align="left" colspan="1" rowspan="1" valign="top">GABA<sub>A</sub>+</td>
<td align="left" colspan="1" rowspan="1" valign="top">CAS:25680-68-6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2.3α-dihydroprogesterone</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">PC:121951</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3.4-pregnen-3α-ol-20-one</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">1.3βDHP<sup>4</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td align="left" colspan="1" rowspan="1" valign="top">PC:121951</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2.3β-dihydroprogesterone</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3.4-pregnen-3β-ol-20-one</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">1. P</td>
<td align="left" colspan="1" rowspan="1" valign="top">M: 0–0.4<sup>6</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">PR+</td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:01830</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2. progesterone</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fpre: 0–80<sup>6</sup></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3.4-pregnene-3,20-dione</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fpost: 0–0.4<sup>6</sup></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">1.17OHP</td>
<td align="left" colspan="1" rowspan="1" valign="top">M: 0.61–7.0<sup>6</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">PR+</td>
<td align="left" colspan="1" rowspan="1" valign="top">CAS:68-96-2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2.17α-hydroxyprogesterone</td>
<td align="left" colspan="1" rowspan="1" valign="top">F: 0.21–2.3<sup>6</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:0000374</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3.17-hydroxypregn-4-en-3,20-dione</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CHEBI:17252</td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">PC:6238</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">1.20αDHP</td>
<td align="center" colspan="1" rowspan="11" style="border-right: thin solid #000000;border-left: thin solid #000000;" valign="middle">PREGNENES</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fpre: 0.8–11.7<sup>6</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">PR+</td>
<td align="left" colspan="1" rowspan="1" valign="top">CAS:145-14-2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2.20α-dihydroprogesterone</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:0003069</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3.20α-hydroxypreg-4-en-3-one</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">PC:8956</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">1.17OHP5</td>
<td align="left" colspan="1" rowspan="1" valign="top">M: 1.0–12 <sup>6</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">CAS:387-79-1</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2.17-hydroxypregnenolone</td>
<td align="left" colspan="1" rowspan="1" valign="top">F: 0–6.0<sup>6</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:0000363</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3.5-Pregnen-3β,17α-diol-20-one</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CHEBI:28750</td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">PC:3032570</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">1. P5</td>
<td align="left" colspan="1" rowspan="1" valign="top">M: 1–15<sup>6</sup>; <italic>S</italic>: 200–1,000<sup>6</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">GABA<sub>A</sub>− (P5-S)</td>
<td align="left" colspan="1" rowspan="1" valign="top">CAS:145-13-1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2. pregnenolone</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fpre: 1.0–15<sup>6</sup>; <italic>S</italic>: 100–1,000<sup>6</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:0000253</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3. pregn-5-en-3β-ol-20-one</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fpost: 1.0–15<sup>6</sup>; <italic>S</italic>: 10–500<sup>6</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">CHEBI:16581</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">PC:8955</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">1. <italic>none</italic></td>
<td align="center" colspan="1" rowspan="23" style="border-right: thin solid #000000;border-left: thin solid #000000;" valign="middle">ANDROSTANES</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:0000899</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2. androstanedione</td>
<td align="left" colspan="1" rowspan="1" valign="top">M: 0.3<sup>7</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">CHEBI:22542</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3.5α-androstane-3,17-dione</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">1. AN</td>
<td align="left" colspan="1" rowspan="1" valign="top">All: 0.5–0.9<sup>7</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">AR+ <sup>weak</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:0000031</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2. androsterone</td>
<td align="left" colspan="1" rowspan="1" valign="top">M: 0.4–4.0<sup>6,10</sup>; <italic>S</italic>: 617–1,080<sup>10</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">GABA<sub>A</sub>+</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">3.3α-hydroxy-5α-androstan-17-one</td>
<td align="left" colspan="1" rowspan="1" valign="top">F: 0.3–0.6<sup>10</sup>; <italic>S</italic>: 359–1,070<sup>10</sup></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">1.5βAN</td>
<td align="left" colspan="1" rowspan="1" valign="top">M: 0.09–0.2<sup>10</sup>; <italic>S</italic>: 32–70<sup>10</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">GABA<sub>A</sub>+</td>
<td align="left" colspan="1" rowspan="1" valign="top">CAS:53-42-9</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2. etiocholanolone</td>
<td align="left" colspan="1" rowspan="1" valign="top">F: 0.1–0.4 <sup>10</sup>; <italic>S</italic>: 34–88<sup>10</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:00490</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3.3α-hydroxy-5β-androstan-17-one</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CHEBI:28195</td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">PC:5880</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">1.3αDIOL</td>
<td align="left" colspan="1" rowspan="1" valign="top">M: 0.4–0.5<sup>9,10</sup>; <italic>S</italic>: 35–121<sup>10</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">ERβ+ <sup>weak</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:0000495</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2. androstanediol</td>
<td align="left" colspan="1" rowspan="1" valign="top">F: 0.03–0.06 <sup>10</sup>; <italic>S</italic>: 2.4–4.8<sup>10</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">GABA<sub>A</sub>+</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">3.5α-androstane-3α,17β-diol</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">1.3βDIOL</td>
<td align="left" colspan="1" rowspan="1" valign="top">All: 0.15<sup>7</sup></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2.3β-androstanediol</td>
<td align="left" colspan="1" rowspan="1" valign="top">M <italic>S</italic>: 34–103<sup>10</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">ERβ+</td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:0000493</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3.5α-androstane-3β,17β-diol</td>
<td align="left" colspan="1" rowspan="1" valign="top">F <italic>S</italic>: 8.7–18<sup>10</sup></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">1. EPI</td>
<td align="left" colspan="1" rowspan="1" valign="top">M: 0.3–0.7<sup>9,10</sup>; <italic>S</italic>: 211–532<sup>10</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">AR+ <sup>weak</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">CAS:481-29-8</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2. epiandrosterone</td>
<td align="left" colspan="1" rowspan="1" valign="top">F: 0.3–0.7<sup>10</sup>; <italic>S</italic>: 172–350<sup>10</sup></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:0000365</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3.3β-hydroxy-17-oxo-5α-androstane</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CHEBI:541975</td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">PC:441302</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">1. DHT</td>
<td align="left" colspan="1" rowspan="1" valign="top">M: 0/85–3.5 (50–100)<sup>6</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">AR+</td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:0002961</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2. dihydrotestosterone</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fpre: 0.08–1.3<sup>6</sup></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CHEBI:16330</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3.17β-hydroxy-5α-androstan-3-one</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fpost: 0.03–1.65<sup>6</sup></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">PC:10635</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="21" style="border-right: thin solid #000000;border-left: thin solid #000000;" valign="middle">ANDROSTENES</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CAS:481-30-1</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">1. EpiT<sup>8</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">M: 1.3–2.9<sup>7</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">AR+ <sup>weak9</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:0000628</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2. epitestosterone</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CHEBI:42534</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3.17α-hydroxy-4-androsten-3-one</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CB:10204</td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CAS 521-17-5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">1. A5</td>
<td align="left" colspan="1" rowspan="1" valign="top">M: 2.6–3.7<sup>9,10</sup>; <italic>S</italic>: 243–494<sup>10</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">AR+ <sup>weak</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:0003818</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2. androstenediol</td>
<td align="left" colspan="1" rowspan="1" valign="top">F: 0.8–1.1<sup>10,11</sup>; <italic>S</italic>: 85–302<sup>10</sup></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CHEBI:2710</td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">3. androst-5-ene-3β,17β-diol</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">PC:10634</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">1.17αA5</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td align="left" colspan="1" rowspan="1" valign="top">AR+ <sup>weak</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">CAS:521-17-5</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2.17α- androstenediol</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">GAB A<sub>A</sub>−</td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:0003818</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3. androst-5-ene-3β,17α-diol</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CHEBI:2710</td>
</tr>
<tr style="border-bottom: thin solid #000000;">
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">PC:10634</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">1. Δ<sup>4</sup>-A5</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CAS:1156-92-9</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2.4-androstenediol</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:0005849</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3. androst-4-ene-3β,17β-diol</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">PC:12476620</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">1. DHEA</td>
<td align="left" colspan="1" rowspan="1" valign="top">M: 10–25<sup>6</sup>; <italic>S</italic>: 2K-10K<sup>6</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">GABA<sub>A</sub>−</td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:0000077</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2. dehydroepiandrosterone</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fpre: 3.0–30<sup>6</sup>; <italic>S</italic>: 1K-8K<sup>6</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">(DHEA and DHEA-S)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3. (3β)-3-hydroxyandrost-5-en-17-one</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fpost: 2.0–20<sup>6</sup>; <italic>S</italic>: 1K-6K<sup>6</sup></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>1. Abbreviation (used here)</bold>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Blood concentration</bold>
<xref ref-type="table-fn" rid="TN2"><sup>**</sup></xref>
<bold>(nM)</bold></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Biologic activity</bold>
<xref ref-type="table-fn" rid="TN3">
<sup>***</sup>
</xref>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Entries</bold>
<xref ref-type="table-fn" rid="TN1">
<sup>*</sup>
</xref>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>2. Common name</bold>
</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>3. Chemical name</bold>
</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">1. A4</td>
<td align="center" colspan="1" rowspan="6" style="border-right: thin solid #000000;border-left: thin solid #000000;" valign="middle">ANDROSTENES</td>
<td align="left" colspan="1" rowspan="1" valign="top">All: 3.1–5.9<sup>7</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">AR+</td>
<td align="left" colspan="1" rowspan="1" valign="top">CAS:63-05-8</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2. androstenedione</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:0000053</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3.4-Androstene-3,17-dione</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CHEBI:16422</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">1. T</td>
<td align="left" colspan="1" rowspan="1" valign="top">M: 5–25<sup>6</sup></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CAS:55-22-0</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2. testosterone</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fpre: 0.2–2.0<sup>6</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">AR+</td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:0000234</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3.17β-hydroxyandrost-4-ene-3-one</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fpost: 0.2–1.0<sup>6</sup></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CHEBI:17347</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">1. E2</td>
<td align="center" colspan="1" rowspan="7" style="border-right: thin solid #000000;border-left: thin solid #000000;" valign="middle">ESTROGENS</td>
<td align="left" colspan="1" rowspan="1" valign="top">M: 0.02–0.04<sup>6</sup></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CAS:50-28-2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2.17β-estradiol</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fpre: 0.005–1.0<sup>6</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">ER+</td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:0000151</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3. (17β)-estra-1,3,5(10)-triene-3,17-diol</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fpost: 0.005–0.08<sup>6</sup></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CHEBI:16469</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">1. E1</td>
<td align="left" colspan="1" rowspan="1" valign="top">M: 0.033–0.1<sup>6</sup>; <italic>S</italic>: 2.0–4.0<sup>6</sup></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CAS:53-16-7</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">2. estrone</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fpre: 0.015–0.5; <italic>S</italic>: 2.0–5.0<sup>6</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">ER+</td>
<td align="left" colspan="1" rowspan="1" valign="top">HMDB:0000145</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3.3-hydroxy-1,3,5(10)-estratrien-17-one</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fpost: 0.01–0.12; <italic>S</italic>: 5–20(X10<sup>−</sup>3) <sup>6</sup></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">CHEBI:17263</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>List of the steroids discussed in the present review with the major features. Nomenclature of these compounds is variable and aliases are given as <bold><xref ref-type="supplementary-material" rid="SM1">Supplemental Materials</xref></bold></italic>.</p>
<fn id="TN1">
<label>*</label>
<p><italic>CAS: Chemical Abstracts Service, a division of the American Chemical Society (<ext-link ext-link-type="uri" xlink:href="http://www.cas.org">www.cas.org</ext-link>. Accessed on date: February 2018); HMDB: Human Metabolome Data Base (<ext-link ext-link-type="uri" xlink:href="http://www.hmdb.ca">www.hmdb.ca</ext-link>. Accessed on date: February 2018) (Wishart et al., <xref ref-type="bibr" rid="B472">2013</xref>); CB: Chemical Book (<ext-link ext-link-type="uri" xlink:href="http://www.chemicalbook.com">www.chemicalbook.com</ext-link>. Accessed on date: February 2018); ChEBI (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/chebi">www.ebi.ac.uk/chebi</ext-link>. Accessed on date: February 2018) (Morgat et al., <xref ref-type="bibr" rid="B265">2015</xref>); PC: PubChem (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov">www.ncbi.nlm.nih.gov</ext-link>; pubchem.ncbi.nlm.nih.gov. Accessed on date: February 2018) (Kim et al., <xref ref-type="bibr" rid="B189">2016</xref>)</italic>.</p>
</fn>
<fn id="TN2">
<label>**</label>
<p><italic>M: male subjects; F: female subjects; Fpre: female premenopausal subjects; Fpost: female postmenopausal subjects; -S: sulphated compounds</italic>.</p>
</fn>
<fn id="TN3">
<label>***</label>
<p><italic>PR, ER, AR: compound activates the indicated steroid receptor; GABA<sub>A</sub> allosteric positive (+) or negative (–) modulator</italic>.</p>
</fn>
<fn id="TN4">
<label>∧</label>
<p><italic>This isomer is shown in Figure <xref ref-type="fig" rid="F2">2</xref></italic>.</p>
</fn>
<p><italic>n.d.: not determined</italic>.</p>
<fn id="TN5">
<label>1</label>
<p><italic>20β-/5β-isomers exist (CB8678436, Chemical Book - <ext-link ext-link-type="uri" xlink:href="http://www.chemicalbook.com">www.chemicalbook.com</ext-link>. Accessed on date: February 2018); <sup>2</sup>Isomer 5α-pregnan-3β,17α-diol-20-one exists (CB:0291774, Chemical Book - <ext-link ext-link-type="uri" xlink:href="http://www.chemicalbook.com">www.chemicalbook.com</ext-link>. Accessed on date: February 2018); <sup>3</sup>In general, 5α-reduced and 3α-hydroxysteroids are positive allosteric modulator of GABA<sub>A</sub>, whereas 3α- and 3β-sulphated hydroxysteroids and 5β-reduced steroids are negative allosteric modulator of GABA<sub>A</sub>. The 3β-hydroxy isomers of THP are inactive (Belelli and Lambert, <xref ref-type="bibr" rid="B29">2005</xref>; Gibbs et al., <xref ref-type="bibr" rid="B126">2006</xref>; <sup>4</sup>This compound is GABA<sub>A</sub> receptor inactive; <sup>5</sup>Pearson Murphy et al., <xref ref-type="bibr" rid="B303">2001</xref>; <sup>6</sup>Mueller et al., <xref ref-type="bibr" rid="B269">2015</xref>), <sup>7</sup>Data extracted from the Human Metabolome Data Base-HMDB (<ext-link ext-link-type="uri" xlink:href="http://www.hmdb.ca">www.hmdb.ca</ext-link>. Accessed on date: February 2018) (Wishart et al., <xref ref-type="bibr" rid="B472">2013</xref>); <sup>8</sup>This compound is strong inhibitor of SRD5As. <sup>9</sup>Kancheva et al. (<xref ref-type="bibr" rid="B183">2007</xref>) and <sup>10</sup>Bicikova et al. (<xref ref-type="bibr" rid="B35">2013</xref>)</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T2" position="float">
<label>Table 2</label>
<caption>
<p>Major enzymes involved in steroidogenesis.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Chromosome</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Protein (aa)<xref ref-type="table-fn" rid="TN7"><sup>**</sup></xref></bold>
</th>
<th colspan="1" rowspan="1"></th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top"><bold>1. Abbr</bold>.</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene size<xref ref-type="table-fn" rid="TN6"><sup>*</sup></xref></bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Dalton</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>1. Name 2. Family</bold>
</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>2. Gene ID</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>mRNA size<xref ref-type="table-fn" rid="TN6"><sup>*</sup></xref></bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Localization (L)<xref ref-type="table-fn" rid="TN8"><sup>***</sup></xref></bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>3. Catalysis 4. Substrates<xref ref-type="table-fn" rid="TN9"><sup>****</sup></xref></bold>
</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>3. <italic>Gene name(s)</italic></bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Exons (no)</bold>
</th>
<th colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>5. Distribution   6. Cofactor</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. StAR</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 8p11.23</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. steroidogenic acute regulatory protein</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 6770</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>gene:</bold> 8.6</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 285</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. cytochrome P450</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>STAR, STARD1</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 1.6</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 31,914</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. facilitate transport of cholesterol to mitochondria</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 8</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> mitochon</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4</bold>. cholesterol</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. restricted (adrenal, testis, ovary, placenta)</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. CYP11A1</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. cytochrome P450 side-chain cleavage enzyme</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 1583</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 15q24.1</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. cytochrome P450, type I</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>CYP11A1</italic>;<break></break><italic>CYP11A</italic>;<break></break><italic>CYPXIA1</italic>;<break></break><italic>P450SCC</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 30.0</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 521</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. cleavage of cholesterol side-chain</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 2.0</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 60,102</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4</bold>. cholesterol<bold>→</bold>P5</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 9</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> mitochon</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. restricted (adrenal, testis, ovary, placenta)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>6</bold>. NADP/NADPH</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. CYP17A1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 10q24.32</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. steroid 17α-hydroxylase/17,20-lyase</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 1586</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 6.6</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 508</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. cytochrome P450, type II</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>CYP17A1</italic>; <italic>CPT7</italic>; <italic>CYP17</italic>; <italic>S17AH</italic>; <italic>P450C17</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 1.9</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 57,371</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. 17α-hydroxylase and 17,20-lyase activities</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 8</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> EndRet</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4</bold>. P5<bold>→</bold>DHEA; P<bold>→</bold>A4<xref ref-type="table-fn" rid="TN10"><sup>$</sup></xref>; 5αDHP<bold>→</bold>androstanedione; THP<bold>→</bold> 5α-pregnan-3,17α-diol-20-one</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. restricted (adrenal, testis, ovary, placenta)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>6</bold>. NADP/NADPH</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. CYP19A1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 15q21.1</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. cytochrome P450 aromatase</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 1588</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 130.6</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 503</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. cytochrome P450, type II</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>CYP19A1; ARO; ARO1; CPV1; CYAR; CYP19; CYPXIX; P-450AROM</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 1.5–4.5</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 57,883</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. oxidative demethylation of C<sub>19</sub> to C<sub>18</sub> (aromatisation)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 10</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> EndRet</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4</bold>. A <bold>→</bold> E1; T <bold>→</bold> E2</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. restricted (adrenal, testis, ovary, placenta)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>6</bold>. NADP/NADPH</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 3βHSD1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 1p11–12</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 3β-hydroxysteroid dehydrogenase/Δ<sup>5 → 4</sup> isomerase type I</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 3283</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 8.1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 373</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. short chain dehydrogenase/reductase superfamily</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>HSD3B1; HSD3B; HSDB3; SDB3A; (more<sup>∧∧</sup>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 1.7</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 42,252</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. oxidative conversion of Δ<sup>5</sup> 3β-hydroxyl to Δ<sup>4</sup> keto-steroids</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 4</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> membrane</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4</bold>. P5<bold>→</bold>P; 17OHP5<bold>→</bold>17OHP4; DHEA<bold>→</bold>A4; A5<bold>→</bold>T; 17αA5<bold>→</bold>EpiT</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. selectively distributed (placenta, periphery)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>6</bold>. NADP/NADPH or NAD/NADH</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 3βHSD2</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 1p11–13</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 3β-hydroxysteroid dehydrogenase/Δ<sup>5<bold>→</bold>4</sup> isomerase type II</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 3284</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 8.1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 372</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. short chain dehydrogenase/reductase superfamily</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>HSD3B2; HSDB; HSD3B; SDR11E2</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 1.7</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 42,052</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. oxidative conversion of Δ<sup>5</sup>-3β-hydroxyl to Δ<sup>4</sup>-ketosteroids</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 4</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> mitochon</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4</bold>. P5<bold>→</bold>P; 17OHP5<bold>→</bold>17OHP4; DHEA<bold>→</bold>A4</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. restricted (adrenal, testis, ovary)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>6</bold>. NADP/NADPH or NAD/NADH</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17βHSD1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 17q11–21</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17β-hydroxysteroid dehydrogenase type 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 3,292</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 6.0</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 328</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. short chain dehydrogenase/reductase superfamily</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>HSD17B1</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 1–2.4</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 34,950</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. reduction of 17-keto to 17β-hydroxyl (estrogens)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>E2DH; HSD17; EDHB17; EDH17B2; SDR28C1; (more<sup>∧∧</sup>)</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 6</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> cytoplasm</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4. (established)</bold> E1<bold>→</bold>E2; (A4<bold>→</bold>T in rodents) <bold>(postulated)</bold> DHEA<bold>→</bold>A5<xref ref-type="table-fn" rid="TN14"><sup>1</sup></xref>; P<bold>→</bold>20αDHP<sup>2</sup>;</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">DHT<bold>→</bold>3βDIOL<sup>11</sup>; DHT<bold>→</bold> androstanedione<sup>11</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. selectively distributed (ovary, placenta (low in endometrium, breast)<sup>14,15</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>6</bold>. NADP/NADPH</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17βHSD2</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 16q24.1–2</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17β-hydroxysteroid dehydrogenase type 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 3294</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 63</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 387</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. short chain dehydrogenase/reductase superfamily</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>HSD17B2 HSD17; SDR9C2; EDH17B2</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 1.5</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 42,785</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. oxidation of 17β-hydroxyl to 17-keto (estrogens &amp; androgens)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 5</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> EndRet</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4. (established)</bold> E2<bold>→</bold>E1; T<bold>→</bold>A4; DHT<bold>→</bold>androstanedione<sup>1,10</sup>; 20αDHP<bold>→</bold>P<sup>16</sup>; 5α-pregnan-20-ol<break></break>-3-one<bold>→</bold>5αDHP<sup>16</sup>; A5<bold>→</bold>DHEA<xref ref-type="table-fn" rid="TN14"><sup>1</sup></xref>; 3αDIOL<bold>→</bold>AN<sup>5</sup>
<bold>(postulated)</bold> 3αDIOL<bold>→</bold>AN<sup>(1, 10)</sup>; DHT<bold>→</bold>androstanedione<xref ref-type="table-fn" rid="TN14"><sup>1</sup></xref>; A5<bold>→</bold>DHEA<xref ref-type="table-fn" rid="TN14"><sup>1</sup></xref>; allopregnandiol<bold>→</bold> THP<sup>16</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. selectively distributed (liver, intestine, endometrium, placenta, pancreas, prostate, colon,<break></break>kidney. <italic>Negative</italic> in heart, brain, skeletal muscle, spleen, thymus, ovary, or testis)<sup>(14, 17)</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>6</bold>. NAD/NADH</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17βHSD3<xref ref-type="table-fn" rid="TN12"><sup>&amp;&amp;</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 9q22</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17β-hydroxysteroid dehydrogenase type 3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 3293</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 67</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 310</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. short chain dehydrogenase/reductase superfamily</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>HSD17B3</italic><break></break><italic>EDH17B3;</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 1.2</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 34,516</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. reduction of 17-keto to 17β-hydroxyl (androgens)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 11</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> EndRet</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4. (established)</bold> A4<bold>→</bold>T<break></break><bold>(postulated)</bold> AN<bold>→</bold>3αDIOL<sup>(1, 3, 10)</sup>; androstanedione<bold>→</bold>DHT<sup>(1, 9, 10)</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. restricted (testis; low in brain, blood, skin, adipose tissue)<sup>14</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>6</bold>. NADP/NADPH</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17βHSD4</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 5q23.1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 736</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17β-hydroxysteroid dehydrogenase type 4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 3295</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 184</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 79,686</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. short chain dehydrogenase/reductase superfamily</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>HSD17B4</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 2.9</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> Peroxisome mitochon</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. fatty acid β-oxidation (steroids in pigs)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DBP; MFE-2; MPF-2; PRLTS1; SDR8C1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 28</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4. (established)</bold> very long chain branched fatty acids, bile acids<break></break><bold>(postulated)</bold> A5<bold>→</bold>DHEA<xref ref-type="table-fn" rid="TN14"><sup>1</sup></xref>; E2<bold>→</bold>E1<sup>14</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. ubiquitous (liver, heart, prostate, testis, lung, skeletal muscle, kidney, pancreas, thymus, ovary, intestine, placenta, brain, spleen, colon, lymphocytes)<sup>14</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>6</bold>. NAD/NADH</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17βHSD6</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 12q13</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 317</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17β-hydroxysteroid dehydrogenase type 6</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 8630</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 24.5</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 35,966</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. short chain dehydrogenase/reductase superfamily</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>HSD17B6</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 1.6</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> EndRet<break></break>microsomes</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. 3α-3β-epimerase; 17β-hydroxyl oxidation (5α-reduced steroids); retinoids</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><italic>HSE; RODH; SDR9C</italic>6</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 8</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4. (established)</bold> 3αDIOL<bold>→</bold>DHT<sup>10</sup>; AN<bold>→</bold>androstanedione<sup>5</sup>; AN<bold>→</bold>EPI<break></break><bold>(postulated)</bold> 3αDIOL<bold>→</bold>AN<sup>5</sup>; E2<bold>→</bold>E1<sup>5</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. selectively distributed (liver, testis, lung, spleen, brain, ovary, kidney, adrenal, prostate)<sup>14</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>6</bold>. NAD/NADP</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17βHSD7</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 1q23</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17β-hydroxysteroid dehydrogenase type 7</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 51478</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 22.1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 341</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. short chain dehydrogenase/reductase superfamily</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>HSD17B7</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 1.5</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 38,206</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. 3-ketosteroid reductase of sterols</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>PRAP; SDR37C1</italic>
</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 9</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> EndRet</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4. (established)</bold> Sterols/cholesterol biosynthesis; DHT<bold>→</bold>3βDIOL<xref ref-type="table-fn" rid="TN14"><sup>1</sup></xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. widely distributed (ovary, uterus, placenta, liver, breast, testis, neuronal tissue, adrenal gland, small intestine, prostate, adipose tissue lung, and thymus)<sup>(14, 18)</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>6</bold>. NADP/NADPH</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17βHSD8</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 6p21.3</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17β-hydroxysteroid dehydrogenase type 8</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 7923</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 2.2</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 261</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. short chain dehydrogenase/reductase superfamily</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>HSD17B8</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 1.0</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 26,974</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. fatty acid elongation; steroid 17βHSD action (rodents).</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>KE6; FABG; HKE6; FABGL; RING2; H2-KE6; (more<sup>∧∧</sup>)</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 9</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> mitochon</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4. (established)</bold> fatty acids <bold>(postulated)</bold> E2<bold>→</bold>E1</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. widely distributed (prostate, placenta, kidney, brain, cerebellum, heart, lung, small intestine, ovary, testis, adrenal, stomach, liver, adrenals)<sup>14−19</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>6</bold>. NAD/NADP</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17βHSD9</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 12q23</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17β-hydroxysteroid dehydrogenase type 9</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 5959</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 4.4</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 318</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. short chain dehydrogenase/reductase superfamily</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>HSD17B9</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 1.4</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 34,979</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. retinoid metabolism (steroid metabolism in rodents)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>RDH5; (more<sup>∧∧</sup>)</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 4</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> EndRet</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4. (established)</bold> retinoids <bold>(postulated)</bold> AN<bold>→</bold>3αDIOL<xref ref-type="table-fn" rid="TN14"><sup>1</sup></xref>; androstanedione<bold>→</bold>DHT<xref ref-type="table-fn" rid="TN14"><sup>1</sup></xref></td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17βHSD10</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> Xp11.2</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17β-hydroxysteroid dehydrogenase type 10</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 3028</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 3.1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 261</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. short chain dehydrogenase/reductase superfamily</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>HSD17B10</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 0.9</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 26,923</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. fatty acids &amp; steroid oxidation; tRNA maturation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ABAD; CAMR; ERAB; HCD2; MHBD; HADH2; MRPP2; MRX17; MRX31; (more<sup>∧∧</sup>)</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 6</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> mitochon</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4. (established)</bold> Isoleucine, fatty acid, bile acid metabolism, THP<bold>→</bold>5αDHP<sup>(20, 34)</sup><break></break><bold>(postulated)</bold> 3αDIOL<bold>→</bold>AN<sup>1,9</sup>; DHT<bold>→</bold>androstanedione<sup>1,9</sup>; T<bold>→</bold>A4<xref ref-type="table-fn" rid="TN14"><sup>1</sup></xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. nearly ubiquitous (liver, small intestine, colon, kidney, heart, brain, placenta, lung, ovary, testis, spleen, thymus, prostate, leukocyte)<sup>14</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>6</bold>. NAD/NADH</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17βHSD11</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 4q22.1</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17β-hydroxysteroid dehydrogenase type 11</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 51170</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 54.9</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 300</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. short chain dehydrogenase/reductase superfamily</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>HSD17B11</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 1.9</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 32,936</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. Short-chain alcohol dehydrogenases</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DHRS8; PAN1B; RETSDR2; SDR16C2; (more<sup>∧∧</sup>)</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 7</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> EndRet</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4. (established)</bold> lipids, sec. alcohols/ketones <bold>(postulated)</bold> 3αDIOL<bold>→</bold>AN<sup>1,9</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. nearly ubiquitous (liver, intestine, kidney, adrenal gland, heart, lung, testis, ovary, placenta, sebaceous gland and pancreas)<sup>14,21</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>6</bold>. NAD/NADH</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17βHSD12</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 11p11.2</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17β-hydroxysteroid dehydrogenase type 12</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 51144</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 170.1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 312</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. short chain dehydrogenase/reductase superfamily</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>HSD17B12</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 2.6</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 34,324</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. fatty acid elongation, steroid 17βHSD reductive action (rodents)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>KAR; SDR12C1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 11</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> EndRet</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4. (established)</bold> branched/long chain fatty acids <bold>(postulated)</bold> E1<bold>→</bold>E2</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. ubiquitous (heart, skeletal muscle, liver, kidney, adrenal gland, testis, placenta, brain, pancreas, GIT, trachea, lung, thyroid, prostate, aorta, bladder, spleen, skin, ovary, breast, uterus, vagina)<sup>(14, 22)</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>6</bold>. NADP/NADPH</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17βHSD13</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 4q22.1</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17β-hydroxysteroid dehydrogenase type 13</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 345275</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 19.1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 300</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. short chain dehydrogenase/reductase superfamily</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>HSD17B13</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 2.3</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 33,655</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3. and 4</bold>. unknown</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>SCDR9; NIIL497; (more<sup>∧∧</sup>)</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 6</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> extracell/EndRet</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. restricted (liver; low in bone marrow, lung, ovary, testis,<break></break>kidney, skeletal muscle brain, bladder)<sup>14</sup></td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17βHSD14</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 19q13.33</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17β-hydroxysteroid dehydrogenase type 14</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 51171</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 23.7</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 270</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. short chain dehydrogenase/reductase superfamily</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>HSD17B14</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 1.3</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 28,317</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. fatty acid &amp; prostaglandin metabolism; 17βHSD activity</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>DHRS10; SDR47C1; retSDR3</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 8</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> cytoplasm</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4. (established)</bold> fatty acids<break></break><bold>(postulated)</bold> 3αDIOL<bold>→</bold>AN<sup>1,9</sup>; E2<bold>→</bold>E1<sup>4</sup>; T<bold>→</bold>A4<sup>4</sup>; A5<bold>→</bold>DHEA<sup>5</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. widely distributed (brain, liver, placenta, breast)<sup>14</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>6</bold>. NAD/NADH</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. 17βHSD15</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 14q24.1</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. retinol dehydrogenase 11</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 51109</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 19.0</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 318</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. short chain dehydrogenase/reductase superfamily</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>RDH11; PSDR1; ARSDR1; (more<sup>∧∧</sup>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 1.8</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 35,386</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. dehydrogenase activity of retinoid and steroids</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 9</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> cytoplasm</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4. (established)</bold> retinoids <bold>(post.)</bold> AN<bold>→</bold>3αDIOL<sup>1,9</sup>; androstanedione<bold>→</bold>DHT<sup>1,9</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. widely distributed<break></break><bold>6</bold>. NADP/NADPH</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. DHRS11<sup>23</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 17q12</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. dehydrogenase/reductase 11</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 79154</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 9.0</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 260</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. short chain dehydrogenase/reductase superfamily</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>DHRS11</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 1.6</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 28,308</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. steroid 17HSD &amp; 3βHSD activities; bile acids metabolism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ARPG836; SDR24C1; spDHRS11</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 7</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> extracell</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4</bold>. E1<bold>→</bold>E2; A4<bold>→</bold>T; DHEA<bold>→</bold>A5; androstanedione<bold>→</bold>DHT; AN<bold>→</bold>3αDIOL; P<bold>→</bold>3αDHP<sup>23</sup><break></break><bold>5</bold>. nearly ubiquitous (testis, small intestine, colon, kidney)<sup>23</sup><break></break><bold>6</bold>. NADP/NADPH</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. AKR1C1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 10p14–15</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. aldo-ketoreductase family 1 member C1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 1645</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 20.0</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 323</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. aldo-ketoreductase family</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>AKR1C1</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 12</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 36,788</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. 20αHSD (strong) and 17βHSD (weak) activities; moderate 3-keto reduction to 3β-hydroxyl (&gt; 3α)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>C9, DDH, DDH1, DD1, H-37, HBAB, MBAB HAKRC; DD1/DD2; 2-ALPHA-HSD; 20-ALPHA-HSD</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 9</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> cytoplasm</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4. (established)</bold> P<bold>→</bold>20αDHP<sup>6</sup>; 5αDHP<bold>→</bold>5α-pregnan-20-ol-3-one<sup>6</sup>; THP<bold>→</bold>allopregnandiol<sup>6</sup>; DHT<bold>→</bold>3βDIOL<sup>7</sup>; androstanedione<bold>→</bold>DHT<sup>7</sup>; 5α-pregnan-20-ol-3-one<bold>→</bold>allopregnandiol<sup>16</sup>; 5αDHP<bold>→</bold>THP<sup>16</sup><break></break><bold>(post.)</bold> DHT<bold>→</bold>3αDIOL<sup>7</sup>; A4<bold>→</bold>T<sup>7</sup>; E1<bold>→</bold>E2<sup>7</sup>; 3αDIOL<bold>→</bold>AN<sup>7</sup>; 20αDHP<bold>→</bold> P<sup>7</sup>; DHT<bold>→</bold>3βDIOL<sup>24</sup>; 5α-pregnan-17α-ol-3,20-dione<bold>→</bold>5α-pregnan-3,17α-diol-20-one<sup>16</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. ubiquitous</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>6</bold>. NADP/NADPH or NAD/NADH</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. AKR1C2</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 10p14–15</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. aldo-ketoreductase family 1 member C2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 1646</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 30.6</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 323</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. aldo-ketoreductase family</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>AKR1C2</italic><break></break><italic>DD; DD2; TDD; BABP; DD-2; DDH2; HBAB; HAKRD; MCDR2; SRXY8; DD/BABP; AKR1C-pseudo</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 1.3 <break></break><bold>Exons:</bold> 9</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 36,735<break></break><bold>L:</bold> cytoplasm</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. 20αHSD (weak) and 17βHSD activities; 3-keto reduction to 3α- hydroxyl; bile-acid binding protein activity</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4. (established)</bold> DHT<bold>→</bold>3αDIOL<sup>7,12</sup>; 5αDHP<bold>→</bold>THP<sup>7</sup>; androstanedione<bold>→</bold>AN<sup>25</sup>; 5α-pregnan-20-ol-3-one<bold>→</bold> allopregnandiol<sup>16</sup>; 5αDHP<bold>→</bold>THP<sup>16</sup>; 5α-pregnan-17α-ol-3,20-dione<bold>→</bold>5α-pregnan-3,17α-diol-20-one<sup>16</sup><break></break><bold>(postulated)</bold> A4<bold>→</bold> T<sup>7</sup>; E1<bold>→</bold>E2<sup>7</sup>; P<bold>→</bold>20αDHP<sup>7</sup>; 3αDIOL<bold>→</bold> DHT<sup>7</sup>; T<bold>→</bold>A4<sup>7</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. ubiquitous</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>6</bold>. NADP/NADPH or NAD/NADH</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. AKR1C3</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 10p14–15</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. aldo-ketoreductase family 1 member C3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 8644</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 13</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 323</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. aldo-ketoreductase family</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>HSD17B5</italic><break></break><italic>AKR1C3</italic><break></break><italic>DD3; DDX; PGFS; HAKRB; HAKRe; HA1753; HSD17B5; hluPGFS</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 1.2<break></break><bold>Exons:</bold> 9</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 36,853<break></break><bold>L:</bold> cytoplasm</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. 20αHSD (weak) and 17βHSD activities (androgens); 3-keto reduction to 3α-/β-hydroxyl (weak); 11-ketoprostaglandin reductase<sup>3</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4. (established)</bold> A4<bold>→</bold>T<sup>7</sup>; DHT<bold>→</bold>3αDIOL<sup>7</sup>; 3αDIOL<bold>→</bold>AN<sup>7</sup>; 5αDHP<bold>→</bold> THP<sup>7</sup>; 5α-pregnan-20-ol-3-one<bold>→</bold> allopregnandiol<sup>16</sup>; 5αDHP<bold>→</bold>THP<sup>16</sup>; DHEA<bold>→</bold>A5<sup>7</sup>; 5α-pregnan-17α-ol-3,20-dione<bold>→</bold>5α-pregnan-3,17α-diol-20-one<sup>16</sup>; androstanedione<bold>→</bold>DHT<sup>24</sup>
<bold>(postulated)</bold> E1<bold>→</bold>E2<sup>7</sup>;T<bold>→</bold>A4<sup>7</sup>; 20αDHP<bold>→</bold> P<sup>7</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. nearly ubiquitous (prostate, mammary gland, liver, kidney, lung, heart, uterus, testis, brain, skeletal muscle, adipose tissue, pancreas, hearth, skeletal muscle, thymus, ovary, small intestine and colon)<sup>14,26</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>6</bold>. NADP/NADPH or NAD/NADH</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. AKR1C4</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 10p15.1</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. aldo-ketoreductase family 1 member C4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 1109</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 25.2</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 323</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. aldo-ketoreductase family</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>AKR1C4</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 1.2</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 37,067</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. 20αHSD (weak) and 17βHSD activities; 3-keto reduction to 3α-hydroxyl (&gt;3β).</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>C11; CDR; DD4; CHDR; DD-4; HAKRA;</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 9</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> cytoplasm</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4. (established)</bold> DHT<bold>→</bold>3αDIOL<sup>7,10</sup>; androstanedione<bold>→</bold>AN<sup>7,8</sup>; other<xref ref-type="table-fn" rid="TN11"><sup>$$$</sup></xref><break></break><bold>(postulated)</bold> A4<bold>→</bold> T<sup>7</sup>; E1,<bold>→</bold>E2<sup>7</sup>; P<bold>→</bold>20αDHP<sup>7</sup>; 3αDIOL<bold>→</bold>DHT<sup>7</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. restricted (liver) <bold>6</bold>. NADP/NADPH or NAD/NADH</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. SRD5A1<break></break><bold>2</bold>. 6715<break></break><bold>3</bold>. <italic>SRD5A1</italic><break></break><italic>S5AR 1</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 5p15.31<break></break><bold>Gene:</bold> 41.0<break></break><bold>mRNA:</bold> 2.3<break></break><bold>Exons:</bold> 5(7)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 259<break></break><bold>Dalton:</bold> 29,459<break></break><bold>L:</bold> EndRet</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. steroid 5α-reductase 1 <bold>2</bold>. steroid 5α reductase family<break></break><bold>3</bold>. androgen and pregnene metabolism<break></break><bold>4</bold>. T<bold>→</bold>DHT; A4<bold>→</bold>androstanedione; 17OHP4<bold>→</bold>5α-pregnan-17α-ol-3,20-dione; P<bold>→</bold>5αDHP; 20αDHP<bold>→</bold>5α-pregnan-20-ol-3-one <bold>5</bold>. ubiquitous</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. SRD5A2</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 2p23.1</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. steroid 5α-reductase 2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 6716</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 178.3</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 254</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. steroid 5α reductase family</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>SRD5A2</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 2.5</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 28,393</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. androgen and pregnene metabolism</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 5</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> microsomes</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4</bold>. T<bold>→</bold>DHT; A4<bold>→</bold>androstanedione</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. restricted (prostate and androgen sensitive tissues)</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. SRD5A3</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 4q12</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. steroid 5α-reductase 3</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 79644</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> ….</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 318</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. steroid 5α reductase AND polyprenol reductase subfamily</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>SRD5A3</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 4.1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Da:</bold> 36,521</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. androgen and pregnene metabolism</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>CDG1P; CDG1Q; KRIZI; SRD5A2L; SRD5A2L1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 6</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> EndRet</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4</bold>. T<bold>→</bold>DHT; A4<bold>→</bold>androstanedione; 17OHP4<bold>→</bold>5α-pregnan-17α-ol-3,20-dione; P<bold>→</bold>5αDHP; 20αDHP<bold>→</bold>5α-pregnan-20-ol-3-one</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. ubiquitous</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. STS</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> Xp22.31</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. steroid sulphatase</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 412</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 208.3</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 583</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. sulphatase</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>STS</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 6.4</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 65,492</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. hydrolyses several 3β-hydroxysteroid sulfates</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>ES; ASC; XLI; ARSC; SSDD; ARSC1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 16</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> microsomes EndRet</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4</bold>. sulpho conjugated cholesterol, E1, E2, DHEA, P5, 17OHP5S, A5, EPI</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. ubiquitous (lung, aorta, thyroid, uterus, liver and testis)<sup>27−30</sup></td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. SULT1E1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 4q13.3</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. estrogen sulphotransferase</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 6783</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 50.0</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 35126</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. sulphotransferase 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>SULT1E1</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 1.8</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 35,126</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. sulpho-conjugation of steroids</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>EST; STE; EST-1; ST1E1; (more<xref ref-type="table-fn" rid="TN13"><sup>∧∧</sup></xref>)</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 9</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> cytoplasm</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4</bold>. E1, DHEA (low affinity for E2)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. moderately distributed (liver, adrenal, small intestine; low in brain, lung, testis,<break></break>leukocytes, placenta, salivary gland, stomach, thymus, trachea, uterus, kidney)<sup>(30, 31)</sup></td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. SULT2A1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 19q13.3</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. dehydroepiandrosterone sulphotransferase</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 6822</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 15.9</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 285</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. sulphotransferase 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>SULT2A1</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 2.0</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 33,780</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. sulpho-conjugation of steroids, bile acids</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HST; ST2; STD; hSTa; DHEAS; ST2A1;</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 6</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> cytoplasm</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4</bold>. DHEA, P5, AN, 17OHP5<sup>32</sup>, A5<sup>32</sup>, AN<sup>33</sup>, EPI, bile acids</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. restricted (liver, adrenal, small intestine (low in colon, hearth,<break></break>prostate, stomach, testis, thyroid)<sup>30</sup></td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. SULT2B1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 19q13.33</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. alcohol sulphotransferase</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 6820</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 48.5</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 365</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. sulphotransferase 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>SULT2B1</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 1.3</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 41,308</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. sulpho-conjugation of steroids</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>HSST2; ARCI14</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 7</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> cytoplasm</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4</bold>. cholesterol, DHEA</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. moderately distributed (placenta, prostate, lung (low in kidney, salivary gland, small intestine, trachea)<sup>30</sup></td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. SULT1A1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Chr:</bold> 16p11.2</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>1</bold>. phenol sulphotransferase 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. 6817</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Gene:</bold> 18.4</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>aa:</bold> 295</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>2</bold>. sulphotransferase 1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. <italic>SULT1A1</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>mRNA:</bold> 1.3</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Dalton:</bold> 34,165</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>3</bold>. sulpho-conjugation of steroids</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>PST; STP; STP1; P-PST; ST1A1; ST1A3; TSPST1; HAST1/HAST2</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Exons:</bold> 13</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>L:</bold> cytoplasm</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>4</bold>. E2</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>5</bold>. nearly ubiquitous (adrenal, bone marrow, brain, colon, hearth, kidney, liver, lung, pancreas, leukocytes, placenta, prostate, salivary gland, skeletal muscle, small intestine, spinal cord, spleen, stomach, testis, thymus, thyroid, trachea, uterus)<sup>30</sup></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>List of all enzymes discussed in the present review with the major features. Gene and gene product nomenclature is complex and variable and alias are given as <xref ref-type="supplementary-material" rid="SM1">Supplemental Materials</xref>. Gene structure (chromosome location, gene length), transcript features (length, exons) and protein characteristics (amino-acid length, molecular weigh and cell localization) were obtained from GeneCards (<ext-link ext-link-type="uri" xlink:href="http://www.genecards.org">www.genecards.org</ext-link>. Accessed on date: February 2018) (Stelzer et al., <xref ref-type="bibr" rid="B410">2016</xref>)</italic>.</p>
<fn id="TN6">
<label>*</label>
<p><italic>Length in kilo nucleotides</italic>.</p>
</fn>
<fn id="TN7">
<label>**</label>
<p><italic>number of amino-acids</italic>.</p>
</fn>
<fn id="TN8">
<label>***</label>
<p><italic>Abbreviations: EndRet: endoplasmic reticulum; extracell: extracellular; mitochon: mitochondria</italic>.</p>
</fn>
<fn id="TN9">
<label>****</label>
<p>For some enzymes, substrate specificity based on robust evidences are indicated as ‘established’, whereas other reactions whose catalyzes is supported by less robust experimental evidences (mostly using recombinant proteins in vitro/cell-free assays) are indicated as “postulated.”</p>
</fn>
<fn id="TN10">
<label>$</label>
<p><italic>This reaction of CYP17A1 does not occur in vivo in humans (Miller and Auchus, <xref ref-type="bibr" rid="B259">2011</xref>)</italic>.</p>
</fn>
<fn id="TN11">
<label>$$$</label>
<p><italic>AKR1C4 has an important detoxifying function in the liver and converts chlordecone into chlordecone alcohol</italic>.</p>
</fn>
<fn id="TN12">
<label>&amp;&amp;</label>
<p><italic>17βHSD3 is testis specific and the reactions catalyzed by this enzyme are not reported in Figure <xref ref-type="fig" rid="F2">2</xref></italic>.</p>
</fn>
<fn id="TN13">
<label>∧∧</label>
<p><italic>For this gene, additional gene names exist, for details see NCBI database (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/">https://www.ncbi.nlm.nih.gov/</ext-link>)</italic>.</p>
</fn>
<fn id="TN14">
<label>1</label>
<p><italic>Luu-The and Labrie (<xref ref-type="bibr" rid="B234">2010</xref>), Labrie and Labrie (<xref ref-type="bibr" rid="B209">2013</xref>), and Labrie (<xref ref-type="bibr" rid="B208">2015</xref>); <sup>2</sup> Smuc and Rizner (<xref ref-type="bibr" rid="B400">2009</xref>), <sup>3</sup> Miller et al. (<xref ref-type="bibr" rid="B258">2012b</xref>), <sup>4</sup> Sivik (<xref ref-type="bibr" rid="B392">2012</xref>); <sup>5</sup> GeneCards (<ext-link ext-link-type="uri" xlink:href="http://www.genecards.org">www.genecards.org</ext-link>. Accessed on date: February, 2018) Stelzer et al. (<xref ref-type="bibr" rid="B410">2016</xref>), <sup>6</sup> Smuc and Rizner (<xref ref-type="bibr" rid="B400">2009</xref>), <sup>7</sup> Penning et al. (<xref ref-type="bibr" rid="B307">2004</xref>), Steckelbroeck et al. (<xref ref-type="bibr" rid="B405">2010</xref>); <sup>8</sup> Jin et al. (<xref ref-type="bibr" rid="B178">2011</xref>), <sup>9</sup>Manenda et al. (<xref ref-type="bibr" rid="B245">2016</xref>), <sup>10</sup>Balk and Knudsen (<xref ref-type="bibr" rid="B26">2008</xref>), <sup>11</sup>Gangloff et al. (<xref ref-type="bibr" rid="B122">2003</xref>), <sup>12</sup>Bélanger et al. (<xref ref-type="bibr" rid="B28">2002</xref>), <sup>13</sup>Perez Carrion et al. (<xref ref-type="bibr" rid="B308">1994</xref>), <sup>14</sup>Möller et al. (<xref ref-type="bibr" rid="B264">1999</xref>), Moeller and Adamski (<xref ref-type="bibr" rid="B263">2009</xref>), <sup>15</sup>Cornel et al. (<xref ref-type="bibr" rid="B69">2017</xref>), <sup>16</sup>Sinreih et al. (<xref ref-type="bibr" rid="B391">2017b</xref>), <sup>17</sup>Casey et al. (<xref ref-type="bibr" rid="B56">1994</xref>), <sup>18</sup>Törn et al. (<xref ref-type="bibr" rid="B440">2003</xref>), <sup>19</sup>Ohno et al. (<xref ref-type="bibr" rid="B291">2008</xref>), <sup>20</sup>Yang et al. (<xref ref-type="bibr" rid="B485">2016</xref>), <sup>21</sup>Chai et al. (<xref ref-type="bibr" rid="B57">2003</xref>), <sup>22</sup>Sakurai et al. (<xref ref-type="bibr" rid="B356">2006</xref>), <sup>23</sup>Endo et al. (<xref ref-type="bibr" rid="B103">2016</xref>). <sup>24</sup>Rižner and Penning (<xref ref-type="bibr" rid="B344">2014</xref>), <sup>25</sup>Manenda et al. (<xref ref-type="bibr" rid="B245">2016</xref>), <sup>26</sup>Lin et al. (<xref ref-type="bibr" rid="B219">1997</xref>), <sup>27</sup>Miki et al. (<xref ref-type="bibr" rid="B255">2002</xref>), <sup>28</sup>Foster et al. (<xref ref-type="bibr" rid="B113">2008a</xref>), <sup>29</sup>Purohit and Foster (<xref ref-type="bibr" rid="B324">2012</xref>), <sup>30</sup>Mueller et al. (<xref ref-type="bibr" rid="B269">2015</xref>), <sup>31</sup>Marchais-Oberwinkler et al. (<xref ref-type="bibr" rid="B246">2011</xref>), Mueller et al. (<xref ref-type="bibr" rid="B269">2015</xref>), <sup>32</sup>Rege et al. (<xref ref-type="bibr" rid="B337">2016</xref>), <sup>33</sup>Strott (<xref ref-type="bibr" rid="B418">2002</xref>), and <sup>34</sup>Yang et al. (<xref ref-type="bibr" rid="B485">2016</xref>)</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<sec>
<title>Ovarian steroidogenesis</title>
<p>Transformation of cholesterol to 17β-estradiol (E2) involves first the production of dehydroepiandrosterone (DHEA) in theca cells through the action of steroidogenic acute regulatory protein (StAR) that facilitates the transport of cholesterol into mitochondria, followed by CYP11A1 (rate-limiting) and CYP17A1 (Figure <xref ref-type="fig" rid="F2">2</xref>); the ovarian pathway is indicated by the yellow background; reviewed by (Miller and Auchus, <xref ref-type="bibr" rid="B259">2011</xref>; Andersen and Ezcurra, <xref ref-type="bibr" rid="B13">2014</xref>). CYP11A1 is a type I CYP localized in mitochondria that uses nicotine-adenine-dinucleotide-phosphate (NADPH) and ferredoxin (Fdx)/ferredoxin reductase (FdR) to cleave the cholesterol side chain and produce pregnenolone (P5). Type II CYP17A1, localized in the endoplasmic reticulum (EndRet), has both 17α-hydroxylase and 17,20-lyase activities. It uses NADPH and P450 oxidoreductase (POR) to first hydroxylate P5 to 17α-hydroxypregnenolone (17OHP5) (17α-hydroxylase action), followed by 17,20-lyase action to release DHEA. Gonad specific type 2 3β-hydroxysteroid dehydrogenase (3βHSD2) has 3β-dehydrogenase and Δ<sup>5</sup> to Δ<sup>4</sup> isomerase activities and converts DHEA to androstenedione (A4). Next, CYP19A1 catalyzes the oxidative demethylation of C<sub>19</sub> androgens to C<sub>18</sub> estrogens, with A-ring aromatisation; hence A4 is converted to estrone (E1). The final conversion of E1 (with low affinity for the estrogen-receptors -ERs) to E2 (high affinity for ERs and high estrogenic potency) is catalyzed by 17βHSD1 that reduces 17-keto to 17β-hydroxyl steroids. In the ovary, the 17-keto group of A4 can be reduced to 17β-hydroxyl by AKR1C3/17βHSD5 yielding testosterone (T) that is converted to E2 by CYP19A1. Upon ovulation, high 3βHSD2 levels in the corpus luteum lead to high progesterone (P) generation from P5.</p>
</sec>
<sec>
<title>Intracrine steroidogenesis</title>
<p>The expression of StAR, CYP11A1 and CYP17A1 is demonstrated in a limited number of peripheral tissues (see later and <bold>Tables 6</bold>–<bold>8</bold>). However, pregnenes, pregnanes, androstenes and androstanes generated from these initial steps (but also abundantly available as circulating precursors) can be further metabolized locally thus generating a plethora of compounds with various biological activities (estrogenic, androgenic, progestogenic and neuroactive; Tables <xref ref-type="table" rid="T1">1</xref>, <xref ref-type="table" rid="T2">2</xref> and Figure <xref ref-type="fig" rid="F2">2</xref>). The Δ<sup>5</sup> to Δ<sup>4</sup> isomerization of androstenes (DHEA, androstenediol -A5- and 17αA5) and pregnenes (P5, 17OHP5) is catalyzed by 3βHSD1, which is the peripheral counterpart of ovarian 3βHSD2. Also 3βHSD2, whose expression was initially considered to be restricted to endocrine tissues, is detected peripherally in recent reports (Stoffel-Wagner, <xref ref-type="bibr" rid="B411">2001</xref>; Tsai et al., <xref ref-type="bibr" rid="B443">2001</xref>; Attar et al., <xref ref-type="bibr" rid="B18">2009</xref>; Huhtinen et al., <xref ref-type="bibr" rid="B160">2014</xref>; Osinski et al., <xref ref-type="bibr" rid="B293">2018</xref>). Due to the high concentration of DHEA (both in blood and tissues), its conversion to A4 by 3βHSDs is relevant to the formation of downstream androgens and of estrogens. Additionally, 3βHSDs convert A5 and the isomer 17αA5 to T and epitestosterone (EpiT). Although minor, in the context of women's health, these pathways are relevant. A5, together with 3α and 3βDIOL (generated by AKR1Cs from DHT and AN, see below) activate both ERs and have estrogenic action (especially 3βDIOL, a potent ERβ binder). A5 possesses immune stimulatory activity whereas its 17α isomer (17αA5) has androgenic, antitumor and neuroactivity. Additionally, EpiT is a weak AR binder and a strong endogenous inhibitor of SRD5As (Loria and Graf, <xref ref-type="bibr" rid="B225">2012</xref>). The endogenous occurrence of 17αA5 is demonstrated in humans (Laatikainen et al., <xref ref-type="bibr" rid="B206">1971</xref>) but its route of synthesis is unclear (Shimizu, <xref ref-type="bibr" rid="B378">1979</xref>). A 17αHSD able to convert A4 to EpiT and DHEA to 17αA5 is characterized in mice (Bellemare et al., <xref ref-type="bibr" rid="B30">2005</xref>) but no human homologous is described yet. Similarly to the ovaries, androgen to estrogen conversion is catalyzed by CYP19A1.</p>
<p>A particularly important reaction is controlled by oxidative and reductive 17βHSDs, which interconvert 17-keto and 17β-hydroxysteroids. Since 17β-hydroxysteroids (T and E2) have higher affinity for the receptors than the keto-steroids (A4 and E1), this balance determines the final androgenic/estrogenic activity. Fourteen 17βHSDs exist, whose specificity is determined by tissue distribution, intracellular localization and biochemistry (Table <xref ref-type="table" rid="T2">2</xref>); reviewed thoroughly in (Mindnich et al., <xref ref-type="bibr" rid="B260">2004</xref>; Moeller and Adamski, <xref ref-type="bibr" rid="B262">2006</xref>, <xref ref-type="bibr" rid="B263">2009</xref>; Prehn et al., <xref ref-type="bibr" rid="B319">2009</xref>; Miller and Auchus, <xref ref-type="bibr" rid="B259">2011</xref>). Unpublished data also refer to a 15th 17βHSD (see Table <xref ref-type="table" rid="T2">2</xref>; reported in Luu-The et al., <xref ref-type="bibr" rid="B233">2008</xref>) with a putative role in androgen metabolism. With the exclusion of 17βHSD5 (AKR1C3, see below), all other 17βHSDs belong to the short-chain dehydrogenase (SRD) family.</p>
<p>Although all 17βHSDs have been postulated to use steroids as substrates based on cell-free or <italic>in vitro</italic> assays, recent investigations based on substrate specificity (Laplante et al., <xref ref-type="bibr" rid="B211">2009</xref>) and knock-out (KO) models (Table <xref ref-type="table" rid="T4">4</xref>) better clarified their roles. Type 1 17βHSD is the estrogenic enzyme and coverts E1 to E2 both in the ovary and in peripheral tissue. Type 2 17βHSD oxidizes 17-hydroxyl groups (E2 and T) to the 17-keto forms (E1 and A4), and possesses also a 20α-hydroxyl oxidative action, through which this enzyme generates P from 20αDHP. Type 6 17βHSD uses 5α-reduced androgens and has 17-hydroxyl oxidative activity (converting androsterone -AN- to androstanedione) and 3-hydroxyl oxidative activity (converting 3αDIOL to the most potent androgen dihydrotestosterone -DHT). Additional catalytic actions for 17βHSD6 (epimerase or 17-hydroxydehydrogenase) are demonstrated <italic>in vitro</italic> (Table <xref ref-type="table" rid="T2">2</xref>). Type 14 17βHSD is postulated to have 17β-hydroxyl oxidative action on various steroids, type 7 is involved in cholesterol metabolism as indicated by KO mice (Table <xref ref-type="table" rid="T4">4</xref>), whereas there is apparently little/no <italic>in vivo</italic> role of types 8, 9, 10, 11 and 12 17βHSDs on steroid metabolism (Table <xref ref-type="table" rid="T2">2</xref> and indicated by KO mice, Table <xref ref-type="table" rid="T4">4</xref>). Recently, a novel SRD, DHRS11, was shown to possess <italic>in vitro</italic> 17-keto to 17β-hydroxyl reductive action (able to use E1, Δ<sup>5</sup> or Δ<sup>4</sup> androstenes, androstanes), plus reductive 3βHSD activity toward Δ<sup>4</sup> pregnenes and other compounds (5β-steroids, bile acids; Table <xref ref-type="table" rid="T2">2</xref> and Figure <xref ref-type="fig" rid="F2">2</xref>; Endo et al., <xref ref-type="bibr" rid="B103">2016</xref>).</p>
<p>Androgens and progestogens can be further metabolized by aldo-ketoreductases (AKRs) and 5α-reductases (SRD5As; Figure <xref ref-type="fig" rid="F2">2</xref>). Cytoplasmic AKRs (AKR1C1, 1C2, 1C3/17βHSD5 and 1C4) have broad substrate specificity with non-stereo-selective 3α/3βHSD, 17- and 20-ketosteroid reductase activities (Table <xref ref-type="table" rid="T2">2</xref>; Penning et al., <xref ref-type="bibr" rid="B307">2004</xref>; Steckelbroeck et al., <xref ref-type="bibr" rid="B405">2010</xref>). Together with the fact that they have wide tissue distribution (only AKR1C4 is restricted), AKR1Cs contribute to make intracrine networks flexible and intricate (Rižner and Penning, <xref ref-type="bibr" rid="B344">2014</xref>; Sinreih et al., <xref ref-type="bibr" rid="B388">2014</xref>).</p>
<p>SRD5As convert 3-keto Δ<sup>4</sup> androstene and pregnene to 5α-reduced steroids (androstanes and pregnanes), hence they are important in progestogen, androgen (DHT production) and neurosteroid metabolism (Di Costanzo et al., <xref ref-type="bibr" rid="B90">2009</xref>). SRD5A1 and 3 are widely expressed, in contrast to SRD5A2. Human 5β-reductase activity, catalyzed by AKR1D1, is restricted to the liver, where 5β-steroids are directed to clearance/catabolism. However, some 5β-compounds are neuroactive and recent studies indicate the presence of AKR1D1 in placenta and myometrium (Jin et al., <xref ref-type="bibr" rid="B178">2011</xref>). With the exclusion of their neuroactivity (Paragraph 4.6), 5β-steroids will not be further considered.</p>
<p>The sulphatase pathway is finally responsible for the balance between sulpho-conjugated and free steroids. Sulpho-conjugated steroids (-S) possess higher water solubility, increased stability and longer half-life than unconjugated compounds (e.g., 10–12 h <italic>vs</italic>. 20–30 min for estrogens), and although they cannot bind steroid-receptors, they serve as a reservoir for the formation of biologically active steroids (Reed et al., <xref ref-type="bibr" rid="B336">2005</xref>). Sulphotransferases (SULTs) are phase-I detoxifying enzymes that use bis-phospho-nucleotide 3′-phospho-adenosine-5′-phosphate- (PAP)-sulfate as donor to conjugate 3β-hydroxyl steroids (e.g., estrogens, DHEA, P5, cholesterol; red circles in Figure <xref ref-type="fig" rid="F2">2</xref>) with a sulfate group (Strott, <xref ref-type="bibr" rid="B418">2002</xref>; Rižner, <xref ref-type="bibr" rid="B343">2016</xref>). Distinct SULTs have different specificities toward substrates, with SULT1E1 being the major estrogen sulphating enzyme (with little contribution of SULT1A1), and SULT2A1 being specific for DHEA (but also for P5, 17OHP5 and A5) (Table <xref ref-type="table" rid="T2">2</xref>). Steroid sulphatase (STS) is a membrane-bound microsomal enzyme that catalyzes the hydrolysis of sulfate ester bonds from sulphated-steroids (cholesterol-S, P5-S, 17OHP5-S, DHEA-S, E1-S) (Mueller et al., <xref ref-type="bibr" rid="B269">2015</xref>; Rižner, <xref ref-type="bibr" rid="B343">2016</xref>), thus releasing unconjugated compounds.</p>
<p>Although sulphated-3α-hydroxysteroids are not thoroughly studied, they are detected in biospecimens (AN-S, 3αDIOL-S; Table <xref ref-type="table" rid="T1">1</xref> and orange circles in Figure <xref ref-type="fig" rid="F2">2</xref>). They are most likely produced by SULT2A1 (active on 3α-hydroxy bile acids) (Strott, <xref ref-type="bibr" rid="B418">2002</xref>; Rižner, <xref ref-type="bibr" rid="B343">2016</xref>) but no 3α-stereo specific sulphatase is known to date. Some intracellular sulphated-steroids are converted to other compounds without prior desulphation (Sánchez-Guijo et al., <xref ref-type="bibr" rid="B361">2016</xref>).</p>
<p>In conclusions, intracrinology presents redundant and complex pathways, which generate compounds with various activities. Genetic variants in intracrine genes are associated with various diseases (classically endocrine and not; Table <xref ref-type="table" rid="T5">5</xref>). Even in the absence of the enzymatic machinery to metabolize cholesterol (StAR, steroidogenic factor, CYP17A1 and CYP11A1), DHEA, P5 and especially their sulphated-conjugates have high blood concentrations (Table <xref ref-type="table" rid="T1">1</xref>), and are used to generate all other steroids in peripheral tissues.</p>
</sec>
</sec>
<sec id="s3">
<title>Drug development</title>
<p>Natural hormones have been historically used as drugs, and depending on definitions, approximately 90 marketed drugs share a steroidal core (see <ext-link ext-link-type="uri" xlink:href="https://www.drugbank.ca">https://www.drugbank.ca</ext-link>). Steroids (T, E2, cortisol, DHEA), simple derivatives (ethinylestrogen, prednisolone) or more complex analogs (abiraterone, fulvestrant) are used in various conditions. This old-and-proven steroidal chemistry based approach is used even in modern era.</p>
<p>By targeting steroid intracrine metabolism, the effects of steroids can be modulated locally. Table <xref ref-type="table" rid="T3">3</xref> overviews the available drugs targeting intracrine enzymes and their developmental status. CYP19A1 (aromatase) inhibitors, currently at their third generation, started to be used for breast cancer during the 80's of last century (Lønning and Eikesdal, <xref ref-type="bibr" rid="B222">2013</xref>), and was followed by drugs able to target other enzymes (CYP11A1, CYP17A1, SRD5As; Table <xref ref-type="table" rid="T3">3</xref>).</p>
<table-wrap id="T3" position="float">
<label>Table 3</label>
<caption>
<p>Drugs targeting intracrine enzymes.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th colspan="1" rowspan="1"></th>
<th align="center" colspan="5" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>Inhibitor name (if known); (Drug Bank ID</bold>
<xref ref-type="table-fn" rid="TN16">
<sup>
<bold>#</bold>
</sup>
</xref>
<bold>)</bold>
</th>
</tr>
<tr>
<th colspan="1" rowspan="1"></th>
<th align="center" colspan="3" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>Developmental phase</bold>
<xref ref-type="table-fn" rid="TN15">
<sup>
<bold>&amp;</bold>
</sup>
</xref>
</th>
<th align="center" colspan="2" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>Approved drugs</bold>
</th>
</tr>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Name</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Discovery</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Preclinical indication</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Clinical indication</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Inhibitor name</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Indication</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CYP11A1</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">Aminoglutethimide<break></break>(DB00357<xref ref-type="table-fn" rid="TN17"><sup>##</sup></xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cushing's syndrome<break></break>Breast cancer</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CYP17A1</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">Abiraterone<break></break>(DB05812)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Prostate cancer, metastatic, castration-resistant</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CYP19A1</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">Letrozole<break></break>(DB01006)<sup>(19, 22, 24)</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top">Anastrozole</td>
<td align="left" colspan="1" rowspan="1" valign="top">Breast cancer: adjuvant treatment, metastatic</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">(DB01217)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Letrozole</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">(DB01006)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Exemestane</td>
<td align="left" colspan="1" rowspan="1" valign="top">Breast cancer, palliative</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">(DB00990)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Formestane<xref ref-type="table-fn" rid="TN24"><sup>1</sup></xref></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Testolactone<xref ref-type="table-fn" rid="TN18"><sup>*</sup></xref></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">(DB00894)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Anastrozole<break></break>(DB01217) <sup>(20, 23)</sup></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Exemestane<break></break>(DB00990) <sup>21</sup></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Advanced stage endometrial cancer, NSCLC<xref ref-type="table-fn" rid="TN22"><sup>∧</sup></xref>, LAM<xref ref-type="table-fn" rid="TN23"><sup>∧∧</sup></xref></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3βHSD1</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">Trilostane*<break></break>(DB01108)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cushing's syndrome<break></break>(veterinary use)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3βHSD2</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">Trilostane*<break></break>(DB01108)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cushing's syndrome<break></break>(veterinary use)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD1</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">Endometriosis<sup>2,3</sup></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Endometrial cancer<sup>4</sup></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Breast cancer<sup>5,6</sup></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Endometrial hyperplasia<sup>7</sup></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD2</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>8,9</sup>
</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD3<xref ref-type="table-fn" rid="TN19"><sup>&amp;&amp;</sup></xref></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Prostate cancer<sup>10</sup></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD7</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>11</sup>
</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">AKR1C1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>12</sup>
</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">AKR1C2</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>12</sup>
</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">AKR1C3</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">ASP-9521<sup>13</sup><break></break>Prostate cancer<xref ref-type="table-fn" rid="TN20"><sup>**</sup></xref></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">BAY 1128688<break></break>Endometriosis<xref ref-type="table-fn" rid="TN21"><sup>***</sup></xref></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">AKR1C4</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>12</sup>
</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SRD5A1</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dutasteride (DB01126)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Prostatic hyperplasia (benign)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SRD5A2</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">Finasteride (DB01216)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Prostatic hyperplasia (benign)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Dutasteride (DB01126)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SRD5A3</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dutasteride (DB01216)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Prostatic hyperplasia (benign)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">STS</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">Irosustat (DB02292)</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Endometrial cancer <sup>14,15</sup></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Breast cancer<sup>14−17</sup></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">E2MATE/PLG2001</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Endometriosis<sup>18</sup></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SULT1E1</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">✓</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cyclizine (DB01176)</td>
<td align="left" colspan="1" rowspan="1" valign="top">antistaminic for nausea/vomiting</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN15">
<label>&amp;</label>
<p><italic>‘Clinical phase’, i.e., in phase I, II or III trial; ‘Preclinical phase’ refers to in vivo testing; ‘Discovery phase’ any previous phase with some candidate compounds</italic>.</p>
</fn>
<fn id="TN16">
<label>#</label>
<p><italic>Drug Bank ID if the compound is deposited in Drug Bank database (<ext-link ext-link-type="uri" xlink:href="http://www.drugbank.ca/drugs">www.drugbank.ca/drugs</ext-link>. Accessed on date: February 2018) (Wishart et al., <xref ref-type="bibr" rid="B471">2018</xref>)</italic>.</p>
</fn>
<fn id="TN17">
<label>##</label>
<p><italic>Aminoglutethimide (ID: DB00357) is an important inhibitor of CYP11A1 with inhibitory activity on CYP19A1 as well</italic>.</p>
</fn>
<fn id="TN18">
<label>*</label>
<p><italic>No longer on the market</italic>.</p>
</fn>
<fn id="TN19">
<label>&amp;&amp;</label>
<p><italic>17βHSD3 is testis specific and the reactions catalyzed by this enzyme are not reported in Figure <xref ref-type="fig" rid="F2">2</xref></italic>.</p>
</fn>
<fn id="TN20">
<label>**</label>
<p><italic>This trial for prostate cancer was prematurely terminated (<ext-link ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov">www.clinicaltrials.gov</ext-link>, NCT01352208)</italic>.</p>
</fn>
<fn id="TN21">
<label>***</label>
<p><italic>Phase I trial is concluded (<ext-link ext-link-type="uri" xlink:href="http://www.clinicaltrials.gov">www.clinicaltrials.gov</ext-link>, NCT02434640. Accessed on date: February 2018) and a phase II trial started 2016 (<ext-link ext-link-type="uri" xlink:href="http://adisinsight.springer.com/drugs/800041929">http://adisinsight.springer.com/drugs/800041929</ext-link>)</italic>.</p>
</fn>
<fn id="TN22">
<label>∧</label>
<p>NSCLC: non-small cell lung cancer</p>
</fn>
<fn id="TN23">
<label>∧∧</label>
<p>LAM: lymphangioleiomyomatosis</p>
</fn>
<fn id="TN24">
<label>1</label>
<p><italic>Perez Carrion et al. (<xref ref-type="bibr" rid="B308">1994</xref>), <sup>2</sup>Arnold and Einspanier (<xref ref-type="bibr" rid="B16">2013</xref>), <sup>3</sup>Delvoux et al. (<xref ref-type="bibr" rid="B84">2014</xref>), <sup>4</sup>Konings et al. (<xref ref-type="bibr" rid="B202">2017</xref>), <sup>5</sup>Järvensivu et al. (<xref ref-type="bibr" rid="B175">2018</xref>), <sup>6</sup>Husen et al. (<xref ref-type="bibr" rid="B162">2006</xref>), <sup>7</sup>Saloniemi et al. (<xref ref-type="bibr" rid="B360">2010</xref>), <sup>8</sup>Gargano et al. (<xref ref-type="bibr" rid="B124">2015</xref>), <sup>9</sup>Soubhye et al. (<xref ref-type="bibr" rid="B403">2015</xref>) <sup>10</sup>Day et al. (<xref ref-type="bibr" rid="B79">2013</xref>), <sup>11</sup> Wang et al. (<xref ref-type="bibr" rid="B467">2017</xref>), <sup>12</sup>BroŽic et al. (<xref ref-type="bibr" rid="B44">2011</xref>), <sup>13</sup> Kikuchi et al. (<xref ref-type="bibr" rid="B187">2014</xref>), <sup>14</sup>Purohit and Foster (<xref ref-type="bibr" rid="B324">2012</xref>), <sup>15</sup>Pautier et al. (<xref ref-type="bibr" rid="B302">2017</xref>), <sup>16</sup>Palmieri et al. (<xref ref-type="bibr" rid="B297">2017a</xref>), <sup>17</sup>Palmieri et al. (<xref ref-type="bibr" rid="B298">2017b</xref>), <sup>18</sup>Pohl et al. (<xref ref-type="bibr" rid="B314">2014</xref>), <sup>19</sup>Ma et al. (<xref ref-type="bibr" rid="B235">2004</xref>), <sup>20</sup>Rose et al. (<xref ref-type="bibr" rid="B348">2000</xref>), <sup>21</sup>Lindemann et al. (<xref ref-type="bibr" rid="B220">2014</xref>), <sup>22</sup>Slomovitz et al. (<xref ref-type="bibr" rid="B395">2015</xref>), <sup>23</sup> NCT00932152; <sup>25</sup>Lu et al. (<xref ref-type="bibr" rid="B229">2017</xref>)</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T4" position="float">
<label>Table 4</label>
<caption>
<p>Mouse models (knockouts - KO or transgenic-TG, i.e., ubiquitous expression of the gene, unless specified) for intracrine enzymes.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene<xref ref-type="table-fn" rid="TN25"><sup>∧</sup></xref></bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Modification MGI ID<xref ref-type="table-fn" rid="TN27"><sup>$</sup></xref></bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Phenotype</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SatAR</td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<xref ref-type="table-fn" rid="TN28"><sup>1</sup></xref><break></break>MGI: 2388706</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Endocrine (steroids) &amp; reproductive endocrinology</bold>
<break></break>- abnormal endocrine organs (adrenal, ovaries, prostate, testis).<break></break>- decreased steroids and increased adrenocorticotropin level.<break></break>- adrenocortical insufficiency.<break></break>- loss of negative feedback regulation at hypothalamic-pituitary levels.</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Additional</bold><break></break>Growth retardation neo/post natal lethality (incomplete penetrance). <italic><bold>Reproductive system</bold></italic>: abnormal uterus; incomplete spermatogenesis; abnormal genitalia.</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">CYP11A1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<sup>2</sup><break></break>MGI:5464022</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Endocrine (steroids) and reproductive endocrinology</bold><break></break>- abnormal adrenal gland morphology.<break></break>- increased circulating adrenocorticotropin level.<break></break>- lack of steroid production.<break></break>- decreased corticosterone and aldosterone levels.</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<sup>3</sup><break></break>MGI: 2183813</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Additional</bold><break></break>Neonatal lethality (rescued by steroid supplementation); abnormal mitochondrion morphology; abnormal lipid level. <italic><bold>Reproductive system</bold></italic>: abnormal genitalia, prostate, testis morphology and spermatogenesis; <italic><bold>Nervous system</bold></italic>: abnormal adrenaline and noradrenaline level; abnormal food intake, hypoactivity; postnatal growth retardation.</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">CYP17A1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<sup>4</sup><break></break>MGI:3722780</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Endocrine (steroids) &amp; reproductive endocrinology</bold><break></break>- increased circulating cholesterol level.<break></break>- decreased T level.<break></break>- early reproductive senescence.</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<sup>5</sup><break></break>MGI:3047328 <break></break><break></break>Null/KO <break></break>MGI:5605834</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Additional</bold><break></break>Homozygous embryonic lethality (Ed7, between implantation and somite formation). <italic><bold>Reproductive system</bold></italic>: abnormal sperm flagellum morphology/asthenozoospermia; reduced male fertility. <italic><bold>Bone:</bold></italic> abnormal bone structure, mineral content and density. <italic><bold>Metabolism:</bold></italic> increased total body fat; decreased lean body mass; increased circulating creatinine level; increased fasted circulating glucose level. <italic><bold>Nervous system</bold></italic>: abnormal sexual interaction.</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">CYP19A1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<sup>6</sup><break></break>MGI:2179439</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Endocrine (steroids) and reproductive endocrinology</bold><break></break>- increased circulating cholesterol, T, DHT, FSH, LH and prolactin.<break></break>- decreased circulating E2 level.<break></break>- abnormal endometrium (thin, decreased uterus weight). <break></break>- abnormal ovary (absence of follicles and corpus luteum, anovulation).</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<sup>7</sup>
<break></break>MGI:2154536<break></break><break></break>Null/KO<sup>8</sup><break></break>MGI:2389548</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Additional</bold><break></break><italic><bold>Reproductive system</bold></italic>: ovary hemorrhage and cysts; increased seminal vesicle weight and abnormal seminiferous tubule epithelium and oligozoospermia; female infertility and reduced male fertility. <italic><bold>Metabolism:</bold></italic> increased fat; obesity and susceptibility to weight gain. <italic><bold>Bone:</bold></italic> decreased bone mineral density and bone mass; increased bone resorption, osteoclast cell number; abnormal compact and trabecular bone morphology. <italic><bold>Metabolism:</bold></italic> increased circulating glucose and triglyceride levels; impaired glucose tolerance; insulin resistance; hepatic steatosis; abnormal liver physiology. <italic><bold>Nervous system</bold></italic>: abnormal short term spatial reference memory; abnormal emotion/affect behavior; abnormal barbering behavior; increased grooming behavior; abnormal locomotor activation, bradykinesia; abnormal mating frequency.</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<sup>9</sup><break></break>MGI:5576042 and 3799948</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Endocrine (steroids</bold>) <bold>&amp; reproductive endocrinology</bold><break></break>- abnormal corpus luteum morphology and decreased number. <break></break>- increased ovarian E1:E2 and A4:T ratios.<break></break>- increased LH level.<break></break>- reduced P level.</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Additional</bold><break></break>Increased circulating alkaline phosphatase level, pigmentation, abnormal retinal pigmentation, abnormal lens morphology, abnormal retina morphology, abnormal retinal pigmentation. <italic><bold>Reproductive system</bold></italic>: increased ovary weight; reduced female fertility. <italic><bold>Metabolism:</bold></italic> decreased circulating glucose level. <italic><bold>Nervous system</bold></italic>: abnormal behavior, response to light, sleep behavior, decreased exploration in new environment; abnormal motor coordination/balance.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17bHSD1</td>
<td align="left" colspan="1" rowspan="1" valign="top">TG<sup>10</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Reproductive endocrinology</bold><break></break>- female have increased T levels.<break></break>- increased E1<inline-graphic xlink:href="fphar-09-00940-i0002.jpg"></inline-graphic>E2 conversion.<break></break>- masculinization in females. <break></break>- develop benign/malignant breast, ovarian and endometrial conditions.</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<sup>11</sup><break></break>MGI:3773836</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>No clear reproductive endocrinology phenotype</bold><break></break><bold>Additional</bold><break></break>Heterozygous mice: growth retardation at birth ant postnatal; premature death; renal degeneration. <italic><bold>Reproductive system</bold></italic>: 70% embryonic lethality (Ed11.5) due to placental defects (homozygous); small and abnormal placenta morphology; <italic><bold>Nervous system</bold></italic>: brain phenotype with enlarged ventricles; abnormal cortex morphology; impaired balance, coordination, abnormal sleep pattern, megacephaly.</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-top: thin solid #000000;" valign="top">TG<sup>12</sup></td>
<td align="left" colspan="1" rowspan="1" style="border-top: thin solid #000000;" valign="top"><bold>Reproductive endocrinology</bold><break></break>- low T level.</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Additional</bold><break></break>Growth retardation; delayed eye opening; impaired retinoic signaling. <italic><bold>Reproductive system</bold></italic>: disrupted spermatogenesis. <italic><bold>Bone:</bold></italic> decreased bone formation (pre-pubertal age); decreased IGF-I and osteocalcin levels.</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD4</td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<sup>13</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>No clear reproductive endocrinology phenotype</bold><break></break><bold>Additional</bold><break></break>Neonatal and postnatal lethality; postnatal growth retardation; abnormal mitochondrion morphology; abnormal bile salt level; hepatic steatosis. <italic><bold>Reproductive system</bold></italic>: abnormal testis and spermatid morphology; seminiferous tubule degeneration; small testis; abnormal gametogenesis; reduced male fertility. <italic><bold>Nervous system</bold></italic>: microgliosis; Purkinje cell degeneration; astrocytosis; axon degeneration; abnormal suckling behavior; increased anxiety-related response, tremors, ataxia, impaired coordination, hypoactivity, lethargy; abnormal gait. <italic><bold>GIT:</bold></italic> abnormal intestinal absorption. <italic><bold>Metabolism:</bold></italic> decreased body weight; abnormal lipid homeostasis and decreased fatty acid level.</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD7</td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<sup>14</sup><break></break>MGI:3811923</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Endocrine (steroids)</bold><break></break>Cholesterol biosynthesis.</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<sup>15</sup><break></break>MGI:4456868</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Additional</bold><break></break>Decreased embryo size; embryo lethality due to heart malformations (Ed10.5); abnormal blood vessel and capillary morphology. <italic><bold>Nervous system</bold></italic>: brain malformations; forebrain hypoplasia; increased neural tube apoptosis.</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD9</td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<sup>16</sup>
<break></break>MGI: 2446073 <break></break><break></break>Null/KO<sup>17</sup>
<break></break>MGI:2388375</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>No clear reproductive endocrinology phenotype</bold><break></break><break></break><break></break><bold>Additional</bold><break></break>Visual defects; abnormal eye electrophysiology, delayed dark adaptation.</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD10</td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<sup>18</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>No clear reproductive endocrinology phenotype</bold><break></break><bold>Additional</bold><break></break>Mitochondria dysfunction; reduced plasma glucose and increase insulin levels. <italic><bold>Nervous system</bold></italic>: neuronal damage.</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" style="border-top: thin solid #000000;" valign="top">TG (brain specific)<sup>19</sup></td>
<td align="left" colspan="1" rowspan="1" style="border-top: thin solid #000000;" valign="top"><bold>No clear reproductive endocrinology phenotype</bold><break></break><bold>Additional</bold><break></break><italic><bold>Nervous system</bold></italic>: Protect against ischemia, Parkinson, Alzheimer disease model</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD11</td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<sup>20</sup>
<break></break>MGI:5581418</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>No clear reproductive endocrinology phenotype</bold><break></break><bold>Additional</bold><break></break>Increased total circulating protein level. <italic><bold>Nervous system</bold></italic>: hyperactivity.</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD12</td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<sup>21</sup></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>No clear reproductive endocrinology phenotype</bold><break></break><bold>Additional</bold><break></break>Embryo lethality Ed 9.5; impaired organogenesis; reduced arachidonic acid synthesis. <italic><bold>Reproductive system</bold></italic>: ovarian dysfunction, fertility problems, smaller litters, significantly fewer numbers of ductal branches than wild type female mammary glands; ovulation problems. <italic><bold>Nervous system</bold></italic>: high embryo expression in neuronal structures.</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD13</td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<sup>22</sup>
<break></break>MGI:5007180</td>
<td align="left" colspan="1" rowspan="1" valign="top">No clear phenotype associated.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD14</td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<sup>23</sup><break></break>MGI:5007181</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>No clear reproductive endocrinology phenotype</bold><break></break><bold>Additional</bold>
<break></break>Increased IgG2a level. <italic><bold>Reproductive system</bold></italic>: oligozoospermia, testis degeneration, male infertility. <italic><bold>Nervous system</bold></italic>: increased response to stress-induced hyperthermia.</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD15</td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<sup>24</sup>
<break></break>MGI:3526658 &amp;<break></break>3586379</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>No clear reproductive endocrinology phenotype</bold><break></break><bold>Additional</bold><break></break>Abnormal eye electrophysiology, delayed dark adaptation</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">AKR1C3/ 17βHSD5<xref ref-type="table-fn" rid="TN26"><sup>*</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<sup>25</sup><break></break>MGI:3527218</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Reproductive endocrinology</bold><break></break>- long gestation, parturition failure.<break></break>- increased levels of P.<break></break>- prolonged estrous and diestrous.</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<sup>26</sup><break></break>MGI:3774264</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Additional</bold><break></break>Small litter size, the number of pups, especially live pups, was markedly decreased hematopoietic system phenotype. <italic><bold>Nervous system</bold></italic>: Some behavioral phonotype,</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">SRD5A1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<sup>27</sup><break></break>MGI:1857454</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Reproductive endocrinology</bold><break></break><bold>-</bold> parturition defects, rescued by 3α-DIOL supplementation.</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Additional</bold><break></break>Decreased litter size; small prostate.</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">SRD5A2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<sup>28</sup><break></break>MGI:2178039</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Reproductive endocrinology</bold>
<break></break><bold>-</bold> T accumulation in reproductive tissues.<break></break>- impaired androgen-dependent gene expression.<break></break><bold>-</bold> parturition defects, rescued by 3α-DIOL supplementation.</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Additional</bold><break></break>Decreased litter size; small prostate.</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">SRD5A3</td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<sup>29</sup><break></break>MGI:5520177</td>
<td align="left" colspan="1" rowspan="1" valign="top"><italic><bold>Mouse not thoroughly characterized</bold></italic><break></break>Embryonic lethality, abnormal heart morphology, abnormal neural tube closure</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">SULT1E1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<sup>30</sup><break></break>MGI:3529586</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Reproductive endocrinology</bold><break></break>- elevated circulating estrogen levels.</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Additional</bold><break></break>Disturbed platelet physiology. <italic><bold>Reproductive system</bold></italic>: leyding cell hyperplasia and abnormal morphology; abnormal testis morphology; abnormal placentation and amniotic fluid composition.</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">SULT2B1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Null/KO<break></break>MGI:5432568<break></break>(unpublished)</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Endocrine (steroids)</bold>
<break></break>disturbed cholesterol metabolism and levels.</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN25">
<label>∧</label>
<p><italic>No report/references was found for 17βHSD3, 17βHSD6, 17βHSD8, 3βHSD1, 3βHSD2, DHRS11, STS, SULT2A1, SULT1A1</italic>.</p>
</fn>
<fn id="TN26">
<label>*</label>
<p><italic>The human AKR1C3/17βHSD5 KO refers to mice with disrupted AKR1C18, however, functional conservation between the four human AKR1Cs and the eight mouse AKR1Cs in unclear (Sudeshna et al., <xref ref-type="bibr" rid="B419">2013</xref>)</italic>.</p>
</fn>
<fn id="TN27">
<label>$</label>
<p><italic>Reference ID refers to the Mouse Genome Informatics (MGI; <ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org">www.informatics.jax.org</ext-link>. Accessed on date: February 2018) (Blake et al., <xref ref-type="bibr" rid="B37">2017</xref>)</italic>.</p>
</fn>
<fn id="TN28">
<label>1</label>
<p><italic>Caron et al. (<xref ref-type="bibr" rid="B55">1997</xref>), <sup>2</sup>Huang et al. (<xref ref-type="bibr" rid="B154">2012</xref>), <sup>3</sup>Hu et al. (<xref ref-type="bibr" rid="B153">2002</xref>), <sup>4</sup>Liu et al. (<xref ref-type="bibr" rid="B221">2005</xref>), <sup>5</sup>Bair and Mellon (<xref ref-type="bibr" rid="B25">2004</xref>), <sup>6</sup>Nemoto et al. (<xref ref-type="bibr" rid="B281">2000</xref>), <sup>7</sup> Fisher et al. (<xref ref-type="bibr" rid="B109">1998</xref>), <sup>8</sup>Honda et al. (<xref ref-type="bibr" rid="B151">1998</xref>), <sup>9</sup>Hakkarainen et al. (<xref ref-type="bibr" rid="B137">2015</xref>), <sup>10</sup>Saloniemi et al. (<xref ref-type="bibr" rid="B360">2010</xref>) and Järvensivu et al. (<xref ref-type="bibr" rid="B175">2018</xref>), <sup>11</sup>Rantakari et al. (<xref ref-type="bibr" rid="B332">2008</xref>), <sup>12</sup>Zhongyi et al. (<xref ref-type="bibr" rid="B497">2007</xref>), <sup>13</sup>Baes et al. (<xref ref-type="bibr" rid="B23">2000</xref>), <sup>14</sup>Shehu et al. (<xref ref-type="bibr" rid="B374">2008</xref>), <sup>15</sup>Jokela et al. (<xref ref-type="bibr" rid="B179">2010</xref>), <sup>16</sup>Shang et al. (<xref ref-type="bibr" rid="B373">2002</xref>), <sup>17</sup>Driessen et al. (<xref ref-type="bibr" rid="B97">2000</xref>) and Sahu et al. (<xref ref-type="bibr" rid="B352">2015</xref>); <sup>18</sup>Li et al. (<xref ref-type="bibr" rid="B215">2010</xref>) and Rauschenberger et al. (<xref ref-type="bibr" rid="B333">2010</xref>); <sup>19</sup>Li et al. (<xref ref-type="bibr" rid="B215">2010</xref>); Rauschenberger et al. (<xref ref-type="bibr" rid="B333">2010</xref>), <sup>20</sup>Dickinson et al. (<xref ref-type="bibr" rid="B93">2016</xref>), <sup>21</sup>Rantakari et al. (<xref ref-type="bibr" rid="B331">2010</xref>); Kemilainen et al. (<xref ref-type="bibr" rid="B185">2016</xref>); <sup>22</sup>Tang et al. (<xref ref-type="bibr" rid="B429">2010</xref>), <sup>23</sup>Tang et al. (<xref ref-type="bibr" rid="B429">2010</xref>), <sup>24</sup>Kim et al. (<xref ref-type="bibr" rid="B190">2005</xref>), <sup>25</sup>Piekorz et al. (<xref ref-type="bibr" rid="B312">2005</xref>), <sup>26</sup>Ishida et al. (<xref ref-type="bibr" rid="B167">2007</xref>), <sup>27</sup>Mahendroo et al. (<xref ref-type="bibr" rid="B241">1996</xref>), <sup>28</sup>Mahendroo et al. (<xref ref-type="bibr" rid="B240">2001</xref>), <sup>29</sup>Dickinson et al. (<xref ref-type="bibr" rid="B93">2016</xref>), <sup>30</sup>Qian et al. (<xref ref-type="bibr" rid="B327">2001</xref>) and Tong et al. (<xref ref-type="bibr" rid="B439">2005</xref>)</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<table-wrap id="T5" position="float">
<label>Table 5</label>
<caption>
<p>Diseases associated with gene variants in intracrine enzymes.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Name</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Affected system or tissue <italic>Disease</italic></bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Phenotype</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>OMIM ID<xref ref-type="table-fn" rid="TN34"><sup>#</sup></xref> References</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">StAR</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Endocrine system</bold>
<break></break>
<italic>Lipoid adrenal hyperplasia</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Deficiency of adrenal or gonadal steroids</td>
<td align="left" colspan="1" rowspan="1" valign="top">OMIM: 201710<xref ref-type="table-fn" rid="TN36"><sup>1</sup></xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">All individuals are phenotypic females</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Infant mortality (mineral- &amp; glucocorticoid deficiency</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">CYP11A1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Endocrine system</bold>
<break></break>
<italic>Congenital adrenal insufficiency, with 46XY sex reversal</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Acute adrenal insufficiency in infancy or childhood</td>
<td align="left" colspan="1" rowspan="1" valign="top">OMIM: 613743<xref ref-type="table-fn" rid="TN36"><sup>1</sup></xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Abnormality of cholesterol metabolism</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Absence of secondary sex characteristics</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Reproductive</bold> (<italic>ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref></italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs<xref ref-type="table-fn" rid="TN33"><sup>∧∧</sup></xref> associated with endometrial cancer</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>2</sup>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Bone</bold> (<italic>ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref></italic>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with skeletal adverse events to AI</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>3</sup>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>CNV</bold> (<italic>ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with neurological disturbances</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>4</sup>
</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">CYP17A1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Endocrine system</bold>
<italic>Congenital adrenal insufficiency (17α-hydroxyl. deficiency)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">Excessive corticosteroids leading to hypertension<break></break>Low aldosterone synthesis<break></break>Abnormal sex determination and secondary sex<break></break>characteristics, amenorrhea</td>
<td align="left" colspan="1" rowspan="1" valign="top">OMIM: 202110<xref ref-type="table-fn" rid="TN36"><sup>1</sup></xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>GIT</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with risk of cancer in the CRC<xref ref-type="table-fn" rid="TN35"><sup>##</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>5</sup>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Reproductive</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with endometrial cancer</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>6</sup>
</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">CYP19A1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Reprod Endocrin</bold>
<xref ref-type="table-fn" rid="TN30">
<sup>**</sup>
</xref>
<italic>Aromatase deficiency</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pseudo hermaphroditism in female</td>
<td align="left" colspan="1" rowspan="1" valign="top">OMIM: 613546</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Cystic ovaries, delayed bone maturation, adiposity</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Aromatase excess syndrome</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Heterosexual precocity and gynecomastia in males</td>
<td align="left" colspan="1" rowspan="1" valign="top">OMIM: 139300</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Isosexual precocity in females</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Reproductive</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with endometrial cancer and ovarian cancer risks, endometriosis risk and risk to develop preeclampsia</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sub>6−14</sub>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Bone</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with osteoporosis and fracture risk</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sub>15, 16</sub>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Lung</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with lung cancer</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>17</sup>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>GIT</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with gastric cancer</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>18</sup>
</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">3βHSD1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Endocr syst</bold>
<xref ref-type="table-fn" rid="TN29">
<sup>*</sup>
</xref>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with hypertension</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>19</sup>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Skin</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with acne susceptibility</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>20</sup>
</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">3βHSD2</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Endocrine system &amp; Reprod Endocrin</bold>
<italic>Congenital adrenal insufficiency (3β-HSD2 deficiency)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">Impaired steroid biosynthesis</td>
<td align="left" colspan="1" rowspan="1" valign="top">OMIM: 201810<xref ref-type="table-fn" rid="TN36"><sup>1</sup></xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Low cortisol, aldosterone, P androgens, estrogens.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Male new-borns exhibit pseudo hermaphroditism</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Incomplete masculinization of the external genitalia</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Affected females can have partial verification</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Urogenital</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with bladder cancer</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>21</sup>
</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Reproductive</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with E2 levels and with endometriosis, cancer risk, abortion</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sub>22−25</sub>
</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD3</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Reprod Endocrin</bold>
<italic>ketosteroidreductase deficiency of testis</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">Males: pseudo hermaphroditism, gynecomastia</td>
<td align="left" colspan="1" rowspan="1" valign="top">OMIM: 264300<xref ref-type="table-fn" rid="TN36"><sup>1</sup></xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Infertility</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD4</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>CNS and</bold>
<break></break>
<bold>Reprod Endocrin</bold>
<break></break>
<italic>Perrault syndrome 1</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ovarian dysgenesis, amenorrhea, low estrogens</td>
<td align="left" colspan="1" rowspan="1" valign="top">OMIM: 233400</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Sensorineural deafness,</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurologic manifestations (mild mental retardation)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>CNS</bold>
<break></break>
<italic>D-bifunctional protein deficiency</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Abnormal peroxisomal fatty acid beta-oxidation</td>
<td align="left" colspan="1" rowspan="1" valign="top">OMIM: 261515</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Deterioration of nervous system functions</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Infantile-onset of hypotonia, seizures, and abnormal facial features, death before the age of 2 years</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD6</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Reproductive</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with PCOS<xref ref-type="table-fn" rid="TN31"><sup>***</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>26</sup>
</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD9</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Eye</bold>
<break></break>
<italic>Fundus albipunctatus</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Fleck retina disease, night blindness, delayed cone and rod photopigment regeneration.</td>
<td align="left" colspan="1" rowspan="1" valign="top">OMIM: 136880</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD10</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>CNS</bold>
<break></break>
<italic>HSD10 mitochondrial disease</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">X-linked neurodegenerative disorder</td>
<td align="left" colspan="1" rowspan="1" valign="top">OMIM: 300438</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Multisystemic features, mitochondrial dysfunction</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<italic>Turner type X-linked mental retardation</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Moderate to profound mental retardation Macrocephaly and variable skeletal features</td>
<td align="left" colspan="1" rowspan="1" valign="top">OMIM: 300706</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD12</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Reproductive</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">(Male) SNPs associated with prostate cancer</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>27</sup>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Lung</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with pulmonary function</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>28</sup>
</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD15</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Eye and CNS</bold>
<break></break>
<italic>Retinal dystrophy, juvenile cataracts, short stature</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Decreased visual acuity, retinitis pigmentosa</td>
<td align="left" colspan="1" rowspan="1" valign="top">OMIM: 616108</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Psychomotor delays from early childhood, lack of fine motor skills and coordination, learning difficulties, facial dysmorphism</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">AKR1C1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Lymphocytes</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with non-Hodgkin lymphoma</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>29</sup>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Lung</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with lung cancer</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>29</sup>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>CNS</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with panic disorders</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>29</sup>
</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">AKR1C2</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Reprod Endocrin</bold>
<italic>46XY sex reversal 8</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">Males: ambiguous external genitalia, cryptorchidism</td>
<td align="left" colspan="1" rowspan="1" valign="top">OMIM: 614279</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Disturbed endocrine features</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Endocr. syst</bold>. <italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with weight-gain predisposition</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>29</sup>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Lung</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with lung cancer</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>29</sup>
</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">AKR1C3</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Reproductive</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with T levels and PCOS</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>29,30</sup>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Lymphocytes</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with large B cell lymphoma</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>29</sup>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Lung</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with lung cancer</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>29</sup>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Leukocytes</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with lung childhood leukemia</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>29</sup>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Urogenital</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with bladder cancer</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>29</sup>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>CNS</bold>
<italic><bold>(ass</bold><xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref><bold>)</bold></italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with amyotrophic lateral sclerosis</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>29</sup>
</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">AKR1C4</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Reprod Endocrin</bold>
<italic>46XY sex reversal 8</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">Males: ambiguous external genitalia, cryptorchidism</td>
<td align="left" colspan="1" rowspan="1" valign="top">OMIM 614279</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Disturbed endocrine features</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">–<italic> (ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with responses to anthracycline</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>29</sup>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>CNS</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with paranoia risk</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>29</sup>
</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">SRD5A1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Reproductive</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">Haplotypes associated with PCOS and hirsutum</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>31</sup>
</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">SRD5A2</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Reprod Endocrin</bold>
<italic>Pseudovaginal perineoscrotal hypospadias</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">Males: pseudo hermaphroditism, ambiguous genitalia, cryptorchidism, small prostate</td>
<td align="left" colspan="1" rowspan="1" valign="top">OMIM: 264600</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">No Mullerian structures, masculinization at puberty</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">No breast development or menstruation at puberty</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Abnormal plasma DHT (and T) level</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Reproductive</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">Haplotypes associated with PCOS</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>31</sup>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Bone</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with low bone mineral density</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>32</sup>
</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">SRD5A3</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>CNS</bold>
<break></break>
<italic>Type Iq congenital glycosylation disorder</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Developmental delay, midline brain malformations</td>
<td align="left" colspan="1" rowspan="1" valign="top">OMIM: 612379</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Variable extents of visual loss</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>CNS</bold>
<break></break>
<italic>Kahrizi syndrome</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mental retardation, delayed motor development, speech impairment, coarse facial features</td>
<td align="left" colspan="1" rowspan="1" valign="top">OMIM: 612713</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">STS</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Skin</bold>
<break></break>
<italic>X-linked ichthyosis</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Cutaneous manifestations: dark brown, polygonal scales and generalized dryness</td>
<td align="left" colspan="1" rowspan="1" valign="top">OMIM: 308100<sup>40</sup></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Bone</bold>
<break></break>
<italic>bone dysplasia</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chondrodysplasia punctata and bone dysplasia</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>33</sup>
</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">SULT1E1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Reproductive</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNP associated with estrogen dependent diseases</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>34</sup>
</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">SULT2A1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Reproductive</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNP associated with DHEA-S, androgens and PCOS</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>40,35</sup>
</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">SULT2B1</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<bold>Skin</bold>
<break></break>
<italic>congenital autosomal recessive ichthyosis</italic>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">Generalized desquamation, dry scaly skin, hyperkeratosis, erythema</td>
<td align="left" colspan="1" rowspan="1" valign="top">OMIM: 604125</td>
</tr>
<tr style="border-top: thin solid #000000;">
<td align="left" colspan="1" rowspan="1" valign="top">SULT1A1</td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Reproductive</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with endometrial cancer</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>11,36</sup>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>Bone</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with low bone mineral density</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>32</sup>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>GIT</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with risk of cancer in the GIT</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>37−38</sup>
</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top"><bold>–</bold>
<italic>(ass<xref ref-type="table-fn" rid="TN32"><sup>∧</sup></xref>)</italic></td>
<td align="left" colspan="1" rowspan="1" valign="top">SNPs associated with activity and termostability</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<sup>37,39</sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Selected papers reporting association between SNPs and diseases are reported. Association studies with enzymes involved in steroid signaling but not discusses in the present review exist (for some references, see Doherty et al., <xref ref-type="bibr" rid="B94">2005</xref>; Freedman et al., <xref ref-type="bibr" rid="B116">2009</xref>; Miller and Auchus, <xref ref-type="bibr" rid="B259">2011</xref>; Mueller et al., <xref ref-type="bibr" rid="B269">2015</xref>)</italic>.</p>
<fn id="TN29">
<label>*</label>
<p><italic>Endocr syst: Endocrine system</italic>.</p>
</fn>
<fn id="TN30">
<label>**</label>
<p><italic>Reprod Endocrin: Reproductive endocrinology</italic>.</p>
</fn>
<fn id="TN31">
<label>***</label>
<p><italic>PCOS: polycystic ovarian syndrome</italic>.</p>
</fn>
<fn id="TN32">
<label>∧</label>
<p><italic>ass: association studies, case controls</italic>.</p>
</fn>
<fn id="TN33">
<label>∧∧</label>
<p><italic>SNP: single nucleotide polymorphism</italic>.</p>
</fn>
<fn id="TN34">
<label>#</label>
<p><italic>OMIM: Online Mendelian Inheritance in Man. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD). (<ext-link ext-link-type="uri" xlink:href="https://omim.org/">https://omim.org/</ext-link>. Accessed on date: February 2018)</italic>.</p>
</fn>
<fn id="TN35">
<label>##</label>
<p><italic>CRC: colorectal cancer</italic>.</p>
</fn>
<fn id="TN36">
<label>1</label>
<p><italic>Miller and Auchus (<xref ref-type="bibr" rid="B259">2011</xref>), <sup>2</sup>Terry et al. (<xref ref-type="bibr" rid="B435">2010</xref>), <sup>3</sup>Rodríguez-Sanz et al. (<xref ref-type="bibr" rid="B347">2015</xref>), <sup>4</sup>Deng et al. (<xref ref-type="bibr" rid="B87">2016</xref>), <sup>5</sup>Zeng et al. (<xref ref-type="bibr" rid="B494">2016</xref>), <sup>6</sup>Olson et al. (<xref ref-type="bibr" rid="B292">2007</xref>), <sup>7</sup>Berstein et al. (<xref ref-type="bibr" rid="B32">2006</xref>), <sup>8</sup>Kitawaki et al. (<xref ref-type="bibr" rid="B194">2002</xref>), <sup>9</sup>Lundin et al. (<xref ref-type="bibr" rid="B231">2012</xref>), <sup>10</sup>Thompson et al. (<xref ref-type="bibr" rid="B438">2016</xref>), <sup>11</sup>Gulyaeva et al. (<xref ref-type="bibr" rid="B135">2008</xref>), <sup>12</sup>Setiawan et al. (<xref ref-type="bibr" rid="B371">2009</xref>), <sup>13</sup>Zacher et al. (<xref ref-type="bibr" rid="B490">2016</xref>), <sup>14</sup>Shimodaira et al. (<xref ref-type="bibr" rid="B379">2012</xref>), <sup>15</sup>Fontein et al. (<xref ref-type="bibr" rid="B111">2014</xref>), <sup>16</sup>Masi et al. (<xref ref-type="bibr" rid="B247">2001</xref>), <sup>17</sup>Zhang et al. (<xref ref-type="bibr" rid="B495">2013</xref>), <sup>18</sup>Cho et al. (<xref ref-type="bibr" rid="B61">2012</xref>), <sup>19</sup>Shimodaira et al. (<xref ref-type="bibr" rid="B380">2010</xref>), <sup>20</sup>Yang et al. (<xref ref-type="bibr" rid="B486">2013</xref>), <sup>21</sup>Andrew et al. (<xref ref-type="bibr" rid="B14">2012</xref>), <sup>22</sup>Tsuchiya et al. (<xref ref-type="bibr" rid="B448">2005</xref>), <sup>23</sup>Huber et al. (<xref ref-type="bibr" rid="B156">2005</xref>), <sup>24</sup>Setiawan et al. (<xref ref-type="bibr" rid="B372">2004</xref>), <sup>25</sup>Shi et al. (<xref ref-type="bibr" rid="B376">2016</xref>), <sup>26</sup>Jones et al. (<xref ref-type="bibr" rid="B181">2009</xref>), <sup>27</sup>Audet-Walsh et al. (<xref ref-type="bibr" rid="B19">2012</xref>), <sup>28</sup>Loth et al. (<xref ref-type="bibr" rid="B227">2014</xref>), <sup>29</sup>Alshogran (<xref ref-type="bibr" rid="B10">2017</xref>), <sup>30</sup>Qin et al. (<xref ref-type="bibr" rid="B328">2006</xref>), <sup>31</sup>Goodarzi et al. (<xref ref-type="bibr" rid="B131">2006</xref>), <sup>32</sup>Zarrabeitia et al. (<xref ref-type="bibr" rid="B492">2007</xref>), <sup>33</sup>Wöhrle et al. (<xref ref-type="bibr" rid="B473">1990</xref>), <sup>34</sup>Adjei et al. (<xref ref-type="bibr" rid="B5">2003</xref>), <sup>35</sup>Goodarzi et al. (<xref ref-type="bibr" rid="B130">2007</xref>), <sup>36</sup>Ashton et al. (<xref ref-type="bibr" rid="B17">2010</xref>), <sup>37</sup>Lilla et al. (<xref ref-type="bibr" rid="B217">2007</xref>), <sup>38</sup>Xiao et al. (<xref ref-type="bibr" rid="B476">2014</xref>), <sup>39</sup>Sun et al. (<xref ref-type="bibr" rid="B420">2005</xref>), and <sup>40</sup>Mueller et al. (<xref ref-type="bibr" rid="B269">2015</xref>)</italic>.</p>
</fn>
<p><italic>Bold text indicates the system affected, italics text indicates the name of the disease</italic>.</p>
</table-wrap-foot>
</table-wrap>
<p>More recently, there is a re-emerging interest in developing novel intracrine drugs. A number of compounds are in their clinical phases, like STS inhibitors (Maltais and Poirier, <xref ref-type="bibr" rid="B244">2011</xref>; Woo et al., <xref ref-type="bibr" rid="B474">2011</xref>; Purohit and Foster, <xref ref-type="bibr" rid="B324">2012</xref>; Pohl et al., <xref ref-type="bibr" rid="B314">2014</xref>; Pautier et al., <xref ref-type="bibr" rid="B302">2017</xref>) or inhibitors of AKR1C3/17βHSD5, which are of particular interest because this enzyme has crucial role in androgen/estrogen and prostaglandin biosynthesis (Penning, <xref ref-type="bibr" rid="B305">2017</xref>). Bayer's AKR1C3/17βHSD5 inhibitor BAY 1128688 has a modified estrogen core, it interferes with both pathways, and is in phase II clinical trial for endometriosis (Bothe et al., <xref ref-type="bibr" rid="B39">2017</xref>). Astellas Pharma potent and selective AKR1C3/17βHSD5 inhibitor ASP-9521 had only modest effect in a phase II study on prostate cancer as single drug, but combination therapy approaches remain to be studied (Kikuchi et al., <xref ref-type="bibr" rid="B187">2014</xref>; Loriot et al., <xref ref-type="bibr" rid="B226">2014</xref>).</p>
<p>HSD inhibitors are being studied in the area of hormone-dependent diseases, with 11βHSD inhibitors being in clinical trials for metabolic disorders (Ye et al., <xref ref-type="bibr" rid="B487">2017</xref>) and 17βHSD inhibitors approaching the clinical phase for a number of gynecological indications (Table <xref ref-type="table" rid="T3">3</xref>; Abdelsamie et al., <xref ref-type="bibr" rid="B1">2017</xref>).</p>
</sec>
<sec id="s4">
<title>Intracrinology in peripheral tissues</title>
<p>In this paragraph, intracrinology of endometrium, GIT, bone, lungs, and CNS is reviewed. To comprehensively understand the ability of these tissues and systems to generate estrogens and other steroids, we have performed a systematic search of all original papers published in English until June 2018 that described the levels of intracrine enzymes (those indicated in Table <xref ref-type="table" rid="T2">2</xref>-mRNA, protein or activity) in healthy tissues. In total 177 if the four extra ref are allowed papers were reviewed, and for details of this search, see <xref ref-type="supplementary-material" rid="SM1">Supplemental panel</xref>: “Systematic Review.” The results of this systematic review are summarized in Tables <xref ref-type="table" rid="T6">6</xref>–<bold>8</bold> and are briefly overviewed in each section dedicated to the distinct tissues or systems. Reports describing the enzymes in cultured cells or cell lines were excluded (may have been discussed elsewhere, though). Each section follows then with a non-systematic overview of the role of intracrinology in pathophysiology. A brief non-systematic description of the intracrinology of the skin, immune system and adipose tissue is also given. We will not describe the intracrinology of breast, prostate and liver (where steroid catabolism is the most relevant aspect), and we redirect the reader to recent reviews (Foster et al., <xref ref-type="bibr" rid="B113">2008a</xref>; Luu-The et al., <xref ref-type="bibr" rid="B233">2008</xref>; Luu-The and Labrie, <xref ref-type="bibr" rid="B234">2010</xref>; Labrie and Labrie, <xref ref-type="bibr" rid="B209">2013</xref>; Labrie, <xref ref-type="bibr" rid="B208">2015</xref>; Mueller et al., <xref ref-type="bibr" rid="B269">2015</xref>; Zhao et al., <xref ref-type="bibr" rid="B496">2016</xref>; Hilborn et al., <xref ref-type="bibr" rid="B149">2017</xref>; Penning, <xref ref-type="bibr" rid="B305">2017</xref>).</p>
<table-wrap id="T6" position="float">
<label>Table 6</label>
<caption>
<p>Expression of intracrine enzymes in endometrium–results of the systematic search.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Name</bold>
</th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th align="center" colspan="2" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>Menopausal status</bold>
</th>
<th colspan="1" rowspan="1"></th>
</tr>
<tr>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Technique</bold>
<xref ref-type="table-fn" rid="TN38">
<bold>
<sup>#</sup>
</bold>
</xref>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Pre</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>Post</bold>
</th>
<th align="center" colspan="1" rowspan="1" valign="top">
<bold>References</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">StAR</td>
<td align="center" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Bukulmez et al., <xref ref-type="bibr" rid="B45">2008a</xref>; Attar et al., <xref ref-type="bibr" rid="B18">2009</xref>; Sinreih et al., <xref ref-type="bibr" rid="B391">2017b</xref><xref ref-type="table-fn" rid="TN42"><sup>&amp;</sup></xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CYP11A1</td>
<td align="center" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">n.d.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tsai et al., <xref ref-type="bibr" rid="B443">2001</xref>; Rhee et al., <xref ref-type="bibr" rid="B339">2003</xref>; Attar et al., <xref ref-type="bibr" rid="B18">2009</xref>; Sinreih et al., <xref ref-type="bibr" rid="B389">2013</xref>; Huhtinen et al., <xref ref-type="bibr" rid="B160">2014</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="center" colspan="1" rowspan="1" valign="top">n.d.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rhee et al., <xref ref-type="bibr" rid="B339">2003</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CYP17A1</td>
<td align="center" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">n.d.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tsai et al., <xref ref-type="bibr" rid="B443">2001</xref>; Attar et al., <xref ref-type="bibr" rid="B18">2009</xref>; Huhtinen et al., <xref ref-type="bibr" rid="B160">2014</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="center" colspan="1" rowspan="1" valign="top">n.d.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rhee et al., <xref ref-type="bibr" rid="B339">2003</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Watanabe et al., <xref ref-type="bibr" rid="B469">1995</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CYP19A1</td>
<td align="center" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dheenadayalu et al., <xref ref-type="bibr" rid="B89">2002</xref>; Brosens et al., <xref ref-type="bibr" rid="B43">2004</xref>; Matsuzaki et al., <xref ref-type="bibr" rid="B249">2006</xref>; Pathirage et al., <xref ref-type="bibr" rid="B301">2006</xref>; Smuc et al., <xref ref-type="bibr" rid="B401">2006</xref>, <xref ref-type="bibr" rid="B398">2009</xref>; Dassen et al., <xref ref-type="bibr" rid="B77">2007</xref>; Bukulmez et al., <xref ref-type="bibr" rid="B46">2008b</xref>; Attar et al., <xref ref-type="bibr" rid="B18">2009</xref>; Smuc and Rizner, <xref ref-type="bibr" rid="B400">2009</xref>; Lépine et al., <xref ref-type="bibr" rid="B214">2010</xref>; Cornel et al., <xref ref-type="bibr" rid="B70">2012</xref>; Huhtinen et al., <xref ref-type="bibr" rid="B159">2012a</xref>; Delvoux et al., <xref ref-type="bibr" rid="B84">2014</xref>; Sinreih et al., <xref ref-type="bibr" rid="B390">2017a</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Bulun et al., <xref ref-type="bibr" rid="B48">1993</xref>, <xref ref-type="bibr" rid="B47">1994</xref>; Watanabe et al., <xref ref-type="bibr" rid="B469">1995</xref>; Noble et al., <xref ref-type="bibr" rid="B284">1996</xref>, <xref ref-type="bibr" rid="B285">1997</xref>; Kitawaki et al., <xref ref-type="bibr" rid="B196">1999</xref>; Bacallao et al., <xref ref-type="bibr" rid="B22">2008</xref>; Colette et al., <xref ref-type="bibr" rid="B66">2009</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">ISH</td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="center" colspan="1" rowspan="1" valign="top">n.d.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Watanabe et al., <xref ref-type="bibr" rid="B469">1995</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="center" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Maentausta et al., <xref ref-type="bibr" rid="B238">1990</xref>; Kitaoka et al., <xref ref-type="bibr" rid="B193">2004</xref>; Maia et al., <xref ref-type="bibr" rid="B243">2006</xref>, <xref ref-type="bibr" rid="B242">2007</xref>; Hudelist et al., <xref ref-type="bibr" rid="B157">2007</xref>; Vouk et al., <xref ref-type="bibr" rid="B463">2011</xref>; Miller et al., <xref ref-type="bibr" rid="B257">2012a</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Watanabe et al., <xref ref-type="bibr" rid="B469">1995</xref>; Kitawaki et al., <xref ref-type="bibr" rid="B196">1999</xref>; Velasco et al., <xref ref-type="bibr" rid="B458">2006</xref>; Acién et al., <xref ref-type="bibr" rid="B2">2007</xref>; Jeon et al., <xref ref-type="bibr" rid="B177">2007</xref>; Bukulmez et al., <xref ref-type="bibr" rid="B46">2008b</xref>; Colette et al., <xref ref-type="bibr" rid="B66">2009</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">WB</td>
<td align="center" colspan="1" rowspan="1" valign="top">N.d.</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Knapp et al., <xref ref-type="bibr" rid="B197">2013</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">activity</td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Bulun et al., <xref ref-type="bibr" rid="B48">1993</xref>; Watanabe et al., <xref ref-type="bibr" rid="B469">1995</xref>; Noble et al., <xref ref-type="bibr" rid="B285">1997</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">activity</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tseng et al., <xref ref-type="bibr" rid="B447">1982</xref>; Yamaki et al., <xref ref-type="bibr" rid="B479">1985</xref>; Taga et al., <xref ref-type="bibr" rid="B424">1990</xref>; Yamamoto et al., <xref ref-type="bibr" rid="B480">1990a</xref>,<xref ref-type="bibr" rid="B483">b</xref>, <xref ref-type="bibr" rid="B481">1993a</xref>,<xref ref-type="bibr" rid="B482">b</xref>; Jongen et al., <xref ref-type="bibr" rid="B182">2005</xref>; Purohit et al., <xref ref-type="bibr" rid="B325">2008</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3βHSD1</td>
<td align="center" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rhee et al., <xref ref-type="bibr" rid="B339">2003</xref>; Vani et al., <xref ref-type="bibr" rid="B455">2007</xref>; Attar et al., <xref ref-type="bibr" rid="B18">2009</xref>; Smuc et al., <xref ref-type="bibr" rid="B398">2009</xref>; Gibson et al., <xref ref-type="bibr" rid="B127">2013</xref>; Sinreih et al., <xref ref-type="bibr" rid="B389">2013</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">Protein<xref ref-type="table-fn" rid="TN39"><sup>*</sup></xref></td>
<td align="center" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">n.d.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rhee et al., <xref ref-type="bibr" rid="B339">2003</xref>; Vani et al., <xref ref-type="bibr" rid="B455">2007</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Watanabe et al., <xref ref-type="bibr" rid="B469">1995</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3βHSD2</td>
<td align="center" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tsai et al., <xref ref-type="bibr" rid="B443">2001</xref>; Attar et al., <xref ref-type="bibr" rid="B18">2009</xref>; Huhtinen et al., <xref ref-type="bibr" rid="B160">2014</xref>; Osinski et al., <xref ref-type="bibr" rid="B293">2018</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSDs</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">oxidative activity</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tseng and Gurpide, <xref ref-type="bibr" rid="B444">1974</xref>; Pollow et al., <xref ref-type="bibr" rid="B315">1975a</xref>,<xref ref-type="bibr" rid="B316">b</xref>, <xref ref-type="bibr" rid="B317">1976</xref>; Polow et al., <xref ref-type="bibr" rid="B318">1975</xref>; Tseng et al., <xref ref-type="bibr" rid="B445">1977</xref>; Lane, <xref ref-type="bibr" rid="B210">1990</xref>; Kitawaki et al., <xref ref-type="bibr" rid="B195">2000</xref>; Utsunomiya et al., <xref ref-type="bibr" rid="B452">2001</xref>; Delvoux et al., <xref ref-type="bibr" rid="B86">2007</xref>, <xref ref-type="bibr" rid="B85">2009</xref>; Cornel et al., <xref ref-type="bibr" rid="B70">2012</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">reductive activity</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Maentausta et al., <xref ref-type="bibr" rid="B238">1990</xref>; Delvoux et al., <xref ref-type="bibr" rid="B86">2007</xref>, <xref ref-type="bibr" rid="B85">2009</xref>, <xref ref-type="bibr" rid="B84">2014</xref>; Bacallao et al., <xref ref-type="bibr" rid="B22">2008</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Utsunomiya et al., <xref ref-type="bibr" rid="B452">2001</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD1</td>
<td align="center" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Zeitoun et al., <xref ref-type="bibr" rid="B493">1998</xref>; Dassen et al., <xref ref-type="bibr" rid="B77">2007</xref>; Smuc et al., <xref ref-type="bibr" rid="B399">2007</xref>, <xref ref-type="bibr" rid="B398">2009</xref>; Bacallao et al., <xref ref-type="bibr" rid="B22">2008</xref>; Huhtinen et al., <xref ref-type="bibr" rid="B159">2012a</xref>; Colette et al., <xref ref-type="bibr" rid="B65">2013</xref>; Delvoux et al., <xref ref-type="bibr" rid="B84">2014</xref>; Sinreih et al., <xref ref-type="bibr" rid="B390">2017a</xref>; Osinski et al., <xref ref-type="bibr" rid="B293">2018</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">NB</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">n.d.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Zeitoun et al., <xref ref-type="bibr" rid="B493">1998</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Casey et al., <xref ref-type="bibr" rid="B56">1994</xref>; Utsunomiya et al., <xref ref-type="bibr" rid="B452">2001</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="center" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Maentausta et al., <xref ref-type="bibr" rid="B238">1990</xref><xref ref-type="table-fn" rid="TN42"><sup>&amp;</sup></xref>; Mäentausta et al., <xref ref-type="bibr" rid="B239">1991</xref>; Li et al., <xref ref-type="bibr" rid="B216">2003</xref>; Dassen et al., <xref ref-type="bibr" rid="B77">2007</xref>; Colette et al., <xref ref-type="bibr" rid="B65">2013</xref>; Mori et al., <xref ref-type="bibr" rid="B266">2015</xref>; He et al., <xref ref-type="bibr" rid="B140">2016</xref>; Sinreih et al., <xref ref-type="bibr" rid="B390">2017a</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Utsunomiya et al., <xref ref-type="bibr" rid="B452">2001</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD2</td>
<td align="center" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Mäentausta et al., <xref ref-type="bibr" rid="B239">1991</xref>; Zeitoun et al., <xref ref-type="bibr" rid="B493">1998</xref>; Kitawaki et al., <xref ref-type="bibr" rid="B195">2000</xref>, <xref ref-type="bibr" rid="B194">2002</xref>; Utsunomiya et al., <xref ref-type="bibr" rid="B452">2001</xref>; Matsuzaki et al., <xref ref-type="bibr" rid="B249">2006</xref>; Smuc et al., <xref ref-type="bibr" rid="B401">2006</xref>, <xref ref-type="bibr" rid="B399">2007</xref>, <xref ref-type="bibr" rid="B398">2009</xref>; Carneiro et al., <xref ref-type="bibr" rid="B54">2007</xref>; Dassen et al., <xref ref-type="bibr" rid="B77">2007</xref>; Vani et al., <xref ref-type="bibr" rid="B455">2007</xref>; Bacallao et al., <xref ref-type="bibr" rid="B22">2008</xref>; Hevir et al., <xref ref-type="bibr" rid="B147">2011b</xref>; Huhtinen et al., <xref ref-type="bibr" rid="B159">2012a</xref>; Colette et al., <xref ref-type="bibr" rid="B65">2013</xref>; Delvoux et al., <xref ref-type="bibr" rid="B84">2014</xref>; Sinreih et al., <xref ref-type="bibr" rid="B390">2017a</xref>; Osinski et al., <xref ref-type="bibr" rid="B293">2018</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">NB</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">n.d.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Zeitoun et al., <xref ref-type="bibr" rid="B493">1998</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="center" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Scublinsky et al., <xref ref-type="bibr" rid="B368">1976</xref>; Ciuffi et al., <xref ref-type="bibr" rid="B62">1982</xref>; Utsunomiya et al., <xref ref-type="bibr" rid="B452">2001</xref>; Dassen et al., <xref ref-type="bibr" rid="B77">2007</xref>; Colette et al., <xref ref-type="bibr" rid="B65">2013</xref>; Cornel et al., <xref ref-type="bibr" rid="B69">2017</xref>; Sinreih et al., <xref ref-type="bibr" rid="B390">2017a</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD4</td>
<td align="center" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dassen et al., <xref ref-type="bibr" rid="B77">2007</xref>; Smuc et al., <xref ref-type="bibr" rid="B398">2009</xref>; Huhtinen et al., <xref ref-type="bibr" rid="B159">2012a</xref>; Delvoux et al., <xref ref-type="bibr" rid="B84">2014</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">NB</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">n.d.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Möller et al., <xref ref-type="bibr" rid="B264">1999</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD6</td>
<td align="center" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">n.d.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Huang and Luu-The, <xref ref-type="bibr" rid="B155">2000</xref>; Huhtinen et al., <xref ref-type="bibr" rid="B159">2012a</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD7</td>
<td align="center" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Smuc et al., <xref ref-type="bibr" rid="B399">2007</xref>, <xref ref-type="bibr" rid="B398">2009</xref>; Smuc and Rizner, <xref ref-type="bibr" rid="B400">2009</xref>; Lépine et al., <xref ref-type="bibr" rid="B214">2010</xref>; Cornel et al., <xref ref-type="bibr" rid="B70">2012</xref>; Huhtinen et al., <xref ref-type="bibr" rid="B159">2012a</xref>; Delvoux et al., <xref ref-type="bibr" rid="B84">2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD8</td>
<td align="center" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Smuc and Rizner, <xref ref-type="bibr" rid="B400">2009</xref>; Smuc et al., <xref ref-type="bibr" rid="B398">2009</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD10</td>
<td align="center" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">n.d.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Huhtinen et al., <xref ref-type="bibr" rid="B159">2012a</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD12</td>
<td align="center" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Smuc and Rizner, <xref ref-type="bibr" rid="B400">2009</xref>; Smuc et al., <xref ref-type="bibr" rid="B398">2009</xref>; Lépine et al., <xref ref-type="bibr" rid="B214">2010</xref>; Cornel et al., <xref ref-type="bibr" rid="B70">2012</xref>; Huhtinen et al., <xref ref-type="bibr" rid="B159">2012a</xref>; Delvoux et al., <xref ref-type="bibr" rid="B84">2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD14</td>
<td align="center" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">n.d.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Huhtinen et al., <xref ref-type="bibr" rid="B159">2012a</xref>; Sinreih et al., <xref ref-type="bibr" rid="B390">2017a</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">AKR1Cs</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">AKR1C1</td>
<td align="center" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rizner et al., <xref ref-type="bibr" rid="B345">2006</xref>; Smuc and Rizner, <xref ref-type="bibr" rid="B400">2009</xref>; Smuc et al., <xref ref-type="bibr" rid="B398">2009</xref>; Hevir et al., <xref ref-type="bibr" rid="B147">2011b</xref>; Sinreih et al., <xref ref-type="bibr" rid="B389">2013</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">AKR1C2</td>
<td align="center" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hevir et al., <xref ref-type="bibr" rid="B147">2011b</xref>; Sinreih et al., <xref ref-type="bibr" rid="B389">2013</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">AKR1C3/17<break></break>βHSD5</td>
<td align="center" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Penning et al., <xref ref-type="bibr" rid="B306">2000</xref>; Rizner et al., <xref ref-type="bibr" rid="B345">2006</xref>; Vani et al., <xref ref-type="bibr" rid="B455">2007</xref>; Smuc and Rizner, <xref ref-type="bibr" rid="B400">2009</xref>; Smuc et al., <xref ref-type="bibr" rid="B398">2009</xref>; Hevir et al., <xref ref-type="bibr" rid="B147">2011b</xref>; Cornel et al., <xref ref-type="bibr" rid="B70">2012</xref>; Huhtinen et al., <xref ref-type="bibr" rid="B159">2012a</xref>; Sinreih et al., <xref ref-type="bibr" rid="B389">2013</xref>; Delvoux et al., <xref ref-type="bibr" rid="B84">2014</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="center" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pelletier et al., <xref ref-type="bibr" rid="B304">1999</xref>; Ito et al., <xref ref-type="bibr" rid="B170">2006</xref>; Vani et al., <xref ref-type="bibr" rid="B455">2007</xref>; Smuc and Rizner, <xref ref-type="bibr" rid="B400">2009</xref>; Zakharov et al., <xref ref-type="bibr" rid="B491">2010</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SRD5As</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SRD5A1</td>
<td align="center" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Carneiro et al., <xref ref-type="bibr" rid="B53">2008</xref>; Hevir et al., <xref ref-type="bibr" rid="B147">2011b</xref>; Sinreih et al., <xref ref-type="bibr" rid="B389">2013</xref>; Huhtinen et al., <xref ref-type="bibr" rid="B160">2014</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="center" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ito et al., <xref ref-type="bibr" rid="B169">2002</xref>; Carneiro et al., <xref ref-type="bibr" rid="B53">2008</xref>; Tanaka et al., <xref ref-type="bibr" rid="B428">2015</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SRD5A2</td>
<td align="center" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Carneiro et al., <xref ref-type="bibr" rid="B53">2008</xref>; Hevir et al., <xref ref-type="bibr" rid="B147">2011b</xref>; Sinreih et al., <xref ref-type="bibr" rid="B389">2013</xref>; Huhtinen et al., <xref ref-type="bibr" rid="B160">2014</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="center" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ito et al., <xref ref-type="bibr" rid="B169">2002</xref>; Carneiro et al., <xref ref-type="bibr" rid="B53">2008</xref>; Tanaka et al., <xref ref-type="bibr" rid="B428">2015</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SRD5A3</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">n.d.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Huhtinen et al., <xref ref-type="bibr" rid="B160">2014</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Sulphatase pathway</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">STS</td>
<td align="center" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tanaka et al., <xref ref-type="bibr" rid="B426">2003</xref>; Utsunomiya et al., <xref ref-type="bibr" rid="B450">2004</xref>; Smuc et al., <xref ref-type="bibr" rid="B401">2006</xref>, <xref ref-type="bibr" rid="B399">2007</xref>, <xref ref-type="bibr" rid="B398">2009</xref>; Dalla Valle et al., <xref ref-type="bibr" rid="B75">2007</xref>; Dassen et al., <xref ref-type="bibr" rid="B77">2007</xref>; Bacallao et al., <xref ref-type="bibr" rid="B22">2008</xref>; Smuc and Rizner, <xref ref-type="bibr" rid="B400">2009</xref>; Lépine et al., <xref ref-type="bibr" rid="B214">2010</xref>; Colette et al., <xref ref-type="bibr" rid="B65">2013</xref>; Huhtinen et al., <xref ref-type="bibr" rid="B160">2014</xref>; Piccinato et al., <xref ref-type="bibr" rid="B311">2016b</xref>; Sinreih et al., <xref ref-type="bibr" rid="B390">2017a</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Miki et al., <xref ref-type="bibr" rid="B255">2002</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">Comp-RT</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">n.d.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Yanaihara et al., <xref ref-type="bibr" rid="B484">2001</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="center" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Yanaihara et al., <xref ref-type="bibr" rid="B484">2001</xref>; Utsunomiya et al., <xref ref-type="bibr" rid="B450">2004</xref>; Dassen et al., <xref ref-type="bibr" rid="B77">2007</xref>; Cornel et al., <xref ref-type="bibr" rid="B69">2017</xref>; Sinreih et al., <xref ref-type="bibr" rid="B390">2017a</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Miki et al., <xref ref-type="bibr" rid="B255">2002</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">activity</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">Warren and French, <xref ref-type="bibr" rid="B468">1965</xref>; Prost and Adessi, <xref ref-type="bibr" rid="B322">1983</xref>; Adessi et al., <xref ref-type="bibr" rid="B4">1984</xref>; Platia et al., <xref ref-type="bibr" rid="B313">1984</xref>; Yamamoto et al., <xref ref-type="bibr" rid="B480">1990a</xref>, <xref ref-type="bibr" rid="B481">1993a</xref>; Tanaka et al., <xref ref-type="bibr" rid="B426">2003</xref>; Bacallao et al., <xref ref-type="bibr" rid="B22">2008</xref>; Purohit et al., <xref ref-type="bibr" rid="B325">2008</xref>; Delvoux et al., <xref ref-type="bibr" rid="B85">2009</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Utsunomiya et al., <xref ref-type="bibr" rid="B450">2004</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SULT1E1</td>
<td align="center" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Yamamoto et al., <xref ref-type="bibr" rid="B481">1993a</xref>; Miki et al., <xref ref-type="bibr" rid="B255">2002</xref>; Tanaka et al., <xref ref-type="bibr" rid="B426">2003</xref>; Utsunomiya et al., <xref ref-type="bibr" rid="B450">2004</xref>; Smuc et al., <xref ref-type="bibr" rid="B401">2006</xref>, <xref ref-type="bibr" rid="B399">2007</xref>; Dassen et al., <xref ref-type="bibr" rid="B77">2007</xref>; Bacallao et al., <xref ref-type="bibr" rid="B22">2008</xref>; Smuc and Rizner, <xref ref-type="bibr" rid="B400">2009</xref>; Lépine et al., <xref ref-type="bibr" rid="B214">2010</xref>; Hevir et al., <xref ref-type="bibr" rid="B146">2011a</xref>, <xref ref-type="bibr" rid="B145">2013</xref>; Colette et al., <xref ref-type="bibr" rid="B65">2013</xref>; Piccinato et al., <xref ref-type="bibr" rid="B311">2016b</xref>; Sinreih et al., <xref ref-type="bibr" rid="B390">2017a</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">NB</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">n.d.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rubin et al., <xref ref-type="bibr" rid="B351">1999</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="center" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Miki et al., <xref ref-type="bibr" rid="B255">2002</xref>; Utsunomiya et al., <xref ref-type="bibr" rid="B450">2004</xref>; Hudelist et al., <xref ref-type="bibr" rid="B157">2007</xref>; Cornel et al., <xref ref-type="bibr" rid="B69">2017</xref>; Sinreih et al., <xref ref-type="bibr" rid="B390">2017a</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">activity</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tanaka et al., <xref ref-type="bibr" rid="B426">2003</xref>; Utsunomiya et al., <xref ref-type="bibr" rid="B450">2004</xref>; Bacallao et al., <xref ref-type="bibr" rid="B22">2008</xref>; Purohit et al., <xref ref-type="bibr" rid="B325">2008</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SULT1A1</td>
<td align="center" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hevir et al., <xref ref-type="bibr" rid="B146">2011a</xref>, <xref ref-type="bibr" rid="B145">2013</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SULT1A1</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">NB</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">n.d.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rubin et al., <xref ref-type="bibr" rid="B351">1999</xref><xref ref-type="table-fn" rid="TN41"><sup>***</sup></xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SULT2A1</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1" valign="top">NB</td>
<td align="center" colspan="1" rowspan="1" valign="top">no</td>
<td align="center" colspan="1" rowspan="1" valign="top">n.d.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rubin et al., <xref ref-type="bibr" rid="B351">1999</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SULT2B1</td>
<td align="center" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="center" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="center" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hevir et al., <xref ref-type="bibr" rid="B146">2011a</xref>, <xref ref-type="bibr" rid="B145">2013</xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Primary/original references were analyzed and reviews were excluded (and are cited ad hoc in the text). The table report only the enzymes whose expression was assessed in reviewed studies<sup>**</sup></italic>.</p>
<fn id="TN38">
<label>#</label>
<p><italic>Technique abbreviations. For mRNA detection, NB: northern blot; ISH: in situ hybridisation; RT-PCR: reverse transcription semi or quantitative PCR; Comp-RT: competitive RT-PCR. For protein detection: IHC: immunohistochemistry; WB: western blotting. For enzyme activity measurement: activity</italic>.</p>
</fn>
<fn id="TN39">
<label>*</label>
<p><italic>Most commercially available antibodies do not distinguish between 3βHSD1 and 3βHSD1</italic>.</p>
</fn>
<fn id="TN40">
<label>**</label>
<p><italic>No publication was found describing the expression of 17βHSD9, 11, 13, 15, DHRS11 and AKR1C4</italic>.</p>
</fn>
<fn id="TN41">
<label>***</label>
<p><italic>The same study also detected expression of SULT1A3 (Rubin et al., <xref ref-type="bibr" rid="B351">1999</xref>)</italic>.</p>
</fn>
<p>n.d.: not determined.</p>
<fn id="TN42">
<label>&amp;</label>
<p><italic>Protein level was measured by radioimmunoassay</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<sec>
<title>Endometrium</title>
<p>The actions of steroid hormones in the endometrium are mediated by hormone-receptors <italic>via</italic> the classical mechanisms, although non-genomic and rapid signaling are also present (Groothuis et al., <xref ref-type="bibr" rid="B132">2007</xref>; Zwart et al., <xref ref-type="bibr" rid="B498">2011</xref>; Flach and Zwart, <xref ref-type="bibr" rid="B110">2016</xref>; Hewitt et al., <xref ref-type="bibr" rid="B148">2016</xref>). Estrogens and P control the menstrual cycle (Groothuis et al., <xref ref-type="bibr" rid="B132">2007</xref>; Andersen and Ezcurra, <xref ref-type="bibr" rid="B13">2014</xref>) and the endometrium during the window of implantation (WOI), occurring in the mid-luteal phase (Wang and Dey, <xref ref-type="bibr" rid="B466">2006</xref>).</p>
<p>In rats, the WOI is characterized by high E2 plasma levels, and endometrial ERα and PR expression shows specific and varying cytosolic/nuclear patterns (Singh et al., <xref ref-type="bibr" rid="B386">1996</xref>). ERα and PR expression decreases after ovulation and in preimplantation stages in both mice (Vasquez and DeMayo, <xref ref-type="bibr" rid="B457">2013</xref>) and primates (<italic>Macaca mulatta</italic>) (Ghosh et al., <xref ref-type="bibr" rid="B125">1999</xref>).</p>
<p>Rodent genetic models unraveled some molecular mechanisms underlying the estrogen-dependency of these processes. ERα-KO mice are infertile, no implantation occurs, endometrium is hypoplastic and estrogen response is absent (Couse and Korach, <xref ref-type="bibr" rid="B72">1999</xref>; Walker and Korach, <xref ref-type="bibr" rid="B464">2004</xref>). Not only its absence, but also sustained estrogen signaling has deleterious effects on endometrial receptivity, as recapitulated by mice with uterine COUP-TFII ablation. These mice exhibit increased estrogen signaling and asynchrony between embryo competency and uterine receptivity with consequent implantation defects. This effect is rescued by treatment with the antiestrogen ICI-182780 (Lee et al., <xref ref-type="bibr" rid="B213">2010</xref>). Additionally, the duration of E2 exposure and its dosage affect endometrial receptivity and WOI length in mice (Ma et al., <xref ref-type="bibr" rid="B236">2003</xref>).</p>
<p>Available human data, mostly obtained in the context of assisted reproduction technologies (ART), also indicate that steroid stimulation retards or shortens the luteal phase, the WOI, causes shifts in the appearance of pinopodes (a classical WOI marker) and causes asynchrony between ovarian and menstrual cycles (Devroey et al., <xref ref-type="bibr" rid="B88">2004</xref>).</p>
<sec>
<title>Intracrinology in healthy endometrium–systematic search</title>
<p>Initial studies on steroid hormone metabolism in the endometrium date back to 1965 with first demonstration of the STS activity, followed by investigation on the oxidative and reductive 17βHSD activities (Table <xref ref-type="table" rid="T6">6</xref>).</p>
<p>Both pre and postmenopausal tissues possess oxidative and reductive 17βHSD activities and the expression of 17βHSD1, 2, 4, 6, 7, 8, 10, 12, 14, and AKR1C3/17βHSD5 was detected at the mRNA or protein levels. Sulphatase pathway (STS and SULT1E1; recently reviewed by Rižner, <xref ref-type="bibr" rid="B343">2016</xref>), CYP19A1, 3βHSDs, SRD5As and AKR1Cs are also present, indicating that human endometrium can metabolize sulphated-compounds and DHEA to form androgens and estrogens.</p>
<p>Few 17βHSDs have been characterized by IHC. The low expression of 17βHSD1 poses sensitivity problems using standard detection methods (Cornel et al., <xref ref-type="bibr" rid="B69">2017</xref>), and few authors reported endometrial absence of 17βHSD1 (Table <xref ref-type="table" rid="T6">6</xref>). Type 1 17βHSD localizes in the cytoplasm of epithelial cells (Dassen et al., <xref ref-type="bibr" rid="B77">2007</xref>; Colette et al., <xref ref-type="bibr" rid="B65">2013</xref>; Mori et al., <xref ref-type="bibr" rid="B266">2015</xref>; Sinreih et al., <xref ref-type="bibr" rid="B390">2017a</xref>) and it is also detected in primary stroma cells cultured <italic>in vitro</italic> (Aghajanova et al., <xref ref-type="bibr" rid="B6">2009</xref>; Mori et al., <xref ref-type="bibr" rid="B266">2015</xref>). Type 2 17βHSD, AKR1C3/17βHSD5 and 3βHSD1 give strong reactivity in the glandular epithelium (Rhee et al., <xref ref-type="bibr" rid="B339">2003</xref>; Ito et al., <xref ref-type="bibr" rid="B170">2006</xref>; Dassen et al., <xref ref-type="bibr" rid="B77">2007</xref>; Vani et al., <xref ref-type="bibr" rid="B455">2007</xref>; Smuc and Rizner, <xref ref-type="bibr" rid="B400">2009</xref>; Zakharov et al., <xref ref-type="bibr" rid="B491">2010</xref>; Colette et al., <xref ref-type="bibr" rid="B65">2013</xref>; Mori et al., <xref ref-type="bibr" rid="B266">2015</xref>; Sinreih et al., <xref ref-type="bibr" rid="B390">2017a</xref>).</p>
<p>CYP19A1 as well has low expression and some authors detected this enzyme only in association with diseases (see below and recently reviewed by Rižner, <xref ref-type="bibr" rid="B342">2013</xref>). Although CYP19A1 immunoreactivity was initially associated with stroma cells (Watanabe et al., <xref ref-type="bibr" rid="B469">1995</xref>), subsequent investigations showed also glandular expression (Kitawaki et al., <xref ref-type="bibr" rid="B196">1999</xref>; Hudelist et al., <xref ref-type="bibr" rid="B157">2007</xref>) and laser-capture-microdissected stroma/epithelial components detected CYP19A1 mRNA in both cell types (Matsuzaki et al., <xref ref-type="bibr" rid="B249">2006</xref>).</p>
<p>The mRNA of those enzymes converting cholesterol to DHEA (CYP11A1, CYP17A1, StAR) and (ovarian) 3βHSD2 was reported in recent studies, suggesting that the endometrium can produce steroids from cholesterol (Table <xref ref-type="table" rid="T6">6</xref>).</p>
</sec>
<sec>
<title>Intratissue steroid levels</title>
<p>Endometrial steroid levels were recently profiled by LC-MS. E2 levels differ between tissue and serum during the menstrual cycle, being up to five-times higher in tissue than in serum during the proliferative phase and 1.5-fold higher in the luteal period (Huhtinen et al., <xref ref-type="bibr" rid="B159">2012a</xref>, <xref ref-type="bibr" rid="B160">2014</xref>). T levels were lower in tissue than in serum with no cyclic changes. The levels P and P5 (and their 17-hydroxy derivatives) did not vary between serum and tissue, indicating that, contrarily to estrogens, progestogen intra-tissue levels are determined by passive diffusion from the blood (Huhtinen et al., <xref ref-type="bibr" rid="B160">2014</xref>).</p>
</sec>
<sec>
<title>Intracrinology and reproduction</title>
<p>Animal models show not only that intracrine enzymes are expressed in the endometrium, but also they vary the expression levels during the endometrial phases and during implantation, as shown already during the 80's in rhesus monkeys for the oxidizing 17βHSD activity (Kreitmann et al., <xref ref-type="bibr" rid="B203">1979</xref>).</p>
<p>In rodents, STS activity measured with [3H]E1-S in 6-days pregnant rats was lower around the implantation site compared with non-implantation sites (Loza, <xref ref-type="bibr" rid="B228">1995</xref>). <italic>In situ</italic> hybridisation signal of 17βHSD7 mRNA varied spatio-temporally throughout implantation and early gestation, being initially detected on luminal epithelium around the implantation site and absent in decidua (embryonic day, Ed5.5). At Ed8 and Ed9.5, 17βHSD7 expression increased in the decidua capsularis (the part that interacts with the trophoblast) and later (after E9) in the junctional zone of the developing placenta and in the spongiotrophoblasts (Nokelainen et al., <xref ref-type="bibr" rid="B287">2000</xref>).</p>
<p>A brilliant study in mice showed that decidualization is dependent on local E2 produced through CYP19A1. CYP19A1 expression increased during pregnancy and decidualization was unaffected by ovariectomy. In contrast, treatment with the aromatase inhibitor (AI) letrozole impaired decidualization and decreased decidual marker expression (e.g., PRP, BMP2 and CX43) (Das et al., <xref ref-type="bibr" rid="B76">2009</xref>).</p>
<p>In human endometrium, 17βHSD2 and SULT1E1 are induced by P as their expression peaks in the luteal phase (Rubin et al., <xref ref-type="bibr" rid="B351">1999</xref>; Tseng and Mazella, <xref ref-type="bibr" rid="B446">2002</xref>; Utsunomiya et al., <xref ref-type="bibr" rid="B450">2004</xref>; Dassen et al., <xref ref-type="bibr" rid="B77">2007</xref>; Huhtinen et al., <xref ref-type="bibr" rid="B159">2012a</xref>; Colette et al., <xref ref-type="bibr" rid="B65">2013</xref>; Piccinato et al., <xref ref-type="bibr" rid="B311">2016b</xref>). Since both enzymes decrease intra-tissue estrogen levels, their up-regulation is one of the mechanisms of the uterine antiestrogenic effects of P. The P-dependency of 17βHSD2 and SULT1E1 was recapitulated <italic>in vitro</italic> using explant cultures and primary cells (Tseng and Mazella, <xref ref-type="bibr" rid="B446">2002</xref>; Dassen et al., <xref ref-type="bibr" rid="B77">2007</xref>; Piccinato et al., <xref ref-type="bibr" rid="B311">2016b</xref>). Luteal peak expression of other SULTs (1A1 and 2B1) was also reported (Rubin et al., <xref ref-type="bibr" rid="B351">1999</xref>; Koizumi et al., <xref ref-type="bibr" rid="B200">2010</xref>). Some reports also suggested that STS expression increased in the luteal phase (Tanaka et al., <xref ref-type="bibr" rid="B426">2003</xref>; Piccinato et al., <xref ref-type="bibr" rid="B311">2016b</xref>) with a potential role during decidualization (Tseng and Mazella, <xref ref-type="bibr" rid="B446">2002</xref>). Mid-luteal phase endometrium shows also peaking expression of 3βHSD1 (mRNA and protein) (Rhee et al., <xref ref-type="bibr" rid="B339">2003</xref>; Vani et al., <xref ref-type="bibr" rid="B455">2007</xref>).</p>
<p>Two studies on human ectopic pregnancies explored the endometrium around the implanted blastocyst. Expression of 3βHSD1 (mRNA and protein) was highest in decidua obtained from ectopic pregnancies (Rhee et al., <xref ref-type="bibr" rid="B339">2003</xref>) and in a study on 23 tubal pregnancies, 17βHSD1 showed highest immunoreactivity at the fetal-maternal interface (Li et al., <xref ref-type="bibr" rid="B216">2003</xref>), suggestive for a role of these enzymes in the nidation site.</p>
</sec>
<sec>
<title>Endometriosis</title>
<p>Endometriosis, an estrogen-dependent benign disorder affecting up to 10% of reproductive-aged women, is associated with pelvic pain, infertility, decreased life-quality and important health care/social costs (Simoens et al., <xref ref-type="bibr" rid="B385">2011</xref>, <xref ref-type="bibr" rid="B384">2012</xref>; De Graaff et al., <xref ref-type="bibr" rid="B80">2013</xref>, <xref ref-type="bibr" rid="B81">2015</xref>, <xref ref-type="bibr" rid="B82">2016</xref>; Vercellini et al., <xref ref-type="bibr" rid="B459">2014</xref>). Endometriosis is characterized by the growth of endometrium-like tissue outside the uterus (ectopic locations), beside the ovaries (endometrioma), as peritoneal implants, or as deep-lesions infiltrating peritoneal organs (deep endometriosis).</p>
<p>The expression of intracrine enzymes in endometriosis was reviewed in 2012, (Huhtinen et al., <xref ref-type="bibr" rid="B161">2012b</xref>) and among other studies, 20 papers published between 1996 and 2009 specifically described the levels of intracrine enzymes in eutopic and ectopic endometrium from patients and control women. With the exclusion of one study that included over 100 patients (Colette et al., <xref ref-type="bibr" rid="B66">2009</xref>), the rest included small study populations, and in most cases, the various endometriosis types (ovarian, peritoneal and deep infiltrating) were pooled together. Various techniques were used (RT-qPCR, immunohistochemistry, enzyme activity assay). Overall, no clear conclusion could be drawn from these studies. Comparing endometriosis with controls, CYP19A1 was up-regulated (six studies), unchanged (three studies) and one study found no expression of this gene. With respect to oxidative and reductive 17βHSDs, 17βHSD1 was reported up-regulated (three studies), 17βHSD2 was reported down-regulated or unchanged and two studies reported an up-regulation of 17βHSD7 and 12 in endometriosis vs. controls (Huhtinen et al., <xref ref-type="bibr" rid="B161">2012b</xref>).</p>
<p>Subsequent investigations also continued to report inconsistent results. No change in mRNA (Delvoux et al., <xref ref-type="bibr" rid="B84">2014</xref>) or increased expression of CYP19A1 in ovarian endometriosis vs. controls (Huhtinen et al., <xref ref-type="bibr" rid="B159">2012a</xref>) were reported. An increased expression of CYP19A1 was also described using <italic>in vitro</italic> spheroids derived from endometrial stroma cells from patients compared with controls (Mori et al., <xref ref-type="bibr" rid="B266">2015</xref>).</p>
<p>The mRNA expression of 17βHSD1 was higher in endometriosis compared with normal tissue using patient biopsies as well as spheroid cultures derived from endometrial stroma cells of patients and controls (Delvoux et al., <xref ref-type="bibr" rid="B84">2014</xref>; Mori et al., <xref ref-type="bibr" rid="B266">2015</xref>). One study assessing the three endometriosis types separately (60 patients in total) described that the increased 17βHSD1 level was restricted to endometrioma during the secretory phase of the menstrual cycle (Huhtinen et al., <xref ref-type="bibr" rid="B159">2012a</xref>), whereas a second study on 79 patients and 41 controls, found no change in 17βHSD1 level, but described an increased 17βHSD1/2 ratio (Colette et al., <xref ref-type="bibr" rid="B65">2013</xref>).</p>
<p>Regarding 17βHSD2, recent investigations reported both unchanged (Delvoux et al., <xref ref-type="bibr" rid="B84">2014</xref>) and down-regulated mRNA in patient biopsies compared with controls (Huhtinen et al., <xref ref-type="bibr" rid="B159">2012a</xref>; Colette et al., <xref ref-type="bibr" rid="B65">2013</xref>). No variations were found in 17βHSD4, 5, 7 and 12 (Smuc et al., <xref ref-type="bibr" rid="B398">2009</xref>; Delvoux et al., <xref ref-type="bibr" rid="B84">2014</xref>) but an increased level of 17βHSD6 mRNA was detected in endometriosis compared with controls (Huhtinen et al., <xref ref-type="bibr" rid="B159">2012a</xref>).</p>
<p>A few studies reported detectable levels of the enzymes involved in the generation of DHEA from cholesterol (StAR, CYP11A1 and CYP17A1) in endometriosis (Tsai et al., <xref ref-type="bibr" rid="B443">2001</xref>; Rhee et al., <xref ref-type="bibr" rid="B339">2003</xref>; Bukulmez et al., <xref ref-type="bibr" rid="B45">2008a</xref>; Attar et al., <xref ref-type="bibr" rid="B18">2009</xref>; Sinreih et al., <xref ref-type="bibr" rid="B389">2013</xref>, <xref ref-type="bibr" rid="B391">2017b</xref>; Huhtinen et al., <xref ref-type="bibr" rid="B160">2014</xref>), suggesting that, in contrast to eutopic endometrium, endometriosis is able to produce steroids from cholesterol. However, it has also been argued that the presence of paracrine confounders of ovarian origin in studies using endometriomas could bias the results (Noël et al., <xref ref-type="bibr" rid="B286">2011</xref>).</p>
<p>The contribution of STS, SULT1E1 and other SULTs was investigated by numerous studies and also in this case, conclusions are unclear (recently reviewed, Rižner, <xref ref-type="bibr" rid="B343">2016</xref>). A recent investigation using 78 specimens described increased STS levels in endometriosis vs. control samples and found that the overall balance between STS and SULT1E1 differed between eutopic and ectopic tissue, implying an unbalanced flux of sulpho-conjugated estrogens in this disease (Piccinato et al., <xref ref-type="bibr" rid="B311">2016b</xref>). The same research group also described an aberrant regulation of the enzymes involved in the estrogen oxidative metabolism in endometriosis (Piccinato et al., <xref ref-type="bibr" rid="B310">2016a</xref>).</p>
<p>Although the level of the single enzymes in the intracrine machinery varies with apparently no clear association with the disease condition, the intracrinological nature of endometriosis was recently proven by comparison between serum and tissue levels of steroids in 60 patients (eutopic and ectopic endometrium) and 16 controls. Although E2 changed cyclically in eutopic tissue, E2 levels remained constant in the lesions and inversely correlated with the mRNA level of 17βHSD2 and 17βHSD6 suggesting an impairment in E2 deactivation to E1. P levels were equal in serum and control tissues, but resulted higher in patients and correlated with high 3βHSD2 mRNA. T, low in the tissue of controls, was over 13-times more concentrated at ectopic locations and correlated with low expression of SRD5A3 (Huhtinen et al., <xref ref-type="bibr" rid="B159">2012a</xref>, <xref ref-type="bibr" rid="B160">2014</xref>).</p>
</sec>
<sec>
<title>Endometrial cancer (EC)</title>
<p>EC is the most common gynecological malignancy in western society and 80% of all cases are estrogen-driven (Amant et al., <xref ref-type="bibr" rid="B11">2005</xref>; Morice et al., <xref ref-type="bibr" rid="B267">2015</xref>). Major serum steroids are increased in patients with EC, including several substrates for intracrine E2 synthesis (Lépine et al., <xref ref-type="bibr" rid="B214">2010</xref>; Audet-Walsh et al., <xref ref-type="bibr" rid="B20">2011</xref>). In addition, tissue-steroid levels differ between cancer, normal tissue and serum and correlate with the levels of specific intracrine enzymes (see below) (Tanaka et al., <xref ref-type="bibr" rid="B428">2015</xref>).</p>
<p>A systematic review recently explored all studies published between 1990 and 2017 assessing the expression of 17βHSD1, 2, STS, SULT1E1, and CYP19A1, with results that describe unbalanced intracrine regulation and important inter-patient variability (Cornel et al., <xref ref-type="bibr" rid="B71">2018</xref>). Most studies compared cases with controls or tumor tissue with adjacent normal endometrium. Compared with normal tissue (from controls or adjacent to tumor), 17βHSD1 was found increased in EC (Cornel et al., <xref ref-type="bibr" rid="B70">2012</xref>), decreased (Smuc and Rizner, <xref ref-type="bibr" rid="B400">2009</xref>; Lépine et al., <xref ref-type="bibr" rid="B214">2010</xref>) and undetected (Utsunomiya et al., <xref ref-type="bibr" rid="B452">2001</xref>, <xref ref-type="bibr" rid="B451">2003</xref>); 17βHSD2 was found decreased (Utsunomiya et al., <xref ref-type="bibr" rid="B451">2003</xref>, <xref ref-type="bibr" rid="B450">2004</xref>) or increased (Lépine et al., <xref ref-type="bibr" rid="B214">2010</xref>; Cornel et al., <xref ref-type="bibr" rid="B70">2012</xref>; Sinreih et al., <xref ref-type="bibr" rid="B389">2013</xref>); AKR1C3/17βHSD5 was found unchanged (Cornel et al., <xref ref-type="bibr" rid="B70">2012</xref>; Sinreih et al., <xref ref-type="bibr" rid="B389">2013</xref>), increased (Ito et al., <xref ref-type="bibr" rid="B168">2016</xref>) and decreased (Zakharov et al., <xref ref-type="bibr" rid="B491">2010</xref>); 17βHSD7 both decreased (Smuc and Rizner, <xref ref-type="bibr" rid="B400">2009</xref>) and unchanged (Lépine et al., <xref ref-type="bibr" rid="B214">2010</xref>; Cornel et al., <xref ref-type="bibr" rid="B70">2012</xref>) and 17βHSD12 was unchanged (Smuc and Rizner, <xref ref-type="bibr" rid="B400">2009</xref>; Cornel et al., <xref ref-type="bibr" rid="B70">2012</xref>) or increased in tumors vs. controls (Lépine et al., <xref ref-type="bibr" rid="B214">2010</xref>). One recent report described decreased 17βHSD14 levels in tumor compared with adjacent tissue (Sinreih et al., <xref ref-type="bibr" rid="B390">2017a</xref>). Controversial results apply to CYP19A1, described as increased (Watanabe et al., <xref ref-type="bibr" rid="B469">1995</xref>; Utsunomiya et al., <xref ref-type="bibr" rid="B452">2001</xref>, <xref ref-type="bibr" rid="B450">2004</xref>; Smuc and Rizner, <xref ref-type="bibr" rid="B400">2009</xref>) and unchanged (Jongen et al., <xref ref-type="bibr" rid="B182">2005</xref>; Pathirage et al., <xref ref-type="bibr" rid="B301">2006</xref>; Cornel et al., <xref ref-type="bibr" rid="B70">2012</xref>). STS/SULT1E1 expression is also inconsistent in different studies (recently reviewed in Mueller et al., <xref ref-type="bibr" rid="B269">2015</xref>; Rižner, <xref ref-type="bibr" rid="B343">2016</xref>).</p>
<p>Recent studies exploring the association between enzyme levels and tumor characteristics found a correlation between STS with tumor grade and lymphovascular invasion (Sinreih et al., <xref ref-type="bibr" rid="B390">2017a</xref>) and described an association between high CYP19A1 or 17βHSD1 and poor patient prognosis (Segawa et al., <xref ref-type="bibr" rid="B369">2005</xref>; Cornel et al., <xref ref-type="bibr" rid="B69">2017</xref>).</p>
<p>Other investigations emphasized the potential antiestrogenic and protective roles of androgens and P. Formation of DHT (via conversion of A4 to T by AKR1C3/17βHSD5 and of T to DHT by SRD5As) has potential antiestrogenic action because it devoids tissue from T (substrate of CYP19A1 yielding E2) and because it has direct endometrial antiproliferative effects via AR (Ito et al., <xref ref-type="bibr" rid="B168">2016</xref>). Similar to the AKR1C3/17βHSD5 data reported earlier, results on SDR5A expression are inconclusive as SRD5A2 was down-regulated in a study on 47 tumor specimens compared with adjacent normal tissue (Sinreih et al., <xref ref-type="bibr" rid="B389">2013</xref>), but both SRD5A1 and SRD5A2 resulted unchanged in another study on 122 tumors (although only five controls were studied) (Tanaka et al., <xref ref-type="bibr" rid="B428">2015</xref>). This last study found however increased androgen levels (T and DHT) in tissue vs. blood. High DHT levels were restricted to samples with high SRD5A1 immunohistochemical staining. In addition, AR and SRD5A1 positivity was associated with good patient prognosis (Tanaka et al., <xref ref-type="bibr" rid="B428">2015</xref>). The prognostic value of AR is confirmed by independent investigations (Tangen et al., <xref ref-type="bibr" rid="B430">2016</xref>).</p>
<p>P is well-known for its antiestrogenic action, PR positivity is a good prognostic marker (Tangen et al., <xref ref-type="bibr" rid="B431">2014</xref>) and P synthesis and metabolism are disturbed in EC (Sinreih et al., <xref ref-type="bibr" rid="B389">2013</xref>). Interestingly, in a study on 47 tumors and adjacent normal tissues, EC had decreased StAR and CYP11A1 mRNA levels, indicative of diminished <italic>de novo</italic> steroid synthesis (Sinreih et al., <xref ref-type="bibr" rid="B389">2013</xref>, <xref ref-type="bibr" rid="B391">2017b</xref>). At the same time, EC showed decreased SRD5A2 and increased 17βHSD2 indicative of a diminished rate of conversion of P to 5αDHP and of 20αDHP to 5α-pregnan-20-ol-3-one, but increased conversion of 20αDHP to P (see Figure <xref ref-type="fig" rid="F2">2</xref>).</p>
</sec>
<sec>
<title>Other endometrial/gynecological disorders</title>
<p>Although literature is scarce, a potential role of intracrinology is postulated for ovarian cancer (Ito et al., <xref ref-type="bibr" rid="B168">2016</xref>), for adenomyosis and fibroids (Rižner, <xref ref-type="bibr" rid="B343">2016</xref>), for sarcoma, where CYP19A1 expression may have prognostic significance (Kitaoka et al., <xref ref-type="bibr" rid="B193">2004</xref>) and among infertile women (Brosens et al., <xref ref-type="bibr" rid="B43">2004</xref>).</p>
</sec>
<sec>
<title>Intracrine drug targets</title>
<p>Endometriosis: blocking the systemic estrogen signaling via P, or GnRH agonist is standard care (Vercellini et al., <xref ref-type="bibr" rid="B459">2014</xref>). Blocking the intracrine E2 generation is the future approach with on-going preclinical/clinical research.</p>
<p>STS inhibition showed promising results. Irosustat (Table <xref ref-type="table" rid="T3">3</xref>) inhibited up to 100% the formation of free steroids using <italic>ex-vivo</italic> material from 27 patients (Purohit et al., <xref ref-type="bibr" rid="B325">2008</xref>) and STS inhibition showed good results in a mouse model of endometriosis, where decreased size and weight of the lesions was observed (Colette et al., <xref ref-type="bibr" rid="B64">2011</xref>). A phase-I clinical trial on 24 volunteers proved the safety of the STS inhibitor E2MATE (PLG2001), which reduced STS activity by over 90% and induced changes in endometrial markers (both alone or co-administered with norethindrone acetate) (Pohl et al., <xref ref-type="bibr" rid="B314">2014</xref>).</p>
<p>Inhibitors of 17βHSD1 are in preclinical phase, and promising results are described using a primate model of endometriosis, where decreased behavior/pain symptoms were reported (Arnold and Einspanier, <xref ref-type="bibr" rid="B16">2013</xref>) and using <italic>ex-vivo</italic> material from endometriosis patient (over 70% of the patients showed over 80% of enzyme inhibition) (Delvoux et al., <xref ref-type="bibr" rid="B84">2014</xref>).</p>
<p>AKR1C3/17βHSD5 inhibition can interfere with E2, androgen synthesis, and reduce prostaglandin-associated inflammation/proliferation and an inhibitor has recently entered a phase II trial for endometriosis (Table <xref ref-type="table" rid="T3">3</xref>). Overall, AIs have limited efficacy for endometriosis (Ferrero et al., <xref ref-type="bibr" rid="B108">2011</xref>; Dunselman et al., <xref ref-type="bibr" rid="B101">2014</xref>),</p>
<p>EC: only in case of advanced stage/metastatic disease hormonal care is given (progestogen, tamoxifen or AIs). AIs alone have limited efficacy with low response rates (Rose et al., <xref ref-type="bibr" rid="B348">2000</xref>; Ma et al., <xref ref-type="bibr" rid="B235">2004</xref>; Lindemann et al., <xref ref-type="bibr" rid="B220">2014</xref>). Promising data were obtained using dual regimen (AI and mTOR inhibitor; Slomovitz et al., <xref ref-type="bibr" rid="B395">2015</xref>) and additional trials on combinatory regimen are on-going. STS inhibitors showed promising results in a mouse subcutaneous model of EC, with decreased tumor growth by 48–67% (Foster et al., <xref ref-type="bibr" rid="B114">2008b</xref>). However, a phase II trial on advanced stage EC was stopped because of the absence of added benefit compared with progestogen treatment (Purohit and Foster, <xref ref-type="bibr" rid="B324">2012</xref>; Pautier et al., <xref ref-type="bibr" rid="B302">2017</xref>).</p>
<p>Preclinical studies on 17βHSD1 inhibitors showed promising results in a mouse model of endometrial hyperplasia (Saloniemi et al., <xref ref-type="bibr" rid="B360">2010</xref>;Järvensivu et al., <xref ref-type="bibr" rid="B176">2015</xref>) and in various models of EC (Konings et al., <xref ref-type="bibr" rid="B201">2018</xref>).</p>
</sec>
<sec>
<title>Endometrium: conclusions</title>
<p>The ability to synthesize DHEA from cholesterol (reported by few studies) needs confirmation. However, the endometrium possesses the enzymatic machinery to metabolize sulphated-compounds and DHEA and form androgens and estrogens, (although this contention is wrangled by other authors: Labrie and Labrie, <xref ref-type="bibr" rid="B209">2013</xref>; Labrie, <xref ref-type="bibr" rid="B208">2015</xref>). Further, the endometrium can metabolize androgens and progestogens via AKR1Cs and SRD5As to produce a wide range of compounds, including estrogens (Table <xref ref-type="table" rid="T6">6</xref> and Figure <xref ref-type="fig" rid="F3">3</xref>). The morphological changes during the menstrual cycle are accompanied by cyclic changes in intracrine steroid and enzyme levels, indicating that steroid exposure needs to be cyclically regulated to support endometrial physiology.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<p>Effect of steroids (mainly estrogens) and intracrine networks in central nervous system, lungs, digestive system, uterus and bone. Italics and by brackets are those metabolism/reactions that need conformation by independent authors (because validated at the mRNA level only or in few studies). * EC, epithelial cells; **SMC, smooth muscle cells; <sup>#</sup>Chol, cholesterol. The drawing was kindly generated by Dr. Margaretha A. Skowron (Department of Urology, University Düsseldorf, Germany) for this review.</p>
</caption>
<graphic xlink:href="fphar-09-00940-g0003"></graphic>
</fig>
</sec>
</sec>
<sec>
<title>Gastrointestinal tract (GIT) and digestive system (DS)</title>
<p>ERα and ERβ are expressed throughout the GIT and DS (esophagus, stomach, colon, gallbladder, pancreas) and epidemiological studies show important influence of sex hormones in DS physiology and disturbances, with a clear gender-dependency. In the duodenum, estrogens regulate bicarbonate secretion (Nayeb-Hashemi and Kaunitz, <xref ref-type="bibr" rid="B280">2009</xref>; Tuo et al., <xref ref-type="bibr" rid="B449">2011</xref>). This is an important defense mechanism of the mucosa against acids discharged from the stomach, and men develop duodenal ulcer two/three-times more often than premenopausal women (Wu et al., <xref ref-type="bibr" rid="B475">2008</xref>). Such estrogen protective effect is recapitulated in animal studies exposed to estrogens and anti-estrogens, and is mediated by a rapid action (i.e., non genomic) of ERα on membrane ion channels (Smith et al., <xref ref-type="bibr" rid="B396">2008</xref>).</p>
<p>ERα, ERβ and GPER mediate important effects on the pancreatic beta-cells during adaptation to insulin resistance periods (e.g., pregnancy, puberty, obesity; Nadal et al., <xref ref-type="bibr" rid="B276">2011</xref>). In mice, ERα signaling regulates proliferation of beta-cell during development and after injury (Yuchi et al., <xref ref-type="bibr" rid="B489">2015</xref>).</p>
<p>Men are also more likely than women to develop cancer in the esophagus, stomach and colon. Accordingly, estrogen treatment for prostate cancer decreases the incidence of gastric cancer and menopausal status in women is associated with colorectal cancer CRC risk (Freedman et al., <xref ref-type="bibr" rid="B117">2007</xref>; Kennelly et al., <xref ref-type="bibr" rid="B186">2008</xref>; Hogan et al., <xref ref-type="bibr" rid="B150">2009</xref>; Duell et al., <xref ref-type="bibr" rid="B100">2010</xref>). ERβ results oncoprotective at several GIT sites (Kennelly et al., <xref ref-type="bibr" rid="B186">2008</xref>; Barzi et al., <xref ref-type="bibr" rid="B27">2013</xref>; Caiazza et al., <xref ref-type="bibr" rid="B49">2015</xref>) and low expression correlate with high CRC stage in mice and with poor differentiated gallbladder cancer in humans (Hogan et al., <xref ref-type="bibr" rid="B150">2009</xref>).</p>
<p>The association between estrogens and DS cancer risk is however controversial. The Women's Health Initiative and other large studies showed that combined estrogens plus P hormone replacement therapy (HRT) decreases CRC risk, but increases that of gallbladder. In addition, CRC during HRT has a higher grade (Kennelly et al., <xref ref-type="bibr" rid="B186">2008</xref>; Hogan et al., <xref ref-type="bibr" rid="B150">2009</xref>; Rennert et al., <xref ref-type="bibr" rid="B338">2009</xref>; Foster, <xref ref-type="bibr" rid="B112">2013</xref>; Mueller et al., <xref ref-type="bibr" rid="B269">2015</xref>). However, a recent randomized, placebo-controlled trial enrolling over 10,000 women receiving estrogens alone vs. placebo found no difference in CRC incidence (Lavasani et al., <xref ref-type="bibr" rid="B212">2015</xref>). Such complexity is recapitulated in animal studies where estrogens and androgens can have distinct and opposite effects on colitis and CRC (Amos-Landgraf et al., <xref ref-type="bibr" rid="B12">2014</xref>; Heijmans et al., <xref ref-type="bibr" rid="B143">2014</xref>). Overall, the association between DS disturbances/cancers with estrogens depends on the moment in life, extent and nature (endogenous or exogenous) of exposure and is influenced by the relative balance of the receptors (Foster, <xref ref-type="bibr" rid="B112">2013</xref>). Similarly, androgens influence DS pathophysiology via complex and unclear mechanisms involving classical, membrane signaling, level of free and SHBG bound T (Roshan et al., <xref ref-type="bibr" rid="B349">2016</xref>).</p>
<p>The lack of clear conclusion and the fact that the levels of circulating endogenous estrogens in women do not influence CRC risk indicates that intracrine steroids may have a predominant role irrespective of their circulating levels (Sato et al., <xref ref-type="bibr" rid="B366">2009</xref>; Falk et al., <xref ref-type="bibr" rid="B107">2015</xref>).</p>
<sec>
<title>Intracrinology in healthy GIT–systematic search</title>
<p>In total, 29 original papers were retrieved that described the levels of the intracrine enzymes in the GIT, published from the late 80's (Table <xref ref-type="table" rid="T7">7</xref> and <xref ref-type="supplementary-material" rid="SM1">Supplemental panel</xref>: “Systematic Review”).</p>
<table-wrap id="T7" position="float">
<label>Table 7</label>
<caption>
<p>Expression of intracrine enzymes in the gastrointestinal tract (GIT)-results of the systematic search.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene</bold>
</th>
<th align="left" colspan="2" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>Detection</bold>
</th>
<th align="left" colspan="6" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>Gastrointestinal tract</bold>
</th>
</tr>
<tr>
<th colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Molecule</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Technique<xref ref-type="table-fn" rid="TN43"><sup>#</sup></xref></bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>St<xref ref-type="table-fn" rid="TN42a"><sup>*</sup></xref></bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>References</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>S.I.<xref ref-type="table-fn" rid="TN42a"><sup>*</sup></xref></bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>References</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>L.I.<xref ref-type="table-fn" rid="TN42a"><sup>*</sup></xref></bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>References</bold>
</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CYP11A1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Saitoh et al., <xref ref-type="bibr" rid="B354">1992</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CYP19A1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">Activity</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">English et al., <xref ref-type="bibr" rid="B104">2000</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CYP19A1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Saitoh et al., <xref ref-type="bibr" rid="B354">1992</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">English et al., <xref ref-type="bibr" rid="B104">2000</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">WB</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Saitoh et al., <xref ref-type="bibr" rid="B354">1992</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">HSD17B oxidative activity</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">English et al., <xref ref-type="bibr" rid="B105">1999</xref></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">HSD17B reductive activity</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">English et al., <xref ref-type="bibr" rid="B105">1999</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD1</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Oduwole et al., <xref ref-type="bibr" rid="B289">2003a</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rawłuszko et al., <xref ref-type="bibr" rid="B334">2011</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">NB</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Casey et al., <xref ref-type="bibr" rid="B56">1994</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Casey et al., <xref ref-type="bibr" rid="B56">1994</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">ISH</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Oduwole et al., <xref ref-type="bibr" rid="B288">2002</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Oduwole et al., <xref ref-type="bibr" rid="B288">2002</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">WB</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rawłuszko et al., <xref ref-type="bibr" rid="B334">2011</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD2</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Oduwole et al., <xref ref-type="bibr" rid="B289">2003a</xref>; Frycz et al., <xref ref-type="bibr" rid="B119">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">NB</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Casey et al., <xref ref-type="bibr" rid="B56">1994</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Casey et al., <xref ref-type="bibr" rid="B56">1994</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">ISH</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Oduwole et al., <xref ref-type="bibr" rid="B288">2002</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Oduwole et al., <xref ref-type="bibr" rid="B288">2002</xref>, <xref ref-type="bibr" rid="B290">2003b</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">English et al., <xref ref-type="bibr" rid="B104">2000</xref>; Mueller et al., <xref ref-type="bibr" rid="B269">2015</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">WB</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Frycz et al., <xref ref-type="bibr" rid="B119">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">English et al., <xref ref-type="bibr" rid="B104">2000</xref>; Mueller et al., <xref ref-type="bibr" rid="B269">2015</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD4</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NB</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Möller et al., <xref ref-type="bibr" rid="B264">1999</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Möller et al., <xref ref-type="bibr" rid="B264">1999</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">English et al., <xref ref-type="bibr" rid="B104">2000</xref>; Mueller et al., <xref ref-type="bibr" rid="B269">2015</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">WB</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">English et al., <xref ref-type="bibr" rid="B104">2000</xref>; Mueller et al., <xref ref-type="bibr" rid="B269">2015</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD10</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">De Preter et al., <xref ref-type="bibr" rid="B83">2012</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD12</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sakurai et al., <xref ref-type="bibr" rid="B356">2006</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">NB</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sakurai et al., <xref ref-type="bibr" rid="B356">2006</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sakurai et al., <xref ref-type="bibr" rid="B356">2006</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sakurai et al., <xref ref-type="bibr" rid="B356">2006</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sakurai et al., <xref ref-type="bibr" rid="B356">2006</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sakurai et al., <xref ref-type="bibr" rid="B356">2006</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">AKR1C3</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Comp-RT</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Frycz et al., <xref ref-type="bibr" rid="B120">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">NB</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Frycz et al., <xref ref-type="bibr" rid="B120">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lin et al., <xref ref-type="bibr" rid="B219">1997</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lin et al., <xref ref-type="bibr" rid="B219">1997</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Miller et al., <xref ref-type="bibr" rid="B258">2012b</xref>; Chang et al., <xref ref-type="bibr" rid="B58">2013</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chang et al., <xref ref-type="bibr" rid="B58">2013</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chang et al., <xref ref-type="bibr" rid="B58">2013</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SRD5A1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Aumüller et al., <xref ref-type="bibr" rid="B21">1996</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Aumüller et al., <xref ref-type="bibr" rid="B21">1996</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Aumüller et al., <xref ref-type="bibr" rid="B21">1996</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SRD5A2</td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Aumüller et al., <xref ref-type="bibr" rid="B21">1996</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Aumüller et al., <xref ref-type="bibr" rid="B21">1996</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Aumüller et al., <xref ref-type="bibr" rid="B21">1996</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">STS</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Miki et al., <xref ref-type="bibr" rid="B255">2002</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dalla Valle et al., <xref ref-type="bibr" rid="B75">2007</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Miki et al., <xref ref-type="bibr" rid="B255">2002</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Miki et al., <xref ref-type="bibr" rid="B255">2002</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Miki et al., <xref ref-type="bibr" rid="B255">2002</xref>; Sato et al., <xref ref-type="bibr" rid="B366">2009</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">Activity</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Munroe and Chang, <xref ref-type="bibr" rid="B273">1987</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SULT1E1</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nishimura and Naito, <xref ref-type="bibr" rid="B283">2006</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Miki et al., <xref ref-type="bibr" rid="B255">2002</xref>; Nishimura and Naito, <xref ref-type="bibr" rid="B283">2006</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Miki et al., <xref ref-type="bibr" rid="B255">2002</xref>; Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref>; Riches et al., <xref ref-type="bibr" rid="B340">2009</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nishimura and Naito, <xref ref-type="bibr" rid="B283">2006</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">NB</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Her et al., <xref ref-type="bibr" rid="B144">1996</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chen et al., <xref ref-type="bibr" rid="B60">2003</xref>; Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Miki et al., <xref ref-type="bibr" rid="B255">2002</xref>; Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Miki et al., <xref ref-type="bibr" rid="B255">2002</xref>; Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref>; Sato et al., <xref ref-type="bibr" rid="B366">2009</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">WB</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Her et al., <xref ref-type="bibr" rid="B144">1996</xref>; Chen et al., <xref ref-type="bibr" rid="B60">2003</xref>; Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref>; Riches et al., <xref ref-type="bibr" rid="B340">2009</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chen et al., <xref ref-type="bibr" rid="B60">2003</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Activity</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chen et al., <xref ref-type="bibr" rid="B60">2003</xref>; Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SULT2A1</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nishimura and Naito, <xref ref-type="bibr" rid="B283">2006</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nishimura and Naito, <xref ref-type="bibr" rid="B283">2006</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nishimura and Naito, <xref ref-type="bibr" rid="B283">2006</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">ISH</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tashiro et al., <xref ref-type="bibr" rid="B433">2000</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">NB</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Her et al., <xref ref-type="bibr" rid="B144">1996</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">WB</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tashiro et al., <xref ref-type="bibr" rid="B433">2000</xref>; Chen et al., <xref ref-type="bibr" rid="B60">2003</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Her et al., <xref ref-type="bibr" rid="B144">1996</xref>; Chen et al., <xref ref-type="bibr" rid="B60">2003</xref>; Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref>; Riches et al., <xref ref-type="bibr" rid="B340">2009</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chen et al., <xref ref-type="bibr" rid="B60">2003</xref>; Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref>; Riches et al., <xref ref-type="bibr" rid="B340">2009</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">WB</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chen et al., <xref ref-type="bibr" rid="B60">2003</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Activity</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tashiro et al., <xref ref-type="bibr" rid="B433">2000</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chen et al., <xref ref-type="bibr" rid="B60">2003</xref>; Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chen et al., <xref ref-type="bibr" rid="B60">2003</xref>; Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Activity</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SULT1A1</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nishimura and Naito, <xref ref-type="bibr" rid="B283">2006</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nishimura and Naito, <xref ref-type="bibr" rid="B283">2006</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nishimura and Naito, <xref ref-type="bibr" rid="B283">2006</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">WB</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref>; Riches et al., <xref ref-type="bibr" rid="B340">2009</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref>; Riches et al., <xref ref-type="bibr" rid="B340">2009</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Activity</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SULT2B1</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nishimura and Naito, <xref ref-type="bibr" rid="B283">2006</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nishimura and Naito, <xref ref-type="bibr" rid="B283">2006</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nishimura and Naito, <xref ref-type="bibr" rid="B283">2006</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">NB</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Meloche and Falany, <xref ref-type="bibr" rid="B254">2001</xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Primary/original references were analyzed and reviews were excluded (and are cited ad hoc in the text). The table report only the enzymes whose expression was assessed in reviewed studies<sup>**</sup></italic>.</p>
<fn id="TN42a">
<label>*</label>
<p><italic>St: stomach; S.I.: small intestine; L.I.: large intestine</italic>.</p>
</fn>
<fn id="TN43">
<label>#</label>
<p><italic>Technique abbreviations. For mRNA detection, NB: northern blot; ISH: in situ hybridisation; RT-PCR: reverse transcription quantitative (or semi-quantitative) PCR; Comp-RT: competitive RT-PCR assay; NB: northern blotting. For protein detection: IHC: immunohistochemistry; WB; western blotting; activity: enzyme activity measurement</italic>.</p>
</fn>
<p><sup>**</sup>No publication was found describing the expression of StAR, 3βHSD1, 3βHSD2, 17βHSD6, 7, 8, 9, 11, 13, 14 15, DHRS11, AKR1C1 AKR1C2 and AKR1C4.</p>
<p><italic>n.d.: not determined</italic>.</p>
</table-wrap-foot>
</table-wrap>
<sec>
<title>Stomach intracrinology.</title>
<p>The stomach is an endocrine tissue, and in rodents it produces steroids starting at birth and throughout adulthood (Kobayashi et al., <xref ref-type="bibr" rid="B198">2013</xref>). Human gastric mucosa expresses 17βHSD1, 2, 12 and AKR1C3/17βHSD5 (Table <xref ref-type="table" rid="T7">7</xref>). The mRNA for 17βHSD2 in mucosa surface and glandular epithelium inversely correlates with age in both genders (Oduwole et al., <xref ref-type="bibr" rid="B289">2003a</xref>). Luminal gastric mucosa has strong AKR1C3/17βHSD5 immunoreactivity that decreases toward the gastric pits (Chang et al., <xref ref-type="bibr" rid="B58">2013</xref>). Weak immunoreactivity for 17βHSD12 localizes in the fundic glands and in the squamous epithelium of the esophagus (Sakurai et al., <xref ref-type="bibr" rid="B356">2006</xref>).</p>
<p>Sulphatases in parietal cells of the gastric glands have a protective role in detoxification. Estrogenic SULT1E1 is not expressed whereas data for SULT2A1 are inconsistent. SULT2A1 was detected in the gastric mucosa in a study on seven subjects (Tashiro et al., <xref ref-type="bibr" rid="B433">2000</xref>), but it was low/absent in other studies on 39 (Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref>) and 23 subjects (Chen et al., <xref ref-type="bibr" rid="B60">2003</xref>).</p>
</sec>
<sec>
<title>Small intestine: duodenum–jejunum–ileum.</title>
<p>Due to its high exposure to food components and harmful xenobiotics, the duodenum expresses several phase I/II enzymes including DHEA/estrogenic SULT1E1, 2A1, 1A1 (Table <xref ref-type="table" rid="T7">7</xref>). Protein and enzyme activity of SULT1E1 and 2A1 are present in human jejunum and ileum but absent in duodenum (Teubner et al., <xref ref-type="bibr" rid="B436">2007</xref>), mRNA and protein levels vary with no relation either with age or gender (Her et al., <xref ref-type="bibr" rid="B144">1996</xref>; Nishimura and Naito, <xref ref-type="bibr" rid="B283">2006</xref>). In a study on 23 subjects, SULT1E1 and 2A1 varied inter-individually and between different intestine tracts (Chen et al., <xref ref-type="bibr" rid="B60">2003</xref>). The duodenal mucosa expresses 17βHSD2, but not 17βHSD1 (Casey et al., <xref ref-type="bibr" rid="B56">1994</xref>; Oduwole et al., <xref ref-type="bibr" rid="B289">2003a</xref>) and shows strong luminal AKR1C3/17βHSD5 (Chang et al., <xref ref-type="bibr" rid="B58">2013</xref>) and weak 17βHSD12 immunoreactivity (Sakurai et al., <xref ref-type="bibr" rid="B356">2006</xref>) that decreases toward the Brunner's gland (Chang et al., <xref ref-type="bibr" rid="B58">2013</xref>).</p>
</sec>
<sec>
<title>Large intestine: colon, cecum, rectum</title>
<p>The intracrinology of healthy colon mucosa and its relation to CRC was recently reviewed (Foster, <xref ref-type="bibr" rid="B112">2013</xref>). Studies dating from 1987 demonstrated the presence of CYP19A1, 17βHSD reductive and oxidative enzymatic activities, plus the expression of 17βHSD1, 2, 4, CYP19A1, STS and SULT1E1 (Table <xref ref-type="table" rid="T7">7</xref>). Most 17βHSDs tend to have higher levels at the surface than in cryptal epithelial cells as indicated for 17βHSD2 mRNA (Oduwole et al., <xref ref-type="bibr" rid="B288">2002</xref>; Foster, <xref ref-type="bibr" rid="B112">2013</xref>), and for the immunoreactivity of AKR1C3/17βHSD5 (very strong; Chang et al., <xref ref-type="bibr" rid="B58">2013</xref>) and 17βHSD12 (weak; Sakurai et al., <xref ref-type="bibr" rid="B356">2006</xref>).</p>
</sec>
<sec>
<title>Pancreas</title>
<p>Radiolabelled substrates demonstrated the presence of CYP19A1 and SRD5A activities in human pancreatic tissue (Iqbal et al., <xref ref-type="bibr" rid="B166">1983</xref>), which expresses 17βHSD2, 12, STS, SULT1E1 (Casey et al., <xref ref-type="bibr" rid="B56">1994</xref>; Miki et al., <xref ref-type="bibr" rid="B255">2002</xref>; Sakurai et al., <xref ref-type="bibr" rid="B356">2006</xref>; Dalla Valle et al., <xref ref-type="bibr" rid="B75">2007</xref>). High levels of AKR1C3/17βHSD5 localized in pancreatic ductules (acini and islets of Langerhans resulted negative; Chang et al., <xref ref-type="bibr" rid="B58">2013</xref>).</p>
</sec>
</sec>
<sec>
<title>Association with diseases</title>
<p>SNPs in genes controlling estrogen synthesis, response and deactivation are associated with GIT cancers (Freedman et al., <xref ref-type="bibr" rid="B116">2009</xref>; Cho et al., <xref ref-type="bibr" rid="B61">2012</xref>; Zeng et al., <xref ref-type="bibr" rid="B494">2016</xref>) and AKR1C4 is a candidate gene in hereditary CRC (Gylfe et al., <xref ref-type="bibr" rid="B136">2013</xref>; Table <xref ref-type="table" rid="T5">5</xref>). Also variations in the expression of these genes associate with GIT disturbances. Low 17βHSD10 levels are associated with aberrant butyrate β-oxidation and ulcerative colitis (De Preter et al., <xref ref-type="bibr" rid="B83">2012</xref>). The epithelial 17βHSD2 level is low in case of stomach, duodenal cancer and chronic gastritis, though it is high in regenerating epithelium close to active gastritis and ulcers (Oduwole et al., <xref ref-type="bibr" rid="B289">2003a</xref>). In a study on 34 gastric tumors and adjacent healthy tissue, the mRNA and protein levels of 17βHSD2 and AKR1C3/17βHSD5 were down-regulated in cancer (Frycz et al., <xref ref-type="bibr" rid="B119">2015</xref>, <xref ref-type="bibr" rid="B120">2016</xref>). Some studies showed lower oxidative 17βHSD activity and mRNA level of 17βHSD2 (and 4) in CRC vs. adjacent normal tissue, suggesting a protective role of estrogen deactivation. However, another study on 35 women and 39 men found that high 17βHSD2 levels were associated with poor prognosis in female patients with distal CRC (reviewed in Foster, <xref ref-type="bibr" rid="B112">2013</xref>). Also 17βHSD1 level measured by RT-qPCR and western blotting in specimens from 52 patients was lower in CRC than adjacent normal mucosa (Rawłuszko et al., <xref ref-type="bibr" rid="B334">2011</xref>). CRC show also higher CYP19A1 mRNA compared with adjacent normal mucosa (<italic>n</italic> = 31) (Sato et al., <xref ref-type="bibr" rid="B365">2012</xref>).</p>
<p>Although no clear target for drugs has been identified in the intracrine network, intracrine enzymes showed some values as biomarkers. In CRC, high STS/SULT1E1 ratio correlates with poor prognosis (Foster, <xref ref-type="bibr" rid="B112">2013</xref>) and AKR1C3/17βHSD5 expression with lymph-node metastasis (Nakarai et al., <xref ref-type="bibr" rid="B279">2015</xref>). In addition, AKR1C1 and AKR1C3/17βHSD5 associate with cisplatin resistance in CRC, hence inhibitors of these AKR1Cs may be used to re-sensitize patients to chemotherapy (Matsunaga et al., <xref ref-type="bibr" rid="B248">2013</xref>). In a study were the levels of E1, E2 and DHEA-S were measured in CRC specimens and adjacent normal mucosa of men and women by LC-MS, intra-tumor estrogens were elevated and (in particular E1) correlated with poor prognosis. In line with an unfavorable role of intra-tissue estrogens, absence on STS was associated with long survival (Sato et al., <xref ref-type="bibr" rid="B366">2009</xref>).</p>
</sec>
<sec>
<title>GIT: conclusions</title>
<p>Human GIT/DS is unable to metabolize cholesterol and there is no clear evidence that it expresses 3βHSDs, hence DHEA cannot be used to generate androgens and estrogens (Table <xref ref-type="table" rid="T7">7</xref> and Figure <xref ref-type="fig" rid="F3">3</xref>). Several SULTs are expressed throughout GIT and involved in detoxification and STS is regulated by estrogen <italic>in vitro</italic> via non-classical GPER signaling (Gilligan et al., <xref ref-type="bibr" rid="B128">2017</xref>).</p>
<p>The role of steroids in pathology is complex, with divergent effects that depend on time, length and extent of exposure. In line with this, intracrine networks have unclear roles in pathogenesis. In the GIT these networks are strongly involved in the metabolisms of fatty acids and bile acids (outside the scope of this review).</p>
</sec>
</sec>
<sec>
<title>Bone tissue and skeletal system</title>
<p>Bones consist of mineralized connective tissue with structural and supportive functions. The hard exterior part (cortical bone) and the trabecular and spongy cancellous tissue filling the bone interior are identical but differ in the level of mineralization. Osteoblasts, derived from multipotent mesenchymal stem cells, build the bone tissue through deposition of Type-I collagen and through the release of ions that combine chemically forming the bone mineral. Osteoclasts differentiate from hematopoietic stem cells and cause resorption of the mineralized bone mass. The balance between osteoblasts and osteoclasts regulates mineral deposition and resorption. Sex steroid hormones contribute to control bone development during puberty, contribute to bone physiology, bone mass maintenance and regulate the rate of mineral bone deposition and resorption (Svoboda et al., <xref ref-type="bibr" rid="B421">2010</xref>).</p>
<p>The presence of the ERs as well as other hormone-receptors in normal osteoblastic cells, osteoclasts and osteoblasts is documented (Gruber et al., <xref ref-type="bibr" rid="B133">2002</xref>) and estrogens and androgens stimulate bone formation and inhibit bone resorption in both males and females. During human puberty and throughout adulthood, E2 and T induce osteoblast proliferation (Kassem et al., <xref ref-type="bibr" rid="B184">1998</xref>), which is mediated by IGF and GH (Riggs et al., <xref ref-type="bibr" rid="B341">2002</xref>; Svoboda et al., <xref ref-type="bibr" rid="B421">2010</xref>). Such human effects are well recapitulated in animal models. ERα-KO (Vidal et al., <xref ref-type="bibr" rid="B462">2000</xref>) and CYP19A1-KO mice (Oz et al., <xref ref-type="bibr" rid="B295">2000</xref>) exhibit low BMD in both genders and E2 treatment rescues the CYP19A1-KO phenotype (Miyaura et al., <xref ref-type="bibr" rid="B261">2001</xref>). Additionally, ovariectomy stimulates osteoclast differentiation through (indirect) increased levels of IL-1, 6 and TNF in osteoblasts and other bone-derived stromal cells (Gruber et al., <xref ref-type="bibr" rid="B133">2002</xref>; Svoboda et al., <xref ref-type="bibr" rid="B421">2010</xref>).</p>
<p>Accelerated bone loss and increased osteoporotic fractures are associated with postmenopausal estrogen deficiency and low sex steroid levels elicit similar manifestations in men (Compston, <xref ref-type="bibr" rid="B67">2001</xref>; Riggs et al., <xref ref-type="bibr" rid="B341">2002</xref>; Syed and Khosla, <xref ref-type="bibr" rid="B423">2005</xref>). Free E2 levels are associated with low lumbar spine and femoral neck bone mineral density (BMD) in both genders (Zarrabeitia et al., <xref ref-type="bibr" rid="B492">2007</xref>) and estrogen therapy reduces bone loss and the risk of fracture in women with osteoporosis (Gruber et al., <xref ref-type="bibr" rid="B133">2002</xref>).</p>
<sec>
<title>Intracrinology in healthy bone–systematic search</title>
<p>Bone expresses CYP19A1 and 17βHSD1, and mRNA <italic>in situ</italic> hybridisation and immunohistochemistry signals were seen in lining cells, osteoblasts, chondrocytes of articular cartilage, and adipocytes adjacent to bone trabeculae in both male and female tibiae. CYP19A1 mRNA was also widely present in various bones (ribs, femurs) with inter-individual variability, but no relation with gender or age (Sasano et al., <xref ref-type="bibr" rid="B363">1997</xref>). STS and 17βHSD activities were demonstrated by recovery of [3H]E1 and [3H]E2 after incubating femur-head fragments with [3H]E1-S (15 women and 12 men with osteoarthritis indicated for hip replacement). No gender-related differences were observed and E2 formation from androgens was lower than that from E1-S, indicating a predominant role of the sulphatase pathway in bone estrogen supply (Muir et al., <xref ref-type="bibr" rid="B270">2004</xref>). Subsequent studies also demonstrated the presence of CYP11A1, CYP17A1, 17βHSD reductive and oxidative activity in bone tissues (Table <xref ref-type="table" rid="T8">8</xref>). Overall, however, only six papers describing the level of intracrine enzymes in bone tissues were retrieved by the systemic search (Table <xref ref-type="table" rid="T8">8</xref>) and most studies on bone intracrinology used <italic>in vitro</italic> cell cultures. <italic>In vitro</italic> studies were not included in our systematic review, but those on bone are briefly described in the next paragraph. These studies demonstrate the presence of a complex intracrine networks.</p>
<table-wrap id="T8" position="float">
<label>Table 8</label>
<caption>
<p>Expression of intracrine enzymes in bone, lungs and central nervous system (CNS) – results of the systematic search.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Gene</bold>
</th>
<th align="left" colspan="2" rowspan="1" style="border-bottom: thin solid #000000;" valign="top">
<bold>Detection</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Bone</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>References</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Lung</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>References</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>CNS</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>References</bold>
</th>
</tr>
<tr>
<th colspan="1" rowspan="1"></th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Molecule</bold>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<bold>Technique<xref ref-type="table-fn" rid="TN48"><sup>#</sup></xref></bold>
</th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
<th colspan="1" rowspan="1"></th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">StAR</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes<xref ref-type="table-fn" rid="TN50"><sup>∧</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Pezzi et al., <xref ref-type="bibr" rid="B309">2003</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CYP11A1</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rodríguez-Sanz et al., <xref ref-type="bibr" rid="B347">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes<xref ref-type="table-fn" rid="TN50"><sup>∧</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Pezzi et al., <xref ref-type="bibr" rid="B309">2003</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stoffel-Wagner, <xref ref-type="bibr" rid="B411">2001</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Comp-RT</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Beyenburg et al., <xref ref-type="bibr" rid="B33">1999</xref>; Watzka et al., <xref ref-type="bibr" rid="B470">1999</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">WB</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes<xref ref-type="table-fn" rid="TN49"><sup>*</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Rodríguez-Sanz et al., <xref ref-type="bibr" rid="B347">2015</xref></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CYP17A1</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Rodríguez-Sanz et al., <xref ref-type="bibr" rid="B347">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">no<xref ref-type="table-fn" rid="TN50"><sup>∧</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Pezzi et al., <xref ref-type="bibr" rid="B309">2003</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stoffel-Wagner, <xref ref-type="bibr" rid="B411">2001</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Steckelbroeck et al., <xref ref-type="bibr" rid="B406">2004b</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">WB</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes<xref ref-type="table-fn" rid="TN49"><sup>*</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Rodríguez-Sanz et al., <xref ref-type="bibr" rid="B347">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Steckelbroeck et al., <xref ref-type="bibr" rid="B406">2004b</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Activity</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Steckelbroeck et al., <xref ref-type="bibr" rid="B406">2004b</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">CYP19A1</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Oz et al., <xref ref-type="bibr" rid="B294">2001</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pezzi et al., <xref ref-type="bibr" rid="B309">2003</xref>; Aresti et al., <xref ref-type="bibr" rid="B15">2014</xref>; Kohno et al., <xref ref-type="bibr" rid="B199">2014</xref>; Konings et al., <xref ref-type="bibr" rid="B202">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sasano et al., <xref ref-type="bibr" rid="B362">1998</xref>; Stoffel-Wagner et al., <xref ref-type="bibr" rid="B416">1998a</xref>; Stoffel-Wagner, <xref ref-type="bibr" rid="B411">2001</xref>; Yague et al., <xref ref-type="bibr" rid="B478">2006</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Comp-RT</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stoffel-Wagner et al., <xref ref-type="bibr" rid="B413">1999a</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">ISH</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sasano et al., <xref ref-type="bibr" rid="B363">1997</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sasano et al., <xref ref-type="bibr" rid="B363">1997</xref>; Oz et al., <xref ref-type="bibr" rid="B294">2001</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Verma et al., <xref ref-type="bibr" rid="B460">2013</xref>; Siegfried and Stabile, <xref ref-type="bibr" rid="B381">2014</xref>; Taniuchi et al., <xref ref-type="bibr" rid="B432">2014</xref>; Konings et al., <xref ref-type="bibr" rid="B202">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Naftolin et al., <xref ref-type="bibr" rid="B277">1996</xref>; Yague et al., <xref ref-type="bibr" rid="B478">2006</xref>, <xref ref-type="bibr" rid="B477">2010</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">ELISA</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Aresti et al., <xref ref-type="bibr" rid="B15">2014</xref>; Skjefstad et al., <xref ref-type="bibr" rid="B393">2016</xref>; Tanaka et al., <xref ref-type="bibr" rid="B427">2016</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Activity</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Schweikert et al., <xref ref-type="bibr" rid="B367">1995</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Taniuchi et al., <xref ref-type="bibr" rid="B432">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Naftolin and MacLusky, <xref ref-type="bibr" rid="B278">1982</xref>; Stoffel-Wagner, <xref ref-type="bibr" rid="B411">2001</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3βHSD1</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes<xref ref-type="table-fn" rid="TN50"><sup>∧</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Pezzi et al., <xref ref-type="bibr" rid="B309">2003</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stoffel-Wagner, <xref ref-type="bibr" rid="B411">2001</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">3βHSD2</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">no<xref ref-type="table-fn" rid="TN50"><sup>∧</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Pezzi et al., <xref ref-type="bibr" rid="B309">2003</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stoffel-Wagner, <xref ref-type="bibr" rid="B411">2001</xref></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">17βHSDs</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">HSD17B oxidative activity</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Muir et al., <xref ref-type="bibr" rid="B270">2004</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Steckelbroeck et al., <xref ref-type="bibr" rid="B407">1999</xref>, <xref ref-type="bibr" rid="B409">2003</xref>; Stoffel-Wagner, <xref ref-type="bibr" rid="B411">2001</xref></td>
</tr>
<tr>
<td align="left" colspan="3" rowspan="1" valign="top">HSD17B reductive activity</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Muir et al., <xref ref-type="bibr" rid="B270">2004</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Tsai et al., <xref ref-type="bibr" rid="B443">2001</xref>; Attar et al., <xref ref-type="bibr" rid="B18">2009</xref>; Huhtinen et al., <xref ref-type="bibr" rid="B160">2014</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Steckelbroeck et al., <xref ref-type="bibr" rid="B407">1999</xref>, <xref ref-type="bibr" rid="B409">2003</xref>; Stoffel-Wagner, <xref ref-type="bibr" rid="B411">2001</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD1</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Takeyama et al., <xref ref-type="bibr" rid="B425">2000</xref>; Drzewiecka et al., <xref ref-type="bibr" rid="B98">2015</xref>; Konings et al., <xref ref-type="bibr" rid="B202">2017</xref>)</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stoffel-Wagner et al., <xref ref-type="bibr" rid="B413">1999a</xref>; Stoffel-Wagner, <xref ref-type="bibr" rid="B411">2001</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Comp-RT</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Beyenburg et al., <xref ref-type="bibr" rid="B34">2000</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">ISH</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sasano et al., <xref ref-type="bibr" rid="B363">1997</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD1</td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">Comp-RT</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stoffel-Wagner et al., <xref ref-type="bibr" rid="B415">1999b</xref>; Beyenburg et al., <xref ref-type="bibr" rid="B34">2000</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sasano et al., <xref ref-type="bibr" rid="B363">1997</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Verma et al., <xref ref-type="bibr" rid="B460">2013</xref>; Drzewiecka et al., <xref ref-type="bibr" rid="B98">2015</xref>; Konings et al., <xref ref-type="bibr" rid="B202">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">WB</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Drzewiecka et al., <xref ref-type="bibr" rid="B98">2015</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD2</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Takeyama et al., <xref ref-type="bibr" rid="B425">2000</xref>; Simard et al., <xref ref-type="bibr" rid="B383">2010</xref>; Konings et al., <xref ref-type="bibr" rid="B202">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stoffel-Wagner, <xref ref-type="bibr" rid="B411">2001</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Comp-RT</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stoffel-Wagner et al., <xref ref-type="bibr" rid="B415">1999b</xref>; Beyenburg et al., <xref ref-type="bibr" rid="B34">2000</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">NB</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Casey et al., <xref ref-type="bibr" rid="B56">1994</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Verma et al., <xref ref-type="bibr" rid="B460">2013</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">WB</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD3</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stoffel-Wagner, <xref ref-type="bibr" rid="B411">2001</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Comp-RT</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stoffel-Wagner et al., <xref ref-type="bibr" rid="B415">1999b</xref>; Beyenburg et al., <xref ref-type="bibr" rid="B34">2000</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD4</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Konings et al., <xref ref-type="bibr" rid="B202">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stoffel-Wagner et al., <xref ref-type="bibr" rid="B413">1999a</xref>; Stoffel-Wagner, <xref ref-type="bibr" rid="B411">2001</xref>; Steckelbroeck et al., <xref ref-type="bibr" rid="B409">2003</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Comp-RT</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stoffel-Wagner et al., <xref ref-type="bibr" rid="B415">1999b</xref>; Beyenburg et al., <xref ref-type="bibr" rid="B34">2000</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">NB</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Möller et al., <xref ref-type="bibr" rid="B264">1999</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Möller et al., <xref ref-type="bibr" rid="B264">1999</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD6</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Huang and Luu-The, <xref ref-type="bibr" rid="B155">2000</xref>; Steckelbroeck et al., <xref ref-type="bibr" rid="B409">2003</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD7</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Törn et al., <xref ref-type="bibr" rid="B440">2003</xref>; Konings et al., <xref ref-type="bibr" rid="B202">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Steckelbroeck et al., <xref ref-type="bibr" rid="B409">2003</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD8</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ohno et al., <xref ref-type="bibr" rid="B291">2008</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Steckelbroeck et al., <xref ref-type="bibr" rid="B409">2003</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD9</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Steckelbroeck et al., <xref ref-type="bibr" rid="B409">2003</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD10</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Steckelbroeck et al., <xref ref-type="bibr" rid="B409">2003</xref>; He and Yang, <xref ref-type="bibr" rid="B142">2006</xref>; Hovorkova et al., <xref ref-type="bibr" rid="B152">2008</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">He et al., <xref ref-type="bibr" rid="B141">2005b</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">C-ELISA</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Hovorkova et al., <xref ref-type="bibr" rid="B152">2008</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD11</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chai et al., <xref ref-type="bibr" rid="B57">2003</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Steckelbroeck et al., <xref ref-type="bibr" rid="B409">2003</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NB</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Chai et al., <xref ref-type="bibr" rid="B57">2003</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Brereton et al., <xref ref-type="bibr" rid="B42">2001</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">17βHSD12</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sakurai et al., <xref ref-type="bibr" rid="B356">2006</xref>; Konings et al., <xref ref-type="bibr" rid="B202">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sakurai et al., <xref ref-type="bibr" rid="B356">2006</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NB</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sakurai et al., <xref ref-type="bibr" rid="B356">2006</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Sakurai et al., <xref ref-type="bibr" rid="B356">2006</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">NB</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Casey et al., <xref ref-type="bibr" rid="B56">1994</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Yes<xref ref-type="table-fn" rid="TN51"><sup>$</sup></xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">Sakurai et al., <xref ref-type="bibr" rid="B356">2006</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="2" rowspan="1" valign="top">AKR1C activity</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Steckelbroeck et al., <xref ref-type="bibr" rid="B405">2010</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">AKR1C1</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Penning et al., <xref ref-type="bibr" rid="B306">2000</xref>; Stoffel-Wagner et al., <xref ref-type="bibr" rid="B414">2003</xref>; Steckelbroeck et al., <xref ref-type="bibr" rid="B405">2010</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">AKR1C2</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Penning et al., <xref ref-type="bibr" rid="B306">2000</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Comp-RT</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stoffel-Wagner et al., <xref ref-type="bibr" rid="B414">2003</xref>; Steckelbroeck et al., <xref ref-type="bibr" rid="B404">2004a</xref>, <xref ref-type="bibr" rid="B405">2010</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">AKR1C3</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Simard et al., <xref ref-type="bibr" rid="B383">2010</xref>; Konings et al., <xref ref-type="bibr" rid="B202">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Comp-RT</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stoffel-Wagner et al., <xref ref-type="bibr" rid="B412">2000</xref>, <xref ref-type="bibr" rid="B414">2003</xref>; Steckelbroeck et al., <xref ref-type="bibr" rid="B408">2001</xref>, <xref ref-type="bibr" rid="B404">2004a</xref>; Stoffel-Wagner, <xref ref-type="bibr" rid="B411">2001</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">NB</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td align="left" colspan="1" rowspan="1" valign="top">Lin et al., <xref ref-type="bibr" rid="B219">1997</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Miller et al., <xref ref-type="bibr" rid="B258">2012b</xref>; Chang et al., <xref ref-type="bibr" rid="B58">2013</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">AKR1C4</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Steckelbroeck et al., <xref ref-type="bibr" rid="B405">2010</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Comp-RT</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stoffel-Wagner et al., <xref ref-type="bibr" rid="B412">2000</xref>, <xref ref-type="bibr" rid="B414">2003</xref>; Steckelbroeck et al., <xref ref-type="bibr" rid="B404">2004a</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SRD5A1</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Comp-RT</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stoffel-Wagner et al., <xref ref-type="bibr" rid="B417">1998b</xref>, <xref ref-type="bibr" rid="B412">2000</xref>, <xref ref-type="bibr" rid="B414">2003</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Aumüller et al., <xref ref-type="bibr" rid="B21">1996</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Aumüller et al., <xref ref-type="bibr" rid="B21">1996</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">activity</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stoffel-Wagner et al., <xref ref-type="bibr" rid="B417">1998b</xref>; Steckelbroeck et al., <xref ref-type="bibr" rid="B408">2001</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SRD5A2</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">Comp-RT</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Stoffel-Wagner et al., <xref ref-type="bibr" rid="B417">1998b</xref>, <xref ref-type="bibr" rid="B412">2000</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Aumüller et al., <xref ref-type="bibr" rid="B21">1996</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Aumüller et al., <xref ref-type="bibr" rid="B21">1996</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">STS</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Konings et al., <xref ref-type="bibr" rid="B202">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Steckelbroeck et al., <xref ref-type="bibr" rid="B406">2004b</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Miki et al., <xref ref-type="bibr" rid="B255">2002</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Miki et al., <xref ref-type="bibr" rid="B255">2002</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Iida et al., <xref ref-type="bibr" rid="B164">2013</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Steckelbroeck et al., <xref ref-type="bibr" rid="B406">2004b</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Miki et al., <xref ref-type="bibr" rid="B255">2002</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Miki et al., <xref ref-type="bibr" rid="B255">2002</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Activity</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Muir et al., <xref ref-type="bibr" rid="B270">2004</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Milewich et al., <xref ref-type="bibr" rid="B256">1983</xref>; Munroe and Chang, <xref ref-type="bibr" rid="B273">1987</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Platia et al., <xref ref-type="bibr" rid="B313">1984</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SULT1E1</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Svoboda et al., <xref ref-type="bibr" rid="B422">2007</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Miki et al., <xref ref-type="bibr" rid="B255">2002</xref>; Konings et al., <xref ref-type="bibr" rid="B202">2017</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Miki et al., <xref ref-type="bibr" rid="B255">2002</xref>; Nishimura and Naito, <xref ref-type="bibr" rid="B283">2006</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Salman et al., <xref ref-type="bibr" rid="B358">2011</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">NB</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Miki et al., <xref ref-type="bibr" rid="B255">2002</xref>; Iida et al., <xref ref-type="bibr" rid="B164">2013</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Miki et al., <xref ref-type="bibr" rid="B255">2002</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Salman et al., <xref ref-type="bibr" rid="B358">2011</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">WB</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Riches et al., <xref ref-type="bibr" rid="B340">2009</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Activity</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Jones et al., <xref ref-type="bibr" rid="B180">1992</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Miki et al., <xref ref-type="bibr" rid="B255">2002</xref></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SULT2A1</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nishimura and Naito, <xref ref-type="bibr" rid="B283">2006</xref>; Salman et al., <xref ref-type="bibr" rid="B358">2011</xref>
<italic>3/4 Table VII continues</italic></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Riches et al., <xref ref-type="bibr" rid="B340">2009</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Steckelbroeck et al., <xref ref-type="bibr" rid="B406">2004b</xref>; Salman et al., <xref ref-type="bibr" rid="B358">2011</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Activity</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Steckelbroeck et al., <xref ref-type="bibr" rid="B406">2004b</xref>.</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SULT1A1</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nishimura and Naito, <xref ref-type="bibr" rid="B283">2006</xref>; Salman et al., <xref ref-type="bibr" rid="B358">2011</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nishimura and Naito, <xref ref-type="bibr" rid="B283">2006</xref>; Salman et al., <xref ref-type="bibr" rid="B358">2011</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">WB</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Riches et al., <xref ref-type="bibr" rid="B340">2009</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">SULT2B1</td>
<td align="left" colspan="1" rowspan="1" valign="top">mRNA</td>
<td align="left" colspan="1" rowspan="1" valign="top">RT-PCR</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">He et al., <xref ref-type="bibr" rid="B139">2004</xref>, <xref ref-type="bibr" rid="B138">2005a</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nishimura and Naito, <xref ref-type="bibr" rid="B283">2006</xref>; Salman et al., <xref ref-type="bibr" rid="B358">2011</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">NB</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">He et al., <xref ref-type="bibr" rid="B139">2004</xref>, <xref ref-type="bibr" rid="B138">2005a</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Meloche and Falany, <xref ref-type="bibr" rid="B254">2001</xref></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">NB</td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">no</td>
<td align="left" colspan="1" rowspan="1" valign="top">Meloche and Falany, <xref ref-type="bibr" rid="B254">2001</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">–</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Protein</td>
<td align="left" colspan="1" rowspan="1" valign="top">IHC</td>
<td align="left" colspan="1" rowspan="1" valign="top">n.d.</td>
<td colspan="1" rowspan="1"></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">He et al., <xref ref-type="bibr" rid="B139">2004</xref>, <xref ref-type="bibr" rid="B138">2005a</xref></td>
<td align="left" colspan="1" rowspan="1" valign="top">yes</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nishimura and Naito, <xref ref-type="bibr" rid="B283">2006</xref>; Salman et al., <xref ref-type="bibr" rid="B358">2011</xref></td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Primary/original references were analyzed and reviews were excluded (and are cited ad hoc in the text). The table report only the enzymes whose expression was assessed in reviewed studies<sup>**</sup></italic>.</p>
<fn id="TN48">
<label>#</label>
<p><italic>Technique abbreviations. For mRNA detection, NB: northern blot; ISH: in situ hybridisation; RT-PCR: reverse transcription quantitative (or semi-quantitative) PCR; Comp-RT: competitive RT-PCR assay; NB: northern blotting. For protein detection: IHC: immunohistochemistry; C-ELISA: competitive ELISA assay; WB: western blotting; activity: enzyme activity measurement</italic>.</p>
</fn>
<fn id="TN49">
<label>*</label>
<p><italic>CYP11A1 and CYP17A1 activities were detected in primary cells of bone</italic>.</p>
</fn>
<p><sup>**</sup>No publication was found describing the expression of 17βHSD13, 14, 15 and DHRS11.</p>
<fn id="TN50">
<label>∧</label>
<p><italic>Detected in fetal lung tissue</italic>.</p>
</fn>
<fn id="TN51">
<label>$</label>
<p><italic>IHC signal in bronchial epithelium</italic>.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Bone intracrinology: <italic>in vitro</italic> and <italic>in vivo</italic></title>
<p>From early ‘90s, various isotopic techniques demonstrated the presence of CYP19A1, 17βHSD reductive/oxidative, 3βHSD and STS activities and the mRNA expression of 17βHSD1, 2, 4, STS, SULT1E1, CYP19A1 and SDR5A in human osteoblastic (e.g., HOS, U20S, HTB-96 and MG63) and osteosarcoma cell lines like CRL-1543 (Purohit et al., <xref ref-type="bibr" rid="B323">1992</xref>; Fujikawa et al., <xref ref-type="bibr" rid="B121">1997</xref>; Jakob et al., <xref ref-type="bibr" rid="B172">1997</xref>; Dong et al., <xref ref-type="bibr" rid="B96">1998</xref>; Saito and Yanaihara, <xref ref-type="bibr" rid="B353">1998</xref>; Janssen et al., <xref ref-type="bibr" rid="B173">1999</xref>; Muir et al., <xref ref-type="bibr" rid="B270">2004</xref>; Svoboda et al., <xref ref-type="bibr" rid="B422">2007</xref>; Dias and Selcer, <xref ref-type="bibr" rid="B91">2014</xref>).</p>
<p><italic>In vitro</italic> evidence using osteoblastic cells show that E2 has mitogenic effects, which is blocked by the ERα antagonist fulvestrant. Since both E1-S and DHEA-S elicit effects similar to E2, which are blocked by STS inhibition (Selcer and Difrancesca, <xref ref-type="bibr" rid="B370">2012</xref>; Dias and Selcer, <xref ref-type="bibr" rid="B91">2014</xref>), these studies demonstrate that conjugated steroids are activated and that DHEA is converted to E2. Studies in rat osteoblast with [14C]T demonstrated that T is converted by SRD5As and AKR1Cs to 3α/3βDIOLs, which induce proliferation via activation of ER (and not AR) (Enríquez et al., <xref ref-type="bibr" rid="B106">2013</xref>).</p>
<p><italic>In vitro</italic> models of osteoblast differentiation showed that various differentiation stages are accompanied by declines in STS, CYP19A1 and 17βHSD1 (Janssen et al., <xref ref-type="bibr" rid="B173">1999</xref>; Dias and Selcer, <xref ref-type="bibr" rid="B92">2016</xref>).</p>
<p>In rats, during and after sexual maturation, <italic>in situ</italic> hybridization showed that ERα and ERβ localize in osteoblasts, osteoclasts and osteocytes covering the tibia metaphysis (responsible for elongation of long bones), and co-localize with STS. Starting at sexual maturation (e.g., 7-week-old), ERs also co-localize with CYP19A1, 17βHSD1, 2 and SRD5A1 (van der Eerden et al., <xref ref-type="bibr" rid="B453">2004</xref>). In addition, male transgenic mice overexpressing 17βHSD2 show disturbed IGF-I/steroid actions in bone, with growth retardation, decreased bone formation at prepuberty and decreased serum levels of IGF-I, osteocalcin and T (Shen et al., <xref ref-type="bibr" rid="B375">2008</xref>).</p>
</sec>
<sec>
<title>Diseases and treatments</title>
<p>Genetic variants of estrogen and intracrine pathways are associated with bone disturbances (Table <xref ref-type="table" rid="T5">5</xref>). Defects in the CYP19A1 and ERα are associated with low BMD and other skeletal disturbances (e.g., high stature, delayed bone age) and estrogen therapy ameliorates some bone abnormalities caused by CYP19A1 deficiencies in men (Smith et al., <xref ref-type="bibr" rid="B397">1994</xref>; Morishima et al., <xref ref-type="bibr" rid="B268">1995</xref>; Carani et al., <xref ref-type="bibr" rid="B51">1997</xref>; Mullis et al., <xref ref-type="bibr" rid="B272">1997</xref>; Bilezikian et al., <xref ref-type="bibr" rid="B36">1998</xref>). In lumbar vertebrae, CYP19A1 levels correlate with changes in osteoporotic degree (Sasano et al., <xref ref-type="bibr" rid="B363">1997</xref>).</p>
<p>Inhibitors of 17βHSD2 attracted attention as potential drugs to oppose the effects of low E2 on BMD, fracture and osteoporosis. Ovariectomised female macaques receiving a 17βHSD2 inhibitor display desirable bone balance, bone strength and lower bone resorption compared with untreated controls (Bagi et al., <xref ref-type="bibr" rid="B24">2008</xref>). Several compounds targeting this enzyme have been developed and their use and challenges in osteoporosis were recently reviewed (Soubhye et al., <xref ref-type="bibr" rid="B403">2015</xref>).</p>
<p>In a study on 35 chondrosarcoma biopsies (a malignant bone cancer occurring in middle aged patients), ERα (mRNA and IHC) and CYP19A1 (mRNA and activity) were demonstrated in the majority of the samples, and the AI exemestane impaired the E2- and androgen-induced proliferation of primary chondrosarcoma cells (Cleton-Jansen et al., <xref ref-type="bibr" rid="B63">2005</xref>). Although AIs were proposed as novel drugs to treat this condition (Bovée et al., <xref ref-type="bibr" rid="B41">2005</xref>), a pilot study on six patients with progressive disease showed no benefit of exemestane in progression-free survival compared with untreated patients (Meijer et al., <xref ref-type="bibr" rid="B253">2011</xref>).</p>
<p>In a study of 28 osteosarcoma specimens (one of the most common bone cancers developing at young age) strong ERβ and PR immunoreactivity was seen in over 80% of the samples (and also correlated with Ki67). ERα and AR staining was seen in 30% of the samples, whereas CYP19A1 was undetected (Dohi et al., <xref ref-type="bibr" rid="B95">2008</xref>). In another study, 20 osteosarcoma specimens, including 11 good responders to chemotherapy and nine poor responders, were subjected to cDNA microarray and 17βHSD10 resulted unregulated in the poor responder group. Results were further confirmed by IHC on 69 archival biopsies, hence targeting 17βHSD10 may be a valuable approach for drug (re)sensitisation (Salas et al., <xref ref-type="bibr" rid="B357">2009</xref>).</p>
<p>Additional intracrine imbalances are described in bone diseases, such as higher androgen reducing 17βHSD activity in benign vs. malignant tumors, declines of CYP19A1 from normal bone to osteosarcoma and expression of SULT1E1 in the majority of the skeletal benign and malignant lesions, originated in bones or from primary tumors elsewhere (Svoboda et al., <xref ref-type="bibr" rid="B422">2007</xref>).</p>
</sec>
<sec>
<title>Bone tissue: conclusions</title>
<p><italic>In vitro</italic>, animal and human studies show that intracrinology controls bone development, benign and malignant conditions, and offer novel potential drug targets (Table <xref ref-type="table" rid="T8">8</xref> and Figure <xref ref-type="fig" rid="F3">3</xref>). Steroids can be synthesized <italic>in situ</italic> from cholesterol (Rodríguez-Sanz et al., <xref ref-type="bibr" rid="B347">2015</xref>) and can be recruited from the serum <italic>via</italic> the sulphatase pathway. DHEA is substrate for androgen and estrogen production. The action of androgens is partly mediated by their conversion to estrogens <italic>via</italic> CYP19A1 or to estrogenic 3α/βDIOLs (Vanderschueren et al., <xref ref-type="bibr" rid="B454">2008</xref>).</p>
</sec>
</sec>
<sec>
<title>Lungs</title>
<p>Sex steroids play an important role in lung development and homeostasis. Androgens, progestogens and estrogens are present and exert genomic and non-genomic actions via their hormone-receptors. Classical ERs (with ERβ as predominant form) and membrane GPER are expressed (Couse et al., <xref ref-type="bibr" rid="B73">1997</xref>; Prossnitz and Barton, <xref ref-type="bibr" rid="B321">2011</xref>; Konings et al., <xref ref-type="bibr" rid="B202">2017</xref>). Sex steroids remain active in the lungs throughout lifetime and modulate lung function in both a beneficial or detrimental way, extensively reviewed (González-Arenas and Agramonte-Hevia, <xref ref-type="bibr" rid="B129">2012</xref>; Townsend et al., <xref ref-type="bibr" rid="B441">2012</xref>; Sathish et al., <xref ref-type="bibr" rid="B364">2015</xref>).</p>
<p>E2 and P regulate epithelial sodium channel expression in alveolar epithelial cells (Luo et al., <xref ref-type="bibr" rid="B232">2015</xref>). In alveolar smooth muscle cells, E2 induces bronchodilation via the reduction of intracellular Ca<sup>2+</sup> (Townsend et al., <xref ref-type="bibr" rid="B442">2010</xref>).</p>
<p>Both human and animal studies support a promoting role for estrogens and inhibitory role for androgens in lung development and maturation. During gestation and neonatal period, AR is expressed in mesenchymal and epithelial cells. Androgens inhibit the production of surfactants, which starts later in male than in female neonatal lungs (Carey et al., <xref ref-type="bibr" rid="B52">2007</xref>), but also support the developing lung during branching morphogenesis (Kimura et al., <xref ref-type="bibr" rid="B192">2003</xref>).</p>
<sec>
<title>Lung intracrinology in lungs–systematic search</title>
<p>Adult human lungs express CYP19A1 and most 17βHSDs (1, 2, 4, 7, 8, 11, 12, 17βHSD5/AKR1C3; Table <xref ref-type="table" rid="T8">8</xref>). STS, SULT and 17βHSD1, 12 and 17βHSD5/AKR1C3 immunoreactivity localizes in the bronchial epithelium (weak for types 1 and 12, strong for type 17βHSD5) and alveolar macrophages (Sakurai et al., <xref ref-type="bibr" rid="B356">2006</xref>; Miller et al., <xref ref-type="bibr" rid="B258">2012b</xref>; Chang et al., <xref ref-type="bibr" rid="B58">2013</xref>; Konings et al., <xref ref-type="bibr" rid="B202">2017</xref>).</p>
<p>Intracrinology controls lung development and maturation as shown in various animal models (Boucher et al., <xref ref-type="bibr" rid="B40">2009</xref>) and intracrine enzymes are expressed already during fetal stages. Human fetal lungs possess StAR, CYP11A1, 3βHSD1 mRNA (Pezzi et al., <xref ref-type="bibr" rid="B309">2003</xref>), SULT1E1 activity (Jones et al., <xref ref-type="bibr" rid="B180">1992</xref>) and show 17βHSD1 and 2 mRNAs expression at 13 and 20 weeks of gestational age (Takeyama et al., <xref ref-type="bibr" rid="B425">2000</xref>). High mRNA levels of AR, 17βHSD2 and 17βHSD5/AKR1C3 in mid-late gestation period and adult lungs indicate the present of androgen metabolism (Simard et al., <xref ref-type="bibr" rid="B383">2010</xref>). Immunoreactivity for 17βHSD11 is detected in bronchioles of 14 and 31 weeks old fetuses, whereas other structures are negative (e.g., alveoli, ciliated epithelium, acini of the trachea). The expression of 17βHSD11 increases during the second half of pregnancy and maintains similar patterns in neonatal (14 days) and adult lugs (Brereton et al., <xref ref-type="bibr" rid="B42">2001</xref>).</p>
</sec>
<sec>
<title>Intracrinology and lung diseases</title>
<p>Altered intracrinology is involved in lung disorders already from neonatal stages toward adulthood, and SNPs in intracrine genes are associated with the onset of diseases (Zhang et al., <xref ref-type="bibr" rid="B495">2013</xref>). Higher concentration of estrogens were measured by LC-MS in women with multiple-synchronous-lung adenocarcinoma compared with single adenocarcinoma (Ikeda et al., <xref ref-type="bibr" rid="B165">2016</xref>) and in neoplastic tissue compared with adjacent normal lungs (Niikawa et al., <xref ref-type="bibr" rid="B282">2008</xref>; Verma et al., <xref ref-type="bibr" rid="B460">2013</xref>). Type 1 17βHSD mRNA, protein and activity are present in various non-small-cell-lung-cancer (NSCLC) cell lines where the mitogenic effect of E1 is abrogated by 17βHSD1 knockdown (Drzewiecka and Jagodzinski, <xref ref-type="bibr" rid="B99">2012</xref>; Verma et al., <xref ref-type="bibr" rid="B460">2013</xref>). In specimens from 48 NSCLC patients, 17βHSD1 expression was associated with squamous cell carcinoma and stage 3A disease (Drzewiecka et al., <xref ref-type="bibr" rid="B98">2015</xref>). In another study on 103 NSCLC specimens, high 17βHSD1 immunoreactivity was associated with low intratumoural E1 and high E2:E1 ratio, whereas higher 17βHSD2 immunoreactivity was associated with high intratumoural E1. Multivariate regression analysis also demonstrated that increased 17βHSD1 immunoreactivity in tumors was an independent negative prognostic factor (Verma et al., <xref ref-type="bibr" rid="B460">2013</xref>).</p>
<p>CYP19A1 is expressed in lung cancer and has potential therapeutic value (Niikawa et al., <xref ref-type="bibr" rid="B282">2008</xref>; Verma et al., <xref ref-type="bibr" rid="B461">2011</xref>; Siegfried and Stabile, <xref ref-type="bibr" rid="B381">2014</xref>). A recent IHC study on 335 NSCLC specimens found an inverse association between CYP19A1 expression with disease specific survival (Skjefstad et al., <xref ref-type="bibr" rid="B393">2016</xref>). Similar data, although restricted to women only, were confirmed in an independent study on 150 primary lung adenocarcinoma specimens, where CYP19A1 was found as the main driver of local estrogen supply (Tanaka et al., <xref ref-type="bibr" rid="B427">2016</xref>). Another study on 110 lung adenocarcinoma specimens found an association between CYP19A1 mRNA (RT-qPCR) and poor prognosis in females, never-smokers and harboring EGFR mutations (Kohno et al., <xref ref-type="bibr" rid="B199">2014</xref>). However, a recent mRNA study on 96 NSCLC patients showed that CYP19A1 in combination with ER is a good prognostic marker (Aresti et al., <xref ref-type="bibr" rid="B15">2014</xref>).</p>
<p>STS and SULT1E1 immunoreactivity is detected in the majority of NSCLC cases, and STS is a good prognostic marker (Iida et al., <xref ref-type="bibr" rid="B164">2013</xref>).</p>
<p>Lymphangioleiomyomatosis (LAM) is a rare, potentially fatal disease affecting predominantly young women. It is strongly hormone sensitive and it is hypothesized to originate from the uterus as lung metastasis (Prizant and Hammes, <xref ref-type="bibr" rid="B320">2016</xref>). The levels of ERs, PR, AR, CYP19A1, STS, 17βHSD1 and SRD5A2 were recently assessed among 30 LAM biopsies. CYP19A1 expression resulted a useful classification marker with implication for potential therapy (Adachi et al., <xref ref-type="bibr" rid="B3">2015</xref>). A recent study on specimens from 73 patients with chronic obstructive pulmonary disease (COPD) and 48 controls described an association between both CYP19A1 and 17βHSD1 with COPD (Konings et al., <xref ref-type="bibr" rid="B202">2017</xref>). CYP19A1 is also implicated in interstitial pneumonia interstitial pneumonia, where local E2 concentration and CYP19A1 activity and immunoreactivity were elevated in diseased compared with normal tissue (Taniuchi et al., <xref ref-type="bibr" rid="B432">2014</xref>).</p>
</sec>
<sec>
<title>Potential novel treatments</title>
<p>Blocking the estrogen signaling showed promising preclinical results in animal models of lung cancer (Verma et al., <xref ref-type="bibr" rid="B461">2011</xref>). In humans, antiestrogen treatments (ER antagonists, GnRH, oophorectomy, P) have been used in LAM (Taveira-DaSilva and Moss, <xref ref-type="bibr" rid="B434">2014</xref>) and lung cancer patients (Verma et al., <xref ref-type="bibr" rid="B461">2011</xref>; Kohno et al., <xref ref-type="bibr" rid="B199">2014</xref>). A phase II study on advanced NSCLC patients non-responsive to platinum-based drugs tested the dual-regimen mTOR/CYP19A1 inhibitors. Unfortunately, this study was prematurely terminated due to high toxicity (Singhal et al., <xref ref-type="bibr" rid="B387">2015</xref>) and one additional trial using ER antagonist plus AI (fulvestrant and anastrozole) as consolidation therapy in postmenopausal women with advanced NSCLC (NCT00932152) was terminated due to poor recruitment.</p>
<p>Better results were obtained using the AI letrozole as single agent or in combination with rapamycin in a phase II trial on 17 postmenopausal women with LAM (NCT01353209). AI treatment was safe and well tolerated also in the dual drug regimen (Lu et al., <xref ref-type="bibr" rid="B229">2017</xref>).</p>
</sec>
<sec>
<title>Lungs: conclusions</title>
<p>Steroids are involved in lung maturation, development and in susceptibility to diseases. Most 17βHSDs, STS/SULT1E1, CYP19A1 are expressed indicating the lung's ability to metabolize androgens, estrogens and progestogens. Evidence of 3βHSDs is limited to fetal tissues (Table <xref ref-type="table" rid="T8">8</xref> and Figure <xref ref-type="fig" rid="F3">3</xref>). Approaches aimed at decreasing local estrogens may offer future novel treatments for various lung diseases.</p>
</sec>
</sec>
<sec>
<title>Brain and central nervous system (CNS)</title>
<p>One of the first CNS actions of sex steroids to be described is the hypothalamus-pituitary-gonadal axes control (Andersen and Ezcurra, <xref ref-type="bibr" rid="B13">2014</xref>). The identification of steroid-receptors outside the hypothalamus, like hippocampus (controlling memory), prefrontal cortex, cerebellum and dopaminergic system regulation indicated that sex steroids have complex and widespread effects in the CNS. They control aggressive behavior, cognitive functions, mood, food intake, appetite, addiction, blood pressure, fine motor skills, motor coordination, pain circuit and both estrogens and androgens are neuroprotective (López and Tena-Sempere, <xref ref-type="bibr" rid="B223">2015</xref>; Soma et al., <xref ref-type="bibr" rid="B402">2015</xref>; McEwen and Milner, <xref ref-type="bibr" rid="B252">2017</xref>). Estrogen deprivation in animals and humans is associated with development of metabolic disorders and estrogen administration has a general catabolic effect (López and Tena-Sempere, <xref ref-type="bibr" rid="B223">2015</xref>). Animal experiments and KO models show that ERα mediates the major actions of estrogens in the CNS, like the metabolic control functions (Musatov et al., <xref ref-type="bibr" rid="B275">2007</xref>) and the negative-feedback on the hypothalamus-pituitary-gonadal axes (Couse et al., <xref ref-type="bibr" rid="B74">2003</xref>). However, both nuclear and non-nuclear ERs are relevant in distinct CNS regions (Almey et al., <xref ref-type="bibr" rid="B9">2015</xref>; López and Tena-Sempere, <xref ref-type="bibr" rid="B223">2015</xref>; McEwen and Milner, <xref ref-type="bibr" rid="B252">2017</xref>).</p>
<p>Local steroid synthesis in the CNS is demonstrated in animal studies. CYP19A1-KO mice have increased ischemic damages compared with ovariectomised wild-type mice, indicating a local action of CYP19A1 (McEwen and Milner, <xref ref-type="bibr" rid="B252">2017</xref>). Similar conclusions were drawn for the estrogen protective effects on stroke, Alzheimer (AD), Parkinson diseases, aggressive behavior (Soma et al., <xref ref-type="bibr" rid="B402">2015</xref>; McEwen and Milner, <xref ref-type="bibr" rid="B252">2017</xref>) and mice with ablation in various 17βHSDs show neuronal defects (Table <xref ref-type="table" rid="T4">4</xref>). In rodents, CNS regions like the hippocampus and the hypothalamus express the enzymes involved in the local generation of steroids, like StAR, CYP11A1, CYP17A1, 3βHSD1, CYP19A1, 17βHSD1, SRD5A1 and 2 (mRNA and protein by immunohistochemistry or western blot), and can produce pregnenolone, DHEA, androgens and estrogens from cholesterol, as confirmed by HPLC using radiolabelled substrates and tissue cultures of brain slices (Mukai et al., <xref ref-type="bibr" rid="B271">2006</xref>; Murakami et al., <xref ref-type="bibr" rid="B274">2006</xref>). CYP enzymes of rat hippocampus co-localize in pyramidal neurons (CA1–CA3 regions) and granule cells (dentate gyrus) (Mukai et al., <xref ref-type="bibr" rid="B271">2006</xref>; Murakami et al., <xref ref-type="bibr" rid="B274">2006</xref>). Regulation of intracrine enzymes varies during development and sexual maturation, as indicated by mRNA expression (RT-qPCR) of 20 intracrine enzymes analyzed in rat hippocampus post-natal and throughout early (1 week) development (Kimoto et al., <xref ref-type="bibr" rid="B191">2010</xref>).</p>
<p>Intracrinology in the CNS is particularly relevant because, beside the traditional pathway <italic>via</italic> the receptors, several steroids have neuroactivity and are allosteric modulators of GABA<sub>A</sub> receptors (Figure <xref ref-type="fig" rid="F2">2</xref>). Such actions are possessed also by steroids that are unable to activate the steroid hormone receptors, such as 3β- and 3α-hydroxyl sulpho-conjugates (P5-S and DHEA-S), 5β-reduced steroids (5βAN, etiocholanolone and 5β-THP isomers; Table <xref ref-type="table" rid="T1">1</xref>), which are all GABA<sub>A</sub> negative modulators (in contrast to unconjugated 3α-hydroxysteroids) (Stoffel-Wagner, <xref ref-type="bibr" rid="B411">2001</xref>; Belelli and Lambert, <xref ref-type="bibr" rid="B29">2005</xref>; Agís-Balboa et al., <xref ref-type="bibr" rid="B7">2006</xref>; Gibbs et al., <xref ref-type="bibr" rid="B126">2006</xref>; Reddy, <xref ref-type="bibr" rid="B335">2010</xref>; Steckelbroeck et al., <xref ref-type="bibr" rid="B405">2010</xref>).</p>
<sec>
<title>Intracrinology in CNS–systematic search</title>
<p>Intracrine enzymes are widely expressed in human CNS (Table <xref ref-type="table" rid="T8">8</xref>) and intratissue concentrations of steroids in distinct regions differ between regions and from the levels in the blood (Mukai et al., <xref ref-type="bibr" rid="B271">2006</xref>; Murakami et al., <xref ref-type="bibr" rid="B274">2006</xref>; Jäntti et al., <xref ref-type="bibr" rid="B174">2010</xref>). In contrast to rodents, however, the presence of the complete steroid biosynthetic pathway is not clearly demonstrated in the human CNS and contrasting data were reported (Table <xref ref-type="table" rid="T8">8</xref>). CYP11A1 mRNA was detected in the temporal, frontal neocortex and subcortical white matter of men, women and children (Stoffel-Wagner, <xref ref-type="bibr" rid="B411">2001</xref>). Low mRNA levels of CYP17A1 were detected in the hippocampus, amygdala, caudate nucleus, cerebellum, corpus callosum, spinal cord and thalamus (Stoffel-Wagner, <xref ref-type="bibr" rid="B411">2001</xref>; Yu et al., <xref ref-type="bibr" rid="B488">2002</xref>), but other authors found no expression of this enzyme (Steckelbroeck et al., <xref ref-type="bibr" rid="B406">2004b</xref>, <xref ref-type="bibr" rid="B405">2010</xref>; MacKenzie et al., <xref ref-type="bibr" rid="B237">2008</xref>). No 3βHSD1 or 2 was detected in temporal lobes, hippocampus, thalamus and amygdala (Stoffel-Wagner, <xref ref-type="bibr" rid="B411">2001</xref>; Steckelbroeck et al., <xref ref-type="bibr" rid="B405">2010</xref>), although other authors detected low levels in amygdala, caudate nucleus, cerebellum, corpus callosum, hippocampus, spinal cord and thalamus (Yu et al., <xref ref-type="bibr" rid="B488">2002</xref>).</p>
<p>The temporal lobes (both neocortex and white matter) have 17βHSD oxidative and reductive activities, CYP19A1 mRNA expression and activity, which is also present in hippocampus (Stoffel-Wagner et al., <xref ref-type="bibr" rid="B413">1999a</xref>; Stoffel-Wagner, <xref ref-type="bibr" rid="B411">2001</xref>). Temporal lobe specimens from 10 men to 12 women indicated that 17βHSD estrogen-oxidative and DHEA-reductive metabolisms are predominant, thus producing E1 and A5, respectively (Stoffel-Wagner, <xref ref-type="bibr" rid="B411">2001</xref>). Regarding the different 17βHSDs, type 1, 3, and 4 mRNAs (but not type 2) were demonstrated by competitive reverse transcription-PCR in specimens from 34 women, 32 men and 10 children (Casey et al., <xref ref-type="bibr" rid="B56">1994</xref>; Beyenburg et al., <xref ref-type="bibr" rid="B34">2000</xref>). Subsequent studies confirmed the expression of types 4, 7, 8, 10, 11 17βHSD and AKR1C3/17βHSD5 in temporal lobes and hippocampus (Stoffel-Wagner, <xref ref-type="bibr" rid="B411">2001</xref>; Steckelbroeck et al., <xref ref-type="bibr" rid="B409">2003</xref>). In particular 17βHSD10 is involved in the deactivation of THP to 5αDHP, and it is an important regulator of neurological functions (Yang et al., <xref ref-type="bibr" rid="B485">2016</xref>).</p>
<p>Production of 5α-androstane and pregnane neurosteroids is mediated by the action of SRD5As and AKR1Cs (Figure <xref ref-type="fig" rid="F2">2</xref>). SRD5A1 (not type 2) mRNA and enzyme activity were demonstrated in temporal neocortex and subcortical white matter, hippocampus, cerebellum, hypothalamus (Steckelbroeck et al., <xref ref-type="bibr" rid="B408">2001</xref>; Stoffel-Wagner, <xref ref-type="bibr" rid="B411">2001</xref>), and AKR1C4 mRNA was detected in both hippocampus and temporal lobe (Stoffel-Wagner, <xref ref-type="bibr" rid="B411">2001</xref>). AKR1C1 and AKR1C2 are widely expressed in CNS and since no specific inhibitors directed against AKR1C1 to 4 could completely inhibit AKR1C brain activity, the involvement of an unidentified enzyme is suggested (Steckelbroeck et al., <xref ref-type="bibr" rid="B405">2010</xref>). Isomeric 5β-neurosteroids require the action of AKR1D1, and it is unknown whether AKR1D1 is expressed in CNS, or liver 5β-steroids reach peripheral regions via the circulation (Jin et al., <xref ref-type="bibr" rid="B178">2011</xref>).</p>
<p>The sulphatase pathway in the CNS is relevant because (although recent studies are revisiting this paradigm; Qaiser et al., <xref ref-type="bibr" rid="B326">2017</xref>), sulphated-steroids do not cross the blood-brain barrier. Therefore, sulphated neurosteroids like DHEA-S and P5-S need to be generated locally, and in line with this, their level in the CNS is independent from the level in the blood (Rajkowski et al., <xref ref-type="bibr" rid="B330">1997</xref>) and varies throughout distinct brain regions (especially hippocampus and hypothalamus) (Jäntti et al., <xref ref-type="bibr" rid="B174">2010</xref>).</p>
<p>STS and SULTs are widely expressed, with no gender-related differences (Table <xref ref-type="table" rid="T8">8</xref>) (Kríz et al., <xref ref-type="bibr" rid="B204">2008a</xref>,<xref ref-type="bibr" rid="B205">b</xref>; Mueller et al., <xref ref-type="bibr" rid="B269">2015</xref>). SULT1A1 has high expression especially in specimens isolated from cerebellum, occipital and frontal lobes (Salman et al., <xref ref-type="bibr" rid="B359">2009</xref>). No brain region expresses SULT2A1, whereas contrasting data exist for SULT2B1 and SULT1E1 (Table <xref ref-type="table" rid="T8">8</xref>).</p>
</sec>
<sec>
<title>Diseases and treatments</title>
<p>Steroid metabolism is deviated in schizophrenia (Bicikova et al., <xref ref-type="bibr" rid="B35">2013</xref>) and aberrations and unbalances of intracrine enzymes are associated with neurological disorders (Luchetti et al., <xref ref-type="bibr" rid="B230">2011</xref> and see Table <xref ref-type="table" rid="T5">5</xref>). In a study of 49 patients with AD, prefrontal cortex mRNA levels of 17βHSD1, CYP19A1 and AKR1C2 increased at late stages (Luchetti et al., <xref ref-type="bibr" rid="B230">2011</xref>). STS and SULT activities, measured by radioimmunoassay and GC-MS in 55 human brain tumor specimens, varied between tumor types (Kríz et al., <xref ref-type="bibr" rid="B205">2008b</xref>). Immunoreactivity for AKR1C3/17βHSD5 was low in medulloblastomas (<italic>n</italic> = 10 analyzed), high in 37 glial neoplasms and 18 meningiomas and was absent in intracranial schwannoma (<italic>n</italic> = 7) (Park et al., <xref ref-type="bibr" rid="B299">2010</xref>). A recent screening of a chemical library of steroid inhibitors using three low grade pediatric glioma cell lines found that inhibition of 17βHSD3 blocked cell growth and induced apoptosis <italic>in vitro</italic> (Ajeawung et al., <xref ref-type="bibr" rid="B8">2013</xref>)</p>
<p>Type 10 17βHSD is associated with AD and is a potential target in diseases like AD, Parkinson, and an X-linked mental retardation, that may arise from the impaired degradation of branched chain fatty acid, isoleucine or aberrant neurosteroid (THP) metabolism (Lim et al., <xref ref-type="bibr" rid="B218">2011</xref>; Yang et al., <xref ref-type="bibr" rid="B485">2016</xref>).</p>
<p>STS has been implicated in ADHD and a recent mouse study indicates that genetic and pharmacological manipulations of the STS axis influence the inhibitory processes and give rise to improvements in response control (Davies et al., <xref ref-type="bibr" rid="B78">2014</xref>). A recent animal experiment using a model of autoimmune encephalomyelitis showed high SULT1A1 mRNA expression in laser-captured-micro-dissected white matter astrocytes, suggesting that deactivation of estrogens (and other phenolic substrates) may be responsible for the resistance to anti-neuro-inflammatory treatments in these cells and could be possibly used as new treatments to protect CNS from inflammatory injuries (Guillot et al., <xref ref-type="bibr" rid="B134">2015</xref>).</p>
</sec>
<sec>
<title>CNS: conclusions</title>
<p>CNS can synthesize steroids from cholesterol, although this is restricted to few brain regions. Steroid metabolism in the CNS is particular complex due to the formation of both 5α-/β-reduced and sulpho-conjugated neurosteroids (Table <xref ref-type="table" rid="T8">8</xref> and Figure <xref ref-type="fig" rid="F3">3</xref>).</p>
</sec>
</sec>
<sec>
<title>Intracrinology in other tissues and systems</title>
<p>Steroid metabolism is also important in the immune system, skin and adipose tissue. A thorough review of these systems is outside the scope of this study, however, a brief mention is given below.</p>
<sec>
<title>Immune system and inflammation</title>
<p>Beside corticosteroids, several other steroids affect the immune system and inflammation. A5 induces white blood cells and platelets production in bone marrow (Chen et al., <xref ref-type="bibr" rid="B59">2004</xref>); estrogens and androgens control B-lymphocyte development in a sex-dependent way and modulate autoimmune diseases (McCarthy, <xref ref-type="bibr" rid="B251">2000</xref>; Calippe et al., <xref ref-type="bibr" rid="B50">2010</xref>; Sakiani et al., <xref ref-type="bibr" rid="B355">2013</xref>).</p>
<p>Lipopolysaccharide-mediated proinflammatory pathway in macrophages and NF-κB activation are blocked by estrogens, which induce T-helper (Th) type 2 responses, whereas androgens stimulate type 1 responses (Iwasa et al., <xref ref-type="bibr" rid="B171">2015</xref>). DHEA and DHEA-S also regulate the maturation of Th1 or Th2 cells. It was shown that plasma Th2 lymphocytes and its major secreted cytokine IL6 increase with age, and this is reversed in mice upon administration of DHEA or DHEA-S (Reed et al., <xref ref-type="bibr" rid="B336">2005</xref>). Such effect was recapitulated <italic>in vitro</italic> by DHEA but not DHEA-S implicating the involvement of macrophage STS in lymphoid tissues where Th cell maturation occurs. In line with this, the effect of DHEA-S, but not DHEA, was impaired <italic>in vivo</italic> by an STS inhibitor (Reed et al., <xref ref-type="bibr" rid="B336">2005</xref>). These data prompted to propose STS inhibition as a therapeutic approach for diseases associated with inappropriate immune responses and excess Th1 cytokines such as rheumatoid arthritis (Reed et al., <xref ref-type="bibr" rid="B336">2005</xref>). Whether the action of DHEA is secondary to its conversion to androgens or estrogens is currently unclear. STS activity of peripheral blood leukocytes is higher in women during the follicular phase of the menstrual cycle than in women in the luteal phase or in men and it becomes highest during pregnancy, suggesting a role for P in regulating STS activity (Reed et al., <xref ref-type="bibr" rid="B336">2005</xref>; Mueller et al., <xref ref-type="bibr" rid="B269">2015</xref>). <italic>In vitro</italic> studies also demonstrated that STS activity is induced by cytokines such as IL6 and TNF (Mueller et al., <xref ref-type="bibr" rid="B269">2015</xref>).</p>
<p>Opposite deregulation of the sulphatase pathway is seen in other chronic inflammatory diseases/cell types. Vascular smooth muscle cells show higher STS activity in women with mild atherosclerosis compared with women with severe disease (and male), whereas SULT1E1 activity is lower in women with severe disease (Mueller et al., <xref ref-type="bibr" rid="B269">2015</xref>).</p>
<p>CYP19A1 is also expressed in macrophages (Konings et al., <xref ref-type="bibr" rid="B202">2017</xref>) and KO mice have increased numbers of peripheral blood and bone marrow cells and inflammatory renal lesions (Shim et al., <xref ref-type="bibr" rid="B377">2004</xref>). CYP19A1 inhibitors exacerbate the autoimmune lesions in a murine model of Sjögren syndrome and estrogen administration reverses such phenotype (Iwasa et al., <xref ref-type="bibr" rid="B171">2015</xref>; Park et al., <xref ref-type="bibr" rid="B300">2015</xref>). Opposite effects are observed in prostate, where elevated intracrine estrogens due to CYP19A1 overexpression induce inflammation and pre-malignant pathology (Ellem et al., <xref ref-type="bibr" rid="B102">2009</xref>) as well as in adipose tissue (Reed et al., <xref ref-type="bibr" rid="B336">2005</xref>).</p>
</sec>
<sec>
<title>Skin</title>
<p>The skin is the largest human organ and first barrier against pathogens where important immune functions interconnected with intracrine steroid metabolism take place (Slominski et al., <xref ref-type="bibr" rid="B394">2013</xref>). Keratinocytes and sebocytes express ERs, intracrine enzymes, and the activity of sebaceous glands is influenced by steroids as indicated by the sebum production at andrenarche (Slominski et al., <xref ref-type="bibr" rid="B394">2013</xref>). CYP17A1, CYP19A1, 17βHSD1, 2, 3, 4 (and enzymes metabolizing corticosteroid - outside the scope of this review) are detected in human skin. Some genes are under the influence of vitamin D and sebocytes can synthesize T from adrenal precursors (Hughes et al., <xref ref-type="bibr" rid="B158">1997</xref>; Thiboutot et al., <xref ref-type="bibr" rid="B437">1998</xref>; Slominski et al., <xref ref-type="bibr" rid="B394">2013</xref>). Low 17βHSD oxidative metabolism characterizes sebaceous glands from skin areas prone to develop acne compared with other locations, suggesting a protective role of the oxidative metabolism against androgen excess (Fritsch et al., <xref ref-type="bibr" rid="B118">2001</xref>). Sulphatase pathway is present in the skin (Reed et al., <xref ref-type="bibr" rid="B336">2005</xref>; Simard et al., <xref ref-type="bibr" rid="B382">2005</xref>), and genetic variants in STS and SULTs are associated with skin disturbances, most likely because of unbalanced steroid accumulation (Table <xref ref-type="table" rid="T5">5</xref>).</p>
</sec>
<sec>
<title>Adipose tissue</title>
<p>The adipose tissue is one of the most complex endocrine organs that besides secreting leptin and adiponectin, is a site of steroid metabolism, it establishes interaction with the CNS for glucose and lipid metabolism control, energy homeostasis and inflammation. The implication of sex steroids in adipose tissue is demonstrated by the different fat distribution that characterizes men and women (Mauvais-Jarvis et al., <xref ref-type="bibr" rid="B250">2013</xref>; Varlamov et al., <xref ref-type="bibr" rid="B456">2014</xref>; López and Tena-Sempere, <xref ref-type="bibr" rid="B223">2015</xref>, <xref ref-type="bibr" rid="B224">2016</xref>; Palmer and Clegg, <xref ref-type="bibr" rid="B296">2015</xref>). ER-KO and CYP19A1-KO mice develop obesity with human-like phenotypes (López and Tena-Sempere, <xref ref-type="bibr" rid="B223">2015</xref>). Estrogens protect against metabolic syndrome and men lacking endogenous estrogens (CYP19A1 or ER-α deficiency) develop hypertriglyceridemia, glucose intolerance and insulin resistance (Kim et al., <xref ref-type="bibr" rid="B188">2014</xref>). In adipose tissue of men, 17βHSD2 levels and androgen inactivation correlate with BMI (Fouad Mansour et al., <xref ref-type="bibr" rid="B115">2015</xref>). A mouse study also showed that increased unsulphated-estrogen availability due to loss of SULT1E1 improved metabolic function in a model of type 2 diabetes, which leads to speculations about a potential role of SULT1E1 inhibition for this disease - at least in women (Gao et al., <xref ref-type="bibr" rid="B123">2012</xref>).</p>
<p>Fat consists of different tissue types (white and brown) and different regional depots with distinct physiological, intracrinological characteristics and distinct relations with pathologies and metabolic disorders (Blouin et al., <xref ref-type="bibr" rid="B38">2009</xref>; Mauvais-Jarvis et al., <xref ref-type="bibr" rid="B250">2013</xref>). White adipose tissue is mainly subcutaneous (abdomen) or visceral (surrounding the inner organs), this last being associated with metabolic risks. A plethora of investigations demonstrated the ability of adipose tissue to aromatise androgens into estrogens and that the intra-tissue steroid levels are higher than the levels in blood (Bélanger et al., <xref ref-type="bibr" rid="B28">2002</xref>). Androgenic and estrogenic 17βHSD activity and the mRNA for 17βHSD1, 2, 3, 7, 12, AKR1C3/17βHSD5 were detected in both intra-abdominal and subcutaneous fat (Bélanger et al., <xref ref-type="bibr" rid="B28">2002</xref>; Quinkler et al., <xref ref-type="bibr" rid="B329">2004</xref>; Bellemare et al., <xref ref-type="bibr" rid="B31">2009</xref>; Wang et al., <xref ref-type="bibr" rid="B465">2013</xref>).</p>
<p>Both subcutaneous and visceral fat tissue of women expresses the androgenic 17βHSD3 (generally considered testis specific) indicating that adipose tissue in women is substantially androgenic. Such characteristic in the visceral depot increased with increasing BMI, suggesting a link between central obesity and metabolic diseases (Corbould et al., <xref ref-type="bibr" rid="B68">2002</xref>).</p>
<p>Additionally, several enzymes (AKR1C2, AKR1C3/17βHSD5, CYP19A1, STS and SULT1E1) vary throughout adipocyte differentiation and maturation (Quinkler et al., <xref ref-type="bibr" rid="B329">2004</xref>; Bellemare et al., <xref ref-type="bibr" rid="B31">2009</xref>; Blouin et al., <xref ref-type="bibr" rid="B38">2009</xref>; Mueller et al., <xref ref-type="bibr" rid="B269">2015</xref>).</p>
</sec>
</sec>
</sec>
<sec id="s5">
<title>Conclusions and recommendations</title>
<p>Intracrinology consists of a complex and intricate network of alternative and redundant pathways that generate, deactivate steroids in peripheral tissues and ultimately control steroid exposure in a tissue specific manner. A number of compounds have that ability to bind and activate more than one nuclear receptors thus exerting multiple biological actions. Blood steroids represent a reservoir of substrates that support these intracrine networks. Studies retrieved by the systematic search demonstrated that most investigations rely on RT-PCR or IHC to detect enzyme and protein, and frequently without multiple-technique confirmation of the data. Since both techniques present limitations, and antibodies for IHC often perform sub-optimally (detection limit is not sufficient to detect some intracrine enzymes, crossreactivity between isoforms) these techniques are not always suitable to infer the real biological role of a reaction/enzyme.</p>
<p>However, the recent technological advances in steroid profiling together with an improved knowledge of intracrine enzymes and the possibility to validate data using multiple approaches (RNA, protein, activity, steroid profiling) create today unprecedented opportunities to expand our understanding of intracrinology, its relation with endocrinology and to exploit this knowledge in patient care. Improved multiplex platforms allowing to profile in peripheral tissues all steroids depicted in Figure <xref ref-type="fig" rid="F2">2</xref> are awaited and will elucidate the relevant tissue-specific networks. It is envisaged that novel prognostic markers and drug targets will become of clinical relevance soon.</p>
<p>We should however be aware that the redundant actions of intracrine enzymes, their substrate promiscuity, the existence of alternative pathways and the patient-to-patient variability might result in drug insensitivity. Dual/triple inhibitors will help solving this problem. In addition, in order to optimize research on novel drugs, the classical preclinical drug discovery pipelines (safety, pharmacokinetics and dynamics), should encompass parallel research lines to learn how to pre-select potentially responsive patients.</p>
<p>Finally, since we know that steroidal and intracrine drugs might have profound effects on the CNS, it is desirable to have in depth research on the neurological effects of potential novel drugs during the nonclinical phase of drug development. This will facilitate to select suitable compounds to the clinical development.</p>
</sec>
<sec id="s6">
<title>Author contributions</title>
<p>GK drafted the study, prepared figures, tables, intermediate versions, final version and approved final version. LB drafted part of the study, contributed to intermediate versions and approved final version. KC drafted part of the study, contributed to intermediate versions and approved final version. BD contributed to intermediate versions and approved final version. TL drafted part of the study, contributed to intermediate versions and approved final version. PK contributed to intermediate versions and approved final version. MB contributed to intermediate versions and approved final version. RK contributed to intermediate versions and approved final version. SX drafted part of the study, contributed to intermediate versions and approved final version. AR drafted the study, prepared figures, tables, intermediate versions, final version and approved final version.</p>
<sec>
<title>Conflict of interest statement</title>
<p>PK and TL are employees of Forendo Pharma Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ack>
<p>We are grateful to Dr. Margaretha A Skowron (Department of Urology, University Düsseldorf, Germany) for graphic arts.</p>
<p>We also would like to thank the management and curator of the online databases we made use of, namely: the database of chemical molecules PubChem (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov">www.ncbi.nlm.nih.gov</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://www.pubchem.ncbi.nlm.nih.gov">pubchem.ncbi.nlm.nih.gov</ext-link>) maintained by the National Center for Biotechnology Information (NCBI; National Library of Medicine/United States National Institutes of Health - NIH); Chemical Abstracts Service (CAS), maintained by the American Chemical Society (<ext-link ext-link-type="uri" xlink:href="http://www.cas.org">www.cas.org</ext-link>); Human Metabolome Data Base (HMDB, <ext-link ext-link-type="uri" xlink:href="http://www.hmdb.ca">www.hmdb.ca</ext-link>), funded and maintained by Genome Canada; Chemical Book (<ext-link ext-link-type="uri" xlink:href="http://www.chemicalbook.com">www.chemicalbook.com</ext-link>), funded by industrial partners; Chemical Entities of Biological Interest (ChEBI; <ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/chebi/init.do">www.ebi.ac.uk/chebi/init.do</ext-link>), curated by the European Bioinformatics Institute of the European Molecular Biology Laboratory (EMBL); drug and drug target database Drugbank (<ext-link ext-link-type="uri" xlink:href="http://www.drugbank.ca/drugs">www.drugbank.ca/drugs</ext-link>), University of Alberta and The Metabolomics Innovation Centre; GeneCards (<ext-link ext-link-type="uri" xlink:href="http://www.genecards.org">www.genecards.org</ext-link>), developed and maintained by the Crown Human Genome Center at the Weizmann Institute of Science; Online Mendelian Inheritance in Man® (OMIM®, <ext-link ext-link-type="uri" xlink:href="https://omim.org/">https://omim.org/</ext-link>), McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD); Mouse Genome Informatics (MGI; <ext-link ext-link-type="uri" xlink:href="http://www.informatics.jax.org">www.informatics.jax.org</ext-link>), Mouse Genome Database at the Mouse Genome Informatics website, The Jackson Laboratory, Bar Harbor, Maine.</p>
</ack>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> The present study was sponsored by the Dutch Cancer Society (KWF Kankerbestrijding: <ext-link ext-link-type="uri" xlink:href="http://www.kwf.nl">www.kwf.nl</ext-link>), contract number UM-13-5782 granted to AR.</p>
</fn>
</fn-group>
<sec id="s7" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fphar.2018.00940/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fphar.2018.00940/full#supplementary-material</ext-link></p>
<supplementary-material content-type="local-data" id="SM1">
<media xlink:href="Presentation_1.pdf">
<caption>
<p>Click here for additional data file.</p>
</caption>
</media>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdelsamie</surname><given-names>A. S.</given-names></name><name><surname>van Koppen</surname><given-names>C. J.</given-names></name><name><surname>Bey</surname><given-names>E.</given-names></name><name><surname>Salah</surname><given-names>M.</given-names></name><name><surname>Börger</surname><given-names>C.</given-names></name><name><surname>Siebenbürger</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>17β-HSD1 inhibitor with sub-nanomolar IC50 for a proof-of-principle study</article-title>. <source/>Eur. J. Med. Chem.
<volume>127</volume>, <fpage>944</fpage>–<lpage>957</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmech.2016.11.004</pub-id><pub-id pub-id-type="pmid">27852458</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Acién</surname><given-names>P.</given-names></name><name><surname>Velasco</surname><given-names>I.</given-names></name><name><surname>Gutiérrez</surname><given-names>M.</given-names></name><name><surname>Martínez-Beltrán</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>Aromatase expression in endometriotic tissues and its relationship to clinical and analytical findings</article-title>. <source/>Fertil. Steril.
<volume>88</volume>, <fpage>32</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/j.fertnstert.2006.11.188</pub-id><pub-id pub-id-type="pmid">17336977</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adachi</surname><given-names>K.</given-names></name><name><surname>Miki</surname><given-names>Y.</given-names></name><name><surname>Saito</surname><given-names>R.</given-names></name><name><surname>Hata</surname><given-names>S.</given-names></name><name><surname>Yamauchi</surname><given-names>M.</given-names></name><name><surname>Mikami</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Intracrine steroid production and mammalian target of rapamycin pathways in pulmonary lymphangioleiomyomatosis</article-title>. <source/>Hum. Pathol.
<volume>46</volume>, <fpage>1685</fpage>–<lpage>1693</lpage>. <pub-id pub-id-type="doi">10.1016/j.humpath.2015.02.019</pub-id><pub-id pub-id-type="pmid">26298231</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adessi</surname><given-names>G. L.</given-names></name><name><surname>Prost</surname><given-names>O.</given-names></name><name><surname>Agnani</surname><given-names>G.</given-names></name><name><surname>Petitjean</surname><given-names>A.</given-names></name><name><surname>Burnod</surname><given-names>J.</given-names></name></person-group> (<year>1984</year>). <article-title>Estrone sulfatase activity in normal and abnormal endometrium</article-title>. <source/>Arch. Gynecol.
<volume>236</volume>, <fpage>13</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1007/BF02114864</pub-id><pub-id pub-id-type="pmid">6508360</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adjei</surname><given-names>A. A.</given-names></name><name><surname>Thomae</surname><given-names>B. A.</given-names></name><name><surname>Prondzinski</surname><given-names>J. L.</given-names></name><name><surname>Eckloff</surname><given-names>B. W.</given-names></name><name><surname>Wieben</surname><given-names>E. D.</given-names></name><name><surname>Weinshilboum</surname><given-names>R. M.</given-names></name></person-group> (<year>2003</year>). <article-title>Human estrogen sulfotransferase (SULT1E1) pharmacogenomics: Gene resequencing and functional genomics</article-title>. <source/>Br. J. Pharmacol.
<volume>139</volume>, <fpage>1373</fpage>–<lpage>1382</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjp.0705369</pub-id><pub-id pub-id-type="pmid">12922923</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aghajanova</surname><given-names>L.</given-names></name><name><surname>Hamilton</surname><given-names>A.</given-names></name><name><surname>Kwintkiewicz</surname><given-names>J.</given-names></name><name><surname>Vo</surname><given-names>K. C.</given-names></name><name><surname>Giudice</surname><given-names>L. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Steroidogenic enzyme and key decidualization marker dysregulation in endometrial stromal cells from women with versus without endometriosis</article-title>. <source/>Biol. Reprod.
<volume>80</volume>, <fpage>105</fpage>–<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1095/biolreprod.108.070300</pub-id><pub-id pub-id-type="pmid">18815356</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agís-Balboa</surname><given-names>R. C.</given-names></name><name><surname>Pinna</surname><given-names>G.</given-names></name><name><surname>Zhubi</surname><given-names>A.</given-names></name><name><surname>Maloku</surname><given-names>E.</given-names></name><name><surname>Veldic</surname><given-names>M.</given-names></name><name><surname>Costa</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>103</volume>, <fpage>14602</fpage>–<lpage>14607</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0606544103</pub-id><pub-id pub-id-type="pmid">16984997</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ajeawung</surname><given-names>N. F.</given-names></name><name><surname>Maltais</surname><given-names>R.</given-names></name><name><surname>Jones</surname><given-names>C.</given-names></name><name><surname>Poirier</surname><given-names>D.</given-names></name><name><surname>Kamnasaran</surname><given-names>D.</given-names></name></person-group> (<year>2013</year>). <article-title>Viability screen on pediatric low grade glioma cell lines unveils a novel anti-cancer drug of the steroid biosynthesis inhibitor family</article-title>. <source/>Cancer Lett.
<volume>330</volume>, <fpage>96</fpage>–<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.canlet.2012.11.034</pub-id><pub-id pub-id-type="pmid">23201138</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almey</surname><given-names>A.</given-names></name><name><surname>Milner</surname><given-names>T. A.</given-names></name><name><surname>Brake</surname><given-names>W. G.</given-names></name></person-group> (<year>2015</year>). <article-title>Estrogen receptors in the central nervous system and their implication for dopamine-dependent cognition in females</article-title>. <source/>Horm. Behav.
<volume>74</volume>, <fpage>125</fpage>–<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1016/j.yhbeh.2015.06.010</pub-id><pub-id pub-id-type="pmid">26122294</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alshogran</surname><given-names>O. Y.</given-names></name></person-group> (<year>2017</year>). <article-title>Pharmacogenetics of aldo-keto reductase 1C (AKR1C) enzymes</article-title>. <source/>Expert Opin. Drug Metab. Toxicol.
<volume>13</volume>, <fpage>1063</fpage>–<lpage>1073</lpage>. <pub-id pub-id-type="doi">10.1080/17425255.2017.1376648</pub-id><pub-id pub-id-type="pmid">28871815</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amant</surname><given-names>F.</given-names></name><name><surname>Moerman</surname><given-names>P.</given-names></name><name><surname>Neven</surname><given-names>P.</given-names></name><name><surname>Timmerman</surname><given-names>D.</given-names></name><name><surname>Van Limbergen</surname><given-names>E.</given-names></name><name><surname>Vergote</surname><given-names>I.</given-names></name></person-group> (<year>2005</year>). <article-title>Endometrial cancer</article-title>. <source/>Lancet
<volume>366</volume>, <fpage>491</fpage>–<lpage>505</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(05)67063-8</pub-id><pub-id pub-id-type="pmid">16084259</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amos-Landgraf</surname><given-names>J. M.</given-names></name><name><surname>Heijmans</surname><given-names>J.</given-names></name><name><surname>Wielenga</surname><given-names>M. C.</given-names></name><name><surname>Dunkin</surname><given-names>E.</given-names></name><name><surname>Krentz</surname><given-names>K. J.</given-names></name><name><surname>Clipson</surname><given-names>L.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Sex disparity in colonic adenomagenesis involves promotion by male hormones, not protection by female hormones</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>111</volume>, <fpage>16514</fpage>–<lpage>16519</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1323064111</pub-id><pub-id pub-id-type="pmid">25368192</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>C. Y.</given-names></name><name><surname>Ezcurra</surname><given-names>D.</given-names></name></person-group> (<year>2014</year>). <article-title>Human steroidogenesis: implications for controlled ovarian stimulation with exogenous gonadotropins</article-title>. <source/>Reprod. Biol. Endocrinol.
<volume>12</volume>:<fpage>128</fpage>. <pub-id pub-id-type="doi">10.1186/1477-7827-12-128</pub-id><pub-id pub-id-type="pmid">25543693</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrew</surname><given-names>A. S.</given-names></name><name><surname>Hu</surname><given-names>T.</given-names></name><name><surname>Gu</surname><given-names>J.</given-names></name><name><surname>Gui</surname><given-names>J.</given-names></name><name><surname>Ye</surname><given-names>Y.</given-names></name><name><surname>Marsit</surname><given-names>C. J.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>HSD3B and gene-gene interactions in a pathway-based analysis of genetic susceptibility to bladder cancer</article-title>. <source/>PLoS ONE
<volume>7</volume>:<fpage>e51301</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0051301</pub-id><pub-id pub-id-type="pmid">23284679</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aresti</surname><given-names>U.</given-names></name><name><surname>Carrera</surname><given-names>S.</given-names></name><name><surname>Iruarrizaga</surname><given-names>E.</given-names></name><name><surname>Fuente</surname><given-names>N.</given-names></name><name><surname>Marrodan</surname><given-names>I.</given-names></name><name><surname>de Lobera</surname><given-names>A. R.</given-names></name><etal></etal></person-group> (<year>2014</year>). <article-title>Estrogen receptor 1 gene expression and its combination with estrogen receptor 2 or aromatase expression predicts survival in non-small cell lung cancer</article-title>. <source/>PLoS ONE
<volume>9</volume>:<fpage>e109659</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0109659</pub-id><pub-id pub-id-type="pmid">25310221</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnold</surname><given-names>C.</given-names></name><name><surname>Einspanier</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Medical treatment improves social behavior in a primate endometriosis model (Callithrix jacchus)</article-title>. <source/>J. Med. Primatol.
<volume>42</volume>, <fpage>112</fpage>–<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1111/jmp.12042</pub-id><pub-id pub-id-type="pmid">23432639</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashton</surname><given-names>K. A.</given-names></name><name><surname>Proietto</surname><given-names>A.</given-names></name><name><surname>Otton</surname><given-names>G.</given-names></name><name><surname>Symonds</surname><given-names>I.</given-names></name><name><surname>McEvoy</surname><given-names>M.</given-names></name><name><surname>Attia</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Polymorphisms in genes of the steroid hormone biosynthesis and metabolism pathways and endometrial cancer risk</article-title>. <source/>Cancer Epidemiol.
<volume>34</volume>, <fpage>328</fpage>–<lpage>337</lpage>. <pub-id pub-id-type="doi">10.1016/j.canep.2010.03.005</pub-id><pub-id pub-id-type="pmid">20381444</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Attar</surname><given-names>E.</given-names></name><name><surname>Tokunaga</surname><given-names>H.</given-names></name><name><surname>Imir</surname><given-names>G.</given-names></name><name><surname>Yilmaz</surname><given-names>M. B.</given-names></name><name><surname>Redwine</surname><given-names>D.</given-names></name><name><surname>Putman</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Prostaglandin E2 via steroidogenic factor-1 coordinately regulates transcription of steroidogenic genes necessary for estrogen synthesis in endometriosis</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>94</volume>, <fpage>623</fpage>–<lpage>631</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2008-1180</pub-id><pub-id pub-id-type="pmid">19001523</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Audet-Walsh</surname><given-names>É.</given-names></name><name><surname>Bellemare</surname><given-names>J.</given-names></name><name><surname>Lacombe</surname><given-names>L.</given-names></name><name><surname>Fradet</surname><given-names>Y.</given-names></name><name><surname>Fradet</surname><given-names>V.</given-names></name><name><surname>Douville</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>The impact of germline genetic variations in hydroxysteroid (17-beta) dehydrogenases on prostate cancer outcomes after prostatectomy</article-title>. <source/>Eur. Urol.
<volume>62</volume>, <fpage>88</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/j.eururo.2011.12.021</pub-id><pub-id pub-id-type="pmid">22209174</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Audet-Walsh</surname><given-names>E.</given-names></name><name><surname>Lepine</surname><given-names>J.</given-names></name><name><surname>Gregoire</surname><given-names>J.</given-names></name><name><surname>Plante</surname><given-names>M.</given-names></name><name><surname>Caron</surname><given-names>P.</given-names></name><name><surname>Tetu</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Profiling of endogenous estrogens, their precursors, and metabolites in endometrial cancer patients: association with risk and relationship to clinical characteristics</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>96</volume>, <fpage>E330</fpage>–<lpage>E339</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2010-2050</pub-id><pub-id pub-id-type="pmid">21147881</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aumüller</surname><given-names>G.</given-names></name><name><surname>Eicheler</surname><given-names>W.</given-names></name><name><surname>Renneberg</surname><given-names>H.</given-names></name><name><surname>Adermann</surname><given-names>K.</given-names></name><name><surname>Vilja</surname><given-names>P.</given-names></name><name><surname>Forssmann</surname><given-names>W. G.</given-names></name></person-group> (<year>1996</year>). <article-title>Immunocytochemical evidence for differential subcellular localization of 5 alpha-reductase isoenzymes in human tissues</article-title>. <source/>Acta Anat. (Basel).
<volume>156</volume>, <fpage>241</fpage>–<lpage>252</lpage>. <pub-id pub-id-type="doi">10.1159/000147852</pub-id><pub-id pub-id-type="pmid">9078395</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bacallao</surname><given-names>K.</given-names></name><name><surname>Leon</surname><given-names>L.</given-names></name><name><surname>Gabler</surname><given-names>F.</given-names></name><name><surname>Soto</surname><given-names>E.</given-names></name><name><surname>Romero</surname><given-names>C.</given-names></name><name><surname>Valladares</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>In situ estrogen metabolism in proliferative endometria from untreated women with polycystic ovarian syndrome with and without endometrial hyperplasia</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>110</volume>, <fpage>163</fpage>–<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsbmb.2008.03.031</pub-id><pub-id pub-id-type="pmid">18467089</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baes</surname><given-names>M.</given-names></name><name><surname>Huyghe</surname><given-names>S.</given-names></name><name><surname>Carmeliet</surname><given-names>P.</given-names></name><name><surname>Declercq</surname><given-names>P. E.</given-names></name><name><surname>Collen</surname><given-names>D.</given-names></name><name><surname>Mannaerts</surname><given-names>G. P.</given-names></name><etal></etal></person-group> (<year>2000</year>). <article-title>Inactivation of the peroxisomal multifunctional protein-2 in mice impedes the degradation of not only 2-methyl-branched fatty acids and bile acid intermediates but also of very long chain fatty acids</article-title>. <source/>J. Biol. Chem.
<volume>275</volume>, <fpage>16329</fpage>–<lpage>16336</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M001994200</pub-id><pub-id pub-id-type="pmid">10748062</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bagi</surname><given-names>C. M.</given-names></name><name><surname>Wood</surname><given-names>J.</given-names></name><name><surname>Wilkie</surname><given-names>D.</given-names></name><name><surname>Dixon</surname><given-names>B.</given-names></name></person-group> (<year>2008</year>). <article-title>Effect of 17β-hydroxysteroid dehydrogenase type 2 inhibitor on bone strength in ovariectomized cynomolgus monkeys</article-title>. <source/>J. Musculoskelet. Neuronal Interact.
<volume>8</volume>, <fpage>267</fpage>–<lpage>280</lpage>.<pub-id pub-id-type="pmid">18799860</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bair</surname><given-names>S. R.</given-names></name><name><surname>Mellon</surname><given-names>S. H.</given-names></name></person-group> (<year>2004</year>). <article-title>Deletion of the mouse P450c17 gene causes early embryonic lethality</article-title>. <source/>Mol. Cell. Biol.
<volume>24</volume>, <fpage>5383</fpage>–<lpage>5390</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.24.12.5383-5390.2004</pub-id><pub-id pub-id-type="pmid">15169901</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balk</surname><given-names>S. P.</given-names></name><name><surname>Knudsen</surname><given-names>K. E.</given-names></name></person-group> (<year>2008</year>). <article-title>AR, the cell cycle, and prostate cancer</article-title>. <source/>Nucl. Recept. Signal.
<volume>6</volume>:<fpage>e001</fpage>.<pub-id pub-id-type="pmid">18301781</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barzi</surname><given-names>A.</given-names></name><name><surname>Lenz</surname><given-names>A. M.</given-names></name><name><surname>Labonte</surname><given-names>M. J.</given-names></name><name><surname>Lenz</surname><given-names>H. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Molecular pathways: estrogen pathway in colorectal cancer</article-title>. <source/>Clin. Cancer Res.
<volume>19</volume>, <fpage>5842</fpage>–<lpage>5848</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-13-0325</pub-id><pub-id pub-id-type="pmid">23965904</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bélanger</surname><given-names>C.</given-names></name><name><surname>Luu-The</surname><given-names>V.</given-names></name><name><surname>Dupont</surname><given-names>P.</given-names></name><name><surname>Tchernof</surname><given-names>A.</given-names></name></person-group> (<year>2002</year>). <article-title>Adipose tissue intracrinology: potential importance of local androgen/estrogen metabolism in the regulation of adiposity</article-title>. <source/>Horm. Metab. Res.
<volume>34</volume>, <fpage>737</fpage>–<lpage>745</lpage>. <pub-id pub-id-type="doi">10.1055/s-2002-38265</pub-id><pub-id pub-id-type="pmid">12660892</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Belelli</surname><given-names>D.</given-names></name><name><surname>Lambert</surname><given-names>J. J.</given-names></name></person-group> (<year>2005</year>). <article-title>Neurosteroids: endogenous regulators of the GABA(A) receptor</article-title>. <source/>Nat. Rev. Neurosci.
<volume>6</volume>, <fpage>565</fpage>–<lpage>575</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1703</pub-id><pub-id pub-id-type="pmid">15959466</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellemare</surname><given-names>V.</given-names></name><name><surname>Faucher</surname><given-names>F.</given-names></name><name><surname>Breton</surname><given-names>R.</given-names></name><name><surname>Luu-The</surname><given-names>V.</given-names></name></person-group> (<year>2005</year>). <article-title>Characterization of 17α-hydroxysteroid dehydrogenase activity (17α-HSD) and its involvement in the biosynthesis of epitestosterone</article-title>. <source/>BMC Biochem.
<volume>6</volume>:<fpage>12</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2091-6-12</pub-id><pub-id pub-id-type="pmid">16018803</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellemare</surname><given-names>V.</given-names></name><name><surname>Laberge</surname><given-names>P.</given-names></name><name><surname>Noel</surname><given-names>S.</given-names></name><name><surname>Tchernof</surname><given-names>A.</given-names></name><name><surname>Luu-The</surname><given-names>V.</given-names></name></person-group> (<year>2009</year>). <article-title>Differential estrogenic 17β-hydroxysteroid dehydrogenase activity and type 12, 17β-hydroxysteroid dehydrogenase expression levels in preadipocytes and differentiated adipocytes</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>114</volume>, <fpage>129</fpage>–<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsbmb.2009.01.002</pub-id><pub-id pub-id-type="pmid">19429442</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berstein</surname><given-names>L.</given-names></name><name><surname>Zimarina</surname><given-names>T.</given-names></name><name><surname>Imyanitov</surname><given-names>E.</given-names></name><name><surname>Kovalevskij</surname><given-names>A.</given-names></name><name><surname>Maximov</surname><given-names>S.</given-names></name><name><surname>Pujol</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Hormonal imbalance in two types of endometrial cancer and genetic polymorphism of steroidogenic enzymes</article-title>. <source/>Maturitas
<volume>54</volume>, <fpage>352</fpage>–<lpage>355</lpage>. <pub-id pub-id-type="doi">10.1016/j.maturitas.2006.04.017</pub-id><pub-id pub-id-type="pmid">16730930</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beyenburg</surname><given-names>S.</given-names></name><name><surname>Stoffel-Wagner</surname><given-names>B.</given-names></name><name><surname>Watzka</surname><given-names>M.</given-names></name><name><surname>Blumcke</surname><given-names>I.</given-names></name><name><surname>Bauer</surname><given-names>J.</given-names></name><name><surname>Schramm</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>Expression of cytochrome P450scc mRNA in the hippocampus of patients with temporal lobe epilepsy</article-title>. <source/>Neuroreport
<volume>10</volume>, <fpage>3067</fpage>–<lpage>3070</lpage>. <pub-id pub-id-type="doi">10.1097/00001756-199909290-00035</pub-id><pub-id pub-id-type="pmid">10549824</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beyenburg</surname><given-names>S.</given-names></name><name><surname>Watzka</surname><given-names>M.</given-names></name><name><surname>Blumcke</surname><given-names>I.</given-names></name><name><surname>Schramm</surname><given-names>J.</given-names></name><name><surname>Bidlingmaier</surname><given-names>F.</given-names></name><name><surname>Elger</surname><given-names>C. E.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Expression of mRNAs encoding for 17β-hydroxisteroid dehydrogenase isozymes 1, 2, 3 and 4 in epileptic human hippocampus</article-title>. <source/>Epilepsy Res.
<volume>41</volume>, <fpage>83</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/S0920-1211(00)00130-3</pub-id><pub-id pub-id-type="pmid">10924871</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bicikova</surname><given-names>M.</given-names></name><name><surname>Hill</surname><given-names>M.</given-names></name><name><surname>Ripova</surname><given-names>D.</given-names></name><name><surname>Mohr</surname><given-names>P.</given-names></name><name><surname>Hampl</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>133</volume>, <fpage>77</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsbmb.2012.08.009</pub-id><pub-id pub-id-type="pmid">22944140</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilezikian</surname><given-names>J. P.</given-names></name><name><surname>Morishima</surname><given-names>A.</given-names></name><name><surname>Bell</surname><given-names>J.</given-names></name><name><surname>Grumbach</surname><given-names>M. M.</given-names></name></person-group> (<year>1998</year>). <article-title>Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency</article-title>. <source/>N. Engl. J. Med.
<volume>339</volume>, <fpage>599</fpage>–<lpage>603</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM199808273390905</pub-id><pub-id pub-id-type="pmid">9718379</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blake</surname><given-names>J. A.</given-names></name><name><surname>Eppig</surname><given-names>J. T.</given-names></name><name><surname>Kadin</surname><given-names>J. A.</given-names></name><name><surname>Richardson</surname><given-names>J. E.</given-names></name><name><surname>Smith</surname><given-names>C. L.</given-names></name><name><surname>Bult</surname><given-names>C. J.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Mouse Genome Database (MGD)-2017: community knowledge resource for the laboratory mouse</article-title>. <source/>Nucleic Acids Res.
<volume>45</volume>, <fpage>D723</fpage>–<lpage>D729</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw1040</pub-id><pub-id pub-id-type="pmid">27899570</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blouin</surname><given-names>K.</given-names></name><name><surname>Nadeau</surname><given-names>M.</given-names></name><name><surname>Mailloux</surname><given-names>J.</given-names></name><name><surname>Daris</surname><given-names>M.</given-names></name><name><surname>Lebel</surname><given-names>S.</given-names></name><name><surname>Luu-The</surname><given-names>V.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Pathways of adipose tissue androgen metabolism in women: depot differences and modulation by adipogenesis</article-title>. <source/>Am. J. Physiol. Endocrinol. Metab.
<volume>296</volume>, <fpage>E244</fpage>–<lpage>E255</lpage>. <pub-id pub-id-type="doi">10.1152/ajpendo.00039.2008</pub-id><pub-id pub-id-type="pmid">18984855</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bothe</surname><given-names>U.</given-names></name><name><surname>Busemann</surname><given-names>M.</given-names></name><name><surname>Steinmeyer</surname><given-names>A.</given-names></name><name><surname>Droescher</surname><given-names>P.</given-names></name><name><surname>Fischer</surname><given-names>O. M.</given-names></name><name><surname>Peters</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2017</year>). <article-title>First time disclosure of BAY 1128688: a novel AKR1C3 inhibitor for the treatment of endometriosis,</article-title> in <source/>254th ACS National Meeting &amp; Exposition (<publisher-loc>Washington, DC</publisher-loc>).</mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boucher</surname><given-names>E.</given-names></name><name><surname>Provost</surname><given-names>P. R.</given-names></name><name><surname>Plante</surname><given-names>J.</given-names></name><name><surname>Tremblay</surname><given-names>Y.</given-names></name></person-group> (<year>2009</year>). <article-title>Androgen receptor and 17β-HSD type 2 regulation in neonatal mouse lung development</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>311</volume>, <fpage>109</fpage>–<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2009.06.012</pub-id><pub-id pub-id-type="pmid">19576262</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bovée</surname><given-names>J. V.</given-names></name><name><surname>Cleton-Jansen</surname><given-names>A. M.</given-names></name><name><surname>Taminiau</surname><given-names>A. H.</given-names></name><name><surname>Hogendoorn</surname><given-names>P. C.</given-names></name></person-group> (<year>2005</year>). <article-title>Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment</article-title>. <source/>Lancet Oncol.
<volume>6</volume>, <fpage>599</fpage>–<lpage>607</lpage>. <pub-id pub-id-type="doi">10.1016/S1470-2045(05)70282-5</pub-id><pub-id pub-id-type="pmid">16054571</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brereton</surname><given-names>P.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Sasano</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>K.</given-names></name><name><surname>Duarte</surname><given-names>C.</given-names></name><name><surname>Obeyesekere</surname><given-names>V.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Pan1b (17βHSD11)-enzymatic activity and distribution in the lung</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>171</volume>, <fpage>111</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/S0303-7207(00)00417-2</pub-id><pub-id pub-id-type="pmid">11165019</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brosens</surname><given-names>J.</given-names></name><name><surname>Verhoeven</surname><given-names>H.</given-names></name><name><surname>Campo</surname><given-names>R.</given-names></name><name><surname>Gianaroli</surname><given-names>L.</given-names></name><name><surname>Gordts</surname><given-names>S.</given-names></name><name><surname>Hazekamp</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>High endometrial aromatase P450 mRNA expression is associated with poor IVF outcome</article-title>. <source/>Hum. Reprod.
<volume>19</volume>, <fpage>352</fpage>–<lpage>356</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/deh075</pub-id><pub-id pub-id-type="pmid">14747179</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>BroŽic</surname><given-names>P.</given-names></name><name><surname>Turk</surname><given-names>S.</given-names></name><name><surname>Rizner</surname><given-names>T. L.</given-names></name><name><surname>Gobec</surname><given-names>S.</given-names></name></person-group> (<year>2011</year>). <article-title>Inhibitors of aldo-keto reductases AKR1C1-AKR1C4</article-title>. <source/>Curr. Med. Chem.
<volume>18</volume>, <fpage>2554</fpage>–<lpage>2565</lpage>. <pub-id pub-id-type="doi">10.2174/092986711795933713</pub-id><pub-id pub-id-type="pmid">21568892</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bukulmez</surname><given-names>O.</given-names></name><name><surname>Hardy</surname><given-names>D. B.</given-names></name><name><surname>Carr</surname><given-names>B. R.</given-names></name><name><surname>Auchus</surname><given-names>R. J.</given-names></name><name><surname>Toloubeydokhti</surname><given-names>T.</given-names></name><name><surname>Word</surname><given-names>R. A.</given-names></name><etal></etal></person-group>. (<year>2008a</year>). <article-title>Androstenedione up-regulation of endometrial aromatase expression via local conversion to estrogen: potential relevance to the pathogenesis of endometriosis</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>93</volume>, <fpage>3471</fpage>–<lpage>3477</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2008-0248</pub-id><pub-id pub-id-type="pmid">18559914</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bukulmez</surname><given-names>O.</given-names></name><name><surname>Hardy</surname><given-names>D. B.</given-names></name><name><surname>Carr</surname><given-names>B. R.</given-names></name><name><surname>Word</surname><given-names>R. A.</given-names></name><name><surname>Mendelson</surname><given-names>C. R.</given-names></name></person-group> (<year>2008b</year>). <article-title>Inflammatory status influences aromatase and steroid receptor expression in endometriosis</article-title>. <source/>Endocrinology
<volume>149</volume>, <fpage>1190</fpage>–<lpage>1204</lpage>. <pub-id pub-id-type="doi">10.1210/en.2007-0665</pub-id><pub-id pub-id-type="pmid">18048499</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulun</surname><given-names>S. E.</given-names></name><name><surname>Economos</surname><given-names>K.</given-names></name><name><surname>Miller</surname><given-names>D.</given-names></name><name><surname>Simpson</surname><given-names>E. R.</given-names></name></person-group> (<year>1994</year>). <article-title>CYP19 (aromatase cytochrome P450) gene expression in human malignant endometrial tumors</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>79</volume>, <fpage>1831</fpage>–<lpage>1834</lpage>.<pub-id pub-id-type="pmid">7989490</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bulun</surname><given-names>S. E.</given-names></name><name><surname>Mahendroo</surname><given-names>M. S.</given-names></name><name><surname>Simpson</surname><given-names>E. R.</given-names></name></person-group> (<year>1993</year>). <article-title>Polymerase chain reaction amplification fails to detect aromatase cytochrome P450 transcripts in normal human endometrium or decidua</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>76</volume>, <fpage>1458</fpage>–<lpage>1463</lpage>.<pub-id pub-id-type="pmid">7684741</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caiazza</surname><given-names>F.</given-names></name><name><surname>Ryan</surname><given-names>E. J.</given-names></name><name><surname>Doherty</surname><given-names>G.</given-names></name><name><surname>Winter</surname><given-names>D. C.</given-names></name><name><surname>Sheahan</surname><given-names>K.</given-names></name></person-group> (<year>2015</year>). <article-title>Estrogen receptors and their implications in colorectal carcinogenesis</article-title>. <source/>Front. Oncol.
<volume>5</volume>:<fpage>19</fpage>. <pub-id pub-id-type="doi">10.3389/fonc.2015.00019</pub-id><pub-id pub-id-type="pmid">25699240</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calippe</surname><given-names>B.</given-names></name><name><surname>Douin-Echinard</surname><given-names>V.</given-names></name><name><surname>Delpy</surname><given-names>L.</given-names></name><name><surname>Laffargue</surname><given-names>M.</given-names></name><name><surname>Lelu</surname><given-names>K.</given-names></name><name><surname>Krust</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>17β-estradiol promotes TLR4-triggered proinflammatory mediator production through direct estrogen receptor alpha signaling in macrophages <italic>in vivo</italic></article-title>. <source/>J. Immunol.
<volume>185</volume>, <fpage>1169</fpage>–<lpage>1176</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.0902383</pub-id><pub-id pub-id-type="pmid">20554954</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carani</surname><given-names>C.</given-names></name><name><surname>Qin</surname><given-names>K.</given-names></name><name><surname>Simoni</surname><given-names>M.</given-names></name><name><surname>Faustini-Fustini</surname><given-names>M.</given-names></name><name><surname>Serpente</surname><given-names>S.</given-names></name><name><surname>Boyd</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>1997</year>). <article-title>Effect of testosterone and estradiol in a man with aromatase deficiency</article-title>. <source/>N. Engl. J. Med.
<volume>337</volume>, <fpage>91</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM199707103370204</pub-id><pub-id pub-id-type="pmid">9211678</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carey</surname><given-names>M. A.</given-names></name><name><surname>Card</surname><given-names>J. W.</given-names></name><name><surname>Voltz</surname><given-names>J. W.</given-names></name><name><surname>Arbes</surname><given-names>S. J.</given-names><suffix>Jr.</suffix></name><name><surname>Germolec</surname><given-names>D. R.</given-names></name><name><surname>Korach</surname><given-names>K. S.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>It's all about sex: gender, lung development and lung disease</article-title>. <source/>Trends Endocrinol. Metab.
<volume>18</volume>, <fpage>308</fpage>–<lpage>313</lpage>. <pub-id pub-id-type="doi">10.1016/j.tem.2007.08.003</pub-id><pub-id pub-id-type="pmid">17764971</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carneiro</surname><given-names>M. M.</given-names></name><name><surname>Morsch</surname><given-names>D. M.</given-names></name><name><surname>Camargos</surname><given-names>A. F.</given-names></name><name><surname>Reis</surname><given-names>F. M.</given-names></name><name><surname>Spritzer</surname><given-names>P. M.</given-names></name></person-group> (<year>2008</year>). <article-title>Androgen receptor and 5α-reductase are expressed in pelvic endometriosis</article-title>. <source/>BJOG
<volume>115</volume>, <fpage>113</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-0528.2007.01521.x</pub-id><pub-id pub-id-type="pmid">17983420</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carneiro</surname><given-names>M. M.</given-names></name><name><surname>Morsch</surname><given-names>D. M.</given-names></name><name><surname>Camargos</surname><given-names>A. F.</given-names></name><name><surname>Spritzer</surname><given-names>P. M.</given-names></name><name><surname>Reis</surname><given-names>F. M.</given-names></name></person-group> (<year>2007</year>). <article-title>Expression of 17β-hydroxysteroid dehydrogenase type 2 in pelvic endometriosis</article-title>. <source/>Gynecol. Endocrinol.
<volume>23</volume>, <fpage>188</fpage>–<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1080/09513590701200850</pub-id><pub-id pub-id-type="pmid">17505937</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caron</surname><given-names>K. M.</given-names></name><name><surname>Soo</surname><given-names>S. C.</given-names></name><name><surname>Wetsel</surname><given-names>W. C.</given-names></name><name><surname>Stocco</surname><given-names>D. M.</given-names></name><name><surname>Clark</surname><given-names>B. J.</given-names></name><name><surname>Parker</surname><given-names>K. L.</given-names></name></person-group> (<year>1997</year>). <article-title>Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>94</volume>, <fpage>11540</fpage>–<lpage>11545</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.94.21.11540</pub-id><pub-id pub-id-type="pmid">9326645</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casey</surname><given-names>M. L.</given-names></name><name><surname>MacDonald</surname><given-names>P. C.</given-names></name><name><surname>Andersson</surname><given-names>S.</given-names></name></person-group> (<year>1994</year>). <article-title>17 beta-Hydroxysteroid dehydrogenase type 2: chromosomal assignment and progestin regulation of gene expression in human endometrium</article-title>. <source/>J. Clin. Invest.
<volume>94</volume>, <fpage>2135</fpage>–<lpage>2141</lpage>. <pub-id pub-id-type="doi">10.1172/JCI117569</pub-id><pub-id pub-id-type="pmid">7962560</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chai</surname><given-names>Z.</given-names></name><name><surname>Brereton</surname><given-names>P.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Sasano</surname><given-names>H.</given-names></name><name><surname>Obeyesekere</surname><given-names>V.</given-names></name><name><surname>Escher</surname><given-names>G.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>17β-hydroxysteroid dehydrogenase type XI localizes to human steroidogenic cells</article-title>. <source/>Endocrinology
<volume>144</volume>, <fpage>2084</fpage>–<lpage>2091</lpage>. <pub-id pub-id-type="doi">10.1210/en.2002-221030</pub-id><pub-id pub-id-type="pmid">12697717</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>T. S.</given-names></name><name><surname>Lin</surname><given-names>H. K.</given-names></name><name><surname>Rogers</surname><given-names>K. A.</given-names></name><name><surname>Brame</surname><given-names>L. S.</given-names></name><name><surname>Yeh</surname><given-names>M. M.</given-names></name><name><surname>Yang</surname><given-names>Q.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Expression of aldo-keto reductase family 1 member C3 (AKR1C3) in neuroendocrine tumors &amp; adenocarcinomas of pancreas, gastrointestinal tract, and lung</article-title>. <source/>Int. J. Clin. Exp. Pathol.
<volume>6</volume>, <fpage>2419</fpage>–<lpage>2429</lpage>.<pub-id pub-id-type="pmid">24228104</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>F.</given-names></name><name><surname>Knecht</surname><given-names>K.</given-names></name><name><surname>Leu</surname><given-names>C.</given-names></name><name><surname>Rutledge</surname><given-names>S. J.</given-names></name><name><surname>Scafonas</surname><given-names>A.</given-names></name><name><surname>Gambone</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Partial agonist/antagonist properties of androstenedione and 4-androsten-3β,17β-diol</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>91</volume>, <fpage>247</fpage>–<lpage>257</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsbmb.2004.04.009</pub-id><pub-id pub-id-type="pmid">15336702</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Zhang</surname><given-names>D.</given-names></name><name><surname>Jing</surname><given-names>N.</given-names></name><name><surname>Yin</surname><given-names>S.</given-names></name><name><surname>Falany</surname><given-names>C. N.</given-names></name><name><surname>Radominska-Pandya</surname><given-names>A.</given-names></name></person-group> (<year>2003</year>). <article-title>Human gastrointestinal sulfotransferases: identification and distribution</article-title>. <source/>Toxicol. Appl. Pharmacol.
<volume>187</volume>, <fpage>186</fpage>–<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1016/S0041-008X(02)00073-X</pub-id><pub-id pub-id-type="pmid">12662902</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>L. Y.</given-names></name><name><surname>Yang</surname><given-names>J. J.</given-names></name><name><surname>Ko</surname><given-names>K. P.</given-names></name><name><surname>Ma</surname><given-names>S. H.</given-names></name><name><surname>Shin</surname><given-names>A.</given-names></name><name><surname>Choi</surname><given-names>B. Y.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Genetic susceptibility factors on genes involved in the steroid hormone biosynthesis pathway and progesterone receptor for gastric cancer risk</article-title>. <source/>PLoS ONE
<volume>7</volume>:<fpage>e47603</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0047603</pub-id><pub-id pub-id-type="pmid">23110082</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciuffi</surname><given-names>M.</given-names></name><name><surname>Savino</surname><given-names>L.</given-names></name><name><surname>Santini</surname><given-names>D.</given-names></name><name><surname>Buzzoni</surname><given-names>P.</given-names></name><name><surname>Scarselli</surname><given-names>G.</given-names></name><name><surname>Mazzei</surname><given-names>T.</given-names></name></person-group> (<year>1982</year>). <article-title>Estradiol and progestin receptors, 17-beta-hydroxysteroid-dehydrogenase and histopathologic grade in endometrial carcinoma</article-title>. <source/>Tumori
<volume>68</volume>, <fpage>217</fpage>–<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1177/030089168206800305</pub-id><pub-id pub-id-type="pmid">6958113</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cleton-Jansen</surname><given-names>A. M.</given-names></name><name><surname>van Beerendonk</surname><given-names>H. M.</given-names></name><name><surname>Baelde</surname><given-names>H. J.</given-names></name><name><surname>Bovee</surname><given-names>J. V.</given-names></name><name><surname>Karperien</surname><given-names>M.</given-names></name><name><surname>Hogendoorn</surname><given-names>P. C.</given-names></name></person-group> (<year>2005</year>). <article-title>Estrogen signaling is active in cartilaginous tumors: implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma</article-title>. <source/>Clin. Cancer Res.
<volume>11</volume>, <fpage>8028</fpage>–<lpage>8035</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-05-1253</pub-id><pub-id pub-id-type="pmid">16299232</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colette</surname><given-names>S.</given-names></name><name><surname>Defrere</surname><given-names>S.</given-names></name><name><surname>Lousse</surname><given-names>J. C.</given-names></name><name><surname>Van Langendonckt</surname><given-names>A.</given-names></name><name><surname>Gotteland</surname><given-names>J. P.</given-names></name><name><surname>Loumaye</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Inhibition of steroid sulfatase decreases endometriosis in an <italic>in vivo</italic> murine model</article-title>. <source/>Hum. Reprod.
<volume>26</volume>, <fpage>1362</fpage>–<lpage>1370</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/der079</pub-id><pub-id pub-id-type="pmid">21441545</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colette</surname><given-names>S.</given-names></name><name><surname>Defrere</surname><given-names>S.</given-names></name><name><surname>Van Kerk</surname><given-names>O.</given-names></name><name><surname>Van Langendonckt</surname><given-names>A.</given-names></name><name><surname>Dolmans</surname><given-names>M. M.</given-names></name><name><surname>Donnez</surname><given-names>J.</given-names></name></person-group> (<year>2013</year>). <article-title>Differential expression of steroidogenic enzymes according to endometriosis type</article-title>. <source/>Fertil. Steril.
<volume>100</volume>, <fpage>1642</fpage>–<lpage>1649</lpage>. <pub-id pub-id-type="doi">10.1016/j.fertnstert.2013.08.003</pub-id><pub-id pub-id-type="pmid">24012197</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colette</surname><given-names>S.</given-names></name><name><surname>Lousse</surname><given-names>J. C.</given-names></name><name><surname>Defrere</surname><given-names>S.</given-names></name><name><surname>Curaba</surname><given-names>M.</given-names></name><name><surname>Heilier</surname><given-names>J. F.</given-names></name><name><surname>Van Langendonckt</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Absence of aromatase protein and mRNA expression in endometriosis</article-title>. <source/>Hum. Reprod.
<volume>24</volume>, <fpage>2133</fpage>–<lpage>2141</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/dep199</pub-id><pub-id pub-id-type="pmid">19493871</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Compston</surname><given-names>J. E.</given-names></name></person-group> (<year>2001</year>). <article-title>Sex steroids and bone</article-title>. <source/>Physiol. Rev.
<volume>81</volume>, <fpage>419</fpage>–<lpage>447</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.2001.81.1.419</pub-id><pub-id pub-id-type="pmid">11152762</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corbould</surname><given-names>A. M.</given-names></name><name><surname>Bawden</surname><given-names>M. J.</given-names></name><name><surname>Lavranos</surname><given-names>T. C.</given-names></name><name><surname>Rodgers</surname><given-names>R. J.</given-names></name><name><surname>Judd</surname><given-names>S. J.</given-names></name></person-group> (<year>2002</year>). <article-title>The effect of obesity on the ratio of type 3, 17β-hydroxysteroid dehydrogenase mRNA to cytochrome P450 aromatase mRNA in subcutaneous abdominal and intra-abdominal adipose tissue of women</article-title>. <source/>Int. J. Obes. Relat. Metab. Disord.
<volume>26</volume>, <fpage>165</fpage>–<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1038/sj.ijo.0801886</pub-id><pub-id pub-id-type="pmid">11850747</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornel</surname><given-names>K. M.</given-names></name><name><surname>Krakstad</surname><given-names>C.</given-names></name><name><surname>Delvoux</surname><given-names>B.</given-names></name><name><surname>Xanthoulea</surname><given-names>S.</given-names></name><name><surname>Jori</surname><given-names>B.</given-names></name><name><surname>Bongers</surname><given-names>M. Y.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>High mRNA levels of 17β-hydroxysteroid dehydrogenase type 1 correlate with poor prognosis in endometrial cancer</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>442</volume>, <fpage>51</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2016.11.030</pub-id><pub-id pub-id-type="pmid">27923582</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornel</surname><given-names>K. M.</given-names></name><name><surname>Kruitwagen</surname><given-names>R. F.</given-names></name><name><surname>Delvoux</surname><given-names>B.</given-names></name><name><surname>Visconti</surname><given-names>L.</given-names></name><name><surname>Van de Vijver</surname><given-names>K. K.</given-names></name><name><surname>Day</surname><given-names>J. M.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Overexpression of 17β-Hydroxysteroid Dehydrogenase Type 1 Increases the exposure of endometrial cancer to 17β-Estradiol</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>97</volume>, <fpage>E591</fpage>–<lpage>E601</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2011-2994</pub-id><pub-id pub-id-type="pmid">22362820</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornel</surname><given-names>K. M. C.</given-names></name><name><surname>Bongers</surname><given-names>M. Y.</given-names></name><name><surname>Kruitwagen</surname><given-names>R. P. F. M.</given-names></name><name><surname>Romano</surname><given-names>A.</given-names></name></person-group> (<year>2018</year>). <article-title>Local estrogen metabolism (intracrinology) in endometrial cancer: a systematic review</article-title>. <source/>Mol. Cell. Endocrinol. Accepted for publication.</mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Couse</surname><given-names>J. F.</given-names></name><name><surname>Korach</surname><given-names>K. S.</given-names></name></person-group> (<year>1999</year>). <article-title>Estrogen receptor null mice: what have we learned and where will they lead us?</article-title>
<source/>Endocr. Rev.
<volume>20</volume>, <fpage>358</fpage>–<lpage>417</lpage>.<pub-id pub-id-type="pmid">10368776</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Couse</surname><given-names>J. F.</given-names></name><name><surname>Lindzey</surname><given-names>J.</given-names></name><name><surname>Grandien</surname><given-names>K.</given-names></name><name><surname>Gustafsson</surname><given-names>J. A.</given-names></name><name><surname>Korach</surname><given-names>K. S.</given-names></name></person-group> (<year>1997</year>). <article-title>Tissue distribution and quantitative analysis of estrogen receptor-α (ERα) and estrogen receptor-β (ERβ) messenger ribonucleic acid in the wild-type and ERα-knockout mouse</article-title>. <source/>Endocrinology
<volume>138</volume>, <fpage>4613</fpage>–<lpage>4621</lpage>. <pub-id pub-id-type="doi">10.1210/endo.138.11.5496</pub-id><pub-id pub-id-type="pmid">9348186</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Couse</surname><given-names>J. F.</given-names></name><name><surname>Yates</surname><given-names>M. M.</given-names></name><name><surname>Walker</surname><given-names>V. R.</given-names></name><name><surname>Korach</surname><given-names>K. S.</given-names></name></person-group> (<year>2003</year>). <article-title>Characterization of the hypothalamic-pituitary-gonadal axis in estrogen receptor (ER) Null mice reveals hypergonadism and endocrine sex reversal in females lacking ERα but not ERβ</article-title>. <source/>Mol. Endocrinol.
<volume>17</volume>, <fpage>1039</fpage>–<lpage>1053</lpage>. <pub-id pub-id-type="doi">10.1210/me.2002-0398</pub-id><pub-id pub-id-type="pmid">12624116</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalla Valle</surname><given-names>L.</given-names></name><name><surname>Toffolo</surname><given-names>V.</given-names></name><name><surname>Nardi</surname><given-names>A.</given-names></name><name><surname>Fiore</surname><given-names>C.</given-names></name><name><surname>Armanini</surname><given-names>D.</given-names></name><name><surname>Belvedere</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>The expression of the human steroid sulfatase-encoding gene is driven by alternative first exons</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>107</volume>, <fpage>22</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsbmb.2007.05.004</pub-id><pub-id pub-id-type="pmid">17601726</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Das</surname><given-names>A.</given-names></name><name><surname>Mantena</surname><given-names>S. R.</given-names></name><name><surname>Kannan</surname><given-names>A.</given-names></name><name><surname>Evans</surname><given-names>D. B.</given-names></name><name><surname>Bagchi</surname><given-names>M. K.</given-names></name><name><surname>Bagchi</surname><given-names>I. C.</given-names></name></person-group> (<year>2009</year>). <article-title><italic>De novo</italic> synthesis of estrogen in pregnant uterus is critical for stromal decidualization and angiogenesis</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>106</volume>, <fpage>12542</fpage>–<lpage>12547</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0901647106</pub-id><pub-id pub-id-type="pmid">19620711</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dassen</surname><given-names>H.</given-names></name><name><surname>Punyadeera</surname><given-names>C.</given-names></name><name><surname>Kamps</surname><given-names>R.</given-names></name><name><surname>Delvoux</surname><given-names>B.</given-names></name><name><surname>Van Langendonckt</surname><given-names>A.</given-names></name><name><surname>Donnez</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Estrogen metabolizing enzymes in endometrium and endometriosis</article-title>. <source/>Hum. Reprod.
<volume>22</volume>, <fpage>3148</fpage>–<lpage>3158</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/dem310</pub-id><pub-id pub-id-type="pmid">17921479</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>W.</given-names></name><name><surname>Humby</surname><given-names>T.</given-names></name><name><surname>Trent</surname><given-names>S.</given-names></name><name><surname>Eddy</surname><given-names>J. B.</given-names></name><name><surname>Ojarikre</surname><given-names>O. A.</given-names></name><name><surname>Wilkinson</surname><given-names>L. S.</given-names></name></person-group> (<year>2014</year>). <article-title>Genetic and pharmacological modulation of the steroid sulfatase axis improves response control; comparison with drugs used in ADHD</article-title>. <source/>Neuropsychopharmacology
<volume>39</volume>, <fpage>2622</fpage>–<lpage>2632</lpage>. <pub-id pub-id-type="doi">10.1038/npp.2014.115</pub-id><pub-id pub-id-type="pmid">24842408</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Day</surname><given-names>J. M.</given-names></name><name><surname>Foster</surname><given-names>P. A.</given-names></name><name><surname>Tutill</surname><given-names>H. J.</given-names></name><name><surname>Schmidlin</surname><given-names>F.</given-names></name><name><surname>Sharland</surname><given-names>C. M.</given-names></name><name><surname>Hargrave</surname><given-names>J. D.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>STX2171, a 17β-hydroxysteroid dehydrogenase type 3 inhibitor, is efficacious <italic>in vivo</italic> in a novel hormone-dependent prostate cancer model</article-title>. <source/>Endocr. Relat. Cancer
<volume>20</volume>, <fpage>53</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1530/ERC-12-0231</pub-id><pub-id pub-id-type="pmid">23132791</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Graaff</surname><given-names>A. A.</given-names></name><name><surname>D'Hooghe</surname><given-names>T. M.</given-names></name><name><surname>Dunselman</surname><given-names>G. A.</given-names></name><name><surname>Dirksen</surname><given-names>C. D.</given-names></name><name><surname>Hummelshoj</surname><given-names>L.</given-names></name><name><surname>Consortium</surname><given-names>W. E.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>The significant effect of endometriosis on physical, mental and social wellbeing: results from an international cross-sectional survey</article-title>. <source/>Hum. Reprod.
<volume>28</volume>, <fpage>2677</fpage>–<lpage>2685</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/det284</pub-id><pub-id pub-id-type="pmid">23847114</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Graaff</surname><given-names>A. A.</given-names></name><name><surname>Dirksen</surname><given-names>C. D.</given-names></name><name><surname>Simoens</surname><given-names>S.</given-names></name><name><surname>De Bie</surname><given-names>B.</given-names></name><name><surname>Hummelshoj</surname><given-names>L.</given-names></name><name><surname>D'Hooghe</surname><given-names>T. M.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Quality of life outcomes in women with endometriosis are highly influenced by recruitment strategies</article-title>. <source/>Hum. Reprod.
<volume>30</volume>, <fpage>1331</fpage>–<lpage>1341</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/dev084</pub-id><pub-id pub-id-type="pmid">25908657</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Graaff</surname><given-names>A. A.</given-names></name><name><surname>Van Lankveld</surname><given-names>J.</given-names></name><name><surname>Smits</surname><given-names>L. J.</given-names></name><name><surname>Van Beek</surname><given-names>J. J.</given-names></name><name><surname>Dunselman</surname><given-names>G. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Dyspareunia and depressive symptoms are associated with impaired sexual functioning in women with endometriosis, whereas sexual functioning in their male partners is not affected</article-title>. <source/>Hum. Reprod.
<volume>31</volume>, <fpage>2577</fpage>–<lpage>2586</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/dew215</pub-id><pub-id pub-id-type="pmid">27619771</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Preter</surname><given-names>V.</given-names></name><name><surname>Arijs</surname><given-names>I.</given-names></name><name><surname>Windey</surname><given-names>K.</given-names></name><name><surname>Vanhove</surname><given-names>W.</given-names></name><name><surname>Vermeire</surname><given-names>S.</given-names></name><name><surname>Schuit</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Impaired butyrate oxidation in ulcerative colitis is due to decreased butyrate uptake and a defect in the oxidation pathway</article-title>. <source/>Inflamm. Bowel Dis.
<volume>18</volume>, <fpage>1127</fpage>–<lpage>1136</lpage>. <pub-id pub-id-type="doi">10.1002/ibd.21894</pub-id><pub-id pub-id-type="pmid">21987487</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delvoux</surname><given-names>B.</given-names></name><name><surname>D'Hooghe</surname><given-names>T.</given-names></name><name><surname>Kyama</surname><given-names>C.</given-names></name><name><surname>Koskimies</surname><given-names>P.</given-names></name><name><surname>Hermans</surname><given-names>R. J.</given-names></name><name><surname>Dunselman</surname><given-names>G. A.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Inhibition of type 1, 17β-hydroxysteroid dehydrogenase impairs the synthesis of 17β-estradiol in endometriosis lesions</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>99</volume>, <fpage>276</fpage>–<lpage>284</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2013-2851</pub-id><pub-id pub-id-type="pmid">24187399</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delvoux</surname><given-names>B.</given-names></name><name><surname>Groothuis</surname><given-names>P.</given-names></name><name><surname>D'Hooghe</surname><given-names>T.</given-names></name><name><surname>Kyama</surname><given-names>C.</given-names></name><name><surname>Dunselman</surname><given-names>G.</given-names></name><name><surname>Romano</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>Increased production of 17β-estradiol in endometriosis lesions is the result of impaired metabolism</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>94</volume>, <fpage>876</fpage>–<lpage>883</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2008-2218</pub-id><pub-id pub-id-type="pmid">19088158</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delvoux</surname><given-names>B.</given-names></name><name><surname>Husen</surname><given-names>B.</given-names></name><name><surname>Aldenhoff</surname><given-names>Y.</given-names></name><name><surname>Koole</surname><given-names>L.</given-names></name><name><surname>Dunselman</surname><given-names>G.</given-names></name><name><surname>Thole</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>A sensitive HPLC method for the assessment of metabolic conversion of estrogens</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>104</volume>, <fpage>246</fpage>–<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsbmb.2007.03.006</pub-id><pub-id pub-id-type="pmid">17481886</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>H. Z.</given-names></name><name><surname>You</surname><given-names>C.</given-names></name><name><surname>Xing</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>K. Y.</given-names></name><name><surname>Zou</surname><given-names>X. B.</given-names></name></person-group> (<year>2016</year>). <article-title>A Family-Based Association Study of CYP11A1 and CYP11B1 Gene Polymorphisms With Autism in Chinese Trios</article-title>. <source/>J. Child Neurol.
<volume>31</volume>, <fpage>733</fpage>–<lpage>737</lpage>. <pub-id pub-id-type="doi">10.1177/0883073815620672</pub-id><pub-id pub-id-type="pmid">26690694</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Devroey</surname><given-names>P.</given-names></name><name><surname>Bourgain</surname><given-names>C.</given-names></name><name><surname>Macklon</surname><given-names>N. S.</given-names></name><name><surname>Fauser</surname><given-names>B. C.</given-names></name></person-group> (<year>2004</year>). <article-title>Reproductive biology and IVF: ovarian stimulation and endometrial receptivity</article-title>. <source/>Trends Endocrinol. Metab.
<volume>15</volume>, <fpage>84</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.tem.2004.01.009</pub-id><pub-id pub-id-type="pmid">15036255</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dheenadayalu</surname><given-names>K.</given-names></name><name><surname>Mak</surname><given-names>I.</given-names></name><name><surname>Gordts</surname><given-names>S.</given-names></name><name><surname>Campo</surname><given-names>R.</given-names></name><name><surname>Higham</surname><given-names>J.</given-names></name><name><surname>Puttemans</surname><given-names>P.</given-names></name><etal></etal></person-group> (<year>2002</year>). <article-title>Aromatase P450 messenger RNA expression in eutopic endometrium is not a specific marker for pelvic endometriosis</article-title>. <source/>Fertil. Steril.
<volume>78</volume>, <fpage>825</fpage>–<lpage>829</lpage>. <pub-id pub-id-type="doi">10.1016/S0015-0282(02)03324-1</pub-id><pub-id pub-id-type="pmid">12372463</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Costanzo</surname><given-names>L.</given-names></name><name><surname>Penning</surname><given-names>T. M.</given-names></name><name><surname>Christianson</surname><given-names>D. W.</given-names></name></person-group> (<year>2009</year>). <article-title>Aldo-keto reductases in which the conserved catalytic histidine is substituted</article-title>. <source/>Chem. Biol. Interact.
<volume>178</volume>, <fpage>127</fpage>–<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbi.2008.10.046</pub-id><pub-id pub-id-type="pmid">19028475</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dias</surname><given-names>N. J.</given-names></name><name><surname>Selcer</surname><given-names>K. W.</given-names></name></person-group> (<year>2014</year>). <article-title>Steroid sulfatase mediated growth Sof human MG-63 pre-osteoblastic cells</article-title>. <source/>Steroids
<volume>88</volume>, <fpage>77</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.steroids.2014.07.001</pub-id><pub-id pub-id-type="pmid">25042472</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dias</surname><given-names>N. J.</given-names></name><name><surname>Selcer</surname><given-names>K. W.</given-names></name></person-group> (<year>2016</year>). <article-title>Steroid sulfatase in the human MG-63 preosteoblastic cell line: Antagonistic regulation by glucocorticoids and NFkappaB</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>420</volume>, <fpage>85</fpage>–<lpage>96</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2015.11.029</pub-id><pub-id pub-id-type="pmid">26631368</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dickinson</surname><given-names>M. E.</given-names></name><name><surname>Flenniken</surname><given-names>A. M.</given-names></name><name><surname>Ji</surname><given-names>X.</given-names></name><name><surname>Teboul</surname><given-names>L.</given-names></name><name><surname>Wong</surname><given-names>M. D.</given-names></name><name><surname>White</surname><given-names>J. K.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>High-throughput discovery of novel developmental phenotypes</article-title>. <source/>Nature
<volume>537</volume>, <fpage>508</fpage>–<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1038/nature19356</pub-id><pub-id pub-id-type="pmid">27626380</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doherty</surname><given-names>J. A.</given-names></name><name><surname>Weiss</surname><given-names>N. S.</given-names></name><name><surname>Freeman</surname><given-names>R. J.</given-names></name><name><surname>Dightman</surname><given-names>D. A.</given-names></name><name><surname>Thornton</surname><given-names>P. J.</given-names></name><name><surname>Houck</surname><given-names>J. R.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer</article-title>. <source/>Cancer Epidemiol. Biomarkers Prev.
<volume>14</volume>, <fpage>357</fpage>–<lpage>366</lpage>. <pub-id pub-id-type="doi">10.1158/1055-9965.EPI-04-0479</pub-id><pub-id pub-id-type="pmid">15734958</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dohi</surname><given-names>O.</given-names></name><name><surname>Hatori</surname><given-names>M.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Ono</surname><given-names>K.</given-names></name><name><surname>Hosaka</surname><given-names>M.</given-names></name><name><surname>Akahira</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Sex steroid receptors expression and hormone-induced cell proliferation in human osteosarcoma</article-title>. <source/>Cancer Sci.
<volume>99</volume>, <fpage>518</fpage>–<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1111/j.1349-7006.2007.00673.x</pub-id><pub-id pub-id-type="pmid">18081879</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>Y.</given-names></name><name><surname>Qiu</surname><given-names>Q. Q.</given-names></name><name><surname>Debear</surname><given-names>J.</given-names></name><name><surname>Lathrop</surname><given-names>W. F.</given-names></name><name><surname>Bertolini</surname><given-names>D. R.</given-names></name><name><surname>Tamburini</surname><given-names>P. P.</given-names></name></person-group> (<year>1998</year>). <article-title>17β-hydroxysteroid dehydrogenases in human bone cells</article-title>. <source/>J. Bone Miner. Res.
<volume>13</volume>, <fpage>1539</fpage>–<lpage>1546</lpage>. <pub-id pub-id-type="doi">10.1359/jbmr.1998.13.10.1539</pub-id><pub-id pub-id-type="pmid">9783542</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Driessen</surname><given-names>C. A.</given-names></name><name><surname>Winkens</surname><given-names>H. J.</given-names></name><name><surname>Hoffmann</surname><given-names>K.</given-names></name><name><surname>Kuhlmann</surname><given-names>L. D.</given-names></name><name><surname>Janssen</surname><given-names>B. P.</given-names></name><name><surname>Van Vugt</surname><given-names>A. H.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Disruption of the 11-cis-retinol dehydrogenase gene leads to accumulation of cis-retinols and cis-retinyl esters</article-title>. <source/>Mol. Cell. Biol.
<volume>20</volume>, <fpage>4275</fpage>–<lpage>4287</lpage>. <pub-id pub-id-type="doi">10.1128/MCB.20.12.4275-4287.2000</pub-id><pub-id pub-id-type="pmid">10825191</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drzewiecka</surname><given-names>H.</given-names></name><name><surname>Galecki</surname><given-names>B.</given-names></name><name><surname>Jarmolowska-Jurczyszyn</surname><given-names>D.</given-names></name><name><surname>Kluk</surname><given-names>A.</given-names></name><name><surname>Dyszkiewicz</surname><given-names>W.</given-names></name><name><surname>Jagodzinski</surname><given-names>P. P.</given-names></name></person-group> (<year>2015</year>). <article-title>Increased expression of 17-beta-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer</article-title>. <source/>Lung Cancer
<volume>87</volume>, <fpage>107</fpage>–<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1016/j.lungcan.2014.12.012</pub-id><pub-id pub-id-type="pmid">25564397</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drzewiecka</surname><given-names>H.</given-names></name><name><surname>Jagodzinski</surname><given-names>P. P.</given-names></name></person-group> (<year>2012</year>). <article-title>Conversion of estrone to 17-beta-estradiol in human non-small-cell lung cancer cells <italic>in vitro</italic></article-title>. <source/>Biomed. Pharmacother.
<volume>66</volume>, <fpage>530</fpage>–<lpage>534</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2012.02.006</pub-id><pub-id pub-id-type="pmid">22705334</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duell</surname><given-names>E. J.</given-names></name><name><surname>Travier</surname><given-names>N.</given-names></name><name><surname>Lujan-Barroso</surname><given-names>L.</given-names></name><name><surname>Boutron-Ruault</surname><given-names>M. C.</given-names></name><name><surname>Clavel-Chapelon</surname><given-names>F.</given-names></name><name><surname>Palli</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Menstrual and reproductive factors, exogenous hormone use, and gastric cancer risk in a cohort of women from the European Prospective Investigation Into Cancer and Nutrition</article-title>. <source/>Am. J. Epidemiol.
<volume>172</volume>, <fpage>1384</fpage>–<lpage>1393</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwq321</pub-id><pub-id pub-id-type="pmid">21051447</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunselman</surname><given-names>G. A.</given-names></name><name><surname>Vermeulen</surname><given-names>N.</given-names></name><name><surname>Becker</surname><given-names>C.</given-names></name><name><surname>Calhaz-Jorge</surname><given-names>C.</given-names></name><name><surname>D'Hooghe</surname><given-names>T.</given-names></name><name><surname>De Bie</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>ESHRE guideline: management of women with endometriosis</article-title>. <source/>Hum. Reprod.
<volume>29</volume>, <fpage>400</fpage>–<lpage>412</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/det457</pub-id><pub-id pub-id-type="pmid">24435778</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellem</surname><given-names>S. J.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Poutanen</surname><given-names>M.</given-names></name><name><surname>Risbridger</surname><given-names>G. P.</given-names></name></person-group> (<year>2009</year>). <article-title>Increased endogenous estrogen synthesis leads to the sequential induction of prostatic inflammation (prostatitis) and prostatic pre-malignancy</article-title>. <source/>Am. J. Pathol.
<volume>175</volume>, <fpage>1187</fpage>–<lpage>1199</lpage>. <pub-id pub-id-type="doi">10.2353/ajpath.2009.081107</pub-id><pub-id pub-id-type="pmid">19700748</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Endo</surname><given-names>S.</given-names></name><name><surname>Miyagi</surname><given-names>N.</given-names></name><name><surname>Matsunaga</surname><given-names>T.</given-names></name><name><surname>Hara</surname><given-names>A.</given-names></name><name><surname>Ikari</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Human dehydrogenase/reductase (SDR family) member 11 is a novel type of 17β-hydroxysteroid dehydrogenase</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>472</volume>, <fpage>231</fpage>–<lpage>236</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2016.01.190</pub-id><pub-id pub-id-type="pmid">26920053</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>English</surname><given-names>M. A.</given-names></name><name><surname>Hughes</surname><given-names>S. V.</given-names></name><name><surname>Kane</surname><given-names>K. F.</given-names></name><name><surname>Langman</surname><given-names>M. J.</given-names></name><name><surname>Stewart</surname><given-names>P. M.</given-names></name><name><surname>Hewison</surname><given-names>M.</given-names></name></person-group> (<year>2000</year>). <article-title>Oestrogen inactivation in the colon: analysis of the expression and regulation of 17β-hydroxysteroid dehydrogenase isozymes in normal colon and colonic cancer</article-title>. <source/>Br. J. Cancer
<volume>83</volume>, <fpage>550</fpage>–<lpage>558</lpage>. <pub-id pub-id-type="doi">10.1054/bjoc.2000.1324</pub-id><pub-id pub-id-type="pmid">10945506</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>English</surname><given-names>M. A.</given-names></name><name><surname>Kane</surname><given-names>K. F.</given-names></name><name><surname>Cruickshank</surname><given-names>N.</given-names></name><name><surname>Langman</surname><given-names>M. J.</given-names></name><name><surname>Stewart</surname><given-names>P. M.</given-names></name><name><surname>Hewison</surname><given-names>M.</given-names></name></person-group> (<year>1999</year>). <article-title>Loss of estrogen inactivation in colonic cancer</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>84</volume>, <fpage>2080</fpage>–<lpage>2085</lpage>. <pub-id pub-id-type="doi">10.1210/jcem.84.6.5772</pub-id><pub-id pub-id-type="pmid">10372714</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enríquez</surname><given-names>J.</given-names></name><name><surname>Larrea</surname><given-names>F.</given-names></name><name><surname>Santillan</surname><given-names>R.</given-names></name><name><surname>Hernandez</surname><given-names>A.</given-names></name><name><surname>Herrero</surname><given-names>B.</given-names></name><name><surname>Perez-Palacios</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Neonatal rat osteoblasts bioconvert testosterone to non-phenolic metabolites with estrogen-like effects on bone cell proliferation and differentiation</article-title>. <source/>Horm. Mol. Biol. Clin. Investig.
<volume>13</volume>, <fpage>41</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1515/hmbci-2012-0035</pub-id><pub-id pub-id-type="pmid">25436712</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falk</surname><given-names>R. T.</given-names></name><name><surname>Dallal</surname><given-names>C. M.</given-names></name><name><surname>Lacey</surname><given-names>J. V.</given-names><suffix>Jr.</suffix></name><name><surname>Bauer</surname><given-names>D. C.</given-names></name><name><surname>Buist</surname><given-names>D. S.</given-names></name><name><surname>Cauley</surname><given-names>J. A.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Estrogen metabolites are not associated with colorectal cancer risk in postmenopausal women</article-title>. <source/>Cancer Epidemiol. Biomarkers Prev.
<volume>24</volume>, <fpage>1419</fpage>–<lpage>1422</lpage>. <pub-id pub-id-type="doi">10.1158/1055-9965.EPI-15-0541</pub-id><pub-id pub-id-type="pmid">26104910</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferrero</surname><given-names>S.</given-names></name><name><surname>Gillott</surname><given-names>D. J.</given-names></name><name><surname>Venturini</surname><given-names>P. L.</given-names></name><name><surname>Remorgida</surname><given-names>V.</given-names></name></person-group> (<year>2011</year>). <article-title>Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review</article-title>. <source/>Reprod. Biol. Endocrinol.
<volume>9</volume>, <fpage>89</fpage>. <pub-id pub-id-type="doi">10.1186/1477-7827-9-89</pub-id><pub-id pub-id-type="pmid">21693038</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>C. R.</given-names></name><name><surname>Graves</surname><given-names>K. H.</given-names></name><name><surname>Parlow</surname><given-names>A. F.</given-names></name><name><surname>Simpson</surname><given-names>E. R.</given-names></name></person-group> (<year>1998</year>). <article-title>Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>95</volume>, <fpage>6965</fpage>–<lpage>6970</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.95.12.6965</pub-id><pub-id pub-id-type="pmid">9618522</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flach</surname><given-names>K. D.</given-names></name><name><surname>Zwart</surname><given-names>W.</given-names></name></person-group> (<year>2016</year>). <article-title>The first decade of estrogen receptor cistromics in breast cancer</article-title>. <source/>J. Endocrinol.
<volume>229</volume>
<fpage>R43</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1530/JOE-16-0003</pub-id><pub-id pub-id-type="pmid">26906743</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontein</surname><given-names>D. B.</given-names></name><name><surname>Houtsma</surname><given-names>D.</given-names></name><name><surname>Nortier</surname><given-names>J. W.</given-names></name><name><surname>Baak-Pablo</surname><given-names>R. F.</given-names></name><name><surname>Kranenbarg</surname><given-names>E. M.</given-names></name><name><surname>van der Straaten</surname><given-names>T. R.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Germline variants in the CYP<sub>19</sub>A<sub>1</sub> gene are related to specific adverse events in aromatase inhibitor users: a substudy of Dutch patients in the TEAM trial</article-title>. <source/>Breast Cancer Res. Treat.
<volume>144</volume>, <fpage>599</fpage>–<lpage>606</lpage>. <pub-id pub-id-type="doi">10.1007/s10549-014-2873-2</pub-id><pub-id pub-id-type="pmid">24590773</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>P. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Oestrogen and colorectal cancer: mechanisms and controversies</article-title>. <source/>Int. J. Colorectal Dis.
<volume>28</volume>, <fpage>737</fpage>–<lpage>749</lpage>. <pub-id pub-id-type="doi">10.1007/s00384-012-1628-y</pub-id><pub-id pub-id-type="pmid">23319136</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>P. A.</given-names></name><name><surname>Reed</surname><given-names>M. J.</given-names></name><name><surname>Purohit</surname><given-names>A.</given-names></name></person-group> (<year>2008a</year>). <article-title>Recent developments of steroid sulfatase inhibitors as anti-cancer agents</article-title>. <source/>Anticancer. Agents Med. Chem.
<volume>8</volume>, <fpage>732</fpage>–<lpage>738</lpage>. <pub-id pub-id-type="doi">10.2174/187152008785914815</pub-id><pub-id pub-id-type="pmid">18855575</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foster</surname><given-names>P. A.</given-names></name><name><surname>Woo</surname><given-names>L. W.</given-names></name><name><surname>Potter</surname><given-names>B. V.</given-names></name><name><surname>Reed</surname><given-names>M. J.</given-names></name><name><surname>Purohit</surname><given-names>A.</given-names></name></person-group> (<year>2008b</year>). <article-title>The use of steroid sulfatase inhibitors as a novel therapeutic strategy against hormone-dependent endometrial cancer</article-title>. <source/>Endocrinology
<volume>149</volume>, <fpage>4035</fpage>–<lpage>4042</lpage>. <pub-id pub-id-type="doi">10.1210/en.2008-0223</pub-id><pub-id pub-id-type="pmid">18450955</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fouad Mansour</surname><given-names>M.</given-names></name><name><surname>Pelletier</surname><given-names>M.</given-names></name><name><surname>Boulet</surname><given-names>M. M.</given-names></name><name><surname>Mayrand</surname><given-names>D.</given-names></name><name><surname>Brochu</surname><given-names>G.</given-names></name><name><surname>Lebel</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Oxidative activity of 17β-hydroxysteroid dehydrogenase on testosterone in male abdominal adipose tissues and cellular localization of 17β-HSD type 2</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>414</volume>, <fpage>168</fpage>–<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2015.06.016</pub-id><pub-id pub-id-type="pmid">26123590</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freedman</surname><given-names>N. D.</given-names></name><name><surname>Ahn</surname><given-names>J.</given-names></name><name><surname>Hou</surname><given-names>L.</given-names></name><name><surname>Lissowska</surname><given-names>J.</given-names></name><name><surname>Zatonski</surname><given-names>W.</given-names></name><name><surname>Yeager</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer</article-title>. <source/>Carcinogenesis
<volume>30</volume>, <fpage>71</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1093/carcin/bgn258</pub-id><pub-id pub-id-type="pmid">19015200</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Freedman</surname><given-names>N. D.</given-names></name><name><surname>Chow</surname><given-names>W. H.</given-names></name><name><surname>Gao</surname><given-names>Y. T.</given-names></name><name><surname>Shu</surname><given-names>X. O.</given-names></name><name><surname>Ji</surname><given-names>B. T.</given-names></name><name><surname>Yang</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Menstrual and reproductive factors and gastric cancer risk in a large prospective study of women</article-title>. <source/>Gut
<volume>56</volume>, <fpage>1671</fpage>–<lpage>1677</lpage>. <pub-id pub-id-type="doi">10.1136/gut.2007.129411</pub-id><pub-id pub-id-type="pmid">17627962</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fritsch</surname><given-names>M.</given-names></name><name><surname>Orfanos</surname><given-names>C. E.</given-names></name><name><surname>Zouboulis</surname><given-names>C. C.</given-names></name></person-group> (<year>2001</year>). <article-title>Sebocytes are the key regulators of androgen homeostasis in human skin</article-title>. <source/>J. Invest. Dermatol.
<volume>116</volume>, <fpage>793</fpage>–<lpage>800</lpage>. <pub-id pub-id-type="doi">10.1046/j.1523-1747.2001.01312.x</pub-id><pub-id pub-id-type="pmid">11348472</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frycz</surname><given-names>B. A.</given-names></name><name><surname>Murawa</surname><given-names>D.</given-names></name><name><surname>Borejsza-Wysocki</surname><given-names>M.</given-names></name><name><surname>Marciniak</surname><given-names>R.</given-names></name><name><surname>Murawa</surname><given-names>P.</given-names></name><name><surname>Drews</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Expression of 17β-hydroxysteroid dehydrogenase type 2 is associated with some clinicopathological features in gastric cancer</article-title>. <source/>Biomed. Pharmacother.
<volume>70</volume>, <fpage>24</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopha.2014.12.042</pub-id><pub-id pub-id-type="pmid">25776474</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frycz</surname><given-names>B. A.</given-names></name><name><surname>Murawa</surname><given-names>D.</given-names></name><name><surname>Borejsza-Wysocki</surname><given-names>M.</given-names></name><name><surname>Wichtowski</surname><given-names>M.</given-names></name><name><surname>Spychala</surname><given-names>A.</given-names></name><name><surname>Marciniak</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Transcript level of AKR1C3 is down-regulated in gastric cancer</article-title>. <source/>Biochem. Cell Biol.
<volume>94</volume>, <fpage>138</fpage>–<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1139/bcb-2015-0096</pub-id><pub-id pub-id-type="pmid">27019068</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fujikawa</surname><given-names>H.</given-names></name><name><surname>Okura</surname><given-names>F.</given-names></name><name><surname>Kuwano</surname><given-names>Y.</given-names></name><name><surname>Sekizawa</surname><given-names>A.</given-names></name><name><surname>Chiba</surname><given-names>H.</given-names></name><name><surname>Shimodaira</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>1997</year>). <article-title>Steroid sulfatase activity in osteoblast cells</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>231</volume>, <fpage>42</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1006/bbrc.1996.6038</pub-id><pub-id pub-id-type="pmid">9070216</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gangloff</surname><given-names>A.</given-names></name><name><surname>Shi</surname><given-names>R.</given-names></name><name><surname>Nahoum</surname><given-names>V.</given-names></name><name><surname>Lin</surname><given-names>S. X.</given-names></name></person-group> (<year>2003</year>). <article-title>Pseudo-symmetry of C19 steroids, alternative binding orientations, and multispecificity in human estrogenic 17β-hydroxysteroid dehydrogenase</article-title>. <source/>FASEB J.
<volume>17</volume>, <fpage>274</fpage>–<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1096/fj.02-0397fje</pub-id><pub-id pub-id-type="pmid">12490543</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>J.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Shi</surname><given-names>X.</given-names></name><name><surname>Stefanovic-Racic</surname><given-names>M.</given-names></name><name><surname>Xu</surname><given-names>M.</given-names></name><name><surname>O'Doherty</surname><given-names>R. M.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Sex-specific effect of estrogen sulfotransferase on mouse models of type 2 diabetes</article-title>. <source/>Diabetes
<volume>61</volume>, <fpage>1543</fpage>–<lpage>1551</lpage>. <pub-id pub-id-type="doi">10.2337/db11-1152</pub-id><pub-id pub-id-type="pmid">22438574</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gargano</surname><given-names>E. M.</given-names></name><name><surname>Allegretta</surname><given-names>G.</given-names></name><name><surname>Perspicace</surname><given-names>E.</given-names></name><name><surname>Carotti</surname><given-names>A.</given-names></name><name><surname>Van Koppen</surname><given-names>C.</given-names></name><name><surname>Frotscher</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>17β-Hydroxysteroid dehydrogenase Type 2 inhibition: discovery of selective and metabolically stable compounds inhibiting both the human enzyme and its murine ortholog</article-title>. <source/>PLoS ONE
<volume>10</volume>:<fpage>e0134754</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0134754</pub-id><pub-id pub-id-type="pmid">26230928</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>D.</given-names></name><name><surname>Dhara</surname><given-names>S.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Sengupta</surname><given-names>J.</given-names></name></person-group> (<year>1999</year>). <article-title>Immunohistochemical localization of receptors for progesterone and oestradiol-17 beta in the implantation site of the rhesus monkey</article-title>. <source/>Hum. Reprod.
<volume>14</volume>, <fpage>505</fpage>–<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/14.2.505</pub-id><pub-id pub-id-type="pmid">10100002</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbs</surname><given-names>T. T.</given-names></name><name><surname>Russek</surname><given-names>S. J.</given-names></name><name><surname>Farb</surname><given-names>D. H.</given-names></name></person-group> (<year>2006</year>). <article-title>Sulfated steroids as endogenous neuromodulators</article-title>. <source/>Pharmacol. Biochem. Behav.
<volume>84</volume>, <fpage>555</fpage>–<lpage>567</lpage>. <pub-id pub-id-type="doi">10.1016/j.pbb.2006.07.031</pub-id><pub-id pub-id-type="pmid">17023038</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibson</surname><given-names>D. A.</given-names></name><name><surname>McInnes</surname><given-names>K. J.</given-names></name><name><surname>Critchley</surname><given-names>H. O.</given-names></name><name><surname>Saunders</surname><given-names>P. T.</given-names></name></person-group> (<year>2013</year>). <article-title>Endometrial Intracrinology–generation of an estrogen-dominated microenvironment in the secretory phase of women</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>98</volume>, <fpage>E1802</fpage>–<lpage>E1806</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2013-2140</pub-id><pub-id pub-id-type="pmid">24014622</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilligan</surname><given-names>L. C.</given-names></name><name><surname>Gondal</surname><given-names>A.</given-names></name><name><surname>Tang</surname><given-names>V.</given-names></name><name><surname>Hussain</surname><given-names>M. T.</given-names></name><name><surname>Arvaniti</surname><given-names>A.</given-names></name><name><surname>Hewitt</surname><given-names>A. M.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Estrone sulfate transport and steroid sulfatase activity in colorectal cancer: implications for hormone replacement therapy</article-title>. <source/>Front. Pharmacol.
<volume>8</volume>:<fpage>103</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2017.00103</pub-id><pub-id pub-id-type="pmid">28326039</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>González-Arenas</surname><given-names>A.</given-names></name><name><surname>Agramonte-Hevia</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Sex steroid hormone effects in normal and pathologic conditions in lung physiology</article-title>. <source/>Mini Rev. Med. Chem.
<volume>12</volume>, <fpage>1055</fpage>–<lpage>1062</lpage>. <pub-id pub-id-type="doi">10.2174/138955712802762194</pub-id><pub-id pub-id-type="pmid">22827216</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodarzi</surname><given-names>M. O.</given-names></name><name><surname>Antoine</surname><given-names>H. J.</given-names></name><name><surname>Azziz</surname><given-names>R.</given-names></name></person-group> (<year>2007</year>). <article-title>Genes for enzymes regulating dehydroepiandrosterone sulfonation are associated with levels of dehydroepiandrosterone sulfate in polycystic ovary syndrome</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>92</volume>, <fpage>2659</fpage>–<lpage>2664</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2006-2600</pub-id><pub-id pub-id-type="pmid">17426092</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodarzi</surname><given-names>M. O.</given-names></name><name><surname>Shah</surname><given-names>N. A.</given-names></name><name><surname>Antoine</surname><given-names>H. J.</given-names></name><name><surname>Pall</surname><given-names>M.</given-names></name><name><surname>Guo</surname><given-names>X.</given-names></name><name><surname>Azziz</surname><given-names>R.</given-names></name></person-group> (<year>2006</year>). <article-title>Variants in the 5α-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>91</volume>, <fpage>4085</fpage>–<lpage>4091</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2006-0227</pub-id><pub-id pub-id-type="pmid">16849416</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groothuis</surname><given-names>P. G.</given-names></name><name><surname>Dassen</surname><given-names>H. H.</given-names></name><name><surname>Romano</surname><given-names>A.</given-names></name><name><surname>Punyadeera</surname><given-names>C.</given-names></name></person-group> (<year>2007</year>). <article-title>Estrogen and the endometrium: lessons learned from gene expression profiling in rodents and human</article-title>. <source/>Hum. Reprod. Update
<volume>13</volume>, <fpage>405</fpage>–<lpage>417</lpage>. <pub-id pub-id-type="doi">10.1093/humupd/dmm009</pub-id><pub-id pub-id-type="pmid">17584823</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gruber</surname><given-names>C. J.</given-names></name><name><surname>Tschugguel</surname><given-names>W.</given-names></name><name><surname>Schneeberger</surname><given-names>C.</given-names></name><name><surname>Huber</surname><given-names>J. C.</given-names></name></person-group> (<year>2002</year>). <article-title>Production and actions of estrogens</article-title>. <source/>N. Engl. J. Med.
<volume>346</volume>, <fpage>340</fpage>–<lpage>352</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra000471</pub-id><pub-id pub-id-type="pmid">11821512</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guillot</surname><given-names>F.</given-names></name><name><surname>Garcia</surname><given-names>A.</given-names></name><name><surname>Salou</surname><given-names>M.</given-names></name><name><surname>Brouard</surname><given-names>S.</given-names></name><name><surname>Laplaud</surname><given-names>D. A.</given-names></name><name><surname>Nicot</surname><given-names>A. B.</given-names></name></person-group> (<year>2015</year>). <article-title>Transcript analysis of laser capture microdissected white matter astrocytes and higher phenol sulfotransferase 1A1 expression during autoimmune neuroinflammation</article-title>. <source/>J. Neuroinflammation
<volume>12</volume>, <fpage>130</fpage>. <pub-id pub-id-type="doi">10.1186/s12974-015-0348-y</pub-id><pub-id pub-id-type="pmid">26141738</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulyaeva</surname><given-names>L. F.</given-names></name><name><surname>Mikhailova</surname><given-names>O. N.</given-names></name><name><surname>PustyInyak</surname><given-names>V. O.</given-names></name><name><surname>Kim</surname><given-names>I. V.</given-names><suffix>IV.</suffix></name><name><surname>Gerasimov</surname><given-names>A. V.</given-names></name><name><surname>Krasilnikov</surname><given-names>S. E.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Comparative analysis of SNP in estrogen-metabolizing enzymes for ovarian, endometrial, and breast cancers in Novosibirsk, Russia</article-title>. <source/>Adv. Exp. Med. Biol.
<volume>617</volume>, <fpage>359</fpage>–<lpage>366</lpage>. <pub-id pub-id-type="doi">10.1007/978-0-387-69080-3_34</pub-id><pub-id pub-id-type="pmid">18497059</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gylfe</surname><given-names>A. E.</given-names></name><name><surname>Katainen</surname><given-names>R.</given-names></name><name><surname>Kondelin</surname><given-names>J.</given-names></name><name><surname>Tanskanen</surname><given-names>T.</given-names></name><name><surname>Cajuso</surname><given-names>T.</given-names></name><name><surname>Hanninen</surname><given-names>U.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Eleven candidate susceptibility genes for common familial colorectal cancer</article-title>. <source/>PLoS Genet.
<volume>9</volume>:<fpage>e1003876</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1003876</pub-id><pub-id pub-id-type="pmid">24146633</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hakkarainen</surname><given-names>J.</given-names></name><name><surname>Jokela</surname><given-names>H.</given-names></name><name><surname>Pakarinen</surname><given-names>P.</given-names></name><name><surname>Heikela</surname><given-names>H.</given-names></name><name><surname>Katkanaho</surname><given-names>L.</given-names></name><name><surname>Vandenput</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Hydroxysteroid (17β)-dehydrogenase 1-deficient female mice present with normal puberty onset but are severely subfertile due to a defect in luteinization and progesterone production</article-title>. <source/>FASEB J.
<volume>29</volume>, <fpage>3806</fpage>–<lpage>3816</lpage>. <pub-id pub-id-type="doi">10.1096/fj.14-269035</pub-id><pub-id pub-id-type="pmid">26018678</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>D.</given-names></name><name><surname>Frost</surname><given-names>A. R.</given-names></name><name><surname>Falany</surname><given-names>C. N.</given-names></name></person-group> (<year>2005a</year>). <article-title>Identification and immunohistochemical localization of Sulfotransferase 2B1b (SULT2B1b) in human lung</article-title>. <source/>Biochim Biophys Act.
<volume>1724</volume>, <fpage>119</fpage>–<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbagen.2005.03.018</pub-id><pub-id pub-id-type="pmid">15878639</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>D.</given-names></name><name><surname>Meloche</surname><given-names>C. A.</given-names></name><name><surname>Dumas</surname><given-names>N. A.</given-names></name><name><surname>Frost</surname><given-names>A. R.</given-names></name><name><surname>Falany</surname><given-names>C. N.</given-names></name></person-group> (<year>2004</year>). <article-title>Different subcellular localization of sulphotransferase 2B1b in human placenta and prostate</article-title>. <source/>Biochem. J.
<volume>379</volume>, <fpage>533</fpage>–<lpage>540</lpage>. <pub-id pub-id-type="doi">10.1042/bj20031524</pub-id><pub-id pub-id-type="pmid">14741047</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>W.</given-names></name><name><surname>Gauri</surname><given-names>M.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>Lin</surname><given-names>S. X.</given-names></name></person-group> (<year>2016</year>). <article-title>Current knowledge of the multifunctional 17β-hydroxysteroid dehydrogenase type 1 (HSD17B1)</article-title>. <source/>Gene
<volume>588</volume>, <fpage>54</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2016.04.031</pub-id><pub-id pub-id-type="pmid">27102893</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>X. Y.</given-names></name><name><surname>Wegiel</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>Y. Z.</given-names></name><name><surname>Pullarkat</surname><given-names>R.</given-names></name><name><surname>Schulz</surname><given-names>H.</given-names></name><name><surname>Yang</surname><given-names>S. Y.</given-names></name></person-group> (<year>2005b</year>). <article-title>Type 10, 17β-hydroxysteroid dehydrogenase catalyzing the oxidation of steroid modulators of gamma-aminobutyric acid type A receptors</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>229</volume>, <fpage>111</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2004.08.011</pub-id><pub-id pub-id-type="pmid">15607535</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>X. Y.</given-names></name><name><surname>Yang</surname><given-names>S. Y.</given-names></name></person-group> (<year>2006</year>). <article-title>Roles of type 10, 17β-hydroxysteroid dehydrogenase in intracrinology and metabolism of isoleucine and fatty acids</article-title>. <source/>Endocr. Metab. Immune Disord. Drug Targets
<volume>6</volume>, <fpage>95</fpage>–<lpage>102</lpage>. <pub-id pub-id-type="doi">10.2174/187153006776056639</pub-id><pub-id pub-id-type="pmid">16611167</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heijmans</surname><given-names>J.</given-names></name><name><surname>Wielenga</surname><given-names>M. C.</given-names></name><name><surname>Rosekrans</surname><given-names>S. L.</given-names></name><name><surname>van Lidth de Jeude</surname><given-names>J. F.</given-names></name><name><surname>Roelofs</surname><given-names>J.</given-names></name><name><surname>Groothuis</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Oestrogens promote tumorigenesis in a mouse model for colitis-associated cancer</article-title>. <source/>Gut
<volume>63</volume>, <fpage>310</fpage>–<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1136/gutjnl-2012-304216</pub-id><pub-id pub-id-type="pmid">23408349</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Her</surname><given-names>C.</given-names></name><name><surname>Szumlanski</surname><given-names>C.</given-names></name><name><surname>Aksoy</surname><given-names>I. A.</given-names></name><name><surname>Weinshilboum</surname><given-names>R. M.</given-names></name></person-group> (<year>1996</year>). <article-title>Human jejunal estrogen sulfotransferase and dehydroepiandrosterone sulfotransferase: immunochemical characterization of individual variation</article-title>. <source/>Drug Metab. Dispos.
<volume>24</volume>, <fpage>1328</fpage>–<lpage>1335</lpage>.<pub-id pub-id-type="pmid">8971138</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hevir</surname><given-names>N.</given-names></name><name><surname>Ribic-Pucelj</surname><given-names>M.</given-names></name><name><surname>Lanisnik Rizner</surname><given-names>T.</given-names></name></person-group> (<year>2013</year>). <article-title>Disturbed balance between phase I and II metabolizing enzymes in ovarian endometriosis: a source of excessive hydroxy-estrogens and ROS?</article-title>
<source/>Mol. Cell. Endocrinol.
<volume>367</volume>, <fpage>74</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2012.12.019</pub-id><pub-id pub-id-type="pmid">23277161</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hevir</surname><given-names>N.</given-names></name><name><surname>Sinkovec</surname><given-names>J.</given-names></name><name><surname>Rizner</surname><given-names>T. L.</given-names></name></person-group> (<year>2011a</year>). <article-title>Disturbed expression of phase I and phase II estrogen-metabolizing enzymes in endometrial cancer: lower levels of CYP1B1 and increased expression of S-COMT</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>331</volume>, <fpage>158</fpage>–<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2010.09.011</pub-id><pub-id pub-id-type="pmid">20887769</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hevir</surname><given-names>N.</given-names></name><name><surname>Vouk</surname><given-names>K.</given-names></name><name><surname>Sinkovec</surname><given-names>J.</given-names></name><name><surname>Ribic-Pucelj</surname><given-names>M.</given-names></name><name><surname>Rizner</surname><given-names>T. L.</given-names></name></person-group> (<year>2011b</year>). <article-title>Aldo-keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metabolism in ovarian endometriosis</article-title>. <source/>Chem. Biol. Interact.
<volume>191</volume>, <fpage>217</fpage>–<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbi.2011.01.003</pub-id><pub-id pub-id-type="pmid">21232532</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hewitt</surname><given-names>S. C.</given-names></name><name><surname>Winuthayanon</surname><given-names>W.</given-names></name><name><surname>Korach</surname><given-names>K. S.</given-names></name></person-group> (<year>2016</year>). <article-title>What's new in estrogen receptor action in the female reproductive tract</article-title>. <source/>J. Mol. Endocrinol.
<volume>56</volume>
<fpage>R55</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1530/JME-15-0254</pub-id><pub-id pub-id-type="pmid">26826253</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilborn</surname><given-names>E.</given-names></name><name><surname>Stal</surname><given-names>O.</given-names></name><name><surname>Jansson</surname><given-names>A.</given-names></name></person-group> (<year>2017</year>). <article-title>Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer</article-title>. <source/>Oncotarget
<volume>8</volume>, <fpage>30552</fpage>–<lpage>30562</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.15547</pub-id><pub-id pub-id-type="pmid">28430630</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hogan</surname><given-names>A. M.</given-names></name><name><surname>Collins</surname><given-names>D.</given-names></name><name><surname>Baird</surname><given-names>A. W.</given-names></name><name><surname>Winter</surname><given-names>D. C.</given-names></name></person-group> (<year>2009</year>). <article-title>Estrogen and gastrointestinal malignancy</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>307</volume>, <fpage>19</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2009.03.016</pub-id><pub-id pub-id-type="pmid">19524122</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Honda</surname><given-names>S.</given-names></name><name><surname>Harada</surname><given-names>N.</given-names></name><name><surname>Ito</surname><given-names>S.</given-names></name><name><surname>Takagi</surname><given-names>Y.</given-names></name><name><surname>Maeda</surname><given-names>S.</given-names></name></person-group> (<year>1998</year>). <article-title>Disruption of sexual behavior in male aromatase-deficient mice lacking exons 1 and 2 of the cyp19 gene</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>252</volume>, <fpage>445</fpage>–<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1006/bbrc.1998.9672</pub-id><pub-id pub-id-type="pmid">9826549</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hovorkova</surname><given-names>P.</given-names></name><name><surname>Kristofikova</surname><given-names>Z.</given-names></name><name><surname>Horinek</surname><given-names>A.</given-names></name><name><surname>Ripova</surname><given-names>D.</given-names></name><name><surname>Majer</surname><given-names>E.</given-names></name><name><surname>Zach</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Lateralization of 17β-hydroxysteroid dehydrogenase type 10 in hippocampi of demented and psychotic people</article-title>. <source/>Dement. Geriatr. Cogn. Disord.
<volume>26</volume>, <fpage>193</fpage>–<lpage>198</lpage>. <pub-id pub-id-type="doi">10.1159/000151778</pub-id><pub-id pub-id-type="pmid">18765932</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>M. C.</given-names></name><name><surname>Hsu</surname><given-names>N. C.</given-names></name><name><surname>El Hadj</surname><given-names>N. B.</given-names></name><name><surname>Pai</surname><given-names>C. I.</given-names></name><name><surname>Chu</surname><given-names>H. P.</given-names></name><name><surname>Wang</surname><given-names>C. K.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Steroid deficiency syndromes in mice with targeted disruption of Cyp11a1</article-title>. <source/>Mol. Endocrinol.
<volume>16</volume>, <fpage>1943</fpage>–<lpage>1950</lpage>. <pub-id pub-id-type="doi">10.1210/me.2002-0055</pub-id><pub-id pub-id-type="pmid">12145347</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C. C.</given-names></name><name><surname>Shih</surname><given-names>M. C.</given-names></name><name><surname>Hsu</surname><given-names>N. C.</given-names></name><name><surname>Chien</surname><given-names>Y.</given-names></name><name><surname>Chung</surname><given-names>B. C.</given-names></name></person-group> (<year>2012</year>). <article-title>Fetal glucocorticoid synthesis is required for development of fetal adrenal medulla and hypothalamus feedback suppression</article-title>. <source/>Endocrinology
<volume>153</volume>, <fpage>4749</fpage>–<lpage>4756</lpage>. <pub-id pub-id-type="doi">10.1210/en.2012-1258</pub-id><pub-id pub-id-type="pmid">22962254</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>X. F.</given-names></name><name><surname>Luu-The</surname><given-names>V.</given-names></name></person-group> (<year>2000</year>). <article-title>Molecular characterization of a first human 3(α-&gt;β)-hydroxysteroid epimerase</article-title>. <source/>J. Biol. Chem.
<volume>275</volume>, <fpage>29452</fpage>–<lpage>29457</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M000562200</pub-id><pub-id pub-id-type="pmid">10896656</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huber</surname><given-names>A.</given-names></name><name><surname>Keck</surname><given-names>C. C.</given-names></name><name><surname>Hefler</surname><given-names>L. A.</given-names></name><name><surname>Schneeberger</surname><given-names>C.</given-names></name><name><surname>Huber</surname><given-names>J. C.</given-names></name><name><surname>Bentz</surname><given-names>E. K.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Ten estrogen-related polymorphisms and endometriosis: a study of multiple gene-gene interactions</article-title>. <source/>Obstet. Gynecol.
<volume>106</volume>, <fpage>1025</fpage>–<lpage>1031</lpage>. <pub-id pub-id-type="doi">10.1097/01.AOG.0000185259.01648.41</pub-id><pub-id pub-id-type="pmid">16260521</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hudelist</surname><given-names>G.</given-names></name><name><surname>Czerwenka</surname><given-names>K.</given-names></name><name><surname>Keckstein</surname><given-names>J.</given-names></name><name><surname>Haas</surname><given-names>C.</given-names></name><name><surname>Fink-Retter</surname><given-names>A.</given-names></name><name><surname>Gschwantler-Kaulich</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Expression of aromatase and estrogen sulfotransferase in eutopic and ectopic endometrium: evidence for unbalanced estradiol production in endometriosis</article-title>. <source/>Reprod. Sci.
<volume>14</volume>, <fpage>798</fpage>–<lpage>805</lpage>. <pub-id pub-id-type="doi">10.1177/1933719107309120</pub-id><pub-id pub-id-type="pmid">18089598</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>S. V.</given-names></name><name><surname>Robinson</surname><given-names>E.</given-names></name><name><surname>Bland</surname><given-names>R.</given-names></name><name><surname>Lewis</surname><given-names>H. M.</given-names></name><name><surname>Stewart</surname><given-names>P. M.</given-names></name><name><surname>Hewison</surname><given-names>M.</given-names></name></person-group> (<year>1997</year>). <article-title>1,25-dihydroxyvitamin D3 regulates estrogen metabolism in cultured keratinocytes</article-title>. <source/>Endocrinology
<volume>138</volume>, <fpage>3711</fpage>–<lpage>3718</lpage>. <pub-id pub-id-type="doi">10.1210/endo.138.9.5406</pub-id><pub-id pub-id-type="pmid">9275056</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huhtinen</surname><given-names>K.</given-names></name><name><surname>Desai</surname><given-names>R.</given-names></name><name><surname>Stahle</surname><given-names>M.</given-names></name><name><surname>Salminen</surname><given-names>A.</given-names></name><name><surname>Handelsman</surname><given-names>D. J.</given-names></name><name><surname>Perheentupa</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2012a</year>). <article-title>Endometrial and endometriotic concentrations of estrone and estradiol are determined by local metabolism rather than circulating levels</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>97</volume>, <fpage>4228</fpage>–<lpage>4235</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2012-1154</pub-id><pub-id pub-id-type="pmid">22969138</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huhtinen</surname><given-names>K.</given-names></name><name><surname>Saloniemi-Heinonen</surname><given-names>T.</given-names></name><name><surname>Keski-Rahkonen</surname><given-names>P.</given-names></name><name><surname>Desai</surname><given-names>R.</given-names></name><name><surname>Laajala</surname><given-names>D.</given-names></name><name><surname>Stahle</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Intra-tissue steroid profiling indicates differential progesterone and testosterone metabolism in the endometrium and endometriosis lesions</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>99</volume>
<fpage>E2188</fpage>–<lpage>2197</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2014-1913</pub-id><pub-id pub-id-type="pmid">25137424</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huhtinen</surname><given-names>K.</given-names></name><name><surname>Stahle</surname><given-names>M.</given-names></name><name><surname>Perheentupa</surname><given-names>A.</given-names></name><name><surname>Poutanen</surname><given-names>M.</given-names></name></person-group> (<year>2012b</year>). <article-title>Estrogen biosynthesis and signaling in endometriosis</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>358</volume>, <fpage>146</fpage>–<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2011.08.022</pub-id><pub-id pub-id-type="pmid">21875644</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Husen</surname><given-names>B.</given-names></name><name><surname>Huhtinen</surname><given-names>K.</given-names></name><name><surname>Poutanen</surname><given-names>M.</given-names></name><name><surname>Kangas</surname><given-names>L.</given-names></name><name><surname>Messinger</surname><given-names>J.</given-names></name><name><surname>Thole</surname><given-names>H.</given-names></name></person-group> (<year>2006</year>). <article-title>Evaluation of inhibitors for 17β-hydroxysteroid dehydrogenase type 1 <italic>in vivo</italic> in immunodeficient mice inoculated with MCF-7 cells stably expressing the recombinant human enzyme</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>248</volume>, <fpage>109</fpage>–<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2005.11.042</pub-id><pub-id pub-id-type="pmid">16406284</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ihlenfeldt</surname><given-names>W. D.</given-names></name><name><surname>Bolton</surname><given-names>E. E.</given-names></name><name><surname>Bryant</surname><given-names>S. H.</given-names></name></person-group> (<year>2009</year>). <article-title>The PubChem chemical structure sketcher</article-title>. <source/>J. Cheminform.
<volume>1</volume>:<fpage>20</fpage>. <pub-id pub-id-type="doi">10.1186/1758-2946-1-20</pub-id><pub-id pub-id-type="pmid">20298522</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iida</surname><given-names>S.</given-names></name><name><surname>Kakinuma</surname><given-names>H.</given-names></name><name><surname>Miki</surname><given-names>Y.</given-names></name><name><surname>Abe</surname><given-names>K.</given-names></name><name><surname>Sakurai</surname><given-names>M.</given-names></name><name><surname>Suzuki</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Steroid sulphatase and oestrogen sulphotransferase in human non-small-cell lung carcinoma</article-title>. <source/>Br. J. Cancer
<volume>108</volume>, <fpage>1415</fpage>–<lpage>1424</lpage>. <pub-id pub-id-type="doi">10.1038/bjc.2013.84</pub-id><pub-id pub-id-type="pmid">23531699</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>K.</given-names></name><name><surname>Shiraishi</surname><given-names>K.</given-names></name><name><surname>Yoshida</surname><given-names>A.</given-names></name><name><surname>Shinchi</surname><given-names>Y.</given-names></name><name><surname>Sanada</surname><given-names>M.</given-names></name><name><surname>Motooka</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Synchronous multiple lung adenocarcinomas: estrogen concentration in peripheral lung</article-title>. <source/>PLoS ONE
<volume>11</volume>:<fpage>e0160910</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0160910</pub-id><pub-id pub-id-type="pmid">27526096</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iqbal</surname><given-names>M. J.</given-names></name><name><surname>Greenway</surname><given-names>B.</given-names></name><name><surname>Wilkinson</surname><given-names>M. L.</given-names></name><name><surname>Johnson</surname><given-names>P. J.</given-names></name><name><surname>Williams</surname><given-names>R.</given-names></name></person-group> (<year>1983</year>). <article-title>Sex-steroid enzymes, aromatase and 5 alpha-reductase in the pancreas: a comparison of normal adult, foetal and malignant tissue</article-title>. <source/>Clin. Sci.
<volume>65</volume>, <fpage>71</fpage>–<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1042/cs0650071</pub-id><pub-id pub-id-type="pmid">6851420</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishida</surname><given-names>M.</given-names></name><name><surname>Choi</surname><given-names>J. H.</given-names></name><name><surname>Hirabayashi</surname><given-names>K.</given-names></name><name><surname>Matsuwaki</surname><given-names>T.</given-names></name><name><surname>Suzuki</surname><given-names>M.</given-names></name><name><surname>Yamanouchi</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Reproductive phenotypes in mice with targeted disruption of the 20α-hydroxysteroid dehydrogenase gene</article-title>. <source/>J. Reprod. Dev.
<volume>53</volume>, <fpage>499</fpage>–<lpage>508</lpage>. <pub-id pub-id-type="doi">10.1262/jrd.18125</pub-id><pub-id pub-id-type="pmid">17272929</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>K.</given-names></name><name><surname>Miki</surname><given-names>Y.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>McNamara</surname><given-names>K. M.</given-names></name><name><surname>Sasano</surname><given-names>H.</given-names></name></person-group> (<year>2016</year>). <article-title>In situ androgen and estrogen biosynthesis in endometrial cancer: focus on androgen actions and intratumoral production</article-title>. <source/>Endocr. Relat. Cancer
<volume>23</volume>
<fpage>R323</fpage>–<lpage>335</lpage>. <pub-id pub-id-type="doi">10.1530/ERC-15-0470</pub-id><pub-id pub-id-type="pmid">27287451</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>K.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Akahira</surname><given-names>J.</given-names></name><name><surname>Moriya</surname><given-names>T.</given-names></name><name><surname>Kaneko</surname><given-names>C.</given-names></name><name><surname>Utsunomiya</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Expression of androgen receptor and 5α-reductases in the human normal endometrium and its disorders</article-title>. <source/>Int. J. Cancer
<volume>99</volume>, <fpage>652</fpage>–<lpage>657</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.10394</pub-id><pub-id pub-id-type="pmid">12115497</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>K.</given-names></name><name><surname>Utsunomiya</surname><given-names>H.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Saitou</surname><given-names>S.</given-names></name><name><surname>Akahira</surname><given-names>J.</given-names></name><name><surname>Okamura</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>17β-hydroxysteroid dehydrogenases in human endometrium and its disorders</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>248</volume>, <fpage>136</fpage>–<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2005.11.038</pub-id><pub-id pub-id-type="pmid">16406263</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iwasa</surname><given-names>A.</given-names></name><name><surname>Arakaki</surname><given-names>R.</given-names></name><name><surname>Honma</surname><given-names>N.</given-names></name><name><surname>Ushio</surname><given-names>A.</given-names></name><name><surname>Yamada</surname><given-names>A.</given-names></name><name><surname>Kondo</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Aromatase controls Sjogren syndrome-like lesions through monocyte chemotactic protein-1 in target organ and adipose tissue-associated macrophages</article-title>. <source/>Am. J. Pathol.
<volume>185</volume>, <fpage>151</fpage>–<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajpath.2014.09.006</pub-id><pub-id pub-id-type="pmid">25447050</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jakob</surname><given-names>F.</given-names></name><name><surname>Siggelkow</surname><given-names>H.</given-names></name><name><surname>Homann</surname><given-names>D.</given-names></name><name><surname>Kohrle</surname><given-names>J.</given-names></name><name><surname>Adamski</surname><given-names>J.</given-names></name><name><surname>Schutze</surname><given-names>N.</given-names></name></person-group> (<year>1997</year>). <article-title>Local estradiol metabolism in osteoblast- and osteoclast-like cells</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>61</volume>, <fpage>167</fpage>–<lpage>174</lpage>. <pub-id pub-id-type="doi">10.1016/S0960-0760(97)80009-X</pub-id><pub-id pub-id-type="pmid">9365187</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janssen</surname><given-names>J. M.</given-names></name><name><surname>Bland</surname><given-names>R.</given-names></name><name><surname>Hewison</surname><given-names>M.</given-names></name><name><surname>Coughtrie</surname><given-names>M. W.</given-names></name><name><surname>Sharp</surname><given-names>S.</given-names></name><name><surname>Arts</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>Estradiol formation by human osteoblasts via multiple pathways: relation with osteoblast function</article-title>. <source/>J. Cell. Biochem.
<volume>75</volume>, <fpage>528</fpage>–<lpage>537</lpage>. <pub-id pub-id-type="doi">10.1002/(SICI)1097-4644(19991201)75:3&lt;528::AID-JCB16&gt;3.0.CO;2-3</pub-id><pub-id pub-id-type="pmid">10536374</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jäntti</surname><given-names>S. E.</given-names></name><name><surname>Tammimaki</surname><given-names>A.</given-names></name><name><surname>Raattamaa</surname><given-names>H.</given-names></name><name><surname>Piepponen</surname><given-names>P.</given-names></name><name><surname>Kostiainen</surname><given-names>R.</given-names></name><name><surname>Ketola</surname><given-names>R. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Determination of steroids and their intact glucuronide conjugates in mouse brain by capillary liquid chromatography-tandem mass spectrometry</article-title>. <source/>Anal. Chem.
<volume>82</volume>, <fpage>3168</fpage>–<lpage>3175</lpage>. <pub-id pub-id-type="doi">10.1021/ac902321z</pub-id><pub-id pub-id-type="pmid">20345173</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Järvensivu</surname><given-names>P.</given-names></name><name><surname>Heinosalo</surname><given-names>T.</given-names></name><name><surname>Hakkarainen</surname><given-names>J.</given-names></name><name><surname>Kronqvist</surname><given-names>P.</given-names></name><name><surname>Saarinen</surname><given-names>N.</given-names></name><name><surname>Poutanen</surname><given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>HSD17B1 expression induces inflammation-aided rupture of mammary gland myoepithelium</article-title>. <source/>Endocr. Relat. Cancer
<volume>25</volume>, <fpage>393</fpage>–<lpage>406</lpage>. <pub-id pub-id-type="doi">10.1530/ERC-17-0476</pub-id><pub-id pub-id-type="pmid">29371331</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Järvensivu</surname><given-names>P.</given-names></name><name><surname>Saloniemi-Heinonen</surname><given-names>T.</given-names></name><name><surname>Awosanya</surname><given-names>M.</given-names></name><name><surname>Koskimies</surname><given-names>P.</given-names></name><name><surname>Saarinen</surname><given-names>N.</given-names></name><name><surname>Poutanen</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>HSD17B1 expression enhances estrogen signaling stimulated by the low active estrone, evidenced by an estrogen responsive element-driven reporter gene <italic>in vivo</italic></article-title>. <source/>Chem. Biol. Interact.
<volume>234</volume>, <fpage>126</fpage>–<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbi.2015.01.008</pub-id><pub-id pub-id-type="pmid">25617485</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeon</surname><given-names>Y. T.</given-names></name><name><surname>Park</surname><given-names>S. Y.</given-names></name><name><surname>Kim</surname><given-names>Y. B.</given-names></name><name><surname>Kim</surname><given-names>J. W.</given-names></name><name><surname>Park</surname><given-names>N. H.</given-names></name><name><surname>Kang</surname><given-names>S. B.</given-names></name><etal></etal></person-group> (<year>2007</year>). <article-title>Aromatase expression was not detected by immunohistochemistry in endometrial cancer</article-title>. <source/>Ann. N. Y. Acad. Sci.
<volume>1095</volume>, <fpage>70</fpage>–<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1196/annals.1397.010</pub-id><pub-id pub-id-type="pmid">17404019</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>Y.</given-names></name><name><surname>Mesaros</surname><given-names>A. C.</given-names></name><name><surname>Blair</surname><given-names>I. A.</given-names></name><name><surname>Penning</surname><given-names>T. M.</given-names></name></person-group> (<year>2011</year>). <article-title>Stereospecific reduction of 5β-reduced steroids by human ketosteroid reductases of the AKR (aldo-keto reductase) superfamily: role of AKR1C1-AKR1C4 in the metabolism of testosterone and progesterone via the 5β-reductase pathway</article-title>. <source/>Biochem. J.
<volume>437</volume>, <fpage>53</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20101804</pub-id><pub-id pub-id-type="pmid">21521174</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jokela</surname><given-names>H.</given-names></name><name><surname>Rantakari</surname><given-names>P.</given-names></name><name><surname>Lamminen</surname><given-names>T.</given-names></name><name><surname>Strauss</surname><given-names>L.</given-names></name><name><surname>Ola</surname><given-names>R.</given-names></name><name><surname>Mutka</surname><given-names>A. L.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Hydroxysteroid (17β) dehydrogenase 7 activity is essential for fetal de novo cholesterol synthesis and for neuroectodermal survival and cardiovascular differentiation in early mouse embryos</article-title>. <source/>Endocrinology
<volume>151</volume>, <fpage>1884</fpage>–<lpage>1892</lpage>. <pub-id pub-id-type="doi">10.1210/en.2009-0928</pub-id><pub-id pub-id-type="pmid">20185768</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>A. L.</given-names></name><name><surname>Hume</surname><given-names>R.</given-names></name><name><surname>Bamforth</surname><given-names>K. J.</given-names></name><name><surname>Coughtrie</surname><given-names>M. W.</given-names></name></person-group> (<year>1992</year>). <article-title>Estrogen and phenol sulfotransferase activities in human fetal lung</article-title>. <source/>Early Hum. Dev.
<volume>28</volume>, <fpage>65</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1016/0378-3782(92)90007-4</pub-id><pub-id pub-id-type="pmid">1582375</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>M. R.</given-names></name><name><surname>Mathur</surname><given-names>R.</given-names></name><name><surname>Cui</surname><given-names>J.</given-names></name><name><surname>Guo</surname><given-names>X.</given-names></name><name><surname>Azziz</surname><given-names>R.</given-names></name><name><surname>Goodarzi</surname><given-names>M. O.</given-names></name></person-group> (<year>2009</year>). <article-title>Independent confirmation of association between metabolic phenotypes of polycystic ovary syndrome and variation in the type 6, 17β-hydroxysteroid dehydrogenase gene</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>94</volume>, <fpage>5034</fpage>–<lpage>5038</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2009-0931</pub-id><pub-id pub-id-type="pmid">19837928</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jongen</surname><given-names>V. H.</given-names></name><name><surname>Thijssen</surname><given-names>J. H.</given-names></name><name><surname>Hollema</surname><given-names>H.</given-names></name><name><surname>Donker</surname><given-names>G. H.</given-names></name><name><surname>Santema</surname><given-names>J. G.</given-names></name><name><surname>Van der Zee</surname><given-names>A. G.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Is aromatase cytochrome P450 involved in the pathogenesis of endometrioid endometrial cancer?</article-title>
<source/>Int. J. Gynecol. Cancer
<volume>15</volume>, <fpage>529</fpage>–<lpage>536</lpage>. <pub-id pub-id-type="doi">10.1111/j.1525-1438.2005.15320.x</pub-id><pub-id pub-id-type="pmid">15882181</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kancheva</surname><given-names>L.</given-names></name><name><surname>Hill</surname><given-names>M.</given-names></name><name><surname>Vcelakova</surname><given-names>H.</given-names></name><name><surname>Vrbikova</surname><given-names>J.</given-names></name><name><surname>Pelikanova</surname><given-names>T.</given-names></name><name><surname>Starka</surname><given-names>L.</given-names></name></person-group> (<year>2007</year>). <article-title>The identification and simultaneous quantification of neuroactive androstane steroids and their polar conjugates in the serum of adult men, using gas chromatography-mass spectrometry</article-title>. <source/>Steroids
<volume>72</volume>, <fpage>792</fpage>–<lpage>801</lpage>. <pub-id pub-id-type="doi">10.1016/j.steroids.2007.06.006</pub-id><pub-id pub-id-type="pmid">17716701</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kassem</surname><given-names>M.</given-names></name><name><surname>Okazaki</surname><given-names>R.</given-names></name><name><surname>Harris</surname><given-names>S. A.</given-names></name><name><surname>Spelsberg</surname><given-names>T. C.</given-names></name><name><surname>Conover</surname><given-names>C. A.</given-names></name><name><surname>Riggs</surname><given-names>B. L.</given-names></name></person-group> (<year>1998</year>). <article-title>Estrogen effects on insulin-like growth factor gene expression in a human osteoblastic cell line with high levels of estrogen receptor</article-title>. <source/>Calcif. Tissue Int.
<volume>62</volume>, <fpage>60</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1007/s002239900395</pub-id><pub-id pub-id-type="pmid">9405735</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kemilainen</surname><given-names>H.</given-names></name><name><surname>Adam</surname><given-names>M.</given-names></name><name><surname>Maki-Jouppila</surname><given-names>J.</given-names></name><name><surname>Damdimopoulou</surname><given-names>P.</given-names></name><name><surname>Damdimopoulos</surname><given-names>A. E.</given-names></name><name><surname>Kere</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>The hydroxysteroid (17β) dehydrogenase family gene HSD17B12 Is involved in the prostaglandin synthesis pathway, the ovarian function, and regulation of fertility</article-title>. <source/>Endocrinology
<volume>157</volume>, <fpage>3719</fpage>–<lpage>3730</lpage>. <pub-id pub-id-type="doi">10.1210/en.2016-1252</pub-id><pub-id pub-id-type="pmid">27490311</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennelly</surname><given-names>R.</given-names></name><name><surname>Kavanagh</surname><given-names>D. O.</given-names></name><name><surname>Hogan</surname><given-names>A. M.</given-names></name><name><surname>Winter</surname><given-names>D. C.</given-names></name></person-group> (<year>2008</year>). <article-title>Oestrogen and the colon: potential mechanisms for cancer prevention</article-title>. <source/>Lancet Oncol.
<volume>9</volume>, <fpage>385</fpage>–<lpage>391</lpage>. <pub-id pub-id-type="doi">10.1016/S1470-2045(08)70100-1</pub-id><pub-id pub-id-type="pmid">18374292</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kikuchi</surname><given-names>A.</given-names></name><name><surname>Furutani</surname><given-names>T.</given-names></name><name><surname>Azami</surname><given-names>H.</given-names></name><name><surname>Watanabe</surname><given-names>K.</given-names></name><name><surname>Niimi</surname><given-names>T.</given-names></name><name><surname>Kamiyama</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title><italic>In vitro</italic> and <italic>in vivo</italic> characterisation of ASP9521: a novel, selective, orally bioavailable inhibitor of 17β-hydroxysteroid dehydrogenase type 5 (17βHSD5; AKR1C3)</article-title>. <source/>Invest. New Drugs
<volume>32</volume>, <fpage>860</fpage>–<lpage>870</lpage>. <pub-id pub-id-type="doi">10.1007/s10637-014-0130-5</pub-id><pub-id pub-id-type="pmid">24981575</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>J. H.</given-names></name><name><surname>Cho</surname><given-names>H. T.</given-names></name><name><surname>Kim</surname><given-names>Y. J.</given-names></name></person-group> (<year>2014</year>). <article-title>The role of estrogen in adipose tissue metabolism: insights into glucose homeostasis regulation</article-title>. <source/>Endocr. J.
<volume>61</volume>, <fpage>1055</fpage>–<lpage>1067</lpage>. <pub-id pub-id-type="doi">10.1507/endocrj.EJ14-0262</pub-id><pub-id pub-id-type="pmid">25109846</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S.</given-names></name><name><surname>Thiessen</surname><given-names>P. A.</given-names></name><name><surname>Bolton</surname><given-names>E. E.</given-names></name><name><surname>Chen</surname><given-names>J.</given-names></name><name><surname>Fu</surname><given-names>G.</given-names></name><name><surname>Gindulyte</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>PubChem substance and compound databases</article-title>. <source/>Nucleic Acids Res.
<volume>44</volume>, <fpage>D1202</fpage>–<lpage>D1213</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkv951</pub-id><pub-id pub-id-type="pmid">26400175</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>T. S.</given-names></name><name><surname>Maeda</surname><given-names>A.</given-names></name><name><surname>Maeda</surname><given-names>T.</given-names></name><name><surname>Heinlein</surname><given-names>C.</given-names></name><name><surname>Kedishvili</surname><given-names>N.</given-names></name><name><surname>Palczewski</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Delayed dark adaptation in 11-cis-retinol dehydrogenase-deficient mice: a role of RDH11 in visual processes <italic>in vivo</italic></article-title>. <source/>J. Biol. Chem.
<volume>280</volume>, <fpage>8694</fpage>–<lpage>8704</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M413172200</pub-id><pub-id pub-id-type="pmid">15634683</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimoto</surname><given-names>T.</given-names></name><name><surname>Ishii</surname><given-names>H.</given-names></name><name><surname>Higo</surname><given-names>S.</given-names></name><name><surname>Hojo</surname><given-names>Y.</given-names></name><name><surname>Kawato</surname><given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Semicomprehensive analysis of the postnatal age-related changes in the mRNA expression of sex steroidogenic enzymes and sex steroid receptors in the male rat hippocampus</article-title>. <source/>Endocrinology
<volume>151</volume>, <fpage>5795</fpage>–<lpage>5806</lpage>. <pub-id pub-id-type="doi">10.1210/en.2010-0581</pub-id><pub-id pub-id-type="pmid">21047951</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>Y.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Kaneko</surname><given-names>C.</given-names></name><name><surname>Darnel</surname><given-names>A. D.</given-names></name><name><surname>Akahira</surname><given-names>J.</given-names></name><name><surname>Ebina</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Expression of androgen receptor and 5α-reductase types 1 and 2 in early gestation fetal lung: a possible correlation with branching morphogenesis</article-title>. <source/>Clin. Sci.
<volume>105</volume>, <fpage>709</fpage>–<lpage>713</lpage>. <pub-id pub-id-type="doi">10.1042/CS20030236</pub-id><pub-id pub-id-type="pmid">12892557</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitaoka</surname><given-names>Y.</given-names></name><name><surname>Kitawaki</surname><given-names>J.</given-names></name><name><surname>Koshiba</surname><given-names>H.</given-names></name><name><surname>Inoue</surname><given-names>S.</given-names></name><name><surname>Ishihara</surname><given-names>H.</given-names></name><name><surname>Teramoto</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Aromatase cytochrome P450 and estrogen and progesterone receptors in uterine sarcomas: correlation with clinical parameters</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>88</volume>, <fpage>183</fpage>–<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsbmb.2003.11.013</pub-id><pub-id pub-id-type="pmid">15084350</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitawaki</surname><given-names>J.</given-names></name><name><surname>Kado</surname><given-names>N.</given-names></name><name><surname>Ishihara</surname><given-names>H.</given-names></name><name><surname>Koshiba</surname><given-names>H.</given-names></name><name><surname>Kitaoka</surname><given-names>Y.</given-names></name><name><surname>Honjo</surname><given-names>H.</given-names></name></person-group> (<year>2002</year>). <article-title>Endometriosis: the pathophysiology as an estrogen-dependent disease</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>83</volume>, <fpage>149</fpage>–<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1016/S0960-0760(02)00260-1</pub-id><pub-id pub-id-type="pmid">12650711</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitawaki</surname><given-names>J.</given-names></name><name><surname>Koshiba</surname><given-names>H.</given-names></name><name><surname>Ishihara</surname><given-names>H.</given-names></name><name><surname>Kusuki</surname><given-names>I.</given-names></name><name><surname>Tsukamoto</surname><given-names>K.</given-names></name><name><surname>Honjo</surname><given-names>H.</given-names></name></person-group> (<year>2000</year>). <article-title>Progesterone induction of 17β-hydroxysteroid dehydrogenase type 2 during the secretory phase occurs in the endometrium of estrogen-dependent benign diseases but not in normal endometrium</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>85</volume>, <fpage>3292</fpage>–<lpage>3296</lpage>. <pub-id pub-id-type="doi">10.1210/jcem.85.9.6829</pub-id><pub-id pub-id-type="pmid">10999824</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitawaki</surname><given-names>J.</given-names></name><name><surname>Kusuki</surname><given-names>I.</given-names></name><name><surname>Koshiba</surname><given-names>H.</given-names></name><name><surname>Tsukamoto</surname><given-names>K.</given-names></name><name><surname>Fushiki</surname><given-names>S.</given-names></name><name><surname>Honjo</surname><given-names>H.</given-names></name></person-group> (<year>1999</year>). <article-title>Detection of aromatase cytochrome P-450 in endometrial biopsy specimens as a diagnostic test for endometriosis</article-title>. <source/>Fertil. Steril.
<volume>72</volume>, <fpage>1100</fpage>–<lpage>1106</lpage>. <pub-id pub-id-type="doi">10.1016/S0015-0282(99)00424-0</pub-id><pub-id pub-id-type="pmid">10593388</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knapp</surname><given-names>P.</given-names></name><name><surname>Chabowski</surname><given-names>A.</given-names></name><name><surname>Blachnio-Zabielska</surname><given-names>A.</given-names></name><name><surname>Walentowicz-Sadlecka</surname><given-names>M.</given-names></name><name><surname>Grabiec</surname><given-names>M.</given-names></name><name><surname>Knapp</surname><given-names>P. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Expression of estrogen receptors (alpha, beta), cyclooxygenase-2 and aromatase in normal endometrium and endometrioid cancer of uterus</article-title>. <source/>Adv. Med. Sci.
<volume>58</volume>, <fpage>96</fpage>–<lpage>103</lpage>. <pub-id pub-id-type="doi">10.2478/v10039-012-0055-1</pub-id><pub-id pub-id-type="pmid">23625281</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>H.</given-names></name><name><surname>Yoshida</surname><given-names>S.</given-names></name><name><surname>Sun</surname><given-names>Y. J.</given-names></name><name><surname>Shirasawa</surname><given-names>N.</given-names></name><name><surname>Naito</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Postnatal development of gastric aromatase and portal venous estradiol-17β levels in male rats</article-title>. <source/>J. Endocrinol.
<volume>218</volume>, <fpage>117</fpage>–<lpage>124</lpage>. <pub-id pub-id-type="doi">10.1530/JOE-13-0074</pub-id><pub-id pub-id-type="pmid">23606751</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kohno</surname><given-names>M.</given-names></name><name><surname>Okamoto</surname><given-names>T.</given-names></name><name><surname>Suda</surname><given-names>K.</given-names></name><name><surname>Shimokawa</surname><given-names>M.</given-names></name><name><surname>Kitahara</surname><given-names>H.</given-names></name><name><surname>Shimamatsu</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Prognostic and therapeutic implications of aromatase expression in lung adenocarcinomas with EGFR mutations</article-title>. <source/>Clin. Cancer Res.
<volume>20</volume>, <fpage>3613</fpage>–<lpage>3622</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-13-2683</pub-id><pub-id pub-id-type="pmid">24803578</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koizumi</surname><given-names>M.</given-names></name><name><surname>Momoeda</surname><given-names>M.</given-names></name><name><surname>Hiroi</surname><given-names>H.</given-names></name><name><surname>Hosokawa</surname><given-names>Y.</given-names></name><name><surname>Tsutsumi</surname><given-names>R.</given-names></name><name><surname>Osuga</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Expression and regulation of cholesterol sulfotransferase (SULT2B1b) in human endometrium</article-title>. <source/>Fertil. Steril.
<volume>93</volume>, <fpage>1538</fpage>–<lpage>1544</lpage>. <pub-id pub-id-type="doi">10.1016/j.fertnstert.2009.01.075</pub-id><pub-id pub-id-type="pmid">19243756</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konings</surname><given-names>G. F.</given-names></name><name><surname>Cornel</surname><given-names>K. M.</given-names></name><name><surname>Xanthoulea</surname><given-names>S.</given-names></name><name><surname>Delvoux</surname><given-names>B.</given-names></name><name><surname>Skowron</surname><given-names>M. A.</given-names></name><name><surname>Kooreman</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Blocking 17β-hydroxysteroid dehydrogenase type 1 in endometrial cancer: a potential novel endocrine therapeutic approach</article-title>. <source/>J. Pathol.
<volume>244</volume>, <fpage>203</fpage>–<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1002/path.5004</pub-id><pub-id pub-id-type="pmid">29144553</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konings</surname><given-names>G. F.</given-names></name><name><surname>Reynaert</surname><given-names>N. L.</given-names></name><name><surname>Delvoux</surname><given-names>B.</given-names></name><name><surname>Verhamme</surname><given-names>F. M.</given-names></name><name><surname>Bracke</surname><given-names>K. R.</given-names></name><name><surname>Brusselle</surname><given-names>G. G.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Increased levels of enzymes involved in local estradiol synthesis in chronic obstructive pulmonary disease</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>443</volume>, <fpage>23</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2016.12.001</pub-id><pub-id pub-id-type="pmid">27940297</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreitmann</surname><given-names>O.</given-names></name><name><surname>Kreitmann-Gimbal</surname><given-names>B.</given-names></name><name><surname>Bayard</surname><given-names>F.</given-names></name><name><surname>Hodgen</surname><given-names>G. D.</given-names></name></person-group> (<year>1979</year>). <article-title>17 beta-hydroxysteroid dehydrogenase in monkey endometrium: characterization of enzyme activity, and effects of estradiol alone or in combination with progesterone</article-title>. <source/>Steroids
<volume>34</volume>, <fpage>693</fpage>–<lpage>703</lpage>. <pub-id pub-id-type="doi">10.1016/0039-128X(79)90139-9</pub-id><pub-id pub-id-type="pmid">120040</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kríz</surname><given-names>L.</given-names></name><name><surname>Bicikova</surname><given-names>M.</given-names></name><name><surname>Hampl</surname><given-names>R.</given-names></name></person-group> (<year>2008a</year>). <article-title>Roles of steroid sulfatase in brain and other tissues</article-title>. <source/>Physiol. Res.
<volume>57</volume>, <fpage>657</fpage>–<lpage>668</lpage>.<pub-id pub-id-type="pmid">17949251</pub-id></mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kríz</surname><given-names>L.</given-names></name><name><surname>Bicikova</surname><given-names>M.</given-names></name><name><surname>Mohapl</surname><given-names>M.</given-names></name><name><surname>Hill</surname><given-names>M.</given-names></name><name><surname>Cerny</surname><given-names>I.</given-names></name><name><surname>Hampl</surname><given-names>R.</given-names></name></person-group> (<year>2008b</year>). <article-title>Steroid sulfatase and sulfuryl transferase activities in human brain tumors</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>109</volume>, <fpage>31</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsbmb.2007.12.004</pub-id><pub-id pub-id-type="pmid">18249534</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laatikainen</surname><given-names>T.</given-names></name><name><surname>Laitinen</surname><given-names>E. A.</given-names></name><name><surname>Vihko</surname><given-names>R.</given-names></name></person-group> (<year>1971</year>). <article-title>Secretion of free and sulfate-conjugated neutral steroids by the human testis. Effect of administration of human chorionic gonadotropin</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>32</volume>, <fpage>59</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1210/jcem-32-1-59</pub-id><pub-id pub-id-type="pmid">5539027</pub-id></mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labrie</surname><given-names>F.</given-names></name></person-group> (<year>1991</year>). <article-title>Intracrinology</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>78</volume>, <fpage>C113</fpage>–<lpage>C118</lpage>. <pub-id pub-id-type="doi">10.1016/0303-7207(91)90116-A</pub-id><pub-id pub-id-type="pmid">1838082</pub-id></mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labrie</surname><given-names>F.</given-names></name></person-group> (<year>2015</year>). <article-title>All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>145</volume>, <fpage>133</fpage>–<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsbmb.2014.06.001</pub-id><pub-id pub-id-type="pmid">24923731</pub-id></mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labrie</surname><given-names>F.</given-names></name><name><surname>Labrie</surname><given-names>C.</given-names></name></person-group> (<year>2013</year>). <article-title>DHEA and intracrinology at menopause, a positive choice for evolution of the human species</article-title>. <source/>Climacteric
<volume>16</volume>, <fpage>205</fpage>–<lpage>213</lpage>. <pub-id pub-id-type="doi">10.3109/13697137.2012.733983</pub-id><pub-id pub-id-type="pmid">23126249</pub-id></mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lane</surname><given-names>G.</given-names></name></person-group> (<year>1990</year>). <article-title>The histochemistry of isocitric and oestradiol-17 beta dehydrogenases in the endometrium of postmenopausal women treated with oestrogens and progestogens</article-title>. <source/>Histochem. J.
<volume>22</volume>, <fpage>45</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1007/BF01962878</pub-id><pub-id pub-id-type="pmid">2312347</pub-id></mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laplante</surname><given-names>Y.</given-names></name><name><surname>Rancourt</surname><given-names>C.</given-names></name><name><surname>Poirier</surname><given-names>D.</given-names></name></person-group> (<year>2009</year>). <article-title>Relative involvement of three 17β-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>301</volume>, <fpage>146</fpage>–<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2008.08.026</pub-id><pub-id pub-id-type="pmid">18812208</pub-id></mixed-citation>
</ref>
<ref id="B212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lavasani</surname><given-names>S.</given-names></name><name><surname>Chlebowski</surname><given-names>R. T.</given-names></name><name><surname>Prentice</surname><given-names>R. L.</given-names></name><name><surname>Kato</surname><given-names>I.</given-names></name><name><surname>Wactawski-Wende</surname><given-names>J.</given-names></name><name><surname>Johnson</surname><given-names>K. C.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Estrogen and colorectal cancer incidence and mortality</article-title>. <source/>Cancer
<volume>121</volume>, <fpage>3261</fpage>–<lpage>3271</lpage>. <pub-id pub-id-type="doi">10.1002/cncr.29464</pub-id><pub-id pub-id-type="pmid">26036212</pub-id></mixed-citation>
</ref>
<ref id="B213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>D. K.</given-names></name><name><surname>Kurihara</surname><given-names>I.</given-names></name><name><surname>Jeong</surname><given-names>J. W.</given-names></name><name><surname>Lydon</surname><given-names>J. P.</given-names></name><name><surname>DeMayo</surname><given-names>F. J.</given-names></name><name><surname>Tsai</surname><given-names>M. J.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Suppression of ERα activity by COUP-TFII is essential for successful implantation and decidualization</article-title>. <source/>Mol. Endocrinol.
<volume>24</volume>, <fpage>930</fpage>–<lpage>940</lpage>. <pub-id pub-id-type="doi">10.1210/me.2009-0531</pub-id><pub-id pub-id-type="pmid">20219888</pub-id></mixed-citation>
</ref>
<ref id="B214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lépine</surname><given-names>J.</given-names></name><name><surname>Audet-Walsh</surname><given-names>E.</given-names></name><name><surname>Gregoire</surname><given-names>J.</given-names></name><name><surname>Tetu</surname><given-names>B.</given-names></name><name><surname>Plante</surname><given-names>M.</given-names></name><name><surname>Menard</surname><given-names>V.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Circulating estrogens in endometrial cancer cases and their relationship with tissular expression of key estrogen biosynthesis and metabolic pathways</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>95</volume>, <fpage>2689</fpage>–<lpage>2698</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2010-2648</pub-id><pub-id pub-id-type="pmid">20371658</pub-id></mixed-citation>
</ref>
<ref id="B215">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Chen</surname><given-names>P.</given-names></name><name><surname>Palladino</surname><given-names>A.</given-names></name><name><surname>Narayan</surname><given-names>S.</given-names></name><name><surname>Russell</surname><given-names>L. K.</given-names></name><name><surname>Sayed</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Mechanism of hyperinsulinism in short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency involves activation of glutamate dehydrogenase</article-title>. <source/>J. Biol. Chem.
<volume>285</volume>, <fpage>31806</fpage>–<lpage>31818</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.123638</pub-id><pub-id pub-id-type="pmid">20670938</pub-id></mixed-citation>
</ref>
<ref id="B216">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Qin</surname><given-names>L.</given-names></name><name><surname>Xiao</surname><given-names>Z. J.</given-names></name><name><surname>Wang</surname><given-names>Y. L.</given-names></name><name><surname>Herva</surname><given-names>R.</given-names></name><name><surname>Leng</surname><given-names>J. H.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Expression of P450 aromatase and 17β-hydroxysteroid dehydrogenase type 1 at fetal-maternal interface during tubal pregnancy</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>87</volume>, <fpage>241</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsbmb.2003.09.013</pub-id><pub-id pub-id-type="pmid">14698204</pub-id></mixed-citation>
</ref>
<ref id="B217">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lilla</surname><given-names>C.</given-names></name><name><surname>Risch</surname><given-names>A.</given-names></name><name><surname>Verla-Tebit</surname><given-names>E.</given-names></name><name><surname>Hoffmeister</surname><given-names>M.</given-names></name><name><surname>Brenner</surname><given-names>H.</given-names></name><name><surname>Chang-Claude</surname><given-names>J.</given-names></name></person-group> (<year>2007</year>). <article-title>SULT1A1 genotype and susceptibility to colorectal cancer</article-title>. <source/>Int. J. Cancer
<volume>120</volume>, <fpage>201</fpage>–<lpage>206</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.22156</pub-id><pub-id pub-id-type="pmid">17013894</pub-id></mixed-citation>
</ref>
<ref id="B218">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lim</surname><given-names>Y. A.</given-names></name><name><surname>Grimm</surname><given-names>A.</given-names></name><name><surname>Giese</surname><given-names>M.</given-names></name><name><surname>Mensah-Nyagan</surname><given-names>A. G.</given-names></name><name><surname>Villafranca</surname><given-names>J. E.</given-names></name><name><surname>Ittner</surname><given-names>L. M.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Inhibition of the mitochondrial enzyme ABAD restores the amyloid-beta-mediated deregulation of estradiol</article-title>. <source/>PLoS ONE
<volume>6</volume>:<fpage>e28887</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0028887</pub-id><pub-id pub-id-type="pmid">22174920</pub-id></mixed-citation>
</ref>
<ref id="B219">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>H. K.</given-names></name><name><surname>Jez</surname><given-names>J. M.</given-names></name><name><surname>Schlegel</surname><given-names>B. P.</given-names></name><name><surname>Peehl</surname><given-names>D. M.</given-names></name><name><surname>Pachter</surname><given-names>J. A.</given-names></name><name><surname>Penning</surname><given-names>T. M.</given-names></name></person-group> (<year>1997</year>). <article-title>Expression and characterization of recombinant type 2, 3 α-hydroxysteroid dehydrogenase (HSD) from human prostate: demonstration of bifunctional 3α/17β-HSD activity and cellular distribution</article-title>. <source/>Mol. Endocrinol.
<volume>11</volume>, <fpage>1971</fpage>–<lpage>1984</lpage>.<pub-id pub-id-type="pmid">9415401</pub-id></mixed-citation>
</ref>
<ref id="B220">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindemann</surname><given-names>K.</given-names></name><name><surname>Malander</surname><given-names>S.</given-names></name><name><surname>Christensen</surname><given-names>R. D.</given-names></name><name><surname>Mirza</surname><given-names>M. R.</given-names></name><name><surname>Kristensen</surname><given-names>G. B.</given-names></name><name><surname>Aavall-Lundqvist</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Examestane in advanced or recurrent endometrial carcinoma: a prospective phase II study by the Nordic Society of Gynecologic Oncology (NSGO)</article-title>. <source/>BMC Cancer
<volume>14</volume>:<fpage>68</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2407-14-68</pub-id><pub-id pub-id-type="pmid">24498853</pub-id></mixed-citation>
</ref>
<ref id="B221">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Yao</surname><given-names>Z. X.</given-names></name><name><surname>Bendavid</surname><given-names>C.</given-names></name><name><surname>Borgmeyer</surname><given-names>C.</given-names></name><name><surname>Han</surname><given-names>Z.</given-names></name><name><surname>Cavalli</surname><given-names>L. R.</given-names></name><etal></etal></person-group> (<year>2005</year>). <article-title>Haploinsufficiency of cytochrome P450, 17β-hydroxylase/17,20 lyase (CYP17) causes infertility in male mice</article-title>. <source/>Mol. Endocrinol.
<volume>19</volume>, <fpage>2380</fpage>–<lpage>2389</lpage>. <pub-id pub-id-type="doi">10.1210/me.2004-0418</pub-id><pub-id pub-id-type="pmid">15890676</pub-id></mixed-citation>
</ref>
<ref id="B222">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lønning</surname><given-names>P. E.</given-names></name><name><surname>Eikesdal</surname><given-names>H. P.</given-names></name></person-group> (<year>2013</year>). <article-title>Aromatase inhibition 2013: clinical state of the art and questions that remain to be solved</article-title>. <source/>Endocr. Relat. Cancer
<volume>20</volume>, <fpage>R183</fpage>–<lpage>R201</lpage>. <pub-id pub-id-type="doi">10.1530/ERC-13-0099</pub-id><pub-id pub-id-type="pmid">23625614</pub-id></mixed-citation>
</ref>
<ref id="B223">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>López</surname><given-names>M.</given-names></name><name><surname>Tena-Sempere</surname><given-names>M.</given-names></name></person-group> (<year>2015</year>). <article-title>Estrogens and the control of energy homeostasis: a brain perspective</article-title>. <source/>Trends Endocrinol. Metab.
<volume>26</volume>, <fpage>411</fpage>–<lpage>421</lpage>. <pub-id pub-id-type="doi">10.1016/j.tem.2015.06.003</pub-id><pub-id pub-id-type="pmid">26126705</pub-id></mixed-citation>
</ref>
<ref id="B224">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>López</surname><given-names>M.</given-names></name><name><surname>Tena-Sempere</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Estradiol and brown fat</article-title>. <source/>Best Pract. Res. Clin. Endocrinol. Metab.
<volume>30</volume>, <fpage>527</fpage>–<lpage>536</lpage>. <pub-id pub-id-type="doi">10.1016/j.beem.2016.08.004</pub-id><pub-id pub-id-type="pmid">27697213</pub-id></mixed-citation>
</ref>
<ref id="B225">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loria</surname><given-names>R. M.</given-names></name><name><surname>Graf</surname><given-names>M. R.</given-names></name></person-group> (<year>2012</year>). <article-title>17α-androstenediol-mediated oncophagy of tumor cells by different mechanisms is determined by the target tumor</article-title>. <source/>Ann. N. Y. Acad. Sci.
<volume>1262</volume>, <fpage>127</fpage>–<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.2012.06602.x</pub-id><pub-id pub-id-type="pmid">22823444</pub-id></mixed-citation>
</ref>
<ref id="B226">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loriot</surname><given-names>Y.</given-names></name><name><surname>Fizazi</surname><given-names>K.</given-names></name><name><surname>Jones</surname><given-names>R. J.</given-names></name><name><surname>Van den Brande</surname><given-names>J.</given-names></name><name><surname>Molife</surname><given-names>R. L.</given-names></name><name><surname>Omlin</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Safety, tolerability and anti-tumour activity of the androgen biosynthesis inhibitor ASP9521 in patients with metastatic castration-resistant prostate cancer: multi-centre phase I/II study</article-title>. <source/>Invest. New Drugs
<volume>32</volume>, <fpage>995</fpage>–<lpage>1004</lpage>. <pub-id pub-id-type="doi">10.1007/s10637-014-0101-x</pub-id><pub-id pub-id-type="pmid">24771350</pub-id></mixed-citation>
</ref>
<ref id="B227">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loth</surname><given-names>D. W.</given-names></name><name><surname>Soler Artigas</surname><given-names>M.</given-names></name><name><surname>Gharib</surname><given-names>S. A.</given-names></name><name><surname>Wain</surname><given-names>L. V.</given-names></name><name><surname>Franceschini</surname><given-names>N.</given-names></name><name><surname>Koch</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Genome-wide association analysis identifies six new loci associated with forced vital capacity</article-title>. <source/>Nat. Genet.
<volume>46</volume>, <fpage>669</fpage>–<lpage>677</lpage>. <pub-id pub-id-type="doi">10.1038/ng.3011</pub-id><pub-id pub-id-type="pmid">24929828</pub-id></mixed-citation>
</ref>
<ref id="B228">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loza</surname><given-names>M. C.</given-names></name></person-group> (<year>1995</year>). <article-title>Hydrolysis of estrone sulfate in uterine minces of the 6-days pregnant rat</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>52</volume>, <fpage>277</fpage>–<lpage>280</lpage>. <pub-id pub-id-type="doi">10.1016/0960-0760(94)00177-N</pub-id><pub-id pub-id-type="pmid">7696149</pub-id></mixed-citation>
</ref>
<ref id="B229">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>C.</given-names></name><name><surname>Lee</surname><given-names>H. S.</given-names></name><name><surname>Pappas</surname><given-names>G. P.</given-names></name><name><surname>Dilling</surname><given-names>D. F.</given-names></name><name><surname>Burger</surname><given-names>C. D.</given-names></name><name><surname>Shifren</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>A Phase II Clinical Trial of an Aromatase Inhibitor for Postmenopausal Women with Lymphangioleiomyomatosis</article-title>. <source/>Ann. Am. Thorac. Soc.
<volume>14</volume>, <fpage>919</fpage>–<lpage>928</lpage>. <pub-id pub-id-type="doi">10.1513/AnnalsATS.201610-824OC</pub-id><pub-id pub-id-type="pmid">28570161</pub-id></mixed-citation>
</ref>
<ref id="B230">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luchetti</surname><given-names>S.</given-names></name><name><surname>Bossers</surname><given-names>K.</given-names></name><name><surname>Van de Bilt</surname><given-names>S.</given-names></name><name><surname>Agrapart</surname><given-names>V.</given-names></name><name><surname>Morales</surname><given-names>R. R.</given-names></name><name><surname>Frajese</surname><given-names>G. V.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Neurosteroid biosynthetic pathways changes in prefrontal cortex in Alzheimer's disease</article-title>. <source/>Neurobiol. Aging
<volume>32</volume>, <fpage>1964</fpage>–<lpage>1976</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2009.12.014</pub-id><pub-id pub-id-type="pmid">20045216</pub-id></mixed-citation>
</ref>
<ref id="B231">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lundin</surname><given-names>E.</given-names></name><name><surname>Wirgin</surname><given-names>I.</given-names></name><name><surname>Lukanova</surname><given-names>A.</given-names></name><name><surname>Afanasyeva</surname><given-names>Y.</given-names></name><name><surname>Krogh</surname><given-names>V.</given-names></name><name><surname>Axelsson</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer</article-title>. <source/>Cancer Epidemiol.
<volume>36</volume>, <fpage>445</fpage>–<lpage>452</lpage>. <pub-id pub-id-type="doi">10.1016/j.canep.2012.04.006</pub-id><pub-id pub-id-type="pmid">22633539</pub-id></mixed-citation>
</ref>
<ref id="B232">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luo</surname><given-names>L.</given-names></name><name><surname>Deng</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>D. X.</given-names></name><name><surname>He</surname><given-names>J.</given-names></name><name><surname>Deng</surname><given-names>W.</given-names></name></person-group> (<year>2015</year>). <article-title>Regulation of epithelial sodium channel expression by oestradiol and progestogen in alveolar epithelial cells</article-title>. <source/>Respir. Physiol. Neurobiol.
<volume>216</volume>, <fpage>52</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.resp.2015.06.001</pub-id><pub-id pub-id-type="pmid">26051998</pub-id></mixed-citation>
</ref>
<ref id="B233">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luu-The</surname><given-names>V.</given-names></name><name><surname>Belanger</surname><given-names>A.</given-names></name><name><surname>Labrie</surname><given-names>F.</given-names></name></person-group> (<year>2008</year>). <article-title>Androgen biosynthetic pathways in the human prostate</article-title>. <source/>Best Pract. Res. Clin. Endocrinol. Metab.
<volume>22</volume>, <fpage>207</fpage>–<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1016/j.beem.2008.01.008</pub-id><pub-id pub-id-type="pmid">18471780</pub-id></mixed-citation>
</ref>
<ref id="B234">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luu-The</surname><given-names>V.</given-names></name><name><surname>Labrie</surname><given-names>F.</given-names></name></person-group> (<year>2010</year>). <article-title>The intracrine sex steroid biosynthesis pathways</article-title>. <source/>Prog. Brain Res.
<volume>181</volume>, <fpage>177</fpage>–<lpage>192</lpage>. <pub-id pub-id-type="doi">10.1016/S0079-6123(08)81010-2</pub-id><pub-id pub-id-type="pmid">20478438</pub-id></mixed-citation>
</ref>
<ref id="B235">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>B. B.</given-names></name><name><surname>Oza</surname><given-names>A.</given-names></name><name><surname>Eisenhauer</surname><given-names>E.</given-names></name><name><surname>Stanimir</surname><given-names>G.</given-names></name><name><surname>Carey</surname><given-names>M.</given-names></name><name><surname>Chapman</surname><given-names>W.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers–a study of the National Cancer Institute of Canada Clinical Trials Group</article-title>. <source/>Int. J. Gynecol. Cancer
<volume>14</volume>, <fpage>650</fpage>–<lpage>658</lpage>. <pub-id pub-id-type="doi">10.1111/j.1048-891X.2004.14419.x</pub-id><pub-id pub-id-type="pmid">15304161</pub-id></mixed-citation>
</ref>
<ref id="B236">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>W. G.</given-names></name><name><surname>Song</surname><given-names>H.</given-names></name><name><surname>Das</surname><given-names>S. K.</given-names></name><name><surname>Paria</surname><given-names>B. C.</given-names></name><name><surname>Dey</surname><given-names>S. K.</given-names></name></person-group> (<year>2003</year>). <article-title>Estrogen is a critical determinant that specifies the duration of the window of uterine receptivity for implantation</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>100</volume>, <fpage>2963</fpage>–<lpage>2968</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0530162100</pub-id><pub-id pub-id-type="pmid">12601161</pub-id></mixed-citation>
</ref>
<ref id="B237">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacKenzie</surname><given-names>S. M.</given-names></name><name><surname>Dewar</surname><given-names>D.</given-names></name><name><surname>Stewart</surname><given-names>W.</given-names></name><name><surname>Fraser</surname><given-names>R.</given-names></name><name><surname>Connell</surname><given-names>J. M.</given-names></name><name><surname>Davies</surname><given-names>E.</given-names></name></person-group> (<year>2008</year>). <article-title>The transcription of steroidogenic genes in the human cerebellum and hippocampus: a comparative survey of normal and Alzheimer's tissue</article-title>. <source/>J. Endocrinol.
<volume>196</volume>, <fpage>123</fpage>–<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1677/JOE-07-0427</pub-id><pub-id pub-id-type="pmid">18180323</pub-id></mixed-citation>
</ref>
<ref id="B238">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maentausta</surname><given-names>O.</given-names></name><name><surname>Peltoketo</surname><given-names>H.</given-names></name><name><surname>Isomaa</surname><given-names>V.</given-names></name><name><surname>Jouppila</surname><given-names>P.</given-names></name><name><surname>Vihko</surname><given-names>R.</given-names></name></person-group> (<year>1990</year>). <article-title>Immunological measurement of human 17β-hydroxysteroid dehydrogenase</article-title>. <source/>J. Steroid. Biochem. <volume>36</volume>, <fpage>673</fpage>–<lpage>680</lpage>.<pub-id pub-id-type="pmid">2170769</pub-id></mixed-citation>
</ref>
<ref id="B239">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mäentausta</surname><given-names>O.</given-names></name><name><surname>Sormunen</surname><given-names>R.</given-names></name><name><surname>Isomaa</surname><given-names>V.</given-names></name><name><surname>Lehto</surname><given-names>V. P.</given-names></name><name><surname>Jouppila</surname><given-names>P.</given-names></name><name><surname>Vihko</surname><given-names>R.</given-names></name></person-group> (<year>1991</year>). <article-title>Immunohistochemical localization of 17 beta-hydroxysteroid dehydrogenase in the human endometrium during the menstrual cycle</article-title>. <source/>Lab. Invest.
<volume>65</volume>, <fpage>582</fpage>–<lpage>587</lpage>.<pub-id pub-id-type="pmid">1721669</pub-id></mixed-citation>
</ref>
<ref id="B240">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahendroo</surname><given-names>M. S.</given-names></name><name><surname>Cala</surname><given-names>K. M.</given-names></name><name><surname>Hess</surname><given-names>D. L.</given-names></name><name><surname>Russell</surname><given-names>D. W.</given-names></name></person-group> (<year>2001</year>). <article-title>Unexpected virilization in male mice lacking steroid 5 alpha-reductase enzymes</article-title>. <source/>Endocrinology
<volume>142</volume>, <fpage>4652</fpage>–<lpage>4662</lpage>. <pub-id pub-id-type="doi">10.1210/endo.142.11.8510</pub-id><pub-id pub-id-type="pmid">11606430</pub-id></mixed-citation>
</ref>
<ref id="B241">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahendroo</surname><given-names>M. S.</given-names></name><name><surname>Cala</surname><given-names>K. M.</given-names></name><name><surname>Russell</surname><given-names>D. W.</given-names></name></person-group> (<year>1996</year>). <article-title>5 alpha-reduced androgens play a key role in murine parturition</article-title>. <source/>Mol. Endocrinol.
<volume>10</volume>, <fpage>380</fpage>–<lpage>392</lpage>.<pub-id pub-id-type="pmid">8721983</pub-id></mixed-citation>
</ref>
<ref id="B242">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maia</surname><given-names>H.</given-names><suffix>Jr.</suffix></name><name><surname>Pimentel</surname><given-names>K.</given-names></name><name><surname>Casoy</surname><given-names>J.</given-names></name><name><surname>Correia</surname><given-names>T.</given-names></name><name><surname>Freitas</surname><given-names>L. A.</given-names></name><name><surname>Zausner</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Aromatase expression in the eutopic endometrium of myomatous uteri: the influence of the menstrual cycle and oral contraceptive use</article-title>. <source/>Gynecol. Endocrinol.
<volume>23</volume>, <fpage>320</fpage>–<lpage>324</lpage>. <pub-id pub-id-type="doi">10.1080/09513590701321565</pub-id><pub-id pub-id-type="pmid">17616855</pub-id></mixed-citation>
</ref>
<ref id="B243">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maia</surname><given-names>H.</given-names><suffix>Jr.</suffix></name><name><surname>Pimentel</surname><given-names>K.</given-names></name><name><surname>Silva</surname><given-names>T. M.</given-names></name><name><surname>Freitas</surname><given-names>L. A.</given-names></name><name><surname>Zausner</surname><given-names>B.</given-names></name><name><surname>Athayde</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Aromatase and cyclooxygenase-2 expression in endometrial polyps during the menstrual cycle</article-title>. <source/>Gynecol. Endocrinol.
<volume>22</volume>, <fpage>219</fpage>–<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1080/09513590600585955</pub-id><pub-id pub-id-type="pmid">16723309</pub-id></mixed-citation>
</ref>
<ref id="B244">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maltais</surname><given-names>R.</given-names></name><name><surname>Poirier</surname><given-names>D.</given-names></name></person-group> (<year>2011</year>). <article-title>Steroid sulfatase inhibitors: a review covering the promising 2000-2010 decade</article-title>. <source/>Steroids
<volume>76</volume>, <fpage>929</fpage>–<lpage>948</lpage>. <pub-id pub-id-type="doi">10.1016/j.steroids.2011.03.010</pub-id><pub-id pub-id-type="pmid">21458474</pub-id></mixed-citation>
</ref>
<ref id="B245">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manenda</surname><given-names>M. S.</given-names></name><name><surname>Hamel</surname><given-names>C. J.</given-names></name><name><surname>Masselot-Joubert</surname><given-names>L.</given-names></name><name><surname>Picard</surname><given-names>M. E.</given-names></name><name><surname>Shi</surname><given-names>R.</given-names></name></person-group> (<year>2016</year>). <article-title>Androgen-metabolizing enzymes: A structural perspective</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>161</volume>, <fpage>54</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsbmb.2016.02.021</pub-id><pub-id pub-id-type="pmid">26924584</pub-id></mixed-citation>
</ref>
<ref id="B246">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marchais-Oberwinkler</surname><given-names>S.</given-names></name><name><surname>Wetzel</surname><given-names>M.</given-names></name><name><surname>Ziegler</surname><given-names>E.</given-names></name><name><surname>Kruchten</surname><given-names>P.</given-names></name><name><surname>Werth</surname><given-names>R.</given-names></name><name><surname>Henn</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>New drug-like hydroxyphenylnaphthol steroidomimetics as potent and selective 17β-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of estrogen-dependent diseases</article-title>. <source/>J. Med. Chem.
<volume>54</volume>, <fpage>534</fpage>–<lpage>547</lpage>. <pub-id pub-id-type="doi">10.1021/jm1009082</pub-id><pub-id pub-id-type="pmid">21189020</pub-id></mixed-citation>
</ref>
<ref id="B247">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Masi</surname><given-names>L.</given-names></name><name><surname>Becherini</surname><given-names>L.</given-names></name><name><surname>Gennari</surname><given-names>L.</given-names></name><name><surname>Amedei</surname><given-names>A.</given-names></name><name><surname>Colli</surname><given-names>E.</given-names></name><name><surname>Falchetti</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Polymorphism of the aromatase gene in postmenopausal Italian women: distribution and correlation with bone mass and fracture risk</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>86</volume>, <fpage>2263</fpage>–<lpage>2269</lpage>. <pub-id pub-id-type="doi">10.1210/jc.86.5.2263</pub-id><pub-id pub-id-type="pmid">11344237</pub-id></mixed-citation>
</ref>
<ref id="B248">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsunaga</surname><given-names>T.</given-names></name><name><surname>Hojo</surname><given-names>A.</given-names></name><name><surname>Yamane</surname><given-names>Y.</given-names></name><name><surname>Endo</surname><given-names>S.</given-names></name><name><surname>El-Kabbani</surname><given-names>O.</given-names></name><name><surname>Hara</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Pathophysiological roles of aldo-keto reductases (AKR1C1 and AKR1C3) in development of cisplatin resistance in human colon cancers</article-title>. <source/>Chem. Biol. Interact.
<volume>202</volume>, <fpage>234</fpage>–<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbi.2012.09.024</pub-id><pub-id pub-id-type="pmid">23165153</pub-id></mixed-citation>
</ref>
<ref id="B249">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuzaki</surname><given-names>S.</given-names></name><name><surname>Canis</surname><given-names>M.</given-names></name><name><surname>Pouly</surname><given-names>J. L.</given-names></name><name><surname>Dechelotte</surname><given-names>P. J.</given-names></name><name><surname>Mage</surname><given-names>G.</given-names></name></person-group> (<year>2006</year>). <article-title>Analysis of aromatase and 17β-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression in deep endometriosis and eutopic endometrium using laser capture microdissection</article-title>. <source/>Fertil. Steril.
<volume>85</volume>, <fpage>308</fpage>–<lpage>313</lpage>. <pub-id pub-id-type="doi">10.1016/j.fertnstert.2005.08.017</pub-id><pub-id pub-id-type="pmid">16595205</pub-id></mixed-citation>
</ref>
<ref id="B250">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mauvais-Jarvis</surname><given-names>F.</given-names></name><name><surname>Clegg</surname><given-names>D. J.</given-names></name><name><surname>Hevener</surname><given-names>A. L.</given-names></name></person-group> (<year>2013</year>). <article-title>The role of estrogens in control of energy balance and glucose homeostasis</article-title>. <source/>Endocr. Rev.
<volume>34</volume>, <fpage>309</fpage>–<lpage>338</lpage>. <pub-id pub-id-type="doi">10.1210/er.2012-1055</pub-id><pub-id pub-id-type="pmid">23460719</pub-id></mixed-citation>
</ref>
<ref id="B251">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCarthy</surname><given-names>M.</given-names></name></person-group> (<year>2000</year>). <article-title>The “gender gap” in autoimmune disease</article-title>. <source/>Lancet
<volume>356</volume>, <fpage>1088</fpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(05)74535-9</pub-id><pub-id pub-id-type="pmid">11009154</pub-id></mixed-citation>
</ref>
<ref id="B252">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McEwen</surname><given-names>B. S.</given-names></name><name><surname>Milner</surname><given-names>T. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Understanding the broad influence of sex hormones and sex differences in the brain</article-title>. <source/>J. Neurosci. Res.
<volume>95</volume>, <fpage>24</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.23809</pub-id><pub-id pub-id-type="pmid">27870427</pub-id></mixed-citation>
</ref>
<ref id="B253">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meijer</surname><given-names>D.</given-names></name><name><surname>Gelderblom</surname><given-names>H.</given-names></name><name><surname>Karperien</surname><given-names>M.</given-names></name><name><surname>Cleton-Jansen</surname><given-names>A. M.</given-names></name><name><surname>Hogendoorn</surname><given-names>P. C.</given-names></name><name><surname>Bovee</surname><given-names>J. V.</given-names></name></person-group> (<year>2011</year>). <article-title>Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both <italic>in vitro</italic> and <italic>in vivo</italic></article-title>. <source/>Clin. Sarcoma Res.
<volume>1</volume>:<fpage>5</fpage>. <pub-id pub-id-type="doi">10.1186/2045-3329-1-5</pub-id><pub-id pub-id-type="pmid">22613849</pub-id></mixed-citation>
</ref>
<ref id="B254">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meloche</surname><given-names>C. A.</given-names></name><name><surname>Falany</surname><given-names>C. N.</given-names></name></person-group> (<year>2001</year>). <article-title>Expression and characterization of the human 3 beta-hydroxysteroid sulfotransferases (SULT2B1a and SULT2B1b)</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>77</volume>, <fpage>261</fpage>–<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1016/S0960-0760(01)00064-4</pub-id><pub-id pub-id-type="pmid">11457664</pub-id></mixed-citation>
</ref>
<ref id="B255">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miki</surname><given-names>Y.</given-names></name><name><surname>Nakata</surname><given-names>T.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Darnel</surname><given-names>A. D.</given-names></name><name><surname>Moriya</surname><given-names>T.</given-names></name><name><surname>Kaneko</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Systemic distribution of steroid sulfatase and estrogen sulfotransferase in human adult and fetal tissues</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>87</volume>, <fpage>5760</fpage>–<lpage>5768</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2002-020670</pub-id><pub-id pub-id-type="pmid">12466383</pub-id></mixed-citation>
</ref>
<ref id="B256">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Milewich</surname><given-names>L.</given-names></name><name><surname>Garcia</surname><given-names>R. L.</given-names></name><name><surname>Johnson</surname><given-names>A. R.</given-names></name></person-group> (<year>1983</year>). <article-title>Steroid sulfatase activity in human lung tissue and in endothelial pulmonary cells in culture</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>57</volume>, <fpage>8</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1210/jcem-57-1-8</pub-id><pub-id pub-id-type="pmid">6222060</pub-id></mixed-citation>
</ref>
<ref id="B257">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>P. B.</given-names></name><name><surname>Parnell</surname><given-names>B. A.</given-names></name><name><surname>Bushnell</surname><given-names>G.</given-names></name><name><surname>Tallman</surname><given-names>N.</given-names></name><name><surname>Forstein</surname><given-names>D. A.</given-names></name><name><surname>Higdon</surname><given-names>H. L</given-names><suffix>III.</suffix></name><etal></etal></person-group>. (<year>2012a</year>). <article-title>Endometrial receptivity defects during IVF cycles with and without letrozole</article-title>. <source/>Hum. Reprod.
<volume>27</volume>, <fpage>881</fpage>–<lpage>888</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/der452</pub-id><pub-id pub-id-type="pmid">22246449</pub-id></mixed-citation>
</ref>
<ref id="B258">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>V. L.</given-names></name><name><surname>Lin</surname><given-names>H. K.</given-names></name><name><surname>Murugan</surname><given-names>P.</given-names></name><name><surname>Fan</surname><given-names>M.</given-names></name><name><surname>Penning</surname><given-names>T. M.</given-names></name><name><surname>Brame</surname><given-names>L. S.</given-names></name><etal></etal></person-group> (<year>2012b</year>). <article-title>Aldo-keto reductase family 1 member C3 (AKR1C3) is expressed in adenocarcinoma and squamous cell carcinoma but not small cell carcinoma</article-title>. <source/>Int. J. Clin. Exp. Pathol.
<volume>5</volume>, <fpage>278</fpage>–<lpage>289</lpage>.<pub-id pub-id-type="pmid">22670171</pub-id></mixed-citation>
</ref>
<ref id="B259">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>W. L.</given-names></name><name><surname>Auchus</surname><given-names>R. J.</given-names></name></person-group> (<year>2011</year>). <article-title>The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders</article-title>. <source/>Endocr. Rev.
<volume>32</volume>, <fpage>81</fpage>–<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1210/er.2010-0013</pub-id><pub-id pub-id-type="pmid">21051590</pub-id></mixed-citation>
</ref>
<ref id="B260">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mindnich</surname><given-names>R.</given-names></name><name><surname>Moller</surname><given-names>G.</given-names></name><name><surname>Adamski</surname><given-names>J.</given-names></name></person-group> (<year>2004</year>). <article-title>The role of 17 beta-hydroxysteroid dehydrogenases</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>218</volume>, <fpage>7</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2003.12.006</pub-id><pub-id pub-id-type="pmid">15130507</pub-id></mixed-citation>
</ref>
<ref id="B261">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyaura</surname><given-names>C.</given-names></name><name><surname>Toda</surname><given-names>K.</given-names></name><name><surname>Inada</surname><given-names>M.</given-names></name><name><surname>Ohshiba</surname><given-names>T.</given-names></name><name><surname>Matsumoto</surname><given-names>C.</given-names></name><name><surname>Okada</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Sex- and age-related response to aromatase deficiency in bone</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>280</volume>, <fpage>1062</fpage>–<lpage>1068</lpage>. <pub-id pub-id-type="doi">10.1006/bbrc.2001.4246</pub-id><pub-id pub-id-type="pmid">11162635</pub-id></mixed-citation>
</ref>
<ref id="B262">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moeller</surname><given-names>G.</given-names></name><name><surname>Adamski</surname><given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>Multifunctionality of human 17β-hydroxysteroid dehydrogenases</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>248</volume>, <fpage>47</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2005.11.031</pub-id><pub-id pub-id-type="pmid">16413960</pub-id></mixed-citation>
</ref>
<ref id="B263">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moeller</surname><given-names>G.</given-names></name><name><surname>Adamski</surname><given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>Integrated view on 17β-hydroxysteroid dehydrogenases</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>301</volume>, <fpage>7</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2008.10.040</pub-id><pub-id pub-id-type="pmid">19027824</pub-id></mixed-citation>
</ref>
<ref id="B264">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Möller</surname><given-names>G.</given-names></name><name><surname>Leenders</surname><given-names>F.</given-names></name><name><surname>van Grunsven</surname><given-names>E. G.</given-names></name><name><surname>Dolez</surname><given-names>V.</given-names></name><name><surname>Qualmann</surname><given-names>B.</given-names></name><name><surname>Kessels</surname><given-names>M. M.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>Characterization of the HSD17B4 gene: D-specific multifunctional protein 2/17β-hydroxysteroid dehydrogenase IV</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>69</volume>, <fpage>441</fpage>–<lpage>446</lpage>. <pub-id pub-id-type="doi">10.1016/S0960-0760(99)00066-7</pub-id><pub-id pub-id-type="pmid">10419023</pub-id></mixed-citation>
</ref>
<ref id="B265">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgat</surname><given-names>A.</given-names></name><name><surname>Axelsen</surname><given-names>K. B.</given-names></name><name><surname>Lombardot</surname><given-names>T.</given-names></name><name><surname>Alcantara</surname><given-names>R.</given-names></name><name><surname>Aimo</surname><given-names>L.</given-names></name><name><surname>Zerara</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Updates in Rhea–a manually curated resource of biochemical reactions</article-title>. <source/>Nucleic Acids Res.
<volume>43</volume>, <fpage>D459</fpage>–<lpage>D464</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gku961</pub-id><pub-id pub-id-type="pmid">25332395</pub-id></mixed-citation>
</ref>
<ref id="B266">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>T.</given-names></name><name><surname>Ito</surname><given-names>F.</given-names></name><name><surname>Matsushima</surname><given-names>H.</given-names></name><name><surname>Takaoka</surname><given-names>O.</given-names></name><name><surname>Koshiba</surname><given-names>A.</given-names></name><name><surname>Tanaka</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Dienogest reduces HSD17β1 expression and activity in endometriosis</article-title>. <source/>J. Endocrinol.
<volume>225</volume>, <fpage>69</fpage>–<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1530/JOE-15-0052</pub-id><pub-id pub-id-type="pmid">25767055</pub-id></mixed-citation>
</ref>
<ref id="B267">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morice</surname><given-names>P.</given-names></name><name><surname>Leary</surname><given-names>A.</given-names></name><name><surname>Creutzberg</surname><given-names>C.</given-names></name><name><surname>Abu-Rustum</surname><given-names>N.</given-names></name><name><surname>Darai</surname><given-names>E.</given-names></name></person-group> (<year>2015</year>). <article-title>Endometrial cancer</article-title>. <source/>Lancet
<volume>387</volume>, <fpage>1094</fpage>–<lpage>1108</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(15)00130-0</pub-id><pub-id pub-id-type="pmid">26354523</pub-id></mixed-citation>
</ref>
<ref id="B268">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morishima</surname><given-names>A.</given-names></name><name><surname>Grumbach</surname><given-names>M. M.</given-names></name><name><surname>Simpson</surname><given-names>E. R.</given-names></name><name><surname>Fisher</surname><given-names>C.</given-names></name><name><surname>Qin</surname><given-names>K.</given-names></name></person-group> (<year>1995</year>). <article-title>Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>80</volume>, <fpage>3689</fpage>–<lpage>3698</lpage>.<pub-id pub-id-type="pmid">8530621</pub-id></mixed-citation>
</ref>
<ref id="B269">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>J. W.</given-names></name><name><surname>Gilligan</surname><given-names>L. C.</given-names></name><name><surname>Idkowiak</surname><given-names>J.</given-names></name><name><surname>Arlt</surname><given-names>W.</given-names></name><name><surname>Foster</surname><given-names>P. A.</given-names></name></person-group> (<year>2015</year>). <article-title>The regulation of steroid action by sulfation and desulfation</article-title>. <source/>Endocr. Rev.
<volume>36</volume>, <fpage>526</fpage>–<lpage>563</lpage>. <pub-id pub-id-type="doi">10.1210/er.2015-1036</pub-id><pub-id pub-id-type="pmid">26213785</pub-id></mixed-citation>
</ref>
<ref id="B270">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muir</surname><given-names>M.</given-names></name><name><surname>Romalo</surname><given-names>G.</given-names></name><name><surname>Wolf</surname><given-names>L.</given-names></name><name><surname>Elger</surname><given-names>W.</given-names></name><name><surname>Schweikert</surname><given-names>H. U.</given-names></name></person-group> (<year>2004</year>). <article-title>Estrone sulfate is a major source of local estrogen formation in human bone</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>89</volume>, <fpage>4685</fpage>–<lpage>4692</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2004-0049</pub-id><pub-id pub-id-type="pmid">15356081</pub-id></mixed-citation>
</ref>
<ref id="B271">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukai</surname><given-names>H.</given-names></name><name><surname>Tsurugizawa</surname><given-names>T.</given-names></name><name><surname>Ogiue-Ikeda</surname><given-names>M.</given-names></name><name><surname>Murakami</surname><given-names>G.</given-names></name><name><surname>Hojo</surname><given-names>Y.</given-names></name><name><surname>Ishii</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Local neurosteroid production in the hippocampus: influence on synaptic plasticity of memory</article-title>. <source/>Neuroendocrinology
<volume>84</volume>, <fpage>255</fpage>–<lpage>263</lpage>. <pub-id pub-id-type="doi">10.1159/000097747</pub-id><pub-id pub-id-type="pmid">17142999</pub-id></mixed-citation>
</ref>
<ref id="B272">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullis</surname><given-names>P. E.</given-names></name><name><surname>Yoshimura</surname><given-names>N.</given-names></name><name><surname>Kuhlmann</surname><given-names>B.</given-names></name><name><surname>Lippuner</surname><given-names>K.</given-names></name><name><surname>Jaeger</surname><given-names>P.</given-names></name><name><surname>Harada</surname><given-names>H.</given-names></name></person-group> (<year>1997</year>). <article-title>Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the P450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>82</volume>, <fpage>1739</fpage>–<lpage>1745</lpage>. <pub-id pub-id-type="doi">10.1210/jc.82.6.1739</pub-id><pub-id pub-id-type="pmid">9177373</pub-id></mixed-citation>
</ref>
<ref id="B273">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munroe</surname><given-names>D. G.</given-names></name><name><surname>Chang</surname><given-names>P. L.</given-names></name></person-group> (<year>1987</year>). <article-title>Tissue-specific expression of human arylsulfatase-C isozymes and steroid sulfatase</article-title>. <source/>Am. J. Hum. Genet.
<volume>40</volume>, <fpage>102</fpage>–<lpage>114</lpage>.<pub-id pub-id-type="pmid">3471087</pub-id></mixed-citation>
</ref>
<ref id="B274">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murakami</surname><given-names>G.</given-names></name><name><surname>Tanabe</surname><given-names>N.</given-names></name><name><surname>Ishii</surname><given-names>H. T.</given-names></name><name><surname>Ogiue-Ikeda</surname><given-names>M.</given-names></name><name><surname>Tsurugizawa</surname><given-names>T.</given-names></name><name><surname>Mukai</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Role of cytochrome p450 in synaptocrinology: endogenous estrogen synthesis in the brain hippocampus</article-title>. <source/>Drug Metab. Rev.
<volume>38</volume>, <fpage>353</fpage>–<lpage>369</lpage>. <pub-id pub-id-type="doi">10.1080/03602530600724068</pub-id><pub-id pub-id-type="pmid">16877257</pub-id></mixed-citation>
</ref>
<ref id="B275">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musatov</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Pfaff</surname><given-names>D. W.</given-names></name><name><surname>Mobbs</surname><given-names>C. V.</given-names></name><name><surname>Yang</surname><given-names>X. J.</given-names></name><name><surname>Clegg</surname><given-names>D. J.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>104</volume>, <fpage>2501</fpage>–<lpage>2506</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0610787104</pub-id><pub-id pub-id-type="pmid">17284595</pub-id></mixed-citation>
</ref>
<ref id="B276">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nadal</surname><given-names>A.</given-names></name><name><surname>Alonso-Magdalena</surname><given-names>P.</given-names></name><name><surname>Soriano</surname><given-names>S.</given-names></name><name><surname>Ripoll</surname><given-names>C.</given-names></name><name><surname>Fuentes</surname><given-names>E.</given-names></name><name><surname>Quesada</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Role of estrogen receptors alpha, beta and GPER1/GPR30 in pancreatic beta-cells</article-title>. <source/>Front Biosci (Landmark Ed)
<volume>16</volume>, <fpage>251</fpage>–<lpage>260</lpage>. <pub-id pub-id-type="doi">10.2741/3686</pub-id><pub-id pub-id-type="pmid">21196169</pub-id></mixed-citation>
</ref>
<ref id="B277">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naftolin</surname><given-names>F.</given-names></name><name><surname>Horvath</surname><given-names>T. L.</given-names></name><name><surname>Jakab</surname><given-names>R. L.</given-names></name><name><surname>Leranth</surname><given-names>C.</given-names></name><name><surname>Harada</surname><given-names>N.</given-names></name><name><surname>Balthazart</surname><given-names>J.</given-names></name></person-group> (<year>1996</year>). <article-title>Aromatase immunoreactivity in axon terminals of the vertebrate brain. An immunocytochemical study on quail, rat, monkey and human tissues</article-title>. <source/>Neuroendocrinology
<volume>63</volume>, <fpage>149</fpage>–<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1159/000126951</pub-id><pub-id pub-id-type="pmid">9053779</pub-id></mixed-citation>
</ref>
<ref id="B278">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naftolin</surname><given-names>F.</given-names></name><name><surname>MacLusky</surname><given-names>N. J.</given-names></name></person-group> (<year>1982</year>). <article-title>Aromatase in the central nervous system</article-title>. <source/>Cancer Res
<volume>42</volume>, <fpage>3274s</fpage>–<lpage>3276s</lpage>. <pub-id pub-id-type="pmid">7083185</pub-id></mixed-citation>
</ref>
<ref id="B279">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakarai</surname><given-names>C.</given-names></name><name><surname>Osawa</surname><given-names>K.</given-names></name><name><surname>Akiyama</surname><given-names>M.</given-names></name><name><surname>Matsubara</surname><given-names>N.</given-names></name><name><surname>Ikeuchi</surname><given-names>H.</given-names></name><name><surname>Yamano</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Expression of AKR1C3 and CNN3 as markers for detection of lymph node metastases in colorectal cancer</article-title>. <source/>Clin. Exp. Med.
<volume>15</volume>, <fpage>333</fpage>–<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1007/s10238-014-0298-1</pub-id><pub-id pub-id-type="pmid">24934327</pub-id></mixed-citation>
</ref>
<ref id="B280">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nayeb-Hashemi</surname><given-names>H.</given-names></name><name><surname>Kaunitz</surname><given-names>J. D.</given-names></name></person-group> (<year>2009</year>). <article-title>Gastroduodenal mucosal defense</article-title>. <source/>Curr. Opin. Gastroenterol.
<volume>25</volume>, <fpage>537</fpage>–<lpage>543</lpage>. <pub-id pub-id-type="doi">10.1097/MOG.0b013e328330da7b</pub-id><pub-id pub-id-type="pmid">19654540</pub-id></mixed-citation>
</ref>
<ref id="B281">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nemoto</surname><given-names>Y.</given-names></name><name><surname>Toda</surname><given-names>K.</given-names></name><name><surname>Ono</surname><given-names>M.</given-names></name><name><surname>Fujikawa-Adachi</surname><given-names>K.</given-names></name><name><surname>Saibara</surname><given-names>T.</given-names></name><name><surname>Onishi</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice</article-title>. <source/>J. Clin. Invest.
<volume>105</volume>, <fpage>1819</fpage>–<lpage>1825</lpage>. <pub-id pub-id-type="doi">10.1172/JCI9575</pub-id><pub-id pub-id-type="pmid">10862797</pub-id></mixed-citation>
</ref>
<ref id="B282">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niikawa</surname><given-names>H.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Miki</surname><given-names>Y.</given-names></name><name><surname>Suzuki</surname><given-names>S.</given-names></name><name><surname>Nagasaki</surname><given-names>S.</given-names></name><name><surname>Akahira</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma</article-title>. <source/>Clin. Cancer Res.
<volume>14</volume>, <fpage>4417</fpage>–<lpage>4426</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-07-1950</pub-id><pub-id pub-id-type="pmid">18579664</pub-id></mixed-citation>
</ref>
<ref id="B283">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishimura</surname><given-names>M.</given-names></name><name><surname>Naito</surname><given-names>S.</given-names></name></person-group> (<year>2006</year>). <article-title>Tissue-specific mRNA expression profiles of human phase I metabolizing enzymes except for cytochrome P450 and phase II metabolizing enzymes</article-title>. <source/>Drug Metab. Pharmacokinet.
<volume>21</volume>, <fpage>357</fpage>–<lpage>374</lpage>. <pub-id pub-id-type="doi">10.2133/dmpk.21.357</pub-id><pub-id pub-id-type="pmid">17072089</pub-id></mixed-citation>
</ref>
<ref id="B284">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noble</surname><given-names>L. S.</given-names></name><name><surname>Simpson</surname><given-names>E. R.</given-names></name><name><surname>Johns</surname><given-names>A.</given-names></name><name><surname>Bulun</surname><given-names>S. E.</given-names></name></person-group> (<year>1996</year>). <article-title>Aromatase expression in endometriosis</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>81</volume>, <fpage>174</fpage>–<lpage>179</lpage>.<pub-id pub-id-type="pmid">8550748</pub-id></mixed-citation>
</ref>
<ref id="B285">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noble</surname><given-names>L. S.</given-names></name><name><surname>Takayama</surname><given-names>K.</given-names></name><name><surname>Zeitoun</surname><given-names>K. M.</given-names></name><name><surname>Putman</surname><given-names>J. M.</given-names></name><name><surname>Johns</surname><given-names>D. A.</given-names></name><name><surname>Hinshelwood</surname><given-names>M. M.</given-names></name><etal></etal></person-group>. (<year>1997</year>). <article-title>Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>82</volume>, <fpage>600</fpage>–<lpage>606</lpage>. <pub-id pub-id-type="doi">10.1210/jc.82.2.600</pub-id><pub-id pub-id-type="pmid">9024261</pub-id></mixed-citation>
</ref>
<ref id="B286">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noël</surname><given-names>J. C.</given-names></name><name><surname>Anaf</surname><given-names>V.</given-names></name><name><surname>Borghese</surname><given-names>B.</given-names></name><name><surname>Vaiman</surname><given-names>D.</given-names></name><name><surname>Fayt</surname><given-names>I.</given-names></name><name><surname>Chapron</surname><given-names>C.</given-names></name></person-group> (<year>2011</year>). <article-title>The steroidogenic factor-1 protein is not expressed in various forms of endometriosis but is strongly present in ovarian cortical or medullary mesenchymatous cells adjacent to endometriotic foci</article-title>. <source/>Fertil. Steril.
<volume>95</volume>, <fpage>2655</fpage>–<lpage>2657</lpage>. <pub-id pub-id-type="doi">10.1016/j.fertnstert.2011.01.131</pub-id><pub-id pub-id-type="pmid">21324456</pub-id></mixed-citation>
</ref>
<ref id="B287">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nokelainen</surname><given-names>P.</given-names></name><name><surname>Peltoketo</surname><given-names>H.</given-names></name><name><surname>Mustonen</surname><given-names>M.</given-names></name><name><surname>Vihko</surname><given-names>P.</given-names></name></person-group> (<year>2000</year>). <article-title>Expression of mouse 17β-hydroxysteroid dehydrogenase/17-ketosteroid reductase type 7 in the ovary, uterus, and placenta: localization from implantation to late pregnancy</article-title>. <source/>Endocrinology
<volume>141</volume>, <fpage>772</fpage>–<lpage>778</lpage>. <pub-id pub-id-type="doi">10.1210/endo.141.2.7309</pub-id><pub-id pub-id-type="pmid">10650959</pub-id></mixed-citation>
</ref>
<ref id="B288">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oduwole</surname><given-names>O. O.</given-names></name><name><surname>Isomaa</surname><given-names>V. V.</given-names></name><name><surname>Nokelainen</surname><given-names>P. A.</given-names></name><name><surname>Stenback</surname><given-names>F.</given-names></name><name><surname>Vihko</surname><given-names>P. T.</given-names></name></person-group> (<year>2002</year>). <article-title>Downregulation of estrogen-metabolizing 17 beta-hydroxysteroid dehydrogenase type 2 expression correlates inversely with Ki67 proliferation marker in colon-cancer development</article-title>. <source/>Int. J. Cancer
<volume>97</volume>, <fpage>1</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.1567</pub-id><pub-id pub-id-type="pmid">11774236</pub-id></mixed-citation>
</ref>
<ref id="B289">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oduwole</surname><given-names>O. O.</given-names></name><name><surname>Makinen</surname><given-names>J. M.</given-names></name><name><surname>Isomaa</surname><given-names>V. V.</given-names></name><name><surname>Karttunen</surname><given-names>T. J.</given-names></name><name><surname>Vihko</surname><given-names>P. T.</given-names></name></person-group> (<year>2003a</year>). <article-title>Sex steroid metabolism in human gastric mucosa: 17 beta-hydroxysteroid dehydrogenase type 2 in normal, inflamed and neoplastic gastric tissues</article-title>. <source/>Anticancer Res.
<volume>23</volume>, <fpage>3889</fpage>–<lpage>3897</lpage>.<pub-id pub-id-type="pmid">14666693</pub-id></mixed-citation>
</ref>
<ref id="B290">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oduwole</surname><given-names>O. O.</given-names></name><name><surname>Makinen</surname><given-names>M. J.</given-names></name><name><surname>Isomaa</surname><given-names>V. V.</given-names></name><name><surname>Pulkka</surname><given-names>A.</given-names></name><name><surname>Jernvall</surname><given-names>P.</given-names></name><name><surname>Karttunen</surname><given-names>T. J.</given-names></name><etal></etal></person-group>. (<year>2003b</year>). <article-title>17β-hydroxysteroid dehydrogenase type 2: independent prognostic significance and evidence of estrogen protection in female patients with colon cancer</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>87</volume>, <fpage>133</fpage>–<lpage>140</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsbmb.2003.08.008</pub-id><pub-id pub-id-type="pmid">14672733</pub-id></mixed-citation>
</ref>
<ref id="B291">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohno</surname><given-names>S.</given-names></name><name><surname>Nishikawa</surname><given-names>K.</given-names></name><name><surname>Honda</surname><given-names>Y.</given-names></name><name><surname>Nakajin</surname><given-names>S.</given-names></name></person-group> (<year>2008</year>). <article-title>Expression in <italic>E. coli</italic> and tissue distribution of the human homologue of the mouse Ke 6 gene, 17β-hydroxysteroid dehydrogenase type 8</article-title>. <source/>Mol. Cell. Biochem.
<volume>309</volume>, <fpage>209</fpage>–<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1007/s11010-007-9637-9</pub-id><pub-id pub-id-type="pmid">17978863</pub-id></mixed-citation>
</ref>
<ref id="B292">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olson</surname><given-names>S. H.</given-names></name><name><surname>Bandera</surname><given-names>E. V.</given-names></name><name><surname>Orlow</surname><given-names>I.</given-names></name></person-group> (<year>2007</year>). <article-title>Variants in estrogen biosynthesis genes, sex steroid hormone levels, and endometrial cancer: a HuGE review</article-title>. <source/>Am. J. Epidemiol.
<volume>165</volume>, <fpage>235</fpage>–<lpage>245</lpage>. <pub-id pub-id-type="doi">10.1093/aje/kwk015</pub-id><pub-id pub-id-type="pmid">17110639</pub-id></mixed-citation>
</ref>
<ref id="B293">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Osinski</surname><given-names>M.</given-names></name><name><surname>Wirstlein</surname><given-names>P.</given-names></name><name><surname>Wender-Ozegowska</surname><given-names>E.</given-names></name><name><surname>Mikolajczyk</surname><given-names>M.</given-names></name><name><surname>Jagodzinski</surname><given-names>P. P.</given-names></name><name><surname>Szczepanska</surname><given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>HSD3B2, HSD17B1, HSD17B2, ESR1, ESR2 and AR expression in infertile women with endometriosis</article-title>. <source/>Ginekol. Pol.
<volume>89</volume>, <fpage>125</fpage>–<lpage>134</lpage>. <pub-id pub-id-type="doi">10.5603/GP.a2018.0022</pub-id><pub-id pub-id-type="pmid">29664547</pub-id></mixed-citation>
</ref>
<ref id="B294">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oz</surname><given-names>O. K.</given-names></name><name><surname>Millsaps</surname><given-names>R.</given-names></name><name><surname>Welch</surname><given-names>R.</given-names></name><name><surname>Birch</surname><given-names>J.</given-names></name><name><surname>Zerwekh</surname><given-names>J. E.</given-names></name></person-group> (<year>2001</year>). <article-title>Expression of aromatase in the human growth plate</article-title>. <source/>J. Mol. Endocrinol.
<volume>27</volume>, <fpage>249</fpage>–<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1677/jme.0.0270249</pub-id><pub-id pub-id-type="pmid">11564607</pub-id></mixed-citation>
</ref>
<ref id="B295">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oz</surname><given-names>O. K.</given-names></name><name><surname>Zerwekh</surname><given-names>J. E.</given-names></name><name><surname>Fisher</surname><given-names>C.</given-names></name><name><surname>Graves</surname><given-names>K.</given-names></name><name><surname>Nanu</surname><given-names>L.</given-names></name><name><surname>Millsaps</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Bone has a sexually dimorphic response to aromatase deficiency</article-title>. <source/>J. Bone Miner. Res.
<volume>15</volume>, <fpage>507</fpage>–<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1359/jbmr.2000.15.3.507</pub-id><pub-id pub-id-type="pmid">10750565</pub-id></mixed-citation>
</ref>
<ref id="B296">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>B. F.</given-names></name><name><surname>Clegg</surname><given-names>D. J.</given-names></name></person-group> (<year>2015</year>). <article-title>The sexual dimorphism of obesity</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>402</volume>, <fpage>113</fpage>–<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2014.11.029</pub-id><pub-id pub-id-type="pmid">25578600</pub-id></mixed-citation>
</ref>
<ref id="B297">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmieri</surname><given-names>C.</given-names></name><name><surname>Stein</surname><given-names>R. C.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Hudson</surname><given-names>E.</given-names></name><name><surname>Nicholas</surname><given-names>H.</given-names></name><name><surname>Sasano</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2017a</year>). <article-title>IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients</article-title>. <source/>Breast Cancer Res. Treat.
<volume>165</volume>, <fpage>343</fpage>–<lpage>353</lpage>. <pub-id pub-id-type="doi">10.1007/s10549-017-4328-z</pub-id><pub-id pub-id-type="pmid">28612226</pub-id></mixed-citation>
</ref>
<ref id="B298">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmieri</surname><given-names>C.</given-names></name><name><surname>Szydlo</surname><given-names>R.</given-names></name><name><surname>Miller</surname><given-names>M.</given-names></name><name><surname>Barker</surname><given-names>L.</given-names></name><name><surname>Patel</surname><given-names>N. H.</given-names></name><name><surname>Sasano</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2017b</year>). <article-title>IPET study: an FLT-PET window study to assess the activity of the steroid sulfatase inhibitor irosustat in early breast cancer</article-title>. <source/>Breast Cancer Res. Treat.
<volume>166</volume>, <fpage>527</fpage>–<lpage>539</lpage>. <pub-id pub-id-type="doi">10.1007/s10549-017-4427-x</pub-id><pub-id pub-id-type="pmid">28795252</pub-id></mixed-citation>
</ref>
<ref id="B299">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>A. L.</given-names></name><name><surname>Lin</surname><given-names>H. K.</given-names></name><name><surname>Yang</surname><given-names>Q.</given-names></name><name><surname>Sing</surname><given-names>C. W.</given-names></name><name><surname>Fan</surname><given-names>M.</given-names></name><name><surname>Mapstone</surname><given-names>T. B.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Differential expression of type 2, 3α/type 5, 17β-hydroxysteroid dehydrogenase (AKR1C3) in tumors of the central nervous system</article-title>. <source/>Int. J. Clin. Exp. Pathol.
<volume>3</volume>, <fpage>743</fpage>–<lpage>754</lpage>.<pub-id pub-id-type="pmid">21151387</pub-id></mixed-citation>
</ref>
<ref id="B300">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>Y. S.</given-names></name><name><surname>Gauna</surname><given-names>A. E.</given-names></name><name><surname>Cha</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Mouse models of primary Sjogren's syndrome</article-title>. <source/>Curr. Pharm. Des.
<volume>21</volume>, <fpage>2350</fpage>–<lpage>2364</lpage>. <pub-id pub-id-type="doi">10.2174/1381612821666150316120024</pub-id><pub-id pub-id-type="pmid">25777752</pub-id></mixed-citation>
</ref>
<ref id="B301">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pathirage</surname><given-names>N.</given-names></name><name><surname>Di Nezza</surname><given-names>L. A.</given-names></name><name><surname>Salmonsen</surname><given-names>L. A.</given-names></name><name><surname>Jobling</surname><given-names>T.</given-names></name><name><surname>Simpson</surname><given-names>E. R.</given-names></name><name><surname>Clyne</surname><given-names>C. D.</given-names></name></person-group> (<year>2006</year>). <article-title>Expression of aromatase, estrogen receptors, and their coactivators in patients with endometrial cancer</article-title>. <source/>Fertil. Steril.
<volume>86</volume>, <fpage>469</fpage>–<lpage>472</lpage>. <pub-id pub-id-type="doi">10.1016/j.fertnstert.2005.12.057</pub-id><pub-id pub-id-type="pmid">16730717</pub-id></mixed-citation>
</ref>
<ref id="B302">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pautier</surname><given-names>P.</given-names></name><name><surname>Vergote</surname><given-names>I.</given-names></name><name><surname>Joly</surname><given-names>F.</given-names></name><name><surname>Melichar</surname><given-names>B.</given-names></name><name><surname>Kutarska</surname><given-names>E.</given-names></name><name><surname>Hall</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>A Phase 2, randomized, open-label study of irosustat versus megestrol acetate in advanced endometrial cancer</article-title>. <source/>Int. J. Gynecol. Cancer
<volume>27</volume>, <fpage>258</fpage>–<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1097/IGC.0000000000000862</pub-id><pub-id pub-id-type="pmid">27870712</pub-id></mixed-citation>
</ref>
<ref id="B303">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pearson Murphy</surname><given-names>B. E.</given-names></name><name><surname>Steinberg</surname><given-names>S. I.</given-names></name><name><surname>Hu</surname><given-names>F. Y.</given-names></name><name><surname>Allison</surname><given-names>C. M.</given-names></name></person-group> (<year>2001</year>). <article-title>Neuroactive ring A-reduced metabolites of progesterone in human plasma during pregnancy: elevated levels of 5 alpha-dihydroprogesterone in depressed patients during the latter half of pregnancy</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>86</volume>, <fpage>5981</fpage>–<lpage>5987</lpage>. <pub-id pub-id-type="doi">10.1210/jcem.86.12.8122</pub-id><pub-id pub-id-type="pmid">11739473</pub-id></mixed-citation>
</ref>
<ref id="B304">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelletier</surname><given-names>G.</given-names></name><name><surname>Luu-The</surname><given-names>V.</given-names></name><name><surname>Tetu</surname><given-names>B.</given-names></name><name><surname>Labrie</surname><given-names>F.</given-names></name></person-group> (<year>1999</year>). <article-title>Immunocytochemical localization of type 5, 17β-hydroxysteroid dehydrogenase in human reproductive tissues</article-title>. <source/>J. Histochem. Cytochem.
<volume>47</volume>, <fpage>731</fpage>–<lpage>738</lpage>. <pub-id pub-id-type="doi">10.1177/002215549904700602</pub-id><pub-id pub-id-type="pmid">10330449</pub-id></mixed-citation>
</ref>
<ref id="B305">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penning</surname><given-names>T. M.</given-names></name></person-group> (<year>2017</year>). <article-title>Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review</article-title>. <source/>Expert Opin. Ther. Pat.
<volume>27</volume>, <fpage>1329</fpage>–<lpage>1340</lpage>. <pub-id pub-id-type="doi">10.1080/13543776.2017.1379503</pub-id><pub-id pub-id-type="pmid">28895472</pub-id></mixed-citation>
</ref>
<ref id="B306">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penning</surname><given-names>T. M.</given-names></name><name><surname>Burczynski</surname><given-names>M. E.</given-names></name><name><surname>Jez</surname><given-names>J. M.</given-names></name><name><surname>Hung</surname><given-names>C. F.</given-names></name><name><surname>Lin</surname><given-names>H. K.</given-names></name><name><surname>Ma</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones</article-title>. <source/>Biochem. J.
<volume>351</volume>, <fpage>67</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1042/bj3510067</pub-id><pub-id pub-id-type="pmid">10998348</pub-id></mixed-citation>
</ref>
<ref id="B307">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Penning</surname><given-names>T. M.</given-names></name><name><surname>Jin</surname><given-names>Y.</given-names></name><name><surname>Steckelbroeck</surname><given-names>S.</given-names></name><name><surname>Lanisnik Rizner</surname><given-names>T.</given-names></name><name><surname>Lewis</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>Structure-function of human 3 alpha-hydroxysteroid dehydrogenases: genes and proteins</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>215</volume>, <fpage>63</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2003.11.006</pub-id><pub-id pub-id-type="pmid">15026176</pub-id></mixed-citation>
</ref>
<ref id="B308">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez Carrion</surname><given-names>R.</given-names></name><name><surname>Alberola Candel</surname><given-names>V.</given-names></name><name><surname>Calabresi</surname><given-names>F.</given-names></name><name><surname>Michel</surname><given-names>R. T.</given-names></name><name><surname>Santos</surname><given-names>R.</given-names></name><name><surname>Delozier</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>1994</year>). <article-title>Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer</article-title>. <source/>Ann. Oncol.
<volume>5</volume>(<issue>Suppl. 7</issue>), <fpage>S19</fpage>–<lpage>S24</lpage>.<pub-id pub-id-type="pmid">7873457</pub-id></mixed-citation>
</ref>
<ref id="B309">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pezzi</surname><given-names>V.</given-names></name><name><surname>Mathis</surname><given-names>J. M.</given-names></name><name><surname>Rainey</surname><given-names>W. E.</given-names></name><name><surname>Carr</surname><given-names>B. R.</given-names></name></person-group> (<year>2003</year>). <article-title>Profiling transcript levels for steroidogenic enzymes in fetal tissues</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>87</volume>, <fpage>181</fpage>–<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsbmb.2003.07.006</pub-id><pub-id pub-id-type="pmid">14672738</pub-id></mixed-citation>
</ref>
<ref id="B310">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piccinato</surname><given-names>C. A.</given-names></name><name><surname>Neme</surname><given-names>R. M.</given-names></name><name><surname>Torres</surname><given-names>N.</given-names></name><name><surname>Sanches</surname><given-names>L. R.</given-names></name><name><surname>Cruz Derogis</surname><given-names>P. B.</given-names></name><name><surname>Brudniewski</surname><given-names>H. F.</given-names></name><etal></etal></person-group>. (<year>2016a</year>). <article-title>Increased expression of CYP1A1 and CYP1B1 in ovarian/peritoneal endometriotic lesions</article-title>. <source/>Reproduction
<volume>151</volume>, <fpage>683</fpage>–<lpage>692</lpage>. <pub-id pub-id-type="doi">10.1530/REP-15-0581</pub-id><pub-id pub-id-type="pmid">27012269</pub-id></mixed-citation>
</ref>
<ref id="B311">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piccinato</surname><given-names>C. A.</given-names></name><name><surname>Neme</surname><given-names>R. M.</given-names></name><name><surname>Torres</surname><given-names>N.</given-names></name><name><surname>Sanches</surname><given-names>L. R.</given-names></name><name><surname>Derogis</surname><given-names>P.</given-names></name><name><surname>Brudniewski</surname><given-names>H. F.</given-names></name><etal></etal></person-group>. (<year>2016b</year>). <article-title>Effects of steroid hormone on estrogen sulfotransferase and on steroid sulfatase expression in endometriosis tissue and stromal cells</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>158</volume>, <fpage>117</fpage>–<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsbmb.2015.12.025</pub-id><pub-id pub-id-type="pmid">26723541</pub-id></mixed-citation>
</ref>
<ref id="B312">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piekorz</surname><given-names>R. P.</given-names></name><name><surname>Gingras</surname><given-names>S.</given-names></name><name><surname>Hoffmeyer</surname><given-names>A.</given-names></name><name><surname>Ihle</surname><given-names>J. N.</given-names></name><name><surname>Weinstein</surname><given-names>Y.</given-names></name></person-group> (<year>2005</year>). <article-title>Regulation of progesterone levels during pregnancy and parturition by signal transducer and activator of transcription 5 and 20α-hydroxysteroid dehydrogenase</article-title>. <source/>Mol. Endocrinol.
<volume>19</volume>, <fpage>431</fpage>–<lpage>440</lpage>. <pub-id pub-id-type="doi">10.1210/me.2004-0302</pub-id><pub-id pub-id-type="pmid">15471942</pub-id></mixed-citation>
</ref>
<ref id="B313">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Platia</surname><given-names>M. P.</given-names></name><name><surname>Fencl</surname><given-names>M. D.</given-names></name><name><surname>Elkind-Hirsch</surname><given-names>K. E.</given-names></name><name><surname>Canick</surname><given-names>J. A.</given-names></name><name><surname>Tulchinsky</surname><given-names>D.</given-names></name></person-group> (<year>1984</year>). <article-title>Estrone sulfatase activity in the human brain and estrone sulfate levels in the normal menstrual cycle</article-title>. <source/>J. Steroid Biochem.
<volume>21</volume>, <fpage>237</fpage>–<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1016/0022-4731(84)90275-9</pub-id><pub-id pub-id-type="pmid">6492790</pub-id></mixed-citation>
</ref>
<ref id="B314">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pohl</surname><given-names>O.</given-names></name><name><surname>Bestel</surname><given-names>E.</given-names></name><name><surname>Gotteland</surname><given-names>J. P.</given-names></name></person-group> (<year>2014</year>). <article-title>Synergistic effects of E2MATE and norethindrone acetate on steroid sulfatase inhibition: a randomized phase I proof-of-principle clinical study in women of reproductive age</article-title>. <source/>Reprod. Sci.
<volume>21</volume>, <fpage>1256</fpage>–<lpage>1265</lpage>. <pub-id pub-id-type="doi">10.1177/1933719114522526</pub-id><pub-id pub-id-type="pmid">24604234</pub-id></mixed-citation>
</ref>
<ref id="B315">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollow</surname><given-names>K.</given-names></name><name><surname>Lubbert</surname><given-names>H.</given-names></name><name><surname>Jeske</surname><given-names>R.</given-names></name><name><surname>Pollow</surname><given-names>B.</given-names></name></person-group> (<year>1975a</year>). <article-title>Studies on 17β-hydroxysteroid dehydrogenase in human endometrium and endometrial carcinoma</article-title>. <source/>Acta Endocrinol.
<volume>79</volume>, <fpage>146</fpage>–<lpage>156</lpage>.<pub-id pub-id-type="pmid">236629</pub-id></mixed-citation>
</ref>
<ref id="B316">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollow</surname><given-names>K.</given-names></name><name><surname>Lubbert</surname><given-names>H.</given-names></name><name><surname>Pollow</surname><given-names>B.</given-names></name></person-group> (<year>1975b</year>). <article-title>Studies on 17 beta-hydroxysteroid dehydrogenase in human endometrium and endometrial carcinoma. III. Partial purification and characterization of the microsomal enzyme</article-title>. <source/>Acta Endocrinol (Copenh)
<volume>80</volume>, <fpage>355</fpage>–<lpage>364</lpage>.<pub-id pub-id-type="pmid">241186</pub-id></mixed-citation>
</ref>
<ref id="B317">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pollow</surname><given-names>K.</given-names></name><name><surname>Lubbert</surname><given-names>H.</given-names></name><name><surname>Pollow</surname><given-names>B.</given-names></name></person-group> (<year>1976</year>). <article-title>On the mitochondrial 17β-hydroxysteroid dehydrogenase from human endometrium and endometrial carcinoma: characterization and intramitochondrial distribution</article-title>. <source/>J. Steroid Biochem.
<volume>7</volume>, <fpage>45</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1016/0022-4731(76)90163-1</pub-id><pub-id pub-id-type="pmid">5632</pub-id></mixed-citation>
</ref>
<ref id="B318">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polow</surname><given-names>K.</given-names></name><name><surname>Lubbert</surname><given-names>H.</given-names></name><name><surname>Boquoi</surname><given-names>E.</given-names></name><name><surname>Kreutzer</surname><given-names>G.</given-names></name><name><surname>Jeske</surname><given-names>R.</given-names></name><name><surname>Pollow</surname><given-names>B.</given-names></name></person-group> (<year>1975</year>). <article-title>Studies on 17β-hydroxysteroid dehydrogenase in human endometrium and endometrial carcinoma I. Subcellular distribution and variations of specific enzyme activity</article-title>. <source/>Acta Endocrinol (Copenh)
<volume>79</volume>, <fpage>134</fpage>–<lpage>145</lpage>.<pub-id pub-id-type="pmid">1173301</pub-id></mixed-citation>
</ref>
<ref id="B319">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prehn</surname><given-names>C.</given-names></name><name><surname>Moller</surname><given-names>G.</given-names></name><name><surname>Adamski</surname><given-names>J.</given-names></name></person-group> (<year>2009</year>). <article-title>Recent advances in 17β-hydroxysteroid dehydrogenases</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>114</volume>, <fpage>72</fpage>–<lpage>77</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsbmb.2008.12.024</pub-id><pub-id pub-id-type="pmid">19444936</pub-id></mixed-citation>
</ref>
<ref id="B320">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prizant</surname><given-names>H.</given-names></name><name><surname>Hammes</surname><given-names>S. R.</given-names></name></person-group> (<year>2016</year>). <article-title>Minireview: lymphangioleiomyomatosis (LAM): the “Other” steroid-sensitive cancer</article-title>. <source/>Endocrinology
<volume>157</volume>, <fpage>3374</fpage>–<lpage>3383</lpage>. <pub-id pub-id-type="doi">10.1210/en.2016-1395</pub-id><pub-id pub-id-type="pmid">27409646</pub-id></mixed-citation>
</ref>
<ref id="B321">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prossnitz</surname><given-names>E. R.</given-names></name><name><surname>Barton</surname><given-names>M.</given-names></name></person-group> (<year>2011</year>). <article-title>The G-protein-coupled estrogen receptor GPER in health and disease</article-title>. <source/>Nat. Rev. Endocrinol.
<volume>7</volume>, <fpage>715</fpage>–<lpage>726</lpage>. <pub-id pub-id-type="doi">10.1038/nrendo.2011.122</pub-id><pub-id pub-id-type="pmid">21844907</pub-id></mixed-citation>
</ref>
<ref id="B322">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prost</surname><given-names>O.</given-names></name><name><surname>Adessi</surname><given-names>G. L.</given-names></name></person-group> (<year>1983</year>). <article-title>Estrone and dehydroepiandrosterone sulfatase activities in normal and pathological human endometrium biopsies</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>56</volume>, <fpage>653</fpage>–<lpage>661</lpage>. <pub-id pub-id-type="doi">10.1210/jcem-56-4-653</pub-id><pub-id pub-id-type="pmid">6220025</pub-id></mixed-citation>
</ref>
<ref id="B323">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purohit</surname><given-names>A.</given-names></name><name><surname>Flanagan</surname><given-names>A. M.</given-names></name><name><surname>Reed</surname><given-names>M. J.</given-names></name></person-group> (<year>1992</year>). <article-title>Estrogen synthesis by osteoblast cell lines</article-title>. <source/>Endocrinology
<volume>131</volume>, <fpage>2027</fpage>–<lpage>2029</lpage>. <pub-id pub-id-type="doi">10.1210/endo.131.4.1396346</pub-id><pub-id pub-id-type="pmid">1396346</pub-id></mixed-citation>
</ref>
<ref id="B324">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purohit</surname><given-names>A.</given-names></name><name><surname>Foster</surname><given-names>P. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers</article-title>. <source/>J. Endocrinol.
<volume>212</volume>, <fpage>99</fpage>–<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1530/JOE-11-0266</pub-id><pub-id pub-id-type="pmid">21859802</pub-id></mixed-citation>
</ref>
<ref id="B325">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Purohit</surname><given-names>A.</given-names></name><name><surname>Fusi</surname><given-names>L.</given-names></name><name><surname>Brosens</surname><given-names>J.</given-names></name><name><surname>Woo</surname><given-names>L. W.</given-names></name><name><surname>Potter</surname><given-names>B. V.</given-names></name><name><surname>Reed</surname><given-names>M. J.</given-names></name></person-group> (<year>2008</year>). <article-title>Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy</article-title>. <source/>Hum. Reprod.
<volume>23</volume>, <fpage>290</fpage>–<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/dem308</pub-id><pub-id pub-id-type="pmid">18056119</pub-id></mixed-citation>
</ref>
<ref id="B326">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qaiser</surname><given-names>M. Z.</given-names></name><name><surname>Dolman</surname><given-names>D. E. M.</given-names></name><name><surname>Begley</surname><given-names>D. J.</given-names></name><name><surname>Abbott</surname><given-names>N. J.</given-names></name><name><surname>Cazacu-Davidescu</surname><given-names>M.</given-names></name><name><surname>Corol</surname><given-names>D. I.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Uptake and metabolism of sulphated steroids by the blood-brain barrier in the adult male rat</article-title>. <source/>J. Neurochem.
<volume>142</volume>, <fpage>672</fpage>–<lpage>685</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.14117</pub-id><pub-id pub-id-type="pmid">28665486</pub-id></mixed-citation>
</ref>
<ref id="B327">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>Y. M.</given-names></name><name><surname>Sun</surname><given-names>X. J.</given-names></name><name><surname>Tong</surname><given-names>M. H.</given-names></name><name><surname>Li</surname><given-names>X. P.</given-names></name><name><surname>Richa</surname><given-names>J.</given-names></name><name><surname>Song</surname><given-names>W. C.</given-names></name></person-group> (<year>2001</year>). <article-title>Targeted disruption of the mouse estrogen sulfotransferase gene reveals a role of estrogen metabolism in intracrine and paracrine estrogen regulation</article-title>. <source/>Endocrinology
<volume>142</volume>, <fpage>5342</fpage>–<lpage>5350</lpage>. <pub-id pub-id-type="doi">10.1210/endo.142.12.8540</pub-id><pub-id pub-id-type="pmid">11713234</pub-id></mixed-citation>
</ref>
<ref id="B328">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>K.</given-names></name><name><surname>Ehrmann</surname><given-names>D. A.</given-names></name><name><surname>Cox</surname><given-names>N.</given-names></name><name><surname>Refetoff</surname><given-names>S.</given-names></name><name><surname>Rosenfield</surname><given-names>R. L.</given-names></name></person-group> (<year>2006</year>). <article-title>Identification of a functional polymorphism of the human type 5, 17β-hydroxysteroid dehydrogenase gene associated with polycystic ovary syndrome</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>91</volume>, <fpage>270</fpage>–<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2005-2012</pub-id><pub-id pub-id-type="pmid">16263811</pub-id></mixed-citation>
</ref>
<ref id="B329">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinkler</surname><given-names>M.</given-names></name><name><surname>Sinha</surname><given-names>B.</given-names></name><name><surname>Tomlinson</surname><given-names>J. W.</given-names></name><name><surname>Bujalska</surname><given-names>I. J.</given-names></name><name><surname>Stewart</surname><given-names>P. M.</given-names></name><name><surname>Arlt</surname><given-names>W.</given-names></name></person-group> (<year>2004</year>). <article-title>Androgen generation in adipose tissue in women with simple obesity–a site-specific role for 17β-hydroxysteroid dehydrogenase type 5</article-title>. <source/>J. Endocrinol.
<volume>183</volume>, <fpage>331</fpage>–<lpage>342</lpage>. <pub-id pub-id-type="doi">10.1677/joe.1.05762</pub-id><pub-id pub-id-type="pmid">15531721</pub-id></mixed-citation>
</ref>
<ref id="B330">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajkowski</surname><given-names>K. M.</given-names></name><name><surname>Robel</surname><given-names>P.</given-names></name><name><surname>Baulieu</surname><given-names>E. E.</given-names></name></person-group> (<year>1997</year>). <article-title>Hydroxysteroid sulfotransferase activity in the rat brain and liver as a function of age and sex</article-title>. <source/>Steroids
<volume>62</volume>, <fpage>427</fpage>–<lpage>436</lpage>. <pub-id pub-id-type="doi">10.1016/S0039-128X(97)00013-5</pub-id><pub-id pub-id-type="pmid">9178430</pub-id></mixed-citation>
</ref>
<ref id="B331">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rantakari</surname><given-names>P.</given-names></name><name><surname>Lagerbohm</surname><given-names>H.</given-names></name><name><surname>Kaimainen</surname><given-names>M.</given-names></name><name><surname>Suomela</surname><given-names>J. P.</given-names></name><name><surname>Strauss</surname><given-names>L.</given-names></name><name><surname>Sainio</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Hydroxysteroid (17{beta}) dehydrogenase 12 is essential for mouse organogenesis and embryonic survival</article-title>. <source/>Endocrinology
<volume>151</volume>, <fpage>1893</fpage>–<lpage>1901</lpage>. <pub-id pub-id-type="doi">10.1210/en.2009-0929</pub-id><pub-id pub-id-type="pmid">20130115</pub-id></mixed-citation>
</ref>
<ref id="B332">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rantakari</surname><given-names>P.</given-names></name><name><surname>Strauss</surname><given-names>L.</given-names></name><name><surname>Kiviranta</surname><given-names>R.</given-names></name><name><surname>Lagerbohm</surname><given-names>H.</given-names></name><name><surname>Paviala</surname><given-names>J.</given-names></name><name><surname>Holopainen</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Placenta defects and embryonic lethality resulting from disruption of mouse hydroxysteroid (17-beta) dehydrogenase 2 gene</article-title>. <source/>Mol. Endocrinol.
<volume>22</volume>, <fpage>665</fpage>–<lpage>675</lpage>. <pub-id pub-id-type="doi">10.1210/me.2007-0257</pub-id><pub-id pub-id-type="pmid">18048640</pub-id></mixed-citation>
</ref>
<ref id="B333">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rauschenberger</surname><given-names>K.</given-names></name><name><surname>Scholer</surname><given-names>K.</given-names></name><name><surname>Sass</surname><given-names>J. O.</given-names></name><name><surname>Sauer</surname><given-names>S.</given-names></name><name><surname>Djuric</surname><given-names>Z.</given-names></name><name><surname>Rumig</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>A non-enzymatic function of 17β-hydroxysteroid dehydrogenase type 10 is required for mitochondrial integrity and cell survival</article-title>. <source/>EMBO Mol. Med.
<volume>2</volume>, <fpage>51</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1002/emmm.200900055</pub-id><pub-id pub-id-type="pmid">20077426</pub-id></mixed-citation>
</ref>
<ref id="B334">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rawłuszko</surname><given-names>A. A.</given-names></name><name><surname>Horbacka</surname><given-names>K.</given-names></name><name><surname>Krokowicz</surname><given-names>P.</given-names></name><name><surname>Jagodzinski</surname><given-names>P. P.</given-names></name></person-group> (<year>2011</year>). <article-title>Decreased expression of 17β-hydroxysteroid dehydrogenase type 1 is associated with DNA hypermethylation in colorectal cancer located in the proximal colon</article-title>. <source/>BMC Cancer
<volume>11</volume>:<fpage>522</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2407-11-522</pub-id><pub-id pub-id-type="pmid">22176788</pub-id></mixed-citation>
</ref>
<ref id="B335">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy</surname><given-names>D. S.</given-names></name></person-group> (<year>2010</year>). <article-title>Neurosteroids: endogenous role in the human brain and therapeutic potentials</article-title>. <source/>Prog. Brain Res.
<volume>186</volume>, <fpage>113</fpage>–<lpage>137</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-444-53630-3.00008-7</pub-id><pub-id pub-id-type="pmid">21094889</pub-id></mixed-citation>
</ref>
<ref id="B336">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reed</surname><given-names>M. J.</given-names></name><name><surname>Purohit</surname><given-names>A.</given-names></name><name><surname>Woo</surname><given-names>L. W.</given-names></name><name><surname>Newman</surname><given-names>S. P.</given-names></name><name><surname>Potter</surname><given-names>B. V.</given-names></name></person-group> (<year>2005</year>). <article-title>Steroid sulfatase: molecular biology, regulation, and inhibition</article-title>. <source/>Endocr. Rev.
<volume>26</volume>, <fpage>171</fpage>–<lpage>202</lpage>. <pub-id pub-id-type="doi">10.1210/er.2004-0003</pub-id><pub-id pub-id-type="pmid">15561802</pub-id></mixed-citation>
</ref>
<ref id="B337">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rege</surname><given-names>J.</given-names></name><name><surname>Karashima</surname><given-names>S.</given-names></name><name><surname>Lerario</surname><given-names>A. M.</given-names></name><name><surname>Smith</surname><given-names>J. M.</given-names></name><name><surname>Auchus</surname><given-names>R. J.</given-names></name><name><surname>Kasa-Vubu</surname><given-names>J. Z.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Age-dependent increases in adrenal cytochrome b5 and serum 5-androstenediol-3-sulfate</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>101</volume>, <fpage>4585</fpage>–<lpage>4593</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2016-2864</pub-id><pub-id pub-id-type="pmid">27623070</pub-id></mixed-citation>
</ref>
<ref id="B338">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rennert</surname><given-names>G.</given-names></name><name><surname>Rennert</surname><given-names>H. S.</given-names></name><name><surname>Pinchev</surname><given-names>M.</given-names></name><name><surname>Lavie</surname><given-names>O.</given-names></name><name><surname>Gruber</surname><given-names>S. B.</given-names></name></person-group> (<year>2009</year>). <article-title>Use of hormone replacement therapy and the risk of colorectal cancer</article-title>. <source/>J. Clin. Oncol.
<volume>27</volume>, <fpage>4542</fpage>–<lpage>4547</lpage>. <pub-id pub-id-type="doi">10.1200/JCO.2009.22.0764</pub-id><pub-id pub-id-type="pmid">19704062</pub-id></mixed-citation>
</ref>
<ref id="B339">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhee</surname><given-names>H. S.</given-names></name><name><surname>Oh</surname><given-names>S. H.</given-names></name><name><surname>Ko</surname><given-names>B. J.</given-names></name><name><surname>Han</surname><given-names>D. M.</given-names></name><name><surname>Jeon</surname><given-names>B. H.</given-names></name><name><surname>Park</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Expression of 3β-hydroxysteroid dehydrogenase and P450 side chain cleavage enzyme in the human uterine endometrium</article-title>. <source/>Exp. Mol. Med.
<volume>35</volume>, <fpage>160</fpage>–<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1038/emm.2003.22</pub-id><pub-id pub-id-type="pmid">12858014</pub-id></mixed-citation>
</ref>
<ref id="B340">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riches</surname><given-names>Z.</given-names></name><name><surname>Stanley</surname><given-names>E. L.</given-names></name><name><surname>Bloomer</surname><given-names>J. C.</given-names></name><name><surname>Coughtrie</surname><given-names>M. W.</given-names></name></person-group> (<year>2009</year>). <article-title>Quantitative evaluation of the expression and activity of five major sulfotransferases (SULTs) in human tissues: the SULT “pie”</article-title>. <source/>Drug Metab. Dispos.
<volume>37</volume>, <fpage>2255</fpage>–<lpage>2261</lpage>. <pub-id pub-id-type="doi">10.1124/dmd.109.028399</pub-id><pub-id pub-id-type="pmid">19679676</pub-id></mixed-citation>
</ref>
<ref id="B341">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riggs</surname><given-names>B. L.</given-names></name><name><surname>Khosla</surname><given-names>S.</given-names></name><name><surname>Melton</surname><given-names>L. J.</given-names><suffix>III.</suffix></name></person-group> (<year>2002</year>). <article-title>Sex steroids and the construction and conservation of the adult skeleton</article-title>. <source/>Endocr. Rev.
<volume>23</volume>, <fpage>279</fpage>–<lpage>302</lpage>. <pub-id pub-id-type="doi">10.1210/edrv.23.3.0465</pub-id><pub-id pub-id-type="pmid">12050121</pub-id></mixed-citation>
</ref>
<ref id="B342">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rižner</surname><given-names>T. L.</given-names></name></person-group> (<year>2013</year>). <article-title>Estrogen biosynthesis, phase I and phase II metabolism, and action in endometrial cancer</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>381</volume>, <fpage>124</fpage>–<lpage>139</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2013.07.026</pub-id><pub-id pub-id-type="pmid">23911898</pub-id></mixed-citation>
</ref>
<ref id="B343">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rižner</surname><given-names>T. L.</given-names></name></person-group> (<year>2016</year>). <article-title>The important roles of steroid sulfatase and sulfotransferases in gynecological diseases</article-title>. <source/>Front. Pharmacol.
<volume>7</volume>:<fpage>30</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2016.00030</pub-id><pub-id pub-id-type="pmid">26924986</pub-id></mixed-citation>
</ref>
<ref id="B344">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rižner</surname><given-names>T. L.</given-names></name><name><surname>Penning</surname><given-names>T. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism</article-title>. <source/>Steroids
<volume>79</volume>, <fpage>49</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1016/j.steroids.2013.10.012</pub-id><pub-id pub-id-type="pmid">24189185</pub-id></mixed-citation>
</ref>
<ref id="B345">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rizner</surname><given-names>T. L.</given-names></name><name><surname>Smuc</surname><given-names>T.</given-names></name><name><surname>Rupreht</surname><given-names>R.</given-names></name><name><surname>Sinkovec</surname><given-names>J.</given-names></name><name><surname>Penning</surname><given-names>T. M.</given-names></name></person-group> (<year>2006</year>). <article-title>AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>248</volume>, <fpage>126</fpage>–<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2005.10.009</pub-id><pub-id pub-id-type="pmid">16338060</pub-id></mixed-citation>
</ref>
<ref id="B346">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rižner</surname><given-names>T. L.</given-names></name><name><surname>Thalhammer</surname><given-names>T.</given-names></name><name><surname>Ozvegy-Laczka</surname><given-names>C.</given-names></name></person-group> (<year>2017</year>). <article-title>The importance of steroid uptake and intracrine action in endometrial and ovarian cancers</article-title>. <source/>Front. Pharmacol.
<volume>8</volume>:<fpage>346</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2017.00346</pub-id><pub-id pub-id-type="pmid">28674494</pub-id></mixed-citation>
</ref>
<ref id="B347">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodríguez-Sanz</surname><given-names>M.</given-names></name><name><surname>Garcia-Giralt</surname><given-names>N.</given-names></name><name><surname>Prieto-Alhambra</surname><given-names>D.</given-names></name><name><surname>Servitja</surname><given-names>S.</given-names></name><name><surname>Balcells</surname><given-names>S.</given-names></name><name><surname>Pecorelli</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>CYP11A1 expression in bone is associated with aromatase inhibitor-related bone loss</article-title>. <source/>J. Mol. Endocrinol.
<volume>55</volume>, <fpage>69</fpage>–<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1530/JME-15-0079</pub-id><pub-id pub-id-type="pmid">26108486</pub-id></mixed-citation>
</ref>
<ref id="B348">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>P. G.</given-names></name><name><surname>Brunetto</surname><given-names>V. L.</given-names></name><name><surname>VanLe</surname><given-names>L.</given-names></name><name><surname>Bell</surname><given-names>J.</given-names></name><name><surname>Walker</surname><given-names>J. L.</given-names></name><name><surname>Lee</surname><given-names>R. B.</given-names></name></person-group> (<year>2000</year>). <article-title>A phase II trial of anastrozole in advanced recurrent or persistent endometrial carcinoma: a Gynecologic Oncology Group study</article-title>. <source/>Gynecol. Oncol.
<volume>78</volume>, <fpage>212</fpage>–<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1006/gyno.2000.5865</pub-id><pub-id pub-id-type="pmid">10926805</pub-id></mixed-citation>
</ref>
<ref id="B349">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roshan</surname><given-names>M. H.</given-names></name><name><surname>Tambo</surname><given-names>A.</given-names></name><name><surname>Pace</surname><given-names>N. P.</given-names></name></person-group> (<year>2016</year>). <article-title>The role of testosterone in colorectal carcinoma: pathomechanisms and open questions</article-title>. <source/>EPMA J.
<volume>7</volume>, <fpage>22</fpage>. <pub-id pub-id-type="doi">10.1186/s13167-016-0071-5</pub-id><pub-id pub-id-type="pmid">27833666</pub-id></mixed-citation>
</ref>
<ref id="B350">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosner</surname><given-names>W.</given-names></name><name><surname>Hankinson</surname><given-names>S. E.</given-names></name><name><surname>Sluss</surname><given-names>P. M.</given-names></name><name><surname>Vesper</surname><given-names>H. W.</given-names></name><name><surname>Wierman</surname><given-names>M. E.</given-names></name></person-group> (<year>2013</year>). <article-title>Challenges to the measurement of estradiol: an endocrine society position statement</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>98</volume>, <fpage>1376</fpage>–<lpage>1387</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2012-3780</pub-id><pub-id pub-id-type="pmid">23463657</pub-id></mixed-citation>
</ref>
<ref id="B351">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rubin</surname><given-names>G. L.</given-names></name><name><surname>Harrold</surname><given-names>A. J.</given-names></name><name><surname>Mills</surname><given-names>J. A.</given-names></name><name><surname>Falany</surname><given-names>C. N.</given-names></name><name><surname>Coughtrie</surname><given-names>M. W.</given-names></name></person-group> (<year>1999</year>). <article-title>Regulation of sulphotransferase expression in the endometrium during the menstrual cycle, by oral contraceptives and during early pregnancy</article-title>. <source/>Mol. Hum. Reprod.
<volume>5</volume>, <fpage>995</fpage>–<lpage>1002</lpage>. <pub-id pub-id-type="doi">10.1093/molehr/5.11.995</pub-id><pub-id pub-id-type="pmid">10541560</pub-id></mixed-citation>
</ref>
<ref id="B352">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sahu</surname><given-names>B.</given-names></name><name><surname>Sun</surname><given-names>W.</given-names></name><name><surname>Perusek</surname><given-names>L.</given-names></name><name><surname>Parmar</surname><given-names>V.</given-names></name><name><surname>Le</surname><given-names>Y. Z.</given-names></name><name><surname>Griswold</surname><given-names>M. D.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Conditional ablation of retinol dehydrogenase 10 in the retinal pigmented epithelium causes delayed dark adaption in mice</article-title>. <source/>J. Biol. Chem.
<volume>290</volume>, <fpage>27239</fpage>–<lpage>27247</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M115.682096</pub-id><pub-id pub-id-type="pmid">26391396</pub-id></mixed-citation>
</ref>
<ref id="B353">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname><given-names>H.</given-names></name><name><surname>Yanaihara</surname><given-names>T.</given-names></name></person-group> (<year>1998</year>). <article-title>Steroid formation in osteoblast-like cells</article-title>. <source/>J. Int. Med. Res.
<volume>26</volume>, <fpage>1</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1177/030006059802600101</pub-id><pub-id pub-id-type="pmid">9513072</pub-id></mixed-citation>
</ref>
<ref id="B354">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saitoh</surname><given-names>Y.</given-names></name><name><surname>Sasano</surname><given-names>H.</given-names></name><name><surname>Naganuma</surname><given-names>H.</given-names></name><name><surname>Ohtani</surname><given-names>H.</given-names></name><name><surname>Sasano</surname><given-names>N.</given-names></name><name><surname>Ohuchi</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>1992</year>). <article-title><italic>De novo</italic> expression of aromatase in gastric carcinoma. Light and electron microscopic immunohistochemical and immunoblot study</article-title>. <source/>Pathol. Res. Pract.
<volume>188</volume>, <fpage>53</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/S0344-0338(11)81156-8</pub-id><pub-id pub-id-type="pmid">1594500</pub-id></mixed-citation>
</ref>
<ref id="B355">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakiani</surname><given-names>S.</given-names></name><name><surname>Olsen</surname><given-names>N. J.</given-names></name><name><surname>Kovacs</surname><given-names>W. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Gonadal steroids and humoral immunity</article-title>. <source/>Nat. Rev. Endocrinol.
<volume>9</volume>, <fpage>56</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1038/nrendo.2012.206</pub-id><pub-id pub-id-type="pmid">23183675</pub-id></mixed-citation>
</ref>
<ref id="B356">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakurai</surname><given-names>N.</given-names></name><name><surname>Miki</surname><given-names>Y.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Watanabe</surname><given-names>K.</given-names></name><name><surname>Narita</surname><given-names>T.</given-names></name><name><surname>Ando</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Systemic distribution and tissue localizations of human 17β-hydroxysteroid dehydrogenase type 12</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>99</volume>, <fpage>174</fpage>–<lpage>181</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsbmb.2006.01.010</pub-id><pub-id pub-id-type="pmid">16621523</pub-id></mixed-citation>
</ref>
<ref id="B357">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salas</surname><given-names>S.</given-names></name><name><surname>Jezequel</surname><given-names>P.</given-names></name><name><surname>Campion</surname><given-names>L.</given-names></name><name><surname>Deville</surname><given-names>J. L.</given-names></name><name><surname>Chibon</surname><given-names>F.</given-names></name><name><surname>Bartoli</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Molecular characterization of the response to chemotherapy in conventional osteosarcomas: predictive value of HSD17B10 and IFITM2</article-title>. <source/>Int. J. Cancer
<volume>125</volume>, <fpage>851</fpage>–<lpage>860</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.24457</pub-id><pub-id pub-id-type="pmid">19449377</pub-id></mixed-citation>
</ref>
<ref id="B358">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salman</surname><given-names>E. D.</given-names></name><name><surname>Faye-Petersen</surname><given-names>O.</given-names></name><name><surname>Falany</surname><given-names>C. N.</given-names></name></person-group> (<year>2011</year>). <article-title>Hydroxysteroid sulfotransferase 2B1b expression and localization in normal human brain</article-title>. <source/>Horm. Mol. Biol. Clin. Investig.
<volume>8</volume>, <fpage>445</fpage>–<lpage>454</lpage>. <pub-id pub-id-type="doi">10.1515/HMBCI.2011.117</pub-id><pub-id pub-id-type="pmid">24683427</pub-id></mixed-citation>
</ref>
<ref id="B359">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salman</surname><given-names>E. D.</given-names></name><name><surname>Kadlubar</surname><given-names>S. A.</given-names></name><name><surname>Falany</surname><given-names>C. N.</given-names></name></person-group> (<year>2009</year>). <article-title>Expression and localization of cytosolic sulfotransferase (SULT) 1A1 and SULT1A3 in normal human brain</article-title>. <source/>Drug Metab. Dispos.
<volume>37</volume>, <fpage>706</fpage>–<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1124/dmd.108.025767</pub-id><pub-id pub-id-type="pmid">19171676</pub-id></mixed-citation>
</ref>
<ref id="B360">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saloniemi</surname><given-names>T.</given-names></name><name><surname>Jarvensivu</surname><given-names>P.</given-names></name><name><surname>Koskimies</surname><given-names>P.</given-names></name><name><surname>Jokela</surname><given-names>H.</given-names></name><name><surname>Lamminen</surname><given-names>T.</given-names></name><name><surname>Ghaem-Maghami</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Novel hydroxysteroid (17β) dehydrogenase 1 inhibitors reverse estrogen-induced endometrial hyperplasia in transgenic mice</article-title>. <source/>Am. J. Pathol.
<volume>176</volume>, <fpage>1443</fpage>–<lpage>1451</lpage>. <pub-id pub-id-type="doi">10.2353/ajpath.2010.090325</pub-id><pub-id pub-id-type="pmid">20093485</pub-id></mixed-citation>
</ref>
<ref id="B361">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sánchez-Guijo</surname><given-names>A.</given-names></name><name><surname>Neunzig</surname><given-names>J.</given-names></name><name><surname>Gerber</surname><given-names>A.</given-names></name><name><surname>Oji</surname><given-names>V.</given-names></name><name><surname>Hartmann</surname><given-names>M. F.</given-names></name><name><surname>Schuppe</surname><given-names>H. C.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Role of steroid sulfatase in steroid homeostasis and characterization of the sulfated steroid pathway: Evidence from steroid sulfatase deficiency</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>437</volume>, <fpage>142</fpage>–<lpage>153</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2016.08.019</pub-id><pub-id pub-id-type="pmid">27531568</pub-id></mixed-citation>
</ref>
<ref id="B362">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasano</surname><given-names>H.</given-names></name><name><surname>Takashashi</surname><given-names>K.</given-names></name><name><surname>Satoh</surname><given-names>F.</given-names></name><name><surname>Nagura</surname><given-names>H.</given-names></name><name><surname>Harada</surname><given-names>N.</given-names></name></person-group> (<year>1998</year>). <article-title>Aromatase in the human central nervous system</article-title>. <source/>Clin. Endocrinol. (Oxf).
<volume>48</volume>, <fpage>325</fpage>–<lpage>329</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2265.1998.00390.x</pub-id><pub-id pub-id-type="pmid">9578823</pub-id></mixed-citation>
</ref>
<ref id="B363">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasano</surname><given-names>H.</given-names></name><name><surname>Uzuki</surname><given-names>M.</given-names></name><name><surname>Sawai</surname><given-names>T.</given-names></name><name><surname>Nagura</surname><given-names>H.</given-names></name><name><surname>Matsunaga</surname><given-names>G.</given-names></name><name><surname>Kashimoto</surname><given-names>O.</given-names></name><etal></etal></person-group>. (<year>1997</year>). <article-title>Aromatase in human bone tissue</article-title>. <source/>J. Bone Miner. Res.
<volume>12</volume>, <fpage>1416</fpage>–<lpage>1423</lpage>. <pub-id pub-id-type="doi">10.1359/jbmr.1997.12.9.1416</pub-id><pub-id pub-id-type="pmid">9286757</pub-id></mixed-citation>
</ref>
<ref id="B364">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sathish</surname><given-names>V.</given-names></name><name><surname>Martin</surname><given-names>Y. N.</given-names></name><name><surname>Prakash</surname><given-names>Y. S.</given-names></name></person-group> (<year>2015</year>). <article-title>Sex steroid signaling: implications for lung diseases</article-title>. <source/>Pharmacol. Ther.
<volume>150</volume>, <fpage>94</fpage>–<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2015.01.007</pub-id><pub-id pub-id-type="pmid">25595323</pub-id></mixed-citation>
</ref>
<ref id="B365">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>R.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Katayose</surname><given-names>Y.</given-names></name><name><surname>Miura</surname><given-names>K.</given-names></name><name><surname>Shiiba</surname><given-names>K.</given-names></name><name><surname>Miki</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Aromatase in colon carcinoma</article-title>. <source/>Anticancer Res.
<volume>32</volume>, <fpage>3069</fpage>–<lpage>3075</lpage>.<pub-id pub-id-type="pmid">22843875</pub-id></mixed-citation>
</ref>
<ref id="B366">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>R.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Katayose</surname><given-names>Y.</given-names></name><name><surname>Miura</surname><given-names>K.</given-names></name><name><surname>Shiiba</surname><given-names>K.</given-names></name><name><surname>Tateno</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Steroid sulfatase and estrogen sulfotransferase in colon carcinoma: regulators of intratumoral estrogen concentrations and potent prognostic factors</article-title>. <source/>Cancer Res.
<volume>69</volume>, <fpage>914</fpage>–<lpage>922</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-0906</pub-id><pub-id pub-id-type="pmid">19141651</pub-id></mixed-citation>
</ref>
<ref id="B367">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schweikert</surname><given-names>H. U.</given-names></name><name><surname>Wolf</surname><given-names>L.</given-names></name><name><surname>Romalo</surname><given-names>G.</given-names></name></person-group> (<year>1995</year>). <article-title>Oestrogen formation from androstenedione in human bone</article-title>. <source/>Clin. Endocrinol. (Oxf).
<volume>43</volume>, <fpage>37</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2265.1995.tb01890.x</pub-id><pub-id pub-id-type="pmid">7641410</pub-id></mixed-citation>
</ref>
<ref id="B368">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scublinsky</surname><given-names>A.</given-names></name><name><surname>Marin</surname><given-names>C.</given-names></name><name><surname>Gurpide</surname><given-names>E.</given-names></name></person-group> (<year>1976</year>). <article-title>Localization of estradiol 17β dehydrogenase in human endometrium</article-title>. <source/>J. Steroid Biochem.
<volume>7</volume>, <fpage>745</fpage>–<lpage>747</lpage>. <pub-id pub-id-type="doi">10.1016/0022-4731(76)90174-6</pub-id><pub-id pub-id-type="pmid">1011831</pub-id></mixed-citation>
</ref>
<ref id="B369">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segawa</surname><given-names>T.</given-names></name><name><surname>Shozu</surname><given-names>M.</given-names></name><name><surname>Murakami</surname><given-names>K.</given-names></name><name><surname>Kasai</surname><given-names>T.</given-names></name><name><surname>Shinohara</surname><given-names>K.</given-names></name><name><surname>Nomura</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Aromatase expression in stromal cells of endometrioid endometrial cancer correlates with poor survival</article-title>. <source/>Clin. Cancer Res.
<volume>11</volume>, <fpage>2188</fpage>–<lpage>2194</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-04-1859</pub-id><pub-id pub-id-type="pmid">15788666</pub-id></mixed-citation>
</ref>
<ref id="B370">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selcer</surname><given-names>K. W.</given-names></name><name><surname>Difrancesca</surname><given-names>H. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Characterization of steroid sulfatase in the MC3T3-E1 mouse pre-osteoblastic cell line</article-title>. <source/>Steroids
<volume>77</volume>, <fpage>696</fpage>–<lpage>702</lpage>. <pub-id pub-id-type="doi">10.1016/j.steroids.2012.02.024</pub-id><pub-id pub-id-type="pmid">22426324</pub-id></mixed-citation>
</ref>
<ref id="B371">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Setiawan</surname><given-names>V. W.</given-names></name><name><surname>Doherty</surname><given-names>J. A.</given-names></name><name><surname>Shu</surname><given-names>X. O.</given-names></name><name><surname>Akbari</surname><given-names>M. R.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>De Vivo</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Two estrogen-related variants in CYP<sub>19</sub>A<sub>1</sub> and endometrial cancer risk: a pooled analysis in the epidemiology of endometrial cancer consortium</article-title>. <source/>Cancer Epidemiol. Biomarkers Prev.
<volume>18</volume>, <fpage>242</fpage>–<lpage>247</lpage>. <pub-id pub-id-type="doi">10.1158/1055-9965.EPI-08-0689</pub-id><pub-id pub-id-type="pmid">19124504</pub-id></mixed-citation>
</ref>
<ref id="B372">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Setiawan</surname><given-names>V. W.</given-names></name><name><surname>Hankinson</surname><given-names>S. E.</given-names></name><name><surname>Colditz</surname><given-names>G. A.</given-names></name><name><surname>Hunter</surname><given-names>D. J.</given-names></name><name><surname>De Vivo</surname><given-names>I.</given-names></name></person-group> (<year>2004</year>). <article-title>HSD17B1 gene polymorphisms and risk of endometrial and breast cancer</article-title>. <source/>Cancer Epidemiol. Biomarkers Prev.
<volume>13</volume>, <fpage>213</fpage>–<lpage>219</lpage>. <pub-id pub-id-type="doi">10.1158/1055-9965.EPI-03-0241</pub-id><pub-id pub-id-type="pmid">14973105</pub-id></mixed-citation>
</ref>
<ref id="B373">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shang</surname><given-names>E.</given-names></name><name><surname>Lai</surname><given-names>K.</given-names></name><name><surname>Packer</surname><given-names>A. I.</given-names></name><name><surname>Paik</surname><given-names>J.</given-names></name><name><surname>Blaner</surname><given-names>W. S.</given-names></name><name><surname>de Morais Vieira</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Targeted disruption of the mouse cis-retinol dehydrogenase gene: visual and nonvisual functions</article-title>. <source/>J. Lipid Res.
<volume>43</volume>, <fpage>590</fpage>–<lpage>597</lpage>.<pub-id pub-id-type="pmid">11907141</pub-id></mixed-citation>
</ref>
<ref id="B374">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shehu</surname><given-names>A.</given-names></name><name><surname>Mao</surname><given-names>J.</given-names></name><name><surname>Gibori</surname><given-names>G. B.</given-names></name><name><surname>Halperin</surname><given-names>J.</given-names></name><name><surname>Le</surname><given-names>J.</given-names></name><name><surname>Devi</surname><given-names>Y. S.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Prolactin receptor-associated protein/17β-hydroxysteroid dehydrogenase type 7 gene (Hsd17b7) plays a crucial role in embryonic development and fetal survival</article-title>. <source/>Mol. Endocrinol.
<volume>22</volume>, <fpage>2268</fpage>–<lpage>2277</lpage>. <pub-id pub-id-type="doi">10.1210/me.2008-0165</pub-id><pub-id pub-id-type="pmid">18669642</pub-id></mixed-citation>
</ref>
<ref id="B375">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>Z.</given-names></name><name><surname>Peng</surname><given-names>Z.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Vaananen</surname><given-names>H. K.</given-names></name><name><surname>Poutanen</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>Overexpression of human hydroxysteroid (17β) dehydrogenase 2 induces disturbance in skeletal development in young male mice</article-title>. <source/>J. Bone Miner. Res.
<volume>23</volume>, <fpage>1217</fpage>–<lpage>1226</lpage>. <pub-id pub-id-type="doi">10.1359/jbmr.080322</pub-id><pub-id pub-id-type="pmid">18348690</pub-id></mixed-citation>
</ref>
<ref id="B376">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Dong</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>B.</given-names></name></person-group> (<year>2016</year>). <article-title>Polymorphism of HSD17B1 Ser312Gly with Cancer Risk: Evidence from 66,147 Subjects</article-title>. <source/>Twin Res. Hum. Genet.
<volume>19</volume>, <fpage>136</fpage>–<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1017/thg.2016.6</pub-id><pub-id pub-id-type="pmid">26923943</pub-id></mixed-citation>
</ref>
<ref id="B377">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shim</surname><given-names>G. J.</given-names></name><name><surname>Warner</surname><given-names>M.</given-names></name><name><surname>Kim</surname><given-names>H. J.</given-names></name><name><surname>Andersson</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Ekman</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Aromatase-deficient mice spontaneously develop a lymphoproliferative autoimmune disease resembling Sjogren's syndrome</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>101</volume>, <fpage>12628</fpage>–<lpage>12633</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0405099101</pub-id><pub-id pub-id-type="pmid">15314222</pub-id></mixed-citation>
</ref>
<ref id="B378">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>K.</given-names></name></person-group> (<year>1979</year>). <article-title>Metabolism of [17-<sup>2</sup>H]pregnenolone into 5-[17β-<sup>2</sup>H, 17α-<sup>18</sup>O]androstene-3β, 17α-diol and other products by incubation with the microsomal fraction of boar testis under <sup>18</sup>O<sub>2</sub> atmosphere</article-title>. <source/>Biochim. Biophys. Acta
<volume>575</volume>, <fpage>37</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/0005-2760(79)90128-0</pub-id><pub-id pub-id-type="pmid">159724</pub-id></mixed-citation>
</ref>
<ref id="B379">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimodaira</surname><given-names>M.</given-names></name><name><surname>Nakayama</surname><given-names>T.</given-names></name><name><surname>Sato</surname><given-names>I.</given-names></name><name><surname>Sato</surname><given-names>N.</given-names></name><name><surname>Izawa</surname><given-names>N.</given-names></name><name><surname>Mizutani</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Estrogen synthesis genes CYP<sub>19</sub>A<sub>1</sub>, HSD<sub>3</sub>B<sub>1</sub>, and HSD<sub>3</sub>B<sub>2</sub> in hypertensive disorders of pregnancy</article-title>. <source/>Endocrine
<volume>42</volume>, <fpage>700</fpage>–<lpage>707</lpage>. <pub-id pub-id-type="doi">10.1007/s12020-012-9699-7</pub-id><pub-id pub-id-type="pmid">22638611</pub-id></mixed-citation>
</ref>
<ref id="B380">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimodaira</surname><given-names>M.</given-names></name><name><surname>Nakayama</surname><given-names>T.</given-names></name><name><surname>Sato</surname><given-names>N.</given-names></name><name><surname>Aoi</surname><given-names>N.</given-names></name><name><surname>Sato</surname><given-names>M.</given-names></name><name><surname>Izumi</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Association of HSD3B1 and HSD3B2 gene polymorphisms with essential hypertension, aldosterone level, and left ventricular structure</article-title>. <source/>Eur. J. Endocrinol.
<volume>163</volume>, <fpage>671</fpage>–<lpage>680</lpage>. <pub-id pub-id-type="doi">10.1530/EJE-10-0428</pub-id><pub-id pub-id-type="pmid">20660004</pub-id></mixed-citation>
</ref>
<ref id="B381">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegfried</surname><given-names>J. M.</given-names></name><name><surname>Stabile</surname><given-names>L. P.</given-names></name></person-group> (<year>2014</year>). <article-title>Estrongenic steroid hormones in lung cancer</article-title>. <source/>Semin. Oncol.
<volume>41</volume>, <fpage>5</fpage>–<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1053/j.seminoncol.2013.12.009</pub-id><pub-id pub-id-type="pmid">24565577</pub-id></mixed-citation>
</ref>
<ref id="B382">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simard</surname><given-names>J.</given-names></name><name><surname>Ricketts</surname><given-names>M. L.</given-names></name><name><surname>Gingras</surname><given-names>S.</given-names></name><name><surname>Soucy</surname><given-names>P.</given-names></name><name><surname>Feltus</surname><given-names>F. A.</given-names></name><name><surname>Melner</surname><given-names>M. H.</given-names></name></person-group> (<year>2005</year>). <article-title>Molecular biology of the 3β-hydroxysteroid dehydrogenase/Δ<sup>5</sup>-Δ<sup>4</sup> isomerase gene family</article-title>. <source/>Endocr. Rev.
<volume>26</volume>, <fpage>525</fpage>–<lpage>582</lpage>. <pub-id pub-id-type="doi">10.1210/er.2002-0050</pub-id><pub-id pub-id-type="pmid">15632317</pub-id></mixed-citation>
</ref>
<ref id="B383">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simard</surname><given-names>M.</given-names></name><name><surname>Plante</surname><given-names>J.</given-names></name><name><surname>Boucher</surname><given-names>M.</given-names></name><name><surname>Provost</surname><given-names>P. R.</given-names></name><name><surname>Tremblay</surname><given-names>Y.</given-names></name></person-group> (<year>2010</year>). <article-title>Type 2 and 5, 17β-hydroxysteroid dehydrogenases and androgen receptor in human fetal lungs</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>319</volume>, <fpage>79</fpage>–<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2009.12.007</pub-id><pub-id pub-id-type="pmid">20025932</pub-id></mixed-citation>
</ref>
<ref id="B384">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simoens</surname><given-names>S.</given-names></name><name><surname>Dunselman</surname><given-names>G.</given-names></name><name><surname>Dirksen</surname><given-names>C.</given-names></name><name><surname>Hummelshoj</surname><given-names>L.</given-names></name><name><surname>Bokor</surname><given-names>A.</given-names></name><name><surname>Brandes</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres</article-title>. <source/>Hum. Reprod.
<volume>27</volume>, <fpage>1292</fpage>–<lpage>1299</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/des073</pub-id><pub-id pub-id-type="pmid">22422778</pub-id></mixed-citation>
</ref>
<ref id="B385">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simoens</surname><given-names>S.</given-names></name><name><surname>Hummelshoj</surname><given-names>L.</given-names></name><name><surname>Dunselman</surname><given-names>G.</given-names></name><name><surname>Brandes</surname><given-names>I.</given-names></name><name><surname>Dirksen</surname><given-names>C.</given-names></name><name><surname>D'Hooghe</surname><given-names>T.</given-names></name></person-group> (<year>2011</year>). <article-title>Endometriosis cost assessment (the EndoCost study): a cost-of-illness study protocol</article-title>. <source/>Gynecol. Obstet. Invest.
<volume>71</volume>, <fpage>170</fpage>–<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1159/000316055</pub-id><pub-id pub-id-type="pmid">21160141</pub-id></mixed-citation>
</ref>
<ref id="B386">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>M. M.</given-names></name><name><surname>Trivedi</surname><given-names>R. N.</given-names></name><name><surname>Chauhan</surname><given-names>S. C.</given-names></name><name><surname>Srivastava</surname><given-names>V. M.</given-names></name><name><surname>Makker</surname><given-names>A.</given-names></name><name><surname>Chowdhury</surname><given-names>S. R.</given-names></name><etal></etal></person-group>. (<year>1996</year>). <article-title>Uterine estradiol and progesterone receptor concentration, activities of certain antioxidant enzymes and dehydrogenases and histoarchitecture in relation to time of secretion of nidatory estrogen and high endometrial sensitivity in rat</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>59</volume>, <fpage>215</fpage>–<lpage>224</lpage>. <pub-id pub-id-type="doi">10.1016/S0960-0760(96)00102-1</pub-id><pub-id pub-id-type="pmid">9010337</pub-id></mixed-citation>
</ref>
<ref id="B387">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singhal</surname><given-names>N.</given-names></name><name><surname>Vatandoust</surname><given-names>S.</given-names></name><name><surname>Brown</surname><given-names>M. P.</given-names></name></person-group> (<year>2015</year>). <article-title>Phase II study evaluating efficacy and safety of everolimus with letrozole for management of advanced (unresectable or metastatic) non-small cell lung cancer after failure of platinum-based treatment: a preliminary analysis of toxicity</article-title>. <source/>Cancer Chemother. Pharmacol.
<volume>75</volume>, <fpage>325</fpage>–<lpage>331</lpage>. <pub-id pub-id-type="doi">10.1007/s00280-014-2644-0</pub-id><pub-id pub-id-type="pmid">25502181</pub-id></mixed-citation>
</ref>
<ref id="B388">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinreih</surname><given-names>M.</given-names></name><name><surname>Anko</surname><given-names>M.</given-names></name><name><surname>Zukunft</surname><given-names>S.</given-names></name><name><surname>Adamski</surname><given-names>J.</given-names></name><name><surname>Rizner</surname><given-names>T. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Important roles of the AKR1C2 and SRD5A1 enzymes in progesterone metabolism in endometrial cancer model cell lines</article-title>. <source/>Chem. Biol. Interact. <volume>234</volume>, <fpage>297</fpage>–<lpage>308</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbi.2014.11.012</pub-id><pub-id pub-id-type="pmid">25463305</pub-id></mixed-citation>
</ref>
<ref id="B389">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinreih</surname><given-names>M.</given-names></name><name><surname>Hevir</surname><given-names>N.</given-names></name><name><surname>Rizner</surname><given-names>T. L.</given-names></name></person-group> (<year>2013</year>). <article-title>Altered expression of genes involved in progesterone biosynthesis, metabolism and action in endometrial cancer</article-title>. <source/>Chem. Biol. Interact.
<volume>202</volume>, <fpage>210</fpage>–<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbi.2012.11.012</pub-id><pub-id pub-id-type="pmid">23200943</pub-id></mixed-citation>
</ref>
<ref id="B390">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinreih</surname><given-names>M.</given-names></name><name><surname>Knific</surname><given-names>T.</given-names></name><name><surname>Anko</surname><given-names>M.</given-names></name><name><surname>Hevir</surname><given-names>N.</given-names></name><name><surname>Vouk</surname><given-names>K.</given-names></name><name><surname>Jerin</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2017a</year>). <article-title>The significance of the sulfatase pathway for local estrogen formation in endometrial cancer</article-title>. <source/>Front. Pharmacol.
<volume>8</volume>:<fpage>368</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2017.00368</pub-id><pub-id pub-id-type="pmid">28690541</pub-id></mixed-citation>
</ref>
<ref id="B391">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinreih</surname><given-names>M.</given-names></name><name><surname>Stupar</surname><given-names>S.</given-names></name><name><surname>Cemazar</surname><given-names>L.</given-names></name><name><surname>Verdenik</surname><given-names>I.</given-names></name><name><surname>Frkovic Grazio</surname><given-names>S.</given-names></name><name><surname>Smrkolj</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2017b</year>). <article-title>STAR and AKR1B10 are down-regulated in high-grade endometrial cancer</article-title>. <source/>J. Steroid Biochem. Mol. Biol.. <pub-id pub-id-type="doi">10.1016/j.jsbmb.2017.02.015</pub-id><pub-id pub-id-type="pmid">28232277</pub-id></mixed-citation>
</ref>
<ref id="B392">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sivik</surname><given-names>T.</given-names></name></person-group> (<year>2012</year>). <article-title>Elucidating the <italic>Role</italic> of 17β <italic>Hydroxysteroid Dehydrogenase Type</italic> 14 in <italic>Normal Physiology and in Breast Cancer</italic></article-title>. <publisher-name>Department of Clinical and Experimental Medicine</publisher-name>: <publisher-loc>Linköping University (Linköping)</publisher-loc>.</mixed-citation>
</ref>
<ref id="B393">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skjefstad</surname><given-names>K.</given-names></name><name><surname>Grindstad</surname><given-names>T.</given-names></name><name><surname>Khanehkenari</surname><given-names>M. R.</given-names></name><name><surname>Richardsen</surname><given-names>E.</given-names></name><name><surname>Donnem</surname><given-names>T.</given-names></name><name><surname>Kilvaer</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Prognostic relevance of estrogen receptor α, β and aromatase expression in non-small cell lung cancer</article-title>. <source/>Steroids
<volume>113</volume>, <fpage>5</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.steroids.2016.05.008</pub-id><pub-id pub-id-type="pmid">27234503</pub-id></mixed-citation>
</ref>
<ref id="B394">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slominski</surname><given-names>A.</given-names></name><name><surname>Zbytek</surname><given-names>B.</given-names></name><name><surname>Nikolakis</surname><given-names>G.</given-names></name><name><surname>Manna</surname><given-names>P. R.</given-names></name><name><surname>Skobowiat</surname><given-names>C.</given-names></name><name><surname>Zmijewski</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Steroidogenesis in the skin: implications for local immune functions</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>137</volume>, <fpage>107</fpage>–<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsbmb.2013.02.006</pub-id><pub-id pub-id-type="pmid">23435015</pub-id></mixed-citation>
</ref>
<ref id="B395">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slomovitz</surname><given-names>B. M.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Yates</surname><given-names>M. S.</given-names></name><name><surname>Soliman</surname><given-names>P. T.</given-names></name><name><surname>Johnston</surname><given-names>T.</given-names></name><name><surname>Nowakowski</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma</article-title>. <source/>J. Clin. Oncol.
<volume>33</volume>, <fpage>930</fpage>–<lpage>936</lpage>. <pub-id pub-id-type="doi">10.1200/JCO.2014.58.3401</pub-id><pub-id pub-id-type="pmid">25624430</pub-id></mixed-citation>
</ref>
<ref id="B396">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>A.</given-names></name><name><surname>Contreras</surname><given-names>C.</given-names></name><name><surname>Ko</surname><given-names>K. H.</given-names></name><name><surname>Chow</surname><given-names>J.</given-names></name><name><surname>Dong</surname><given-names>X.</given-names></name><name><surname>Tuo</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Gender-specific protection of estrogen against gastric acid-induced duodenal injury: stimulation of duodenal mucosal bicarbonate secretion</article-title>. <source/>Endocrinology
<volume>149</volume>, <fpage>4554</fpage>–<lpage>4566</lpage>. <pub-id pub-id-type="doi">10.1210/en.2007-1597</pub-id><pub-id pub-id-type="pmid">18499763</pub-id></mixed-citation>
</ref>
<ref id="B397">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>E. P.</given-names></name><name><surname>Boyd</surname><given-names>J.</given-names></name><name><surname>Frank</surname><given-names>G. R.</given-names></name><name><surname>Takahashi</surname><given-names>H.</given-names></name><name><surname>Cohen</surname><given-names>R. M.</given-names></name><name><surname>Specker</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>1994</year>). <article-title>Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man</article-title>. <source/>N. Engl. J. Med.
<volume>331</volume>, <fpage>1056</fpage>–<lpage>1061</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM199410203311604</pub-id><pub-id pub-id-type="pmid">8090165</pub-id></mixed-citation>
</ref>
<ref id="B398">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smuc</surname><given-names>T.</given-names></name><name><surname>Hevir</surname><given-names>N.</given-names></name><name><surname>Ribic-Pucelj</surname><given-names>M.</given-names></name><name><surname>Husen</surname><given-names>B.</given-names></name><name><surname>Thole</surname><given-names>H.</given-names></name><name><surname>Rizner</surname><given-names>T. L.</given-names></name></person-group> (<year>2009</year>). <article-title>Disturbed estrogen and progesterone action in ovarian endometriosis</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>301</volume>, <fpage>59</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2008.07.020</pub-id><pub-id pub-id-type="pmid">18762229</pub-id></mixed-citation>
</ref>
<ref id="B399">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smuc</surname><given-names>T.</given-names></name><name><surname>Pucelj</surname><given-names>M. R.</given-names></name><name><surname>Sinkovec</surname><given-names>J.</given-names></name><name><surname>Husen</surname><given-names>B.</given-names></name><name><surname>Thole</surname><given-names>H.</given-names></name><name><surname>Lanisnik Rizner</surname><given-names>T.</given-names></name></person-group> (<year>2007</year>). <article-title>Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis</article-title>. <source/>Gynecol. Endocrinol.
<volume>23</volume>, <fpage>105</fpage>–<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1080/09513590601152219</pub-id><pub-id pub-id-type="pmid">17454161</pub-id></mixed-citation>
</ref>
<ref id="B400">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smuc</surname><given-names>T.</given-names></name><name><surname>Rizner</surname><given-names>T. L.</given-names></name></person-group> (<year>2009</year>). <article-title>Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>301</volume>, <fpage>74</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2008.09.019</pub-id><pub-id pub-id-type="pmid">18930784</pub-id></mixed-citation>
</ref>
<ref id="B401">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smuc</surname><given-names>T.</given-names></name><name><surname>Rupreht</surname><given-names>R.</given-names></name><name><surname>Sinkovec</surname><given-names>J.</given-names></name><name><surname>Adamski</surname><given-names>J.</given-names></name><name><surname>Rizner</surname><given-names>T. L.</given-names></name></person-group> (<year>2006</year>). <article-title>Expression analysis of estrogen-metabolizing enzymes in human endometrial cancer</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>248</volume>, <fpage>114</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2005.10.013</pub-id><pub-id pub-id-type="pmid">16337331</pub-id></mixed-citation>
</ref>
<ref id="B402">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soma</surname><given-names>K. K.</given-names></name><name><surname>Rendon</surname><given-names>N. M.</given-names></name><name><surname>Boonstra</surname><given-names>R.</given-names></name><name><surname>Albers</surname><given-names>H. E.</given-names></name><name><surname>Demas</surname><given-names>G. E.</given-names></name></person-group> (<year>2015</year>). <article-title>DHEA effects on brain and behavior: insights from comparative studies of aggression</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>145</volume>, <fpage>261</fpage>–<lpage>272</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsbmb.2014.05.011</pub-id><pub-id pub-id-type="pmid">24928552</pub-id></mixed-citation>
</ref>
<ref id="B403">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soubhye</surname><given-names>J.</given-names></name><name><surname>Alard</surname><given-names>I. C.</given-names></name><name><surname>van Antwerpen</surname><given-names>P.</given-names></name><name><surname>Dufrasne</surname><given-names>F.</given-names></name></person-group> (<year>2015</year>). <article-title>Type 2, 17-beta hydroxysteroid dehydrogenase as a novel target for the treatment of osteoporosis</article-title>. <source/>Future Med. Chem.
<volume>7</volume>, <fpage>1431</fpage>–<lpage>1456</lpage>. <pub-id pub-id-type="doi">10.4155/fmc.15.74</pub-id><pub-id pub-id-type="pmid">26230882</pub-id></mixed-citation>
</ref>
<ref id="B404">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steckelbroeck</surname><given-names>S.</given-names></name><name><surname>Jin</surname><given-names>Y.</given-names></name><name><surname>Gopishetty</surname><given-names>S.</given-names></name><name><surname>Oyesanmi</surname><given-names>B.</given-names></name><name><surname>Penning</surname><given-names>T. M.</given-names></name></person-group> (<year>2004a</year>). <article-title>Human cytosolic 3alpha-hydroxysteroid dehydrogenases of the aldo-keto reductase superfamily display significant 3beta-hydroxysteroid dehydrogenase activity: implications for steroid hormone metabolism and action</article-title>. <source/>J. Biol. Chem.
<volume>279</volume>, <fpage>10784</fpage>–<lpage>10795</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M313308200</pub-id><pub-id pub-id-type="pmid">14672942</pub-id></mixed-citation>
</ref>
<ref id="B405">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steckelbroeck</surname><given-names>S.</given-names></name><name><surname>Lutjohann</surname><given-names>D.</given-names></name><name><surname>Bauman</surname><given-names>D. R.</given-names></name><name><surname>Ludwig</surname><given-names>M.</given-names></name><name><surname>Friedl</surname><given-names>A.</given-names></name><name><surname>Hans</surname><given-names>V. H.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Non-stereo-selective cytosolic human brain tissue 3-ketosteroid reductase is refractory to inhibition by AKR1C inhibitors</article-title>. <source/>Biochim. Biophys. Act.
<volume>1801</volume>, <fpage>1221</fpage>–<lpage>1231</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbalip.2010.07.005</pub-id><pub-id pub-id-type="pmid">20673851</pub-id></mixed-citation>
</ref>
<ref id="B406">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steckelbroeck</surname><given-names>S.</given-names></name><name><surname>Nassen</surname><given-names>A.</given-names></name><name><surname>Ugele</surname><given-names>B.</given-names></name><name><surname>Ludwig</surname><given-names>M.</given-names></name><name><surname>Watzka</surname><given-names>M.</given-names></name><name><surname>Reissinger</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2004b</year>). <article-title>Steroid sulfatase (STS) expression in the human temporal lobe: enzyme activity, mRNA expression and immunohistochemistry study</article-title>. <source/>J. Neurochem.
<volume>89</volume>, <fpage>403</fpage>–<lpage>417</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.2004.02336.x</pub-id><pub-id pub-id-type="pmid">15056284</pub-id></mixed-citation>
</ref>
<ref id="B407">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steckelbroeck</surname><given-names>S.</given-names></name><name><surname>Stoffel-Wagner</surname><given-names>B.</given-names></name><name><surname>Reichelt</surname><given-names>R.</given-names></name><name><surname>Schramm</surname><given-names>J.</given-names></name><name><surname>Bidlingmaier</surname><given-names>F.</given-names></name><name><surname>Siekmann</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>Characterization of 17β-hydroxysteroid dehydrogenase activity in brain tissue: testosterone formation in the human temporal lobe</article-title>. <source/>J. Neuroendocrinol.
<volume>11</volume>, <fpage>457</fpage>–<lpage>464</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2826.1999.00363.x</pub-id><pub-id pub-id-type="pmid">10336727</pub-id></mixed-citation>
</ref>
<ref id="B408">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steckelbroeck</surname><given-names>S.</given-names></name><name><surname>Watzka</surname><given-names>M.</given-names></name><name><surname>Reichelt</surname><given-names>R.</given-names></name><name><surname>Hans</surname><given-names>V. H.</given-names></name><name><surname>Stoffel-Wagner</surname><given-names>B.</given-names></name><name><surname>Heidrich</surname><given-names>D. D.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Characterization of the 5α-reductase-3α-hydroxysteroid dehydrogenase complex in the human brain</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>86</volume>, <fpage>1324</fpage>–<lpage>1331</lpage>. <pub-id pub-id-type="doi">10.1210/jcem.86.3.7325</pub-id><pub-id pub-id-type="pmid">11238528</pub-id></mixed-citation>
</ref>
<ref id="B409">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steckelbroeck</surname><given-names>S.</given-names></name><name><surname>Watzka</surname><given-names>M.</given-names></name><name><surname>Reissinger</surname><given-names>A.</given-names></name><name><surname>Wegener-Toper</surname><given-names>P.</given-names></name><name><surname>Bidlingmaier</surname><given-names>F.</given-names></name><name><surname>Bliesener</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Characterisation of estrogenic 17β-hydroxysteroid dehydrogenase (17β-HSD) activity in the human brain</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>86</volume>, <fpage>79</fpage>–<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/S0960-0760(03)00251-6</pub-id><pub-id pub-id-type="pmid">12943747</pub-id></mixed-citation>
</ref>
<ref id="B410">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stelzer</surname><given-names>G.</given-names></name><name><surname>Rosen</surname><given-names>N.</given-names></name><name><surname>Plaschkes</surname><given-names>I.</given-names></name><name><surname>Zimmerman</surname><given-names>S.</given-names></name><name><surname>Twik</surname><given-names>M.</given-names></name><name><surname>Fishilevich</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>The GeneCards suite: from gene data mining to disease genome sequence analyses</article-title>. <source/>Curr Protoc Bioinformatics
<volume>54</volume>, <fpage>1.30, 31</fpage>–<lpage>31</lpage>, 30, 33. <pub-id pub-id-type="doi">10.1002/cpbi.5</pub-id><pub-id pub-id-type="pmid">27322403</pub-id></mixed-citation>
</ref>
<ref id="B411">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoffel-Wagner</surname><given-names>B.</given-names></name></person-group> (<year>2001</year>). <article-title>Neurosteroid metabolism in the human brain</article-title>. <source/>Eur. J. Endocrinol.
<volume>145</volume>, <fpage>669</fpage>–<lpage>679</lpage>. <pub-id pub-id-type="doi">10.1530/eje.0.1450669</pub-id><pub-id pub-id-type="pmid">11720889</pub-id></mixed-citation>
</ref>
<ref id="B412">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoffel-Wagner</surname><given-names>B.</given-names></name><name><surname>Beyenburg</surname><given-names>S.</given-names></name><name><surname>Watzka</surname><given-names>M.</given-names></name><name><surname>Blumcke</surname><given-names>I.</given-names></name><name><surname>Bauer</surname><given-names>J.</given-names></name><name><surname>Schramm</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Expression of 5α-reductase and 3α-hydroxisteroid oxidoreductase in the hippocampus of patients with chronic temporal lobe epilepsy</article-title>. <source/>Epilepsia
<volume>41</volume>, <fpage>140</fpage>–<lpage>147</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1157.2000.tb00133.x</pub-id><pub-id pub-id-type="pmid">10691110</pub-id></mixed-citation>
</ref>
<ref id="B413">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoffel-Wagner</surname><given-names>B.</given-names></name><name><surname>Watzka</surname><given-names>M.</given-names></name><name><surname>Schramm</surname><given-names>J.</given-names></name><name><surname>Bidlingmaier</surname><given-names>F.</given-names></name><name><surname>Klingmuller</surname><given-names>D.</given-names></name></person-group> (<year>1999a</year>). <article-title>Expression of CYP19 (aromatase) mRNA in different areas of the human brain</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>70</volume>, <fpage>237</fpage>–<lpage>241</lpage>. <pub-id pub-id-type="doi">10.1016/S0960-0760(99)00114-4</pub-id><pub-id pub-id-type="pmid">10622413</pub-id></mixed-citation>
</ref>
<ref id="B414">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoffel-Wagner</surname><given-names>B.</given-names></name><name><surname>Watzka</surname><given-names>M.</given-names></name><name><surname>Steckelbroeck</surname><given-names>S.</given-names></name><name><surname>Ludwig</surname><given-names>M.</given-names></name><name><surname>Clusmann</surname><given-names>H.</given-names></name><name><surname>Bidlingmaier</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Allopregnanolone serum levels and expression of 5 alpha-reductase and 3 alpha-hydroxysteroid dehydrogenase isoforms in hippocampal and temporal cortex of patients with epilepsy</article-title>. <source/>Epilepsy Res.
<volume>54</volume>, <fpage>11</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/S0920-1211(03)00036-6</pub-id><pub-id pub-id-type="pmid">12742591</pub-id></mixed-citation>
</ref>
<ref id="B415">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoffel-Wagner</surname><given-names>B.</given-names></name><name><surname>Watzka</surname><given-names>M.</given-names></name><name><surname>Steckelbroeck</surname><given-names>S.</given-names></name><name><surname>Schramm</surname><given-names>J.</given-names></name><name><surname>Bidlingmaier</surname><given-names>J. F.</given-names></name><name><surname>Klingmuller</surname><given-names>D.</given-names></name></person-group> (<year>1999b</year>). <article-title>Expression of 17β-hydroxysteroid dehydrogenase types 1, 2, 3 and 4 in the human temporal lobe</article-title>. <source/>J. Endocrinol.
<volume>160</volume>, <fpage>119</fpage>–<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1677/joe.0.1600119</pub-id><pub-id pub-id-type="pmid">9854183</pub-id></mixed-citation>
</ref>
<ref id="B416">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoffel-Wagner</surname><given-names>B.</given-names></name><name><surname>Watzka</surname><given-names>M.</given-names></name><name><surname>Steckelbroeck</surname><given-names>S.</given-names></name><name><surname>Schwaab</surname><given-names>R.</given-names></name><name><surname>Schramm</surname><given-names>J.</given-names></name><name><surname>Bidlingmaier</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>1998a</year>). <article-title>Expression of CYP19 (aromatase) mRNA in the human temporal lobe</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>244</volume>, <fpage>768</fpage>–<lpage>771</lpage>. <pub-id pub-id-type="doi">10.1006/bbrc.1998.8337</pub-id><pub-id pub-id-type="pmid">9535740</pub-id></mixed-citation>
</ref>
<ref id="B417">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoffel-Wagner</surname><given-names>B.</given-names></name><name><surname>Watzka</surname><given-names>M.</given-names></name><name><surname>Steckelbroeck</surname><given-names>S.</given-names></name><name><surname>Wickert</surname><given-names>L.</given-names></name><name><surname>Schramm</surname><given-names>J.</given-names></name><name><surname>Romalo</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>1998b</year>). <article-title>Expression of 5α-reductase in the human temporal lobe of children and adults</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>83</volume>, <fpage>3636</fpage>–<lpage>3642</lpage>.<pub-id pub-id-type="pmid">9768677</pub-id></mixed-citation>
</ref>
<ref id="B418">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strott</surname><given-names>C. A.</given-names></name></person-group> (<year>2002</year>). <article-title>Sulfonation and molecular action</article-title>. <source/>Endocr. Rev.
<volume>23</volume>, <fpage>703</fpage>–<lpage>732</lpage>. <pub-id pub-id-type="doi">10.1210/er.2001-0040</pub-id><pub-id pub-id-type="pmid">12372849</pub-id></mixed-citation>
</ref>
<ref id="B419">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sudeshna</surname><given-names>T.</given-names></name><name><surname>Anand</surname><given-names>K.</given-names></name><name><surname>Medhamurthy</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Analysis of 20α-hydroxysteroid dehydrogenase expression in the corpus luteum of the buffalo cow: effect of prostaglandin F2-α treatment on circulating 20α-hydroxyprogesterone levels</article-title>. <source/>Reprod. Biol. Endocrinol. 1<volume>1</volume>:<fpage>111</fpage>
<pub-id pub-id-type="doi">10.1186/1477-7827-11-111</pub-id></mixed-citation>
</ref>
<ref id="B420">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>X. F.</given-names></name><name><surname>Ahmadi</surname><given-names>A.</given-names></name><name><surname>Arbman</surname><given-names>G.</given-names></name><name><surname>Wallin</surname><given-names>A.</given-names></name><name><surname>Asklid</surname><given-names>D.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name></person-group> (<year>2005</year>). <article-title>Polymorphisms in sulfotransferase 1A1 and glutathione S-transferase P1 genes in relation to colorectal cancer risk and patients' survival</article-title>. <source/>World J. Gastroenterol.
<volume>11</volume>, <fpage>6875</fpage>–<lpage>6879</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v11.i43.6875</pub-id><pub-id pub-id-type="pmid">16425401</pub-id></mixed-citation>
</ref>
<ref id="B421">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Svoboda</surname><given-names>M.</given-names></name><name><surname>Hamilton</surname><given-names>G.</given-names></name><name><surname>Thalhammer</surname><given-names>T.</given-names></name></person-group> (<year>2010</year>). <article-title>Steroid hormone metabolizing enzymes in benign and malignant human bone tumors</article-title>. <source/>Expert Opin. Drug Metab. Toxicol.
<volume>6</volume>, <fpage>427</fpage>–<lpage>437</lpage>. <pub-id pub-id-type="doi">10.1517/17425251003592129</pub-id><pub-id pub-id-type="pmid">20102288</pub-id></mixed-citation>
</ref>
<ref id="B422">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Svoboda</surname><given-names>M.</given-names></name><name><surname>Thalhammer</surname><given-names>T.</given-names></name><name><surname>Aust</surname><given-names>S.</given-names></name><name><surname>Arrich</surname><given-names>F.</given-names></name><name><surname>Assadian</surname><given-names>O.</given-names></name><name><surname>Toma</surname><given-names>C. D.</given-names></name></person-group> (<year>2007</year>). <article-title>Estrogen sulfotransferase (SULT1E1) expression in benign and malignant human bone tumors</article-title>. <source/>J. Surg. Oncol.
<volume>95</volume>, <fpage>572</fpage>–<lpage>581</lpage>. <pub-id pub-id-type="doi">10.1002/jso.20748</pub-id><pub-id pub-id-type="pmid">17230544</pub-id></mixed-citation>
</ref>
<ref id="B423">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Syed</surname><given-names>F.</given-names></name><name><surname>Khosla</surname><given-names>S.</given-names></name></person-group> (<year>2005</year>). <article-title>Mechanisms of sex steroid effects on bone</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>328</volume>, <fpage>688</fpage>–<lpage>696</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2004.11.097</pub-id><pub-id pub-id-type="pmid">15694402</pub-id></mixed-citation>
</ref>
<ref id="B424">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taga</surname><given-names>S.</given-names></name><name><surname>Yoshida</surname><given-names>N.</given-names></name><name><surname>Sekiba</surname><given-names>K.</given-names></name></person-group> (<year>1990</year>). <article-title>Distribution and cyclic change of aromatase cytochrome P-450 activity in human uteri</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>37</volume>, <fpage>741</fpage>–<lpage>745</lpage>. <pub-id pub-id-type="doi">10.1016/0960-0760(90)90359-S</pub-id><pub-id pub-id-type="pmid">2278858</pub-id></mixed-citation>
</ref>
<ref id="B425">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeyama</surname><given-names>J.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Hirasawa</surname><given-names>G.</given-names></name><name><surname>Muramatsu</surname><given-names>Y.</given-names></name><name><surname>Nagura</surname><given-names>H.</given-names></name><name><surname>Iinuma</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>17β-hydroxysteroid dehydrogenase type 1 and 2 expression in the human fetus</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>85</volume>, <fpage>410</fpage>–<lpage>416</lpage>. <pub-id pub-id-type="doi">10.1210/jcem.85.1.6323</pub-id><pub-id pub-id-type="pmid">10634418</pub-id></mixed-citation>
</ref>
<ref id="B426">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>K.</given-names></name><name><surname>Kubushiro</surname><given-names>K.</given-names></name><name><surname>Iwamori</surname><given-names>Y.</given-names></name><name><surname>Okairi</surname><given-names>Y.</given-names></name><name><surname>Kiguchi</surname><given-names>K.</given-names></name><name><surname>Ishiwata</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Estrogen sulfotransferase and sulfatase: Roles in the regulation of estrogen activity in human uterine endometrial carcinomas</article-title>. <source/>Cancer Sci.
<volume>94</volume>, <fpage>871</fpage>–<lpage>876</lpage>. <pub-id pub-id-type="doi">10.1111/j.1349-7006.2003.tb01369.x</pub-id><pub-id pub-id-type="pmid">14556660</pub-id></mixed-citation>
</ref>
<ref id="B427">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>K.</given-names></name><name><surname>Shimizu</surname><given-names>K.</given-names></name><name><surname>Kakegawa</surname><given-names>S.</given-names></name><name><surname>Ohtaki</surname><given-names>Y.</given-names></name><name><surname>Nagashima</surname><given-names>T.</given-names></name><name><surname>Kaira</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Prognostic significance of aromatase and estrogen receptor beta expression in EGFR wild-type lung adenocarcinoma</article-title>. <source/>Am. J. Transl. Res.
<volume>8</volume>, <fpage>81</fpage>–<lpage>97</lpage>.<pub-id pub-id-type="pmid">27069542</pub-id></mixed-citation>
</ref>
<ref id="B428">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>S.</given-names></name><name><surname>Miki</surname><given-names>Y.</given-names></name><name><surname>Hashimoto</surname><given-names>C.</given-names></name><name><surname>Takagi</surname><given-names>K.</given-names></name><name><surname>Doe</surname><given-names>Z.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>The role of 5α-reductase type 1 associated with intratumoral dihydrotestosterone concentrations in human endometrial carcinoma</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>401</volume>, <fpage>56</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2014.11.022</pub-id><pub-id pub-id-type="pmid">25475427</pub-id></mixed-citation>
</ref>
<ref id="B429">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>T.</given-names></name><name><surname>Li</surname><given-names>L.</given-names></name><name><surname>Tang</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Lin</surname><given-names>W. Y.</given-names></name><name><surname>Martin</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>A mouse knockout library for secreted and transmembrane proteins</article-title>. <source/>Nat. Biotechnol.
<volume>28</volume>, <fpage>749</fpage>–<lpage>755</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.1644</pub-id><pub-id pub-id-type="pmid">20562862</pub-id></mixed-citation>
</ref>
<ref id="B430">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tangen</surname><given-names>I. L.</given-names></name><name><surname>Onyango</surname><given-names>T. B.</given-names></name><name><surname>Kopperud</surname><given-names>R.</given-names></name><name><surname>Berg</surname><given-names>A.</given-names></name><name><surname>Halle</surname><given-names>M. K.</given-names></name><name><surname>Oyan</surname><given-names>A. M.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Androgen receptor as potential therapeutic target in metastatic endometrial cancer</article-title>. <source/>Oncotarget
<volume>7</volume>, <fpage>49289</fpage>–<lpage>49298</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.10334</pub-id><pub-id pub-id-type="pmid">27384477</pub-id></mixed-citation>
</ref>
<ref id="B431">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tangen</surname><given-names>I. L.</given-names></name><name><surname>Werner</surname><given-names>H. M.</given-names></name><name><surname>Berg</surname><given-names>A.</given-names></name><name><surname>Halle</surname><given-names>M. K.</given-names></name><name><surname>Kusonmano</surname><given-names>K.</given-names></name><name><surname>Trovik</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions</article-title>. <source/>Eur J Cancer
<volume>50</volume>, <fpage>3003</fpage>–<lpage>3010</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejca.2014.09.003</pub-id><pub-id pub-id-type="pmid">25281525</pub-id></mixed-citation>
</ref>
<ref id="B432">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taniuchi</surname><given-names>S.</given-names></name><name><surname>Fujishima</surname><given-names>F.</given-names></name><name><surname>Miki</surname><given-names>Y.</given-names></name><name><surname>Abe</surname><given-names>K.</given-names></name><name><surname>Nakamura</surname><given-names>Y.</given-names></name><name><surname>Sato</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Tissue concentrations of estrogens and aromatase immunolocalization in interstitial pneumonia of human lung</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>392</volume>, <fpage>136</fpage>–<lpage>143</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2014.05.016</pub-id><pub-id pub-id-type="pmid">24861259</pub-id></mixed-citation>
</ref>
<ref id="B433">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tashiro</surname><given-names>A.</given-names></name><name><surname>Sasano</surname><given-names>H.</given-names></name><name><surname>Nishikawa</surname><given-names>T.</given-names></name><name><surname>Yabuki</surname><given-names>N.</given-names></name><name><surname>Muramatsu</surname><given-names>Y.</given-names></name><name><surname>Coughtrie</surname><given-names>M. W.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Expression and activity of dehydroepiandrosterone sulfotransferase in human gastric mucosa</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>72</volume>, <fpage>149</fpage>–<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1016/S0960-0760(00)00020-0</pub-id><pub-id pub-id-type="pmid">10775806</pub-id></mixed-citation>
</ref>
<ref id="B434">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taveira-DaSilva</surname><given-names>A. M.</given-names></name><name><surname>Moss</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Management of lymphangioleiomyomatosis</article-title>. <source/>F1000Prime Rep.
<volume>6</volume>, <fpage>116</fpage>. <pub-id pub-id-type="doi">10.12703/P6-116</pub-id><pub-id pub-id-type="pmid">25580270</pub-id></mixed-citation>
</ref>
<ref id="B435">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terry</surname><given-names>K.</given-names></name><name><surname>McGrath</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>I. M.</given-names></name><name><surname>Buring</surname><given-names>J.</given-names></name><name><surname>De Vivo</surname><given-names>I.</given-names></name></person-group> (<year>2010</year>). <article-title>Genetic variation in CYP11A1 and StAR in relation to endometrial cancer risk</article-title>. <source/>Gynecol. Oncol.
<volume>117</volume>, <fpage>255</fpage>–<lpage>259</lpage>. <pub-id pub-id-type="doi">10.1016/j.ygyno.2010.02.002</pub-id><pub-id pub-id-type="pmid">20199803</pub-id></mixed-citation>
</ref>
<ref id="B436">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teubner</surname><given-names>W.</given-names></name><name><surname>Meinl</surname><given-names>W.</given-names></name><name><surname>Florian</surname><given-names>S.</given-names></name><name><surname>Kretzschmar</surname><given-names>M.</given-names></name><name><surname>Glatt</surname><given-names>H.</given-names></name></person-group> (<year>2007</year>). <article-title>Identification and localization of soluble sulfotransferases in the human gastrointestinal tract</article-title>. <source/>Biochem. J.
<volume>404</volume>, <fpage>207</fpage>–<lpage>215</lpage>. <pub-id pub-id-type="doi">10.1042/BJ20061431</pub-id><pub-id pub-id-type="pmid">17335415</pub-id></mixed-citation>
</ref>
<ref id="B437">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thiboutot</surname><given-names>D.</given-names></name><name><surname>Martin</surname><given-names>P.</given-names></name><name><surname>Volikos</surname><given-names>L.</given-names></name><name><surname>Gilliland</surname><given-names>K.</given-names></name></person-group> (<year>1998</year>). <article-title>Oxidative activity of the type 2 isozyme of 17β-hydroxysteroid dehydrogenase (17β-HSD) predominates in human sebaceous glands</article-title>. <source/>J. Invest. Dermatol.
<volume>111</volume>, <fpage>390</fpage>–<lpage>395</lpage>. <pub-id pub-id-type="doi">10.1046/j.1523-1747.1998.00322.x</pub-id><pub-id pub-id-type="pmid">9740229</pub-id></mixed-citation>
</ref>
<ref id="B438">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>D. J.</given-names></name><name><surname>O'Mara</surname><given-names>T. A.</given-names></name><name><surname>Glubb</surname><given-names>D. M.</given-names></name><name><surname>Painter</surname><given-names>J. N.</given-names></name><name><surname>Cheng</surname><given-names>T.</given-names></name><name><surname>Folkerd</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>CYP<sub>19</sub>A<sub>1</sub> fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer</article-title>. <source/>Endocr. Relat. Cancer
<volume>23</volume>, <fpage>77</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1530/ERC-15-0386</pub-id><pub-id pub-id-type="pmid">26574572</pub-id></mixed-citation>
</ref>
<ref id="B439">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong</surname><given-names>M. H.</given-names></name><name><surname>Jiang</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>P.</given-names></name><name><surname>Lawson</surname><given-names>J. A.</given-names></name><name><surname>Brass</surname><given-names>L. F.</given-names></name><name><surname>Song</surname><given-names>W. C.</given-names></name></person-group> (<year>2005</year>). <article-title>Spontaneous fetal loss caused by placental thrombosis in estrogen sulfotransferase-deficient mice</article-title>. <source/>Nat. Med.
<volume>11</volume>, <fpage>153</fpage>–<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1038/nm1184</pub-id><pub-id pub-id-type="pmid">15685171</pub-id></mixed-citation>
</ref>
<ref id="B440">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Törn</surname><given-names>S.</given-names></name><name><surname>Nokelainen</surname><given-names>P.</given-names></name><name><surname>Kurkela</surname><given-names>R.</given-names></name><name><surname>Pulkka</surname><given-names>A.</given-names></name><name><surname>Menjivar</surname><given-names>M.</given-names></name><name><surname>Ghosh</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Production, purification, and functional analysis of recombinant human and mouse 17β-hydroxysteroid dehydrogenase type 7</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>305</volume>, <fpage>37</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-291X(03)00694-6</pub-id><pub-id pub-id-type="pmid">12732193</pub-id></mixed-citation>
</ref>
<ref id="B441">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Townsend</surname><given-names>E. A.</given-names></name><name><surname>Miller</surname><given-names>V. M.</given-names></name><name><surname>Prakash</surname><given-names>Y. S.</given-names></name></person-group> (<year>2012</year>). <article-title>Sex differences and sex steroids in lung health and disease</article-title>. <source/>Endocr. Rev.
<volume>33</volume>, <fpage>1</fpage>–<lpage>47</lpage>. <pub-id pub-id-type="doi">10.1210/er.2010-0031</pub-id><pub-id pub-id-type="pmid">22240244</pub-id></mixed-citation>
</ref>
<ref id="B442">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Townsend</surname><given-names>E. A.</given-names></name><name><surname>Thompson</surname><given-names>M. A.</given-names></name><name><surname>Pabelick</surname><given-names>C. M.</given-names></name><name><surname>Prakash</surname><given-names>Y. S.</given-names></name></person-group> (<year>2010</year>). <article-title>Rapid effects of estrogen on intracellular Ca<sup>2+</sup> regulation in human airway smooth muscle</article-title>. <source/>Am. J. Physiol. Lung Cell. Mol. Physiol.
<volume>298</volume>
<fpage>L521</fpage>–<lpage>530</lpage>. <pub-id pub-id-type="doi">10.1152/ajplung.00287.2009</pub-id><pub-id pub-id-type="pmid">20097735</pub-id></mixed-citation>
</ref>
<ref id="B443">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>S. J.</given-names></name><name><surname>Wu</surname><given-names>M. H.</given-names></name><name><surname>Lin</surname><given-names>C. C.</given-names></name><name><surname>Sun</surname><given-names>H. S.</given-names></name><name><surname>Chen</surname><given-names>H. M.</given-names></name></person-group> (<year>2001</year>). <article-title>Regulation of steroidogenic acute regulatory protein expression and progesterone production in endometriotic stromal cells</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>86</volume>, <fpage>5765</fpage>–<lpage>5773</lpage>. <pub-id pub-id-type="doi">10.1210/jcem.86.12.8082</pub-id><pub-id pub-id-type="pmid">11739437</pub-id></mixed-citation>
</ref>
<ref id="B444">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tseng</surname><given-names>L.</given-names></name><name><surname>Gurpide</surname><given-names>E.</given-names></name></person-group> (<year>1974</year>). <article-title>Estradiol and 20α-dihydroprogesterone dehydrogenase activities in human endometrium during the menstrual cycle</article-title>. <source/>Endocrinology
<volume>94</volume>, <fpage>419</fpage>–<lpage>423</lpage>. <pub-id pub-id-type="doi">10.1210/endo-94-2-419</pub-id><pub-id pub-id-type="pmid">4359125</pub-id></mixed-citation>
</ref>
<ref id="B445">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tseng</surname><given-names>L.</given-names></name><name><surname>Gusberg</surname><given-names>S. B.</given-names></name><name><surname>Gurpide</surname><given-names>E.</given-names></name></person-group> (<year>1977</year>). <article-title>Estradiol receptor and 17 beta-dehydrogenase in normal and abnormal human endometrium</article-title>. <source/>Ann. N. Y. Acad. Sci.
<volume>286</volume>, <fpage>190</fpage>–<lpage>198</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.1977.tb29416.x</pub-id><pub-id pub-id-type="pmid">281172</pub-id></mixed-citation>
</ref>
<ref id="B446">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tseng</surname><given-names>L.</given-names></name><name><surname>Mazella</surname><given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>Endometrial cell specific gene activation during implantation and early pregnancy</article-title>. <source/>Front. Biosci.
<volume>7</volume>, <fpage>d1566</fpage>–<lpage>d1574</lpage>. <pub-id pub-id-type="doi">10.2741/A861</pub-id><pub-id pub-id-type="pmid">12045017</pub-id></mixed-citation>
</ref>
<ref id="B447">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tseng</surname><given-names>L.</given-names></name><name><surname>Mazella</surname><given-names>J.</given-names></name><name><surname>Mann</surname><given-names>W. J.</given-names></name><name><surname>Chumas</surname><given-names>J.</given-names></name></person-group> (<year>1982</year>). <article-title>Estrogen synthesis in normal and malignant human endometrium</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>55</volume>, <fpage>1029</fpage>–<lpage>1031</lpage>. <pub-id pub-id-type="doi">10.1210/jcem-55-5-1029</pub-id><pub-id pub-id-type="pmid">7119084</pub-id></mixed-citation>
</ref>
<ref id="B448">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsuchiya</surname><given-names>M.</given-names></name><name><surname>Nakao</surname><given-names>H.</given-names></name><name><surname>Katoh</surname><given-names>T.</given-names></name><name><surname>Sasaki</surname><given-names>H.</given-names></name><name><surname>Hiroshima</surname><given-names>M.</given-names></name><name><surname>Tanaka</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Association between endometriosis and genetic polymorphisms of the estradiol-synthesizing enzyme genes HSD17B1 and CYP19</article-title>. <source/>Hum. Reprod.
<volume>20</volume>, <fpage>974</fpage>–<lpage>978</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/deh726</pub-id><pub-id pub-id-type="pmid">15640252</pub-id></mixed-citation>
</ref>
<ref id="B449">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuo</surname><given-names>B.</given-names></name><name><surname>Wen</surname><given-names>G.</given-names></name><name><surname>Wei</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Estrogen regulation of duodenal bicarbonate secretion and sex-specific protection of human duodenum</article-title>. <source/>Gastroenterology
<volume>141</volume>, <fpage>854</fpage>–<lpage>863</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2011.05.044</pub-id><pub-id pub-id-type="pmid">21699784</pub-id></mixed-citation>
</ref>
<ref id="B450">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utsunomiya</surname><given-names>H.</given-names></name><name><surname>Ito</surname><given-names>K.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Kitamura</surname><given-names>T.</given-names></name><name><surname>Kaneko</surname><given-names>C.</given-names></name><name><surname>Nakata</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma</article-title>. <source/>Clin. Cancer Res.
<volume>10</volume>, <fpage>5850</fpage>–<lpage>5856</lpage>. <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-04-0040</pub-id><pub-id pub-id-type="pmid">15355916</pub-id></mixed-citation>
</ref>
<ref id="B451">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utsunomiya</surname><given-names>H.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Ito</surname><given-names>K.</given-names></name><name><surname>Moriya</surname><given-names>T.</given-names></name><name><surname>Konno</surname><given-names>R.</given-names></name><name><surname>Sato</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>The correlation between the response to progestogen treatment and the expression of progesterone receptor B and 17β-hydroxysteroid dehydrogenase type 2 in human endometrial carcinoma</article-title>. <source/>Clin. Endocrinol. (Oxf).
<volume>58</volume>, <fpage>696</fpage>–<lpage>703</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2265.2003.01766.x</pub-id><pub-id pub-id-type="pmid">12780745</pub-id></mixed-citation>
</ref>
<ref id="B452">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Utsunomiya</surname><given-names>H.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Kaneko</surname><given-names>C.</given-names></name><name><surname>Takeyama</surname><given-names>J.</given-names></name><name><surname>Nakamura</surname><given-names>J.</given-names></name><name><surname>Kimura</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>The analyses of 17β-hydroxysteroid dehydrogenase isozymes in human endometrial hyperplasia and carcinoma</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>86</volume>, <fpage>3436</fpage>–<lpage>3443</lpage>. <pub-id pub-id-type="doi">10.1210/jcem.86.7.7661</pub-id><pub-id pub-id-type="pmid">11443221</pub-id></mixed-citation>
</ref>
<ref id="B453">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Eerden</surname><given-names>B. C.</given-names></name><name><surname>Lowik</surname><given-names>C. W.</given-names></name><name><surname>Wit</surname><given-names>J. M.</given-names></name><name><surname>Karperien</surname><given-names>M.</given-names></name></person-group> (<year>2004</year>). <article-title>Expression of estrogen receptors and enzymes involved in sex steroid metabolism in the rat tibia during sexual maturation</article-title>. <source/>J. Endocrinol.
<volume>180</volume>, <fpage>457</fpage>–<lpage>467</lpage>. <pub-id pub-id-type="doi">10.1677/joe.0.1800457</pub-id><pub-id pub-id-type="pmid">15012600</pub-id></mixed-citation>
</ref>
<ref id="B454">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vanderschueren</surname><given-names>D.</given-names></name><name><surname>Gaytant</surname><given-names>J.</given-names></name><name><surname>Boonen</surname><given-names>S.</given-names></name><name><surname>Venken</surname><given-names>K.</given-names></name></person-group> (<year>2008</year>). <article-title>Androgens and bone</article-title>. <source/>Curr. Opin. Endocrinol. Diabetes Obes.
<volume>15</volume>, <fpage>250</fpage>–<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1097/MED.0b013e3282fe6ca9</pub-id><pub-id pub-id-type="pmid">18438173</pub-id></mixed-citation>
</ref>
<ref id="B455">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vani</surname><given-names>S.</given-names></name><name><surname>McDonald</surname><given-names>S. E.</given-names></name><name><surname>Williams</surname><given-names>A. R.</given-names></name><name><surname>Mason</surname><given-names>J. I.</given-names></name><name><surname>Thong</surname><given-names>K. J.</given-names></name><name><surname>Critchley</surname><given-names>H. O.</given-names></name></person-group> (<year>2007</year>). <article-title>Mid-luteal endometrial intracrinology following controlled ovarian hyperstimulation involving use of a gonadotrophin releasing hormone antagonist</article-title>. <source/>Hum. Reprod.
<volume>22</volume>, <fpage>2981</fpage>–<lpage>2991</lpage>. <pub-id pub-id-type="doi">10.1093/humrep/dem269</pub-id><pub-id pub-id-type="pmid">17848403</pub-id></mixed-citation>
</ref>
<ref id="B456">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varlamov</surname><given-names>O.</given-names></name><name><surname>Bethea</surname><given-names>C. L.</given-names></name><name><surname>Roberts</surname><given-names>C. T.</given-names><suffix>Jr.</suffix></name></person-group> (<year>2014</year>). <article-title>Sex-specific differences in lipid and glucose metabolism</article-title>. <source/>Front. Endocrinol. (Lausanne).
<volume>5</volume>:<fpage>241</fpage>. <pub-id pub-id-type="doi">10.3389/fendo.2014.00241</pub-id><pub-id pub-id-type="pmid">25646091</pub-id></mixed-citation>
</ref>
<ref id="B457">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasquez</surname><given-names>Y. M.</given-names></name><name><surname>DeMayo</surname><given-names>F. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Role of nuclear receptors in blastocyst implantation</article-title>. <source/>Semin. Cell Dev. Biol.
<volume>24</volume>, <fpage>724</fpage>–<lpage>735</lpage>. <pub-id pub-id-type="doi">10.1016/j.semcdb.2013.08.004</pub-id><pub-id pub-id-type="pmid">23994285</pub-id></mixed-citation>
</ref>
<ref id="B458">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Velasco</surname><given-names>I.</given-names></name><name><surname>Rueda</surname><given-names>J.</given-names></name><name><surname>Acien</surname><given-names>P.</given-names></name></person-group> (<year>2006</year>). <article-title>Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis</article-title>. <source/>Mol. Hum. Reprod.
<volume>12</volume>, <fpage>377</fpage>–<lpage>381</lpage>. <pub-id pub-id-type="doi">10.1093/molehr/gal041</pub-id><pub-id pub-id-type="pmid">16641167</pub-id></mixed-citation>
</ref>
<ref id="B459">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vercellini</surname><given-names>P.</given-names></name><name><surname>Vigano</surname><given-names>P.</given-names></name><name><surname>Somigliana</surname><given-names>E.</given-names></name><name><surname>Fedele</surname><given-names>L.</given-names></name></person-group> (<year>2014</year>). <article-title>Endometriosis: pathogenesis and treatment</article-title>. <source/>Nat. Rev. Endocrinol.
<volume>10</volume>, <fpage>261</fpage>–<lpage>275</lpage>. <pub-id pub-id-type="doi">10.1038/nrendo.2013.255</pub-id><pub-id pub-id-type="pmid">24366116</pub-id></mixed-citation>
</ref>
<ref id="B460">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>M. K.</given-names></name><name><surname>Miki</surname><given-names>Y.</given-names></name><name><surname>Abe</surname><given-names>K.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Niikawa</surname><given-names>H.</given-names></name><name><surname>Suzuki</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Intratumoral localization and activity of 17β-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer: a potent prognostic factor</article-title>. <source/>J. Transl. Med.
<volume>11</volume>, <fpage>167</fpage>. <pub-id pub-id-type="doi">10.1186/1479-5876-11-167</pub-id><pub-id pub-id-type="pmid">23837683</pub-id></mixed-citation>
</ref>
<ref id="B461">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verma</surname><given-names>M. K.</given-names></name><name><surname>Miki</surname><given-names>Y.</given-names></name><name><surname>Sasano</surname><given-names>H.</given-names></name></person-group> (<year>2011</year>). <article-title>Aromatase in human lung carcinoma</article-title>. <source/>Steroids
<volume>76</volume>, <fpage>759</fpage>–<lpage>764</lpage>. <pub-id pub-id-type="doi">10.1016/j.steroids.2011.02.020</pub-id><pub-id pub-id-type="pmid">21392519</pub-id></mixed-citation>
</ref>
<ref id="B462">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vidal</surname><given-names>O.</given-names></name><name><surname>Lindberg</surname><given-names>M. K.</given-names></name><name><surname>Hollberg</surname><given-names>K.</given-names></name><name><surname>Baylink</surname><given-names>D. J.</given-names></name><name><surname>Andersson</surname><given-names>G.</given-names></name><name><surname>Lubahn</surname><given-names>D. B.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>97</volume>, <fpage>5474</fpage>–<lpage>5479</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.97.10.5474</pub-id><pub-id pub-id-type="pmid">10805804</pub-id></mixed-citation>
</ref>
<ref id="B463">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vouk</surname><given-names>K.</given-names></name><name><surname>Smuc</surname><given-names>T.</given-names></name><name><surname>Guggenberger</surname><given-names>C.</given-names></name><name><surname>Ribic-Pucelj</surname><given-names>M.</given-names></name><name><surname>Sinkovec</surname><given-names>J.</given-names></name><name><surname>Husen</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Novel estrogen-related genes and potential biomarkers of ovarian endometriosis identified by differential expression analysis</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>125</volume>, <fpage>231</fpage>–<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsbmb.2011.03.010</pub-id><pub-id pub-id-type="pmid">21397694</pub-id></mixed-citation>
</ref>
<ref id="B464">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>V. R.</given-names></name><name><surname>Korach</surname><given-names>K. S.</given-names></name></person-group> (<year>2004</year>). <article-title>Estrogen receptor knockout mice as a model for endocrine research</article-title>. <source/>ILAR J.
<volume>45</volume>, <fpage>455</fpage>–<lpage>461</lpage>. <pub-id pub-id-type="doi">10.1093/ilar.45.4.455</pub-id><pub-id pub-id-type="pmid">15454684</pub-id></mixed-citation>
</ref>
<ref id="B465">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>F.</given-names></name><name><surname>Vihma</surname><given-names>V.</given-names></name><name><surname>Soronen</surname><given-names>J.</given-names></name><name><surname>Turpeinen</surname><given-names>U.</given-names></name><name><surname>Hamalainen</surname><given-names>E.</given-names></name><name><surname>Savolainen-Peltonen</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>17β-Estradiol and estradiol fatty acyl esters and estrogen-converting enzyme expression in adipose tissue in obese men and women</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>98</volume>, <fpage>4923</fpage>–<lpage>4931</lpage>. <pub-id pub-id-type="doi">10.1210/jc.2013-2605</pub-id><pub-id pub-id-type="pmid">24081738</pub-id></mixed-citation>
</ref>
<ref id="B466">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Dey</surname><given-names>S. K.</given-names></name></person-group> (<year>2006</year>). <article-title>Roadmap to embryo implantation: clues from mouse models</article-title>. <source/>Nat. Rev. Genet.
<volume>7</volume>, <fpage>185</fpage>–<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1038/nrg1808</pub-id><pub-id pub-id-type="pmid">16485018</pub-id></mixed-citation>
</ref>
<ref id="B467">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X. Q.</given-names></name><name><surname>Aka</surname><given-names>J. A.</given-names></name><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Xu</surname><given-names>D.</given-names></name><name><surname>Doillon</surname><given-names>C. J.</given-names></name><name><surname>Lin</surname><given-names>S. X.</given-names></name></person-group> (<year>2017</year>). <article-title>Inhibition of 17β-hydroxysteroid dehydrogenase type 7 modulates breast cancer protein profile and enhances apoptosis by down-regulating GRP78</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>172</volume>, <fpage>188</fpage>–<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1016/j.jsbmb.2017.06.009</pub-id><pub-id pub-id-type="pmid">28645527</pub-id></mixed-citation>
</ref>
<ref id="B468">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warren</surname><given-names>J. C.</given-names></name><name><surname>French</surname><given-names>A. P.</given-names></name></person-group> (<year>1965</year>). <article-title>DISTRIBUTION OF STEROID SULFATASE IN HUMAN TISSUES</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>25</volume>, <fpage>278</fpage>–<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1210/jcem-25-2-278</pub-id><pub-id pub-id-type="pmid">14264248</pub-id></mixed-citation>
</ref>
<ref id="B469">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>K.</given-names></name><name><surname>Sasano</surname><given-names>H.</given-names></name><name><surname>Harada</surname><given-names>N.</given-names></name><name><surname>Ozaki</surname><given-names>M.</given-names></name><name><surname>Niikura</surname><given-names>H.</given-names></name><name><surname>Sato</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>1995</year>). <article-title>Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies</article-title>. <source/>Am. J. Pathol.
<volume>146</volume>, <fpage>491</fpage>–<lpage>500</lpage>.<pub-id pub-id-type="pmid">7856758</pub-id></mixed-citation>
</ref>
<ref id="B470">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watzka</surname><given-names>M.</given-names></name><name><surname>Bidlingmaier</surname><given-names>F.</given-names></name><name><surname>Schramm</surname><given-names>J.</given-names></name><name><surname>Klingmuller</surname><given-names>D.</given-names></name><name><surname>Stoffel-Wagner</surname><given-names>B.</given-names></name></person-group> (<year>1999</year>). <article-title>Sex- and age-specific differences in human brain CYP11A1 mRNA expression</article-title>. <source/>J. Neuroendocrinol.
<volume>11</volume>, <fpage>901</fpage>–<lpage>905</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2826.1999.00407.x</pub-id><pub-id pub-id-type="pmid">10583724</pub-id></mixed-citation>
</ref>
<ref id="B471">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wishart</surname><given-names>D. S.</given-names></name><name><surname>Feunang</surname><given-names>Y. D.</given-names></name><name><surname>Guo</surname><given-names>A. C.</given-names></name><name><surname>Lo</surname><given-names>E. J.</given-names></name><name><surname>Marcu</surname><given-names>A.</given-names></name><name><surname>Grant</surname><given-names>J. R.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>DrugBank 5.0: a major update to the DrugBank database for 2018</article-title>. <source/>Nucleic Acids Res.
<volume>46</volume>, <fpage>D1074</fpage>–<lpage>D1082</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx1037</pub-id><pub-id pub-id-type="pmid">29126136</pub-id></mixed-citation>
</ref>
<ref id="B472">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wishart</surname><given-names>D. S.</given-names></name><name><surname>Jewison</surname><given-names>T.</given-names></name><name><surname>Guo</surname><given-names>A. C.</given-names></name><name><surname>Wilson</surname><given-names>M.</given-names></name><name><surname>Knox</surname><given-names>C.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>HMDB 3.0–the human metabolome database in 2013</article-title>. <source/>Nucleic Acids Res.
<volume>41</volume>, <fpage>D801</fpage>–<lpage>D807</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gks1065</pub-id><pub-id pub-id-type="pmid">23161693</pub-id></mixed-citation>
</ref>
<ref id="B473">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wöhrle</surname><given-names>D.</given-names></name><name><surname>Barbi</surname><given-names>G.</given-names></name><name><surname>Schulz</surname><given-names>W.</given-names></name><name><surname>Steinbach</surname><given-names>P.</given-names></name></person-group> (<year>1990</year>). <article-title>Heterozygous expression of X-linked chondrodysplasia punctata. Complex chromosome aberration including deletion of MIC2 and STS</article-title>. <source/>Hum. Genet.
<volume>86</volume>, <fpage>215</fpage>–<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1007/BF00197708</pub-id><pub-id pub-id-type="pmid">2265834</pub-id></mixed-citation>
</ref>
<ref id="B474">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>L. W.</given-names></name><name><surname>Purohit</surname><given-names>A.</given-names></name><name><surname>Potter</surname><given-names>B. V.</given-names></name></person-group> (<year>2011</year>). <article-title>Development of steroid sulfatase inhibitors</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>340</volume>, <fpage>175</fpage>–<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2010.12.035</pub-id><pub-id pub-id-type="pmid">21238537</pub-id></mixed-citation>
</ref>
<ref id="B475">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>H. C.</given-names></name><name><surname>Tuo</surname><given-names>B. G.</given-names></name><name><surname>Wu</surname><given-names>W. M.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><name><surname>Xu</surname><given-names>Q. Q.</given-names></name><name><surname>Zhao</surname><given-names>K.</given-names></name></person-group> (<year>2008</year>). <article-title>Prevalence of peptic ulcer in dyspeptic patients and the influence of age, sex, and <italic>Helicobacter pylori</italic> infection</article-title>. <source/>Dig. Dis. Sci.
<volume>53</volume>, <fpage>2650</fpage>–<lpage>2656</lpage>. <pub-id pub-id-type="doi">10.1007/s10620-007-0177-7</pub-id><pub-id pub-id-type="pmid">18270835</pub-id></mixed-citation>
</ref>
<ref id="B476">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname><given-names>J.</given-names></name><name><surname>Zheng</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Shen</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Sulfotransferase SULT1A1 Arg213His polymorphism with cancer risk: a meta-analysis of 53 case-control studies</article-title>. <source/>PLoS ONE
<volume>9</volume>:<fpage>e106774</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0106774</pub-id><pub-id pub-id-type="pmid">25225888</pub-id></mixed-citation>
</ref>
<ref id="B477">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yague</surname><given-names>J. G.</given-names></name><name><surname>Azcoitia</surname><given-names>I.</given-names></name><name><surname>DeFelipe</surname><given-names>J.</given-names></name><name><surname>Garcia-Segura</surname><given-names>L. M.</given-names></name><name><surname>Munoz</surname><given-names>A.</given-names></name></person-group> (<year>2010</year>). <article-title>Aromatase expression in the normal and epileptic human hippocampus</article-title>. <source/>Brain Res.
<volume>1315</volume>, <fpage>41</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2009.09.111</pub-id><pub-id pub-id-type="pmid">19815003</pub-id></mixed-citation>
</ref>
<ref id="B478">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yague</surname><given-names>J. G.</given-names></name><name><surname>Munoz</surname><given-names>A.</given-names></name><name><surname>de Monasterio-Schrader</surname><given-names>P.</given-names></name><name><surname>Defelipe</surname><given-names>J.</given-names></name><name><surname>Garcia-Segura</surname><given-names>L. M.</given-names></name><name><surname>Azcoitia</surname><given-names>I.</given-names></name></person-group> (<year>2006</year>). <article-title>Aromatase expression in the human temporal cortex</article-title>. <source/>Neuroscience
<volume>138</volume>, <fpage>389</fpage>–<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2005.11.054</pub-id><pub-id pub-id-type="pmid">16426763</pub-id></mixed-citation>
</ref>
<ref id="B479">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamaki</surname><given-names>J.</given-names></name><name><surname>Yamamoto</surname><given-names>T.</given-names></name><name><surname>Okada</surname><given-names>H.</given-names></name></person-group> (<year>1985</year>). <article-title>Aromatization of androstenedione by normal and neoplastic endometrium of the uterus</article-title>. <source/>J. Steroid Biochem.
<volume>22</volume>, <fpage>63</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1016/0022-4731(85)90142-6</pub-id><pub-id pub-id-type="pmid">3974228</pub-id></mixed-citation>
</ref>
<ref id="B480">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>T.</given-names></name><name><surname>Fukuoka</surname><given-names>M.</given-names></name><name><surname>Fujimoto</surname><given-names>Y.</given-names></name><name><surname>Kitawaki</surname><given-names>J.</given-names></name><name><surname>Nakakoshi</surname><given-names>M.</given-names></name><name><surname>Yoshihama</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>1990a</year>). <article-title>Inhibitory effect of a new androstenedione derivative, 14α-hydroxy-4-androstene-3,6,17-trione (14α-OHAT) on aromatase activity of human uterine tumors</article-title>. <source/>J. Steroid Biochem.
<volume>36</volume>, <fpage>517</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/0022-4731(90)90167-Q</pub-id><pub-id pub-id-type="pmid">2214767</pub-id></mixed-citation>
</ref>
<ref id="B481">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>T.</given-names></name><name><surname>Kitawaki</surname><given-names>J.</given-names></name><name><surname>Urabe</surname><given-names>M.</given-names></name><name><surname>Honjo</surname><given-names>H.</given-names></name><name><surname>Tamura</surname><given-names>T.</given-names></name><name><surname>Noguchi</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>1993a</year>). <article-title>Estrogen productivity of endometrium and endometrial cancer tissue; influence of aromatase on proliferation of endometrial cancer cells</article-title>. <source/>J. Steroid Biochem. Mol. Biol.
<volume>44</volume>, <fpage>463</fpage>–<lpage>468</lpage>. <pub-id pub-id-type="doi">10.1016/0960-0760(93)90251-Q</pub-id><pub-id pub-id-type="pmid">8476761</pub-id></mixed-citation>
</ref>
<ref id="B482">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>T.</given-names></name><name><surname>Noguchi</surname><given-names>T.</given-names></name><name><surname>Tamura</surname><given-names>T.</given-names></name><name><surname>Kitawaki</surname><given-names>J.</given-names></name><name><surname>Okada</surname><given-names>H.</given-names></name></person-group> (<year>1993b</year>). <article-title>Evidence for estrogen synthesis in adenomyotic tissues</article-title>. <source/>Am. J. Obstet. Gynecol. <volume>169</volume>, <fpage>734</fpage>–<lpage>738</lpage>. <pub-id pub-id-type="doi">10.1016/0002-9378(93)90654-2</pub-id><pub-id pub-id-type="pmid">8372890</pub-id></mixed-citation>
</ref>
<ref id="B483">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>T.</given-names></name><name><surname>Urabe</surname><given-names>M.</given-names></name><name><surname>Naitoh</surname><given-names>K.</given-names></name><name><surname>Kitawaki</surname><given-names>J.</given-names></name><name><surname>Honjo</surname><given-names>H.</given-names></name><name><surname>Okada</surname><given-names>H.</given-names></name></person-group> (<year>1990b</year>). <article-title>Estrone sulfatase activity in human uterine leiomyoma</article-title>. <source/>Gynecol. Oncol.
<volume>37</volume>, <fpage>315</fpage>–<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1016/0090-8258(90)90358-R</pub-id><pub-id pub-id-type="pmid">2351313</pub-id></mixed-citation>
</ref>
<ref id="B484">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yanaihara</surname><given-names>Yanaihara, T.</given-names></name><name><surname>Toma</surname><given-names>Y.</given-names></name><name><surname>Shimizu</surname><given-names>Y.</given-names></name><name><surname>Saito</surname><given-names>H.</given-names></name><name><surname>Okai</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Localization and expression of steroid sulfatase in human fallopian tubes</article-title>. <source/>Steroids
<volume>66</volume>, <fpage>87</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1016/S0039-128X(00)00204-X</pub-id><pub-id pub-id-type="pmid">11146087</pub-id></mixed-citation>
</ref>
<ref id="B485">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>W.</given-names></name><name><surname>Wu</surname><given-names>G.</given-names></name><name><surname>Broeckel</surname><given-names>U.</given-names></name><name><surname>Smith</surname><given-names>C. A.</given-names></name><name><surname>Turner</surname><given-names>V.</given-names></name><name><surname>Haidar</surname><given-names>C. E.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Comparison of genome sequencing and clinical genotyping for pharmacogenes</article-title>. <source/>Clin. Pharmacol. Ther.
<volume>100</volume>, <fpage>380</fpage>–<lpage>388</lpage>. <pub-id pub-id-type="doi">10.1002/cpt.411</pub-id><pub-id pub-id-type="pmid">27311679</pub-id></mixed-citation>
</ref>
<ref id="B486">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X. Y.</given-names></name><name><surname>Wu</surname><given-names>W. J.</given-names></name><name><surname>Yang</surname><given-names>C.</given-names></name><name><surname>Yang</surname><given-names>T.</given-names></name><name><surname>He</surname><given-names>J. D.</given-names></name><name><surname>Yang</surname><given-names>Z.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Association of HSD17B3 and HSD3B1 polymorphisms with acne vulgaris in Southwestern Han Chinese</article-title>. <source/>Dermatology
<volume>227</volume>, <fpage>202</fpage>–<lpage>208</lpage>. <pub-id pub-id-type="doi">10.1159/000353581</pub-id><pub-id pub-id-type="pmid">24157973</pub-id></mixed-citation>
</ref>
<ref id="B487">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>X. Y.</given-names></name><name><surname>Chen</surname><given-names>S. Y.</given-names></name><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Yoon</surname><given-names>D. S.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Hong</surname><given-names>Z.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Discovery of Clinical Candidate 2-((2S,6S)-2-Phenyl-6-hydroxyadamantan-2-yl)-1-(3'-hydroxyazetidin-1-yl)ethanone [BMS-816336], an orally active novel selective 11β-Hydroxysteroid dehydrogenase type 1 inhibitor</article-title>. <source/>J. Med. Chem.
<volume>60</volume>, <fpage>4932</fpage>–<lpage>4948</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.7b00211</pub-id><pub-id pub-id-type="pmid">28537398</pub-id></mixed-citation>
</ref>
<ref id="B488">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>L.</given-names></name><name><surname>Romero</surname><given-names>D. G.</given-names></name><name><surname>Gomez-Sanchez</surname><given-names>C. E.</given-names></name><name><surname>Gomez-Sanchez</surname><given-names>E. P.</given-names></name></person-group> (<year>2002</year>). <article-title><italic>Steroidogenic enzyme</italic> gene expression in the human brain</article-title>. <source/>Mol. Cell. Endocrinol.
<volume>190</volume>, <fpage>9</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1016/S0303-7207(02)00041-2</pub-id><pub-id pub-id-type="pmid">11997174</pub-id></mixed-citation>
</ref>
<ref id="B489">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuchi</surname><given-names>Y.</given-names></name><name><surname>Cai</surname><given-names>Y.</given-names></name><name><surname>Legein</surname><given-names>B.</given-names></name><name><surname>De Groef</surname><given-names>S.</given-names></name><name><surname>Leuckx</surname><given-names>G.</given-names></name><name><surname>Coppens</surname><given-names>V.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Estrogen receptor α regulates β-cell formation during pancreas development and following injury</article-title>. <source/>Diabetes
<volume>64</volume>, <fpage>3218</fpage>–<lpage>3228</lpage>. <pub-id pub-id-type="doi">10.2337/db14-1798</pub-id><pub-id pub-id-type="pmid">26015547</pub-id></mixed-citation>
</ref>
<ref id="B490">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zacher</surname><given-names>A.</given-names></name><name><surname>Kaulich</surname><given-names>K.</given-names></name><name><surname>Stepanow</surname><given-names>S.</given-names></name><name><surname>Wolter</surname><given-names>M.</given-names></name><name><surname>Kohrer</surname><given-names>K.</given-names></name><name><surname>Felsberg</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Molecular diagnostics of gliomas using next generation sequencing of a glioma-tailored gene panel</article-title>. <source/>Brain Pathol. <volume>27</volume>, <fpage>146</fpage>–<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1111/bpa.12367</pub-id><pub-id pub-id-type="pmid">26919320</pub-id></mixed-citation>
</ref>
<ref id="B491">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zakharov</surname><given-names>V.</given-names></name><name><surname>Lin</surname><given-names>H. K.</given-names></name><name><surname>Azzarello</surname><given-names>J.</given-names></name><name><surname>McMeekin</surname><given-names>S.</given-names></name><name><surname>Moore</surname><given-names>K. N.</given-names></name><name><surname>Penning</surname><given-names>T. M.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Suppressed expression of type 2, 3α/type 5, 17β-hydroxysteroid dehydrogenase (AKR1C3) in endometrial hyperplasia and carcinoma</article-title>. <source/>Int. J. Clin. Exp. Pathol.
<volume>3</volume>, <fpage>608</fpage>–<lpage>617</lpage>.<pub-id pub-id-type="pmid">20661409</pub-id></mixed-citation>
</ref>
<ref id="B492">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarrabeitia</surname><given-names>M. T.</given-names></name><name><surname>Hernandez</surname><given-names>J. L.</given-names></name><name><surname>Valero</surname><given-names>C.</given-names></name><name><surname>Zarrabeitia</surname><given-names>A.</given-names></name><name><surname>Amado</surname><given-names>J. A.</given-names></name><name><surname>Gonzalez-Macias</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Adiposity, estradiol, and genetic variants of steroid-metabolizing enzymes as determinants of bone mineral density</article-title>. <source/>Eur. J. Endocrinol.
<volume>156</volume>, <fpage>117</fpage>–<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1530/eje.1.02318</pub-id><pub-id pub-id-type="pmid">17218734</pub-id></mixed-citation>
</ref>
<ref id="B493">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeitoun</surname><given-names>K.</given-names></name><name><surname>Takayama</surname><given-names>K.</given-names></name><name><surname>Sasano</surname><given-names>H.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Moghrabi</surname><given-names>N.</given-names></name><name><surname>Andersson</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>Deficient 17β-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17β-estradiol</article-title>. <source/>J. Clin. Endocrinol. Metab.
<volume>83</volume>, <fpage>4474</fpage>–<lpage>4480</lpage>.<pub-id pub-id-type="pmid">9851796</pub-id></mixed-citation>
</ref>
<ref id="B494">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>C.</given-names></name><name><surname>Matsuda</surname><given-names>K.</given-names></name><name><surname>Jia</surname><given-names>W. H.</given-names></name><name><surname>Chang</surname><given-names>J.</given-names></name><name><surname>Kweon</surname><given-names>S. S.</given-names></name><name><surname>Xiang</surname><given-names>Y. B.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Identification of susceptibility loci and genes for colorectal cancer risk</article-title>. <source/>Gastroenterology
<volume>150</volume>, <fpage>1633</fpage>–<lpage>1645</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2016.02.076</pub-id><pub-id pub-id-type="pmid">26965516</pub-id></mixed-citation>
</ref>
<ref id="B495">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Yin</surname><given-names>Y.</given-names></name><name><surname>Niu</surname><given-names>X. M.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Garfield</surname><given-names>D.</given-names></name><name><surname>Chen</surname><given-names>S. F.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>CYP<sub>19</sub>A<sub>1</sub> gene polymorphisms and risk of lung cancer</article-title>. <source/>J. Int. Med. Res.
<volume>41</volume>, <fpage>735</fpage>–<lpage>742</lpage>. <pub-id pub-id-type="doi">10.1177/0300060513477291</pub-id><pub-id pub-id-type="pmid">23669293</pub-id></mixed-citation>
</ref>
<ref id="B496">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>H.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Shangguan</surname><given-names>A. J.</given-names></name><name><surname>Bulun</surname><given-names>S. E.</given-names></name></person-group> (<year>2016</year>). <article-title>Aromatase expression and regulation in breast and endometrial cancer</article-title>. <source/>J. Mol. Endocrinol.
<volume>57</volume>
<fpage>R19</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1530/JME-15-0310</pub-id><pub-id pub-id-type="pmid">27067638</pub-id></mixed-citation>
</ref>
<ref id="B497">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhongyi</surname><given-names>S.</given-names></name><name><surname>Rantakari</surname><given-names>P.</given-names></name><name><surname>Lamminen</surname><given-names>T.</given-names></name><name><surname>Toppari</surname><given-names>J.</given-names></name><name><surname>Poutanen</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>Transgenic male mice expressing human hydroxysteroid dehydrogenase 2 indicate a role for the enzyme independent of its action on sex steroids</article-title>. <source/>Endocrinology
<volume>148</volume>, <fpage>3827</fpage>–<lpage>3836</lpage>. <pub-id pub-id-type="doi">10.1210/en.2007-0365</pub-id><pub-id pub-id-type="pmid">17510238</pub-id></mixed-citation>
</ref>
<ref id="B498">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zwart</surname><given-names>W.</given-names></name><name><surname>Theodorou</surname><given-names>V.</given-names></name><name><surname>Kok</surname><given-names>M.</given-names></name><name><surname>Canisius</surname><given-names>S.</given-names></name><name><surname>Linn</surname><given-names>S.</given-names></name><name><surname>Carroll</surname><given-names>J. S.</given-names></name></person-group> (<year>2011</year>). <article-title>Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancer</article-title>. <source/>EMBO J.
<volume>30</volume>, <fpage>4764</fpage>–<lpage>4776</lpage>. <pub-id pub-id-type="doi">10.1038/emboj.2011.368</pub-id><pub-id pub-id-type="pmid">22002538</pub-id></mixed-citation>
</ref>
</ref-list>
<glossary>
<def-list>
<title>Abbreviations</title>
<def-item>
<term>[3H]</term>
<def>
<p>tritiated hydrogen</p>
</def>
</def-item>
<def-item>
<term>[14C]</term>
<def>
<p>radioactive carbon</p>
</def>
</def-item>
<def-item>
<term>AD</term>
<def>
<p>Alzheimer disease</p>
</def>
</def-item>
<def-item>
<term>ADHD</term>
<def>
<p>attention deficit hyperactivity disorder</p>
</def>
</def-item>
<def-item>
<term>AI</term>
<def>
<p>aromatase inhibitor</p>
</def>
</def-item>
<def-item>
<term>AKR</term>
<def>
<p>aldo-ketoreductase</p>
</def>
</def-item>
<def-item>
<term>AR</term>
<def>
<p>androgen-receptor</p>
</def>
</def-item>
<def-item>
<term>ART</term>
<def>
<p>assisted reproduction technology</p>
</def>
</def-item>
<def-item>
<term>BMD</term>
<def>
<p>bone mineral density</p>
</def>
</def-item>
<def-item>
<term>BMP-2</term>
<def>
<p>bone morphogenetic protein 2</p>
</def>
</def-item>
<def-item>
<term>COPD</term>
<def>
<p>chronic obstructive pulmonary disease</p>
</def>
</def-item>
<def-item>
<term>COUP-TFII</term>
<def>
<p>chicken-ovalbumin-upstream-promoter-transcription-factor II</p>
</def>
</def-item>
<def-item>
<term>CNS</term>
<def>
<p>central nervous system</p>
</def>
</def-item>
<def-item>
<term>CRC</term>
<def>
<p>colorectal cancer</p>
</def>
</def-item>
<def-item>
<term>CX43</term>
<def>
<p>connexin 43</p>
</def>
</def-item>
<def-item>
<term>DS</term>
<def>
<p>digestive system</p>
</def>
</def-item>
<def-item>
<term>Ed</term>
<def>
<p>embryonic day</p>
</def>
</def-item>
<def-item>
<term>EC</term>
<def>
<p>endometrial cancer</p>
</def>
</def-item>
<def-item>
<term>EndRet</term>
<def>
<p>endoplasmic reticulum</p>
</def>
</def-item>
<def-item>
<term>ER</term>
<def>
<p>estrogen-receptor</p>
</def>
</def-item>
<def-item>
<term>Fdx</term>
<def>
<p>ferredoxin</p>
</def>
</def-item>
<def-item>
<term>FdR</term>
<def>
<p>ferredoxin reductase</p>
</def>
</def-item>
<def-item>
<term>GC-MS</term>
<def>
<p>gas-chromatography tandem mass-spectrometry</p>
</def>
</def-item>
<def-item>
<term>GnRH</term>
<def>
<p>gonadotropin releasing hormone</p>
</def>
</def-item>
<def-item>
<term>GH</term>
<def>
<p>growth hormone</p>
</def>
</def-item>
<def-item>
<term>GIT</term>
<def>
<p>gastrointestinal tract</p>
</def>
</def-item>
<def-item>
<term>GPER</term>
<def>
<p>G protein-coupled estrogen-receptor</p>
</def>
</def-item>
<def-item>
<term>HPLC</term>
<def>
<p>high performance liquid-chromatography</p>
</def>
</def-item>
<def-item>
<term>HRT</term>
<def>
<p>hormone-replacement-therapy</p>
</def>
</def-item>
<def-item>
<term>hCG</term>
<def>
<p>human chorionic gonadotropin</p>
</def>
</def-item>
<def-item>
<term>IGF1</term>
<def>
<p>insulin-like growth factor 1</p>
</def>
</def-item>
<def-item>
<term>IHC</term>
<def>
<p>immunohistochemistry</p>
</def>
</def-item>
<def-item>
<term>IL-1</term>
<def>
<p>interleukin-1</p>
</def>
</def-item>
<def-item>
<term>IL-6</term>
<def>
<p>interleukin-6</p>
</def>
</def-item>
<def-item>
<term>KO</term>
<def>
<p>knock-out</p>
</def>
</def-item>
<def-item>
<term>LC-MS</term>
<def>
<p>liquid-chromatography tandem mass-spectrometry</p>
</def>
</def-item>
<def-item>
<term>mTOR</term>
<def>
<p>mammalian target of rapamycin</p>
</def>
</def-item>
<def-item>
<term>NAPDH</term>
<def>
<p>nicotine-adenine-dinucleotide-phosphate</p>
</def>
</def-item>
<def-item>
<term>NSCLC</term>
<def>
<p>non-small cell lung cancer</p>
</def>
</def-item>
<def-item>
<term>PAIN</term>
<def>
<p>phenomena of pan-assay interfering compounds</p>
</def>
</def-item>
<def-item>
<term>PAP</term>
<def>
<p>bis-phospho-nucleotide-3′-phospho-adenosine-5′-phosphate</p>
</def>
</def-item>
<def-item>
<term>PCOC</term>
<def>
<p>poly cystic ovarian syndrome</p>
</def>
</def-item>
<def-item>
<term>POR</term>
<def>
<p>P450 oxidoreductase</p>
</def>
</def-item>
<def-item>
<term>RT-qPCR</term>
<def>
<p>reverse-transcriptase quantitative polymerase-chain-reaction</p>
</def>
</def-item>
<def-item>
<term>SF1</term>
<def>
<p>steroidogenic factor 1</p>
</def>
</def-item>
<def-item>
<term>SHBG</term>
<def>
<p>sex hormone binding globulin</p>
</def>
</def-item>
<def-item>
<term>SNP</term>
<def>
<p>single nucleotide polymorphism</p>
</def>
</def-item>
<def-item>
<term>SRD</term>
<def>
<p>short-chain dehydrogenase</p>
</def>
</def-item>
<def-item>
<term>Th</term>
<def>
<p>T-helper</p>
</def>
</def-item>
<def-item>
<term>TNF</term>
<def>
<p>tumor necrosis factor</p>
</def>
</def-item>
<def-item>
<term>VEGF</term>
<def>
<p>vascular endothelial growth factor</p>
</def>
</def-item>
<def-item>
<term>WB</term>
<def>
<p>western blot/blotting</p>
</def>
</def-item>
<def-item>
<term>WOI</term>
<def>
<p>window of implantation.</p>
</def>
</def-item>
</def-list>
</glossary>
</back>
</article>
</pmc-articleset>